<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06465590-20021015-C00001.CDX SYSTEM "US06465590-20021015-C00001.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00001.MOL SYSTEM "US06465590-20021015-C00001.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00001.TIF SYSTEM "US06465590-20021015-C00001.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00002.CDX SYSTEM "US06465590-20021015-C00002.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00002.MOL SYSTEM "US06465590-20021015-C00002.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00002.TIF SYSTEM "US06465590-20021015-C00002.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00003.CDX SYSTEM "US06465590-20021015-C00003.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00003.MOL SYSTEM "US06465590-20021015-C00003.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00003.TIF SYSTEM "US06465590-20021015-C00003.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00004.CDX SYSTEM "US06465590-20021015-C00004.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00004.MOL SYSTEM "US06465590-20021015-C00004.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00004.TIF SYSTEM "US06465590-20021015-C00004.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00005.CDX SYSTEM "US06465590-20021015-C00005.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00005.MOL SYSTEM "US06465590-20021015-C00005.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00005.TIF SYSTEM "US06465590-20021015-C00005.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00006.CDX SYSTEM "US06465590-20021015-C00006.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00006.MOL SYSTEM "US06465590-20021015-C00006.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00006.TIF SYSTEM "US06465590-20021015-C00006.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00007.CDX SYSTEM "US06465590-20021015-C00007.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00007.MOL SYSTEM "US06465590-20021015-C00007.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00007.TIF SYSTEM "US06465590-20021015-C00007.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00008.CDX SYSTEM "US06465590-20021015-C00008.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00008.MOL SYSTEM "US06465590-20021015-C00008.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00008.TIF SYSTEM "US06465590-20021015-C00008.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00009.CDX SYSTEM "US06465590-20021015-C00009.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00009.MOL SYSTEM "US06465590-20021015-C00009.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00009.TIF SYSTEM "US06465590-20021015-C00009.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00010.CDX SYSTEM "US06465590-20021015-C00010.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00010.MOL SYSTEM "US06465590-20021015-C00010.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00010.TIF SYSTEM "US06465590-20021015-C00010.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00011.CDX SYSTEM "US06465590-20021015-C00011.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00011.MOL SYSTEM "US06465590-20021015-C00011.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00011.TIF SYSTEM "US06465590-20021015-C00011.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00012.CDX SYSTEM "US06465590-20021015-C00012.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00012.MOL SYSTEM "US06465590-20021015-C00012.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00012.TIF SYSTEM "US06465590-20021015-C00012.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00013.CDX SYSTEM "US06465590-20021015-C00013.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00013.MOL SYSTEM "US06465590-20021015-C00013.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00013.TIF SYSTEM "US06465590-20021015-C00013.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00014.CDX SYSTEM "US06465590-20021015-C00014.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00014.MOL SYSTEM "US06465590-20021015-C00014.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00014.TIF SYSTEM "US06465590-20021015-C00014.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00015.CDX SYSTEM "US06465590-20021015-C00015.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00015.MOL SYSTEM "US06465590-20021015-C00015.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00015.TIF SYSTEM "US06465590-20021015-C00015.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00016.CDX SYSTEM "US06465590-20021015-C00016.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00016.MOL SYSTEM "US06465590-20021015-C00016.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00016.TIF SYSTEM "US06465590-20021015-C00016.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00017.CDX SYSTEM "US06465590-20021015-C00017.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00017.MOL SYSTEM "US06465590-20021015-C00017.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00017.TIF SYSTEM "US06465590-20021015-C00017.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00018.CDX SYSTEM "US06465590-20021015-C00018.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00018.MOL SYSTEM "US06465590-20021015-C00018.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00018.TIF SYSTEM "US06465590-20021015-C00018.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00019.CDX SYSTEM "US06465590-20021015-C00019.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00019.MOL SYSTEM "US06465590-20021015-C00019.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00019.TIF SYSTEM "US06465590-20021015-C00019.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00020.CDX SYSTEM "US06465590-20021015-C00020.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00020.MOL SYSTEM "US06465590-20021015-C00020.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00020.TIF SYSTEM "US06465590-20021015-C00020.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00021.CDX SYSTEM "US06465590-20021015-C00021.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00021.MOL SYSTEM "US06465590-20021015-C00021.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00021.TIF SYSTEM "US06465590-20021015-C00021.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00022.CDX SYSTEM "US06465590-20021015-C00022.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00022.MOL SYSTEM "US06465590-20021015-C00022.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00022.TIF SYSTEM "US06465590-20021015-C00022.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00023.CDX SYSTEM "US06465590-20021015-C00023.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00023.MOL SYSTEM "US06465590-20021015-C00023.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00023.TIF SYSTEM "US06465590-20021015-C00023.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00024.CDX SYSTEM "US06465590-20021015-C00024.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00024.MOL SYSTEM "US06465590-20021015-C00024.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00024.TIF SYSTEM "US06465590-20021015-C00024.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00025.CDX SYSTEM "US06465590-20021015-C00025.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00025.MOL SYSTEM "US06465590-20021015-C00025.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00025.TIF SYSTEM "US06465590-20021015-C00025.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00026.CDX SYSTEM "US06465590-20021015-C00026.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00026.MOL SYSTEM "US06465590-20021015-C00026.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00026.TIF SYSTEM "US06465590-20021015-C00026.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00027.CDX SYSTEM "US06465590-20021015-C00027.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00027.MOL SYSTEM "US06465590-20021015-C00027.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00027.TIF SYSTEM "US06465590-20021015-C00027.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00028.CDX SYSTEM "US06465590-20021015-C00028.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00028.MOL SYSTEM "US06465590-20021015-C00028.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00028.TIF SYSTEM "US06465590-20021015-C00028.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00029.CDX SYSTEM "US06465590-20021015-C00029.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00029.MOL SYSTEM "US06465590-20021015-C00029.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00029.TIF SYSTEM "US06465590-20021015-C00029.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00030.CDX SYSTEM "US06465590-20021015-C00030.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00030.MOL SYSTEM "US06465590-20021015-C00030.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00030.TIF SYSTEM "US06465590-20021015-C00030.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-C00031.CDX SYSTEM "US06465590-20021015-C00031.CDX" NDATA CDX>
<!ENTITY US06465590-20021015-C00031.MOL SYSTEM "US06465590-20021015-C00031.MOL" NDATA MOL>
<!ENTITY US06465590-20021015-C00031.TIF SYSTEM "US06465590-20021015-C00031.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-D00000.TIF SYSTEM "US06465590-20021015-D00000.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-D00001.TIF SYSTEM "US06465590-20021015-D00001.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-D00002.TIF SYSTEM "US06465590-20021015-D00002.TIF" NDATA TIF>
<!ENTITY US06465590-20021015-D00003.TIF SYSTEM "US06465590-20021015-D00003.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06465590</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021015</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09271348</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19990317</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C08F 1226</PDAT></B511>
<B512><PDAT>C08F 2068</PDAT></B512>
<B512><PDAT>C08F 2070</PDAT></B512>
<B512><PDAT>C08F  444</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>526264</PDAT></B521>
<B522><PDAT>526269</PDAT></B522>
<B522><PDAT>526270</PDAT></B522>
<B522><PDAT>526276</PDAT></B522>
<B522><PDAT>526333</PDAT></B522>
<B522><PDAT>526336</PDAT></B522>
<B522><PDAT>526339</PDAT></B522>
<B522><PDAT>526308</PDAT></B522>
<B522><PDAT>526319</PDAT></B522>
<B522><PDAT>526329</PDAT></B522>
<B522><PDAT>526171</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Telechelic alkadiene polymers with crosslinkable end groups and methods for making the same</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5312940</PDAT></DNUM>
<DATE><PDAT>19940500</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Grubbs et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556136</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5710298</PDAT></DNUM>
<DATE><PDAT>19980100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Grubbs et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556 22</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5728917</PDAT></DNUM>
<DATE><PDAT>19980300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Grubbs et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>585653</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5831108</PDAT></DNUM>
<DATE><PDAT>19981100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Grubbs et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>556 21</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B562><NCIT><STEXT><PDAT>Grubbs et al., Preparation of Hydroxytelechelic Poly(butadiene), Macromolecules 26 (1993) 872-874, 1993.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nubel. et al., Preparation of an ester-terminated telechelic polybutadiene by a two-step olefin metathesis process, Journal of Molecular Catalysis A, 115 (1997) 43-50, 1997.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Otton et al, Metathesis of Functionalized Olfeins, Journal of Molecular Catalysis, 8 (1980) 313-324, 1980.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Fukui, S. et al., &ldquo;Application of Photo-Crosslinkable Resin to Immobilization of an Enzyme,&rdquo; FEBS Letters, vol. 66, No. 2, Jul. 1976. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Van Caeter, P., et al., &ldquo;Telechelic Polymers: New Developments,&rdquo; Trip, vol. 3, No. 7, Jul. 1995, pp. 227-233. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nguyen, S.T., et al., &ldquo;Syntheses and Activities of New Single-Component, Rutheniym-Based Olefin Metathesis Catalysts,&rdquo; Journal of the American Chemical Society, 115, 1993, pp. 9858-9859. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Schwab, P., et al., &ldquo;A Series of Well-Defined Metathesis Catalysts- Synthesis of &lsqb;RuCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(&equals;CHR&prime;)(PR</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rsqb; and its Reactions,&rdquo; Communications, Angew. Chem. Int. Ed. Engl., 34, No. 18, 1995, pp. 2039-2041. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nubel, P.O., &ldquo;Preparation of an Ester-Terminated Telechelic Polybutadiene by a Two-Step Olefin Metathesis Process&rdquo;, Journal of Molecular Catalysis A: Chem. 115 (1997) 43-50. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kennedy, J.P., et al., &ldquo;New Telechelic Polymers and Sequential Copolymers by Polyfunctional Initiator-Transfer Agents (Inifers) 28. Glycidyl Ethers of Bisphenol- and Trisphenol-PIB and Their Curing to Epoxy Resins&rdquo;, Polymer Bulletin 8 (1982) 571-578. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kennedy, J.P., et al., &ldquo;New Telechelic Polymers and Sequential Copolymers by Polyfunctional Initiator-Transfer Agents (Inifers) 36. New Networks from &agr;, &ohgr;-Di(Methacryloyloxy)-Polysiobutylene&rdquo;, Polymer Bulletin 10 (1983) 146-151. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Marmo, J.C., et al., &ldquo;ADMET Depolymerization. Synthesis of Perfectly Difunctional (f&equals;2.0) Telechelic Polybutadiene Oligomers&rdquo;, Macromolecules 28 (1995) 2602-2606. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Chung, T.C., &ldquo;Synthesis of Functional Polymers via Borane Monomers and Metathesis Catalysts&rdquo;Journal of Molecular Catalysis, 76 (1992) 15-31. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Otton, J., &ldquo;Metathesis of Functionalised Olefins: Homogeneous Cross-Metathesis of Cycloolefin and Ethylenic Esters&rdquo; Journal of Molecular Catalysis. 8 (1980) 313-324. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Pinazzi, C.P., et al., &ldquo;Application of Metathesis Reactions too the Synthesis of &agr;,&ohgr; Functional Prepolymers&rdquo;, Journal of Molecular Catalysis, 8 (1980) 325-328. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Gu, Xue-Ping, et al., &ldquo;Synthesis of Glycol Diglycidyl Ethers Using Phase-Transfer Catalysis&rdquo;, Communications Jun./Jul. (1985) 649-651. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Reyx, D., et al., &ldquo;Application de la Reaction De Metathese a la Syntheses De Prepolymeres &agr;, &ohgr;-Bifonctionnels. Partie 3: Mise au Point des Conditions d&apos;Obtention de Composes Dieniques et Trieniques par Cometathese du Cyclopentene avec l&apos;Octene-4 et l&apos;Hexene-3 Dioate de Dimethyl&rdquo;, Journal of Molecular Catalysis, 42 (1987) 289-299. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cramail, H., et al., &ldquo;Functional Oligomers of Norbornene. Part 1, Oligomerization by Ring-Opening Metathesis Polymerization in the Presence of Unsaturated Diesters&rdquo;, Journal of Molecular Catalysis, 65 (1991) 193-203. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hummel, K., &ldquo;Polymer Degradation by Cross-Metathesis&rdquo;, Pur &amp; Appl. Chem., 54 2, (1982) 351-364. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Aoshima, S., &ldquo;Synthesis of Functionalized Linear Poly(divinylbenzene) with Hydroxyl Pendants and/or Endgroups&rdquo;, Journal of Polymer Science: Polymer Chemistry Edition, 22 (1984) 2443-2453. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Webster, O.W., &ldquo;Living Polymerization Methods&rdquo;, Science, 251 (1991) 887-893. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kennedy, J.P., &ldquo;New Telechelic Polymers and Sequential Copolymers by Polyfunctional Initiator-Transfer Agents (Inifers) XVIII. Epoxy and Aldehyde Telechelic Polyisobutylenes&rdquo;, Journal of Polymer Scuence: Polymer Chemistry Edition, 20 (1982) 2809-2817. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Chung, T.C., et al., &ldquo;A New Synthetic Route to Telechelic Polymers&rdquo;, Macromolecules 24 (1991) 3718-3720. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Chung, T.C. et al., &ldquo;Synthesis of Telechelic 1,4-Polybutadiene by Metathesis Reactions and Borane Monomers&rdquo;, Macromolecules 25 91992) 5137-5144. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Marmo, J.C., et al., Acyclic Diene Metathesis (ADMET) Depolymerization. Synthesis of Mass Extract Telechelic Polybutadiene Oligomers. Macromolecules 26 91993) 2137-2138. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Chasmawala, M., et al., &ldquo;Telechelic Polyisobutylene: A Facile Synthesis via the Cross Metathesis Reaction and Trialkylborane-Containing Olefins&rdquo;, Macromolecules 28 (1995) 1333-1339. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Maughon, B. R., &ldquo;Ruthenium Alkylidene Initiated Living Ring-Opening Metathesis Polymerization (ROMP) of 3-Substituted Cyclobutenes&rdquo; Macromolecules 30 (1997) 3459-3469. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hillmyer, M.A., et al., Ring-Opening Metathesis Polymerization of Functionalized Cyclooctenes by a Ruthenium-Based Metathesis Catalyst. Macromolecules 28 (1995) 6311-6316. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Grubbs, R.H., et al., &ldquo;Ring-Closing Metathesis and Related Processed in Organic Synthesis&rdquo; Acc. Chem. Res. 28 (1995) 446-452. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Fu, G.C., et al., &ldquo;Catalytic Ring-Closing Metathesis of Functionalized Dienes by a Ruthenium Carbene Complex&rdquo;, J. Am. Chem., 115 (1993) 9856-9857. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Maughon, B.R., &ldquo;Synthesis and Controlled Cross-Linking of Polymers Derived from Ring-Opening Metathesis Polymerization (ROMP)&rdquo; Macromolecules 29 (1996) 5766-5769. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Schwab, P., et al., &ldquo;Synthesis and Applications of RuCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(&equals;CHR&prime;)(PR</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>: The Influence of the Alkylidene Moiety on Metathesis Activity&rdquo; Journal of the American Chemical Society 118, (1996) 100-110. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Scwab, P., et al., &ldquo;Eine Reihe Definierter Metathesekatalysatoren&mdash;Synthese von und Reaktionen mit RuCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(&equals;CHR&prime;)(PR</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rdquo;, Angew. Chem. 107 (1995) 2179-2181. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nguyen, S.T., et al., &ldquo;Syntheses and Activities of New-Single-Component Ruthenium-Based Olefin Metathesis Catalyst&rdquo; Journal of the American Chemical Society 115(1993) 9858-9859. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hillmyer, M.A., et al., &ldquo;Utility of a Ruthenium Metathesis Catalyst for the Preparation of End-Functionionalized Polybutadiene&rdquo; Macromolecules 30(1997) 7&prime;8-721. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Fraser, C.A., et al., &ldquo;Degradable Cyclooctadiene/Acetal Copolymers: Versatile Precursors to 1,4-Hydroxytelechelic Polybutadiene and Hydroxytelechelic Polyethylene&rdquo;, Macromolecules 28 (1995) 7256-7261. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hillmyer. M.A., et al., &ldquo;Chain Transfer in the Ring-Opening Metathesis Polymerization of Cyclooctadiene Using Discrete Metal Alkylidenes&rdquo;, Macromolecules 28 (1995) 8662-8667. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hillmyer. M.A., et al., &ldquo;Preparation of Hydroxytelechelic Poly(butadiene) via Ring-Opening Metathesis Polymerization Employing a Well-Defined Metathesis Catalyst&rdquo;, Macromolecules 26 91993) 872-874.</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>4</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>526336</PDAT></B582>
<B582><PDAT>526337</PDAT></B582>
<B582><PDAT>526339</PDAT></B582>
<B582><PDAT>526333</PDAT></B582>
<B582><PDAT>526321</PDAT></B582>
<B582><PDAT>526308</PDAT></B582>
<B582><PDAT>526171</PDAT></B582>
<B582><PDAT>526264</PDAT></B582>
<B582><PDAT>526269</PDAT></B582>
<B582><PDAT>526270</PDAT></B582>
<B582><PDAT>526276</PDAT></B582>
<B582><PDAT>526319</PDAT></B582>
</B580>
<B590><B595><PDAT>3</PDAT></B595><B596><PDAT>3</PDAT></B596><B597US/>
</B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/079949</PDAT></DNUM><DATE><PDAT>19980330</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Bob R.</PDAT></FNM><SNM><STEXT><PDAT>Maughon</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Midland</PDAT></CITY>
<STATE><PDAT>MI</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Takeharu</PDAT></FNM><SNM><STEXT><PDAT>Morita</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Osaka</PDAT></CITY>
<CTRY><PDAT>JP</PDAT></CTRY>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Robert H.</PDAT></FNM><SNM><STEXT><PDAT>Grubbs</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>South Pasadena</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>California Institute of Technology</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Pasadena</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Pillsbury Winthrop LLP</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>David W.</PDAT></FNM><SNM><STEXT><PDAT>Wu</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>R.</PDAT></FNM><SNM><STEXT><PDAT>Harlan</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>1713</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention relates to telechelic polymers having crosslinkable end groups of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00001">
<CHEMCDX ID="CHEMCDX-00001" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00001.CDX"/>
<CHEMMOL ID="CHEMMOL-00001" ALT="chemistry mol file" FILE="US06465590-20021015-C00001.MOL"/>
<EMI ID="EMI-C00001" ALT="embedded image" HE="17.03835" WI="85.70205" FILE="US06465590-20021015-C00001.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00002" LVL="7"><PTEXT><PDAT>and methods for preparing the same wherein n is an integer; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00002">
<CHEMCDX ID="CHEMCDX-00002" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00002.CDX"/>
<CHEMMOL ID="CHEMMOL-00002" ALT="chemistry mol file" FILE="US06465590-20021015-C00002.MOL"/>
<EMI ID="EMI-C00002" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00002.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00003" LVL="7"><PTEXT><PDAT>is an alkadienyl group; Y is an alkyl group; and Z is crosslinkable end group. In general, the inventive synthesis involves reacting a functionalized chain transfer agent having crosslinkable ends with a cycloalkene in the presence of a ruthenium or osmium catalyst of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00003">
<CHEMCDX ID="CHEMCDX-00003" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00003.CDX"/>
<CHEMMOL ID="CHEMMOL-00003" ALT="chemistry mol file" FILE="US06465590-20021015-C00003.MOL"/>
<EMI ID="EMI-C00003" ALT="embedded image" HE="38.41425" WI="50.4063" FILE="US06465590-20021015-C00003.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00004" LVL="7"><PTEXT><PDAT>wherein:</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="2"><PTEXT><PDAT>M is ruthenium or osmium;</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="2"><PTEXT><PDAT>X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are independently any anionic ligand;</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="2"><PTEXT><PDAT>L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are any neutral electron donor ligand;</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="7"><PTEXT><PDAT>R and R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each hydrogen or a substituted or unsubstituted substituent wherein the substituent is selected from the group consisting of C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkynyl, aryl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>carboxylate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyloxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkynyloxy, aryloxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxycarbonyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylthio, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfonyl and C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfinyl. In another aspect of the invention, methods for controlling the molecular weight of the resulting telechelic polymer are also presented.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>This application claims the benefit of and incorporates by reference herein U.S. Provisional Application No. 60/079,949 filed Mar. 30, 1998 entitled TELECHELIC ALKADIENE POLYMERS WITH CROSS-LINKABLE END GROUPS AND METHODS FOR MAKING THE SAME by inventors Bob Robinson Maughon, Takeharu Morita; and Robert H. Grubbs.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>The U.S. Government has certain rights in this invention pursuant to Grant No. CHE-9509745 awarded by the National Science Foundation.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>The present invention relates to telechelic polymers and methods for making the same. More particularly, the present invention relates to telechelic polymer segments of controlled molecular weight having crosslinkable end groups and methods for preparing the same.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>Telechelic polymers can be simply defined as polymers that bear reactive functional groups at their chain termini. The interest in these polymeric materials is derived from the fact that through these reactive end groups, a vast number of macromolecular materials can be prepared. Telechelic polymers have found application in the synthesis of block copolymers, star polymers, cross-linked polymer networks, and ionic polymer networks. Low molecular weight liquid telechelic polymers have been successfully used in reaction injection molding, and the formation of ABA triblock and multiblock copolymers via telechelic polymers has dramatically impacted the development of thermoplastic elastomers. Based on these numerous valuable applications, considerable research efforts have been devoted to improving the synthesis of telechelic polymers.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>The development of telechelic polymers with crosslinkable end groups such as methacrylate or epoxide groups is of interest for the preparation of interpenetrating polymer networks, AB cross-linked polymeric materials, more thermally and chemically resistant materials, and for the immobilization of biomaterials. However, these reactive end groups have been typically incorporated through a post-polymerization transformation due to the instability of these functional groups to tolerate many of the typical conditions associated with polymerization reactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>Recently, a non-metathesis-mediated polymer degradation approach was applied to polymers derived from ROMP. Copolymerization of cyclooctadiene (&ldquo;COD&rdquo;) with either cis-4,7-dihydro-1,3-dioxepan (1) or cis-4,7-dihydro-2-phenyl-1,3-dioxepan (2) using well-defined ruthenium-based metathesis initiators, (PCy</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Ru&boxH;CHR&prime; (wherein R&prime;&equals;Ph (3)or wherein R&prime;&equals;(CH&boxH;CPh</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)(4)), resulted in a polymer bearing both poly(butadiene) and acetal units along the backbone. Subsequent acid hydrolysis of these acetal units resulted in the desired hydroxytelechelic poly(butadiene) (&ldquo;HTPBD&rdquo;) oligomers in moderate yields. Although this method proved to be successful for the synthesis of HTPBD, this method is not generally applicable for the preparation of telechelic polymers with other functional end groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>As a result, a need exists for methods for synthesizing telechelic polymers having a variety of end groups, particularly crosslinkable end groups and which does not require post-polymerization transformations for polymer functionalization.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>The present invention relates to telechelic polymers having crosslinkable end groups of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00004">
<CHEMCDX ID="CHEMCDX-00004" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00004.CDX"/>
<CHEMMOL ID="CHEMMOL-00004" ALT="chemistry mol file" FILE="US06465590-20021015-C00004.MOL"/>
<EMI ID="EMI-C00004" ALT="embedded image" HE="17.03835" WI="85.70205" FILE="US06465590-20021015-C00004.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00017" LVL="7"><PTEXT><PDAT>and methods for preparing the same wherein n is an integer </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00005">
<CHEMCDX ID="CHEMCDX-00005" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00005.CDX"/>
<CHEMMOL ID="CHEMMOL-00005" ALT="chemistry mol file" FILE="US06465590-20021015-C00005.MOL"/>
<EMI ID="EMI-C00005" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00005.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00018" LVL="7"><PTEXT><PDAT>is an alkadienyl group; Y is an alkyl group; and Z is crosslinkable end group. In general , the inventive synthesis involves reacting a chain transfer agent having crosslinkable end groups with a cycloalkene in the presence of a ruthenium or osmium initiator of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00006">
<CHEMCDX ID="CHEMCDX-00006" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00006.CDX"/>
<CHEMMOL ID="CHEMMOL-00006" ALT="chemistry mol file" FILE="US06465590-20021015-C00006.MOL"/>
<EMI ID="EMI-C00006" ALT="embedded image" HE="38.41425" WI="50.4063" FILE="US06465590-20021015-C00006.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00019" LVL="7"><PTEXT><PDAT>wherein:</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="2"><PTEXT><PDAT>M is ruthenium or osmium;</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="2"><PTEXT><PDAT>X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are independently any anionic ligand;</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="2"><PTEXT><PDAT>L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are any neutral electron donor ligand;</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="7"><PTEXT><PDAT>R and R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each hydrogen or a substituted or unsubstituted substituent wherein the substituent is selected from the group consisting of C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkynyl, aryl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>carboxylate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyloxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkynyloxy, aryloxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxycarbonyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylthio, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfonyl and C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfinyl.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>In particularly preferred embodiments, the initiator is as described above wherein R is hydrogen, R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is phenyl or (&mdash;CH&boxH;CPh</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>), X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are both chloride, and L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>ligands are &mdash;P(cyclohexyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>; the cycloalkene is cyclooctadiene; and the chain transfer agent is cis-2-butene-1,4-diol dimethacrylate or cis-2-butene-1,4-diol diglycidyl ether.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE FIGURES</PDAT></STEXT></H>
<PARA ID="P-00025" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> is an illustrative reaction scheme for the synthesis of a telechelic polymer with methacrylate end groups.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is graphic representation of the dependence of the observed {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>values for the bis(methacrylate)-functionalized telechelic poly(butadiene)s 9 on the &lsqb;COD&rsqb;/&lsqb;CTA&rsqb; ratio. The {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>was determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration assuming a number average functionality of 2.0.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is a graphic representation of the dependence of the observed {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>values for the bis(epoxide)-functionalized telechelic poly(butadiene)s 10 on the &lsqb;COD&rsqb;/&lsqb;CTA&rsqb; ratio. The {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>was determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration assuming a number average functionality of 2.0.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DESCRIPTION OF THE PREFERRED EMBODIMENTS</PDAT></STEXT></H>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>The present invention relates to novel organic polymers with crosslinkable end groups and to a simplified and direct procedure for the synthesis of these polymers. These crosslinkable end groups may be subsequently reacted to form a network of crosslinked polymers.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>The present invention relates to unbranched or linear telechelic polymers of the general formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00007">
<CHEMCDX ID="CHEMCDX-00007" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00007.CDX"/>
<CHEMMOL ID="CHEMMOL-00007" ALT="chemistry mol file" FILE="US06465590-20021015-C00007.MOL"/>
<EMI ID="EMI-C00007" ALT="embedded image" HE="17.03835" WI="85.70205" FILE="US06465590-20021015-C00007.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00030" LVL="7"><PTEXT><PDAT>wherein:</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="2"><PTEXT><PDAT>n is an integer; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00008">
<CHEMCDX ID="CHEMCDX-00008" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00008.CDX"/>
<CHEMMOL ID="CHEMMOL-00008" ALT="chemistry mol file" FILE="US06465590-20021015-C00008.MOL"/>
<EMI ID="EMI-C00008" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00008.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00032" LVL="2"><PTEXT><PDAT>&emsp;is a alkadienyl group;</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="2"><PTEXT><PDAT>Y is an alkyl group; and,</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="2"><PTEXT><PDAT>Z is a crosslinkable end group.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>As used herein, an alkadienyl group is a hydrocarbon having at least two carbon&mdash;carbon double bonds. In preferred embodiments, </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00009">
<CHEMCDX ID="CHEMCDX-00009" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00009.CDX"/>
<CHEMMOL ID="CHEMMOL-00009" ALT="chemistry mol file" FILE="US06465590-20021015-C00009.MOL"/>
<EMI ID="EMI-C00009" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00009.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00036" LVL="7"><PTEXT><PDAT>is a C</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkadienyl group; Y is a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl and Z is selected from the group consisting of methacrylate, acylate, cinnamate, epoxide, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes. In more preferred embodiments, Y is a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>alkyl and Z is methacrylate or epoxide.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>In another aspect of the present invention, telechelic polymers of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00010">
<CHEMCDX ID="CHEMCDX-00010" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00010.CDX"/>
<CHEMMOL ID="CHEMMOL-00010" ALT="chemistry mol file" FILE="US06465590-20021015-C00010.MOL"/>
<EMI ID="EMI-C00010" ALT="embedded image" HE="17.2935" WI="109.2042" FILE="US06465590-20021015-C00010.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00038" LVL="7"><PTEXT><PDAT>are disclosed wherein:</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="2"><PTEXT><PDAT>n is an integer; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00011">
<CHEMCDX ID="CHEMCDX-00011" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00011.CDX"/>
<CHEMMOL ID="CHEMMOL-00011" ALT="chemistry mol file" FILE="US06465590-20021015-C00011.MOL"/>
<EMI ID="EMI-C00011" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00011.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00040" LVL="2"><PTEXT><PDAT>&emsp;is an alkadienyl group; and,</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="2"><PTEXT><PDAT>Z is a crosslinkable end group.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>In preferred embodiments, </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00012">
<CHEMCDX ID="CHEMCDX-00012" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00012.CDX"/>
<CHEMMOL ID="CHEMMOL-00012" ALT="chemistry mol file" FILE="US06465590-20021015-C00012.MOL"/>
<EMI ID="EMI-C00012" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00012.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00043" LVL="7"><PTEXT><PDAT>is a C</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkadienyl group and Z is selected from the group consisting of methacrylate, acylate, cinnamate, epoxide, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes. In more preferred embodiments, Z is methacrylate or epoxide.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>In yet another aspect of the present invention, telechelic polymers of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00013">
<CHEMCDX ID="CHEMCDX-00013" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00013.CDX"/>
<CHEMMOL ID="CHEMMOL-00013" ALT="chemistry mol file" FILE="US06465590-20021015-C00013.MOL"/>
<EMI ID="EMI-C00013" ALT="embedded image" HE="15.5925" WI="185.77755" FILE="US06465590-20021015-C00013.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00045" LVL="7"><PTEXT><PDAT>wherein n is an integer and Z is a crosslinkable end group. In preferred embodiments, Z is selected from the group consisting of methacrylate, acylate, cinnamate, epoxide, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes. In more preferred embodiments, Z is methacrylate or epoxide.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>In another embodiment of the present inventions, methods for synthesizing the above disclosed telechelic polymers are disclosed.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="7"><PTEXT><PDAT>Initiators</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>In general, initiators (or catalysts) that may be used in the practice of the present invention are ruthenium or osmium carbene complexes that include a ruthenium or osmium metal center that is in a &plus;2 oxidation state, have an electron count of 16, and are penta-coordinated. More specifically, the initiators are of the formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00014">
<CHEMCDX ID="CHEMCDX-00014" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00014.CDX"/>
<CHEMMOL ID="CHEMMOL-00014" ALT="chemistry mol file" FILE="US06465590-20021015-C00014.MOL"/>
<EMI ID="EMI-C00014" ALT="embedded image" HE="38.41425" WI="50.4063" FILE="US06465590-20021015-C00014.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00049" LVL="7"><PTEXT><PDAT>wherein:</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="2"><PTEXT><PDAT>M is ruthenium or osmium;</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="2"><PTEXT><PDAT>X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are independently any anionic ligand;</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="2"><PTEXT><PDAT>L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are any neutral electron donor ligand;</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="7"><PTEXT><PDAT>R and R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each hydrogen or one of the following substituent groups: C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkynyl, aryl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>carboxylate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyloxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkynyloxy, aryloxy, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxycarbonyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylthio, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfonyl and C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfinyl. Optionally, the substituent group may be substituted with one or more groups selected from C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkoxy, and aryl. When the substitute aryl group is phenyl, it may be further substituted with one or more groups selected from a halogen, a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkyl, or a C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkoxy. Moreover, the initiator may further include one or more functional groups. Examples of suitable functional groups include but are not limited to: hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, and halogen.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>These ruthenium and osmium carbene complexes have been described in U.S. Pat. Nos. 5,312,940, 5,342,909, 5,710,298, and 5,831,108 and PCT Publication No. WO 98/21214, all of which are incorporated herein by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>In preferred embodiments of these catalysts, the R substituent is hydrogen and the R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>substituent is selected from the group consisting C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkenyl, and aryl. In even more preferred embodiments, the R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>substituent is phenyl or vinyl, optionally substituted with one or more moieties selected from the group consisting of C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkoxy, phenyl, and a functional group. In especially preferred embodiments, R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is phenyl or vinyl substituted with one or more moieties selected from the group consisting of chloride, bromide, iodide, fluoride, &mdash;NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, &mdash;NMe</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, methyl, methoxy and phenyl. In the most preferred embodiments, the R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>substituent is phenyl.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>In preferred embodiments of these catalysts, L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each independently selected from the group consisting of phosphine, sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide, imine, sulfoxide, carboxyl, nitrosyl, pyridine, and thioether. In more preferred embodiments, L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each a phosphine of the formula PR</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>R</PDAT><HIL><SP><PDAT>4</PDAT></SP></HIL><PDAT>R</PDAT><HIL><SP><PDAT>5</PDAT></SP></HIL><PDAT>, where R</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>, R</PDAT><HIL><SP><PDAT>4</PDAT></SP></HIL><PDAT>, and R</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>are each independently aryl or C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, particularly primary alkyl, secondary alkyl or cycloalkyl . In the most preferred embodiments, L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>ligands are each selected from the group consisting of &mdash;P(cyclohexyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;P(cyclopentyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;P(isopropyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, and &mdash;P(phenyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>In preferred embodiments of these catalysts, X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each independently hydrogen, halide, or one of the following groups: C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyl, aryl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkoxide, aryloxide, C</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyldiketonate, aryldiketonate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>carboxylate, arylsulfonate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfonate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylthio, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfonyl, or C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkylsulfinyl. Optionally, X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>may be substituted with one or more moieties selected from the group consisting of C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkoxy, and aryl which in turn may each be further substituted with one or more groups selected from halogen, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkoxy, and phenyl. In more preferred embodiments, X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are halide, benzoate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>carboxylate, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkyl, phenoxy, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkoxy, C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkylthio, aryl, and C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>alkyl sulfonate. In even more preferred embodiments, X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each halide, CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CFH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CO, (CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)CO, (CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate. In the most preferred embodiments, X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are each chloride.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>The most preferred initiators in the practice of the present invention are as described above wherein M is ruthenium; X and X</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>are both chloride; L and L</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>ligands are both &mdash;P(cyclohexyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>; R is hydrogen; and R</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>is either phenyl (3), (&mdash;CH&boxH;CPh</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) (4), or (CH&boxH;C(CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>The above initiators are stable in the presence of a variety of functional groups including hydroxyl, thiol, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, and halogen. Therefore, the starting materials and products of the reactions described below may contain one or more of these functional groups without poisoning the catalyst. In addition, the initiators are stable in the presence of aqueous, organic, or protic solvents, including aromatic hydrocarbons, chlorinated hydrocarbons, ethers, aliphatic hydrocarbons, alcohols, water, or mixtures of the above.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>Using an initiator described above, practice of one embodiment of the inventive method may be summarized as follows: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00015">
<CHEMCDX ID="CHEMCDX-00015" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00015.CDX"/>
<CHEMMOL ID="CHEMMOL-00015" ALT="chemistry mol file" FILE="US06465590-20021015-C00015.MOL"/>
<EMI ID="EMI-C00015" ALT="embedded image" HE="33.59475" WI="214.0992" FILE="US06465590-20021015-C00015.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00061" LVL="7"><PTEXT><PDAT>wherein:</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="2"><PTEXT><PDAT>n is an integer; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00016">
<CHEMCDX ID="CHEMCDX-00016" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00016.CDX"/>
<CHEMMOL ID="CHEMMOL-00016" ALT="chemistry mol file" FILE="US06465590-20021015-C00016.MOL"/>
<EMI ID="EMI-C00016" ALT="embedded image" HE="13.69305" WI="19.93005" FILE="US06465590-20021015-C00016.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00063" LVL="7"><PTEXT><PDAT>is a cycloalkene;</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="2"><PTEXT><PDAT>Z&mdash;Y&boxH;Y&mdash;Z is a chain transfer agent wherein Z is a crosslinkable end group and &mdash;Y&boxH;Y&mdash; is an alkenyl group; and, </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00017">
<CHEMCDX ID="CHEMCDX-00017" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00017.CDX"/>
<CHEMMOL ID="CHEMMOL-00017" ALT="chemistry mol file" FILE="US06465590-20021015-C00017.MOL"/>
<EMI ID="EMI-C00017" ALT="embedded image" HE="17.03835" WI="85.70205" FILE="US06465590-20021015-C00017.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00065" LVL="7"><PTEXT><PDAT>is the resulting telechelic polymer.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>Any cycloalkene (also referred to as cyclic olefin) that can participate in a ring- opening metathesis polymerization (&ldquo;ROMP&rdquo;) reaction may be used. Because of the generally high metathesis activity of the initiators of the present invention, the cycloalkene may be strained or unstrained. In addition, the cycloalkene may include one or more substituent groups selected from the group consisting of C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkenyl, C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkynyl, and aryl and one or more functional groups selected from the group consisting of hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, and halogen.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>Illustrative examples of suitable cycloalkenes include but are not limited to: norbornene, norbornadiene, cyclopentene, dicyclopentadiene, cyclo-octene, 7-oxanorbornene, 7-oxanorbornadiene, cyclodocene, 1,3-cyclooctadiene, 1,5-cyclooctadiene, 1,3-cycloheptadiene, and derivatives thereof. In preferred embodiments, the cycloalkene is a cycloalkadiene. In more preferred embodiments, the cycloalkene is selected from the group consisting of norbornadiene, dicyclopentadiene, 1,3-cyclo-octadiene, 1,5-cyclo-octadiene, 1,3-cycloheptadiene, and derivatives thereof. The use of 1,3-cyclooctadiene or 1,5-cyclo-octadiene as the cycloalkene is most preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>The chain transfer agent (&ldquo;CTA&rdquo;) is of the general formula, Z&mdash;Y&boxH;Y&mdash;Z, wherein &mdash;Y&boxH;Y&mdash; is an alkenyl group and Z is a crosslinkable end group. As used herein, a crosslinkable end group is group that is capable of forming a covalent bond either by reacting directly with another crosslinkable end group or by reacting indirectly through a crosslinking agent with another crosslinkable end group.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>In preferred embodiments, &mdash;Y&boxH;Y&mdash; is a C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkene and Z is selected from a group consisting of methacrylate, acylate, cinnamate, epoxide, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes. In more preferred embodiments, &mdash;Y&boxH;Y&mdash; is a C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>alkenyl and Z is methacrylate or epoxide. In the most preferred embodiments, the chain transfer agent is cis-2-butene- 1,4-diol dimethacrylate (5) or cis-2-butene- 1,4-diol diglycidyl ether (6).</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>In another embodiment, the inventive method may be summarized as follows: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00018">
<CHEMCDX ID="CHEMCDX-00018" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00018.CDX"/>
<CHEMMOL ID="CHEMMOL-00018" ALT="chemistry mol file" FILE="US06465590-20021015-C00018.MOL"/>
<EMI ID="EMI-C00018" ALT="embedded image" HE="34.33185" WI="214.35435" FILE="US06465590-20021015-C00018.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00071" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="2"><PTEXT><PDAT>n is an integer; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00019">
<CHEMCDX ID="CHEMCDX-00019" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00019.CDX"/>
<CHEMMOL ID="CHEMMOL-00019" ALT="chemistry mol file" FILE="US06465590-20021015-C00019.MOL"/>
<EMI ID="EMI-C00019" ALT="embedded image" HE="13.69305" WI="19.93005" FILE="US06465590-20021015-C00019.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00073" LVL="2"><PTEXT><PDAT>&emsp;is a cycloalkene; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00020">
<CHEMCDX ID="CHEMCDX-00020" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00020.CDX"/>
<CHEMMOL ID="CHEMMOL-00020" ALT="chemistry mol file" FILE="US06465590-20021015-C00020.MOL"/>
<EMI ID="EMI-C00020" ALT="embedded image" HE="14.175" WI="77.0553" FILE="US06465590-20021015-C00020.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00074" LVL="2"><PTEXT><PDAT>&emsp;is a chain transfer agent wherein Z is a crosslinkable end group; and, </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00021">
<CHEMCDX ID="CHEMCDX-00021" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00021.CDX"/>
<CHEMMOL ID="CHEMMOL-00021" ALT="chemistry mol file" FILE="US06465590-20021015-C00021.MOL"/>
<EMI ID="EMI-C00021" ALT="embedded image" HE="17.2935" WI="109.2042" FILE="US06465590-20021015-C00021.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00075" LVL="2"><PTEXT><PDAT>&emsp;is the resulting telechelic polymer.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>In preferred embodiments, the cycloalkene is selected from a group consisting of norbornene, norbornadiene, cyclopentene, dicyclopentadiene, cyclo-octene, 7-oxanorbornene, 7-oxanorbornadiene, cyclodocene, 1,3-cyclooctadiene, 1,5-cyclooctadiene, 1,3-cycloheptadiene, and derivatives thereof, and Z is selected from the group consisting of methacrylate, acylate, cinnamate, epoxides, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>In more preferred embodiments, the cycloalkene is a cycloalkadiene. In especially preferred embodiments, the cycloalkene is selected from the group consisting of norbornadiene, dicyclopentadiene, 1,3-cyclo-octadiene, 1,5-cyclo-octadiene, 1,3-cycloheptadiene, and derivatives thereof, and Z is methacrylate or epoxide. The use of 1,3-cyclooctadiene or 1,5-cyclo-octadiene as the cycloalkene, and cis-2-butene-1,4-diol dimethacrylate (5) or cis-2-butene-1,4-diol diglycidyl ether (6) as the chain transfer agent is most preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>In another embodiment, the inventive method may be described as follows: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00022">
<CHEMCDX ID="CHEMCDX-00022" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00022.CDX"/>
<CHEMMOL ID="CHEMMOL-00022" ALT="chemistry mol file" FILE="US06465590-20021015-C00022.MOL"/>
<EMI ID="EMI-C00022" ALT="embedded image" HE="59.7618" WI="214.35435" FILE="US06465590-20021015-C00022.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00079" LVL="7"><PTEXT><PDAT>wherein n is an integer and Z is a crosslinkable end.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>In preferred embodiments, Z is selected from the group consisting of methacrylate, acylate, cinnamate, epoxides, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes. In the most preferred embodiments, Z is either </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00023">
<CHEMCDX ID="CHEMCDX-00023" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00023.CDX"/>
<CHEMMOL ID="CHEMMOL-00023" ALT="chemistry mol file" FILE="US06465590-20021015-C00023.MOL"/>
<EMI ID="EMI-C00023" ALT="embedded image" HE="45.1332" WI="157.2291" FILE="US06465590-20021015-C00023.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>In addition to the ease of synthesis, the practice of the molecular weight of the telechelic polymer product may be readily controlled by modulating the ratio of the cycloalkene concentration to the chain transfer agent concentration. In a surprising and unexpected finding, the molecular weight of the resulting polymer is directly proportional to the molecular weight of the resulting telechelic polymer. As a result, by modulating the starting materials in the form of a &lsqb;cycloalkene&rsqb;/&lsqb;chain transfer agent&rsqb; ratio, the telechelic polymers having the desired molecular weight may be synthesized.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>For the purposes of clarity, the specific details of the present invention will be illustrated with reference to especially preferred embodiments wherein the initiator is 3 or 4, the cycloalkene is cyclooctadiene, and the chain transfer agent is cis-2-butene-1,4-diol dimethacrylate (5) or cis-2-butene-1,4-diol diglycidyl ether (6). However, it should be appreciated that these embodiments and the appended experimental protocols are for purposes of illustration only and are not intended to limit the scope of the present invention.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Synthesis of the cis-2-Butene-1,4-diol Dimethacrylate</PDAT></STEXT></H>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>Synthesis of the bis(methacrylate)-functionalized chain transfer agent, cis-2-butene-1,4-diol dimethacrylate (5), was accomplished as shown in Scheme 1. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00024">
<CHEMCDX ID="CHEMCDX-00024" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00024.CDX"/>
<CHEMMOL ID="CHEMMOL-00024" ALT="chemistry mol file" FILE="US06465590-20021015-C00024.MOL"/>
<EMI ID="EMI-C00024" ALT="embedded image" HE="118.58805" WI="214.35435" FILE="US06465590-20021015-C00024.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>Commercially available cis-2-butene-1,4-diol was esterified using methacryloyl chloride to synthesize compound 5 in 72% yield. Because compound 5 was not generally stable, it was stored at &minus;30&deg; C. with 20 weight percent of p-methoxyphenol (a free radical inhibitor). In this manner, compound 5 was stored for over six months without any appreciable degradation or polymerization. Because of the general tolerance of initiators 3 and 4, compound 5 could be used without removing p-methoxyphenol prior to its used in polymerization reactions.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Synthesis of the cis-2-Butene- 1 ,4-diol Diglycidyl Ether</PDAT></STEXT></H>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>The synthesis of the bis(epoxide)-functionalized chain transfer agent, cis-2-butene-1,4-diol diglycidyl ether (6), was accomplished in one step as illustrated in Scheme 2. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00025">
<CHEMCDX ID="CHEMCDX-00025" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00025.CDX"/>
<CHEMMOL ID="CHEMMOL-00025" ALT="chemistry mol file" FILE="US06465590-20021015-C00025.MOL"/>
<EMI ID="EMI-C00025" ALT="embedded image" HE="103.9311" WI="214.58115" FILE="US06465590-20021015-C00025.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>Cis-2-butene- 1,4-diol was treated with excess epichlorohydrin in the presence of aqueous NaOH (50% w/w) and the phase transfer catalyst, Bu</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>HSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, to resulted in chain transfer agent 6 in 65% yield. Because compound 6 was extremely stable, it was purified by distillation at 105-110&deg; C. in vacuo. Samples of compound 6 stored at room temperature for over six months, exhibited virtually no decomposition or polymerization.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Reaction of CTAs 5 and 6 with the Ruthenium Benzylidene Initiator 3</PDAT></STEXT></H>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>As shown by </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, the generation of an end group functionalized ruthenium alkylidene species is a key step in the practice of the present invention. However, it was initially unclear whether a ROMP-type protocol using a chain transfer agent, Z&mdash;Y&boxH;Y&mdash;Z, would be a viable synthetic strategy. Previous mechanistic studies indicated that ruthenium-based metathesis initiators including 3 and 4 were susceptible to a side reaction where the functional end group (e.g. from a chain transfer agent) would chelate to the metal center with a concomitant loss of a L ligand (typically a phosphine). The resulting chelated species were less reactive and often decomposed on the time scale of a typical polymerization reaction. Consequently, whether reactions of ruthenium benzylidene 3 with both 5 and 6 would proceed according to Scheme 4 were investigated. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00026">
<CHEMCDX ID="CHEMCDX-00026" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00026.CDX"/>
<CHEMMOL ID="CHEMMOL-00026" ALT="chemistry mol file" FILE="US06465590-20021015-C00026.MOL"/>
<EMI ID="EMI-C00026" ALT="embedded image" HE="266.91525" WI="214.35435" FILE="US06465590-20021015-C00026.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>Unexpectedly, treatment of 3 with 50 equivalents of the bis(methacrylate)-functionalized CTA 5 at 45&deg; C. for 30 min resulted in the formation of a methacrylate-functionalized ruthenium alkylidene 7 as outlined by Scheme 4. Alkylidene 7 exhibited an &agr;-H carbene resonance at 19.48 ppm (t, J</PDAT><HIL><SB><PDAT>HH</PDAT></SB></HIL><PDAT>&equals;4.4 Hz) in the </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR and a </PDAT><HIL><SP><PDAT>31</PDAT></SP></HIL><PDAT>P resonance at 37.42 ppm with no observed free phosphine. Moreover, alkylidene 7 showed no decomposition over 24 hours at room temperature.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>Similarly, treatment of 3 with 50 equivalents of the bis(epoxide)-functionalized CTA 6 at 45&deg; C. for 30 min resulted in the formation of an epoxide-functionalized ruthenium alkylidene 8. This alkylidene exhibited an &agr;-H carbene resonance at 19.79 ppm (t, J</PDAT><HIL><SB><PDAT>HH</PDAT></SB></HIL><PDAT>&equals;3.6 Hz) in the </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR and a </PDAT><HIL><SP><PDAT>31</PDAT></SP></HIL><PDAT>P resonance at 36.91 ppm with no observed free phosphine. Decomposition of alkylidene 8 was not observed even after being stored for 24 hours at room temperature. As a result, the lack of observed free phosphine and the </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H and </PDAT><HIL><SP><PDAT>31</PDAT></SP></HIL><PDAT>P resonances indicated that telechelic polymers with crosslinkable end groups may be synthesized using ROMP in the presence of a chain transfer agent of the general formula Z&mdash;Y&boxH;Y&mdash;Z.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Polymerization of COD in the Presence of 5</PDAT></STEXT></H>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>In the presence of the CTA 5, polymerization of COD resulted in the bis(methacrylate)-functionalized telechelic poly(butadiene) 9 as shown in Scheme 5. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00027">
<CHEMCDX ID="CHEMCDX-00027" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00027.CDX"/>
<CHEMMOL ID="CHEMMOL-00027" ALT="chemistry mol file" FILE="US06465590-20021015-C00027.MOL"/>
<EMI ID="EMI-C00027" ALT="embedded image" HE="165.6207" WI="214.0992" FILE="US06465590-20021015-C00027.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>In an initial study, the impact of the &lsqb;COD&rsqb;/&lsqb;3&rsqb; (&lsqb;COD&rsqb;/&lsqb;initiator&rsqb;) ratio, reaction time, and temperature on the polymer yield and CTA incorporation was investigated. The polymerizations were run neat according to the different sets of conditions described in Table 1.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>In the first two entries, reaction time and temperature were held constant at 24 h and 25&deg; C. while the &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; ratio was increased from 2000:1 to 4000:1. Although only a slight decrease in the yield of 5% was observed, the {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>increased from 3500 to 5500 presumably due to a reduced incorporation of the CTA 5 during the polymerization. The impact of reaction time was investigated by comparing the results for reaction times of 24 and 48 hours (at: &lsqb;COD&rsqb;/&lsqb;5&rsqb;&equals;10; &lsqb;COD&rsqb;/&lsqb;initiator&rsqb;&equals;2000; and a temperature of 25&deg; C.). As seen in the third and fourth entries, increasing the reaction time resulted in a slight increase in yield and a lower molecular weight due to an improved incorporation of 5. Unfortunately, the impact of temperature was unable to be investigated because of the relative instability of 5. For example, presumably due to the thermally-induced polymerization of the methacrylate groups, insoluble polymeric materials were formed when polymerizations were run at 45&deg; C.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>Based on these results, all COD polymerization reactions with 5 were run with a &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; ratio of 2000:1 for 48 hours at 25&deg; C. In addition, efforts were taken to minimize photo-induced polymerization of the methacrylate groups by shielding the reaction vesicle from light.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="28pt" align="center"/>
<colspec colname="2" colwidth="28pt" align="center"/>
<colspec colname="3" colwidth="21pt" align="center"/>
<colspec colname="4" colwidth="28pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="center"/>
<colspec colname="6" colwidth="49pt" align="center"/>
<colspec colname="7" colwidth="28pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="7" rowsep="1"><PTEXT><PDAT>TABLE 1</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>&lsqb;COD&rsqb;/</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Rxn.</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lsqb;COD&rsqb;/</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&lsqb;init-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Time</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Temp.</PDAT></PTEXT></entry>
<entry></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lsqb;5&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>iator&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(h)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(&deg; C.)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>% Yield</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(Theoretical)</PDAT><HIL><SP><PDAT>b</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(NMR)</PDAT><HIL><SP><PDAT>c</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>24</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>80</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1844</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3500</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>4000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>24</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>75</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1844</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>5500</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>10</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>24</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>85</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1304</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2500</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>10</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>48</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>87</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1304</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2300</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00001"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>Isolated yields after purification. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00002"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>Determined by (&lsqb;COD&rsqb;/&lsqb;5&rsqb;)(MW of COD) &plus; (MW of 5). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00003"><PTEXT><HIL><SP><PDAT>c</PDAT></SP></HIL><PDAT>Determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration assuming a number average functionality of 2. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>Practice of the present invention is extremely advantageous because of the ability to control the polymer molecular weights through the manipulation of the &lsqb;monomer&rsqb;/&lsqb;CTA&rsqb; ratio. A series of bis(methacrylate)-functionalized telechelic poly(butadiene)s were synthesized with &lsqb;COD&rsqb;/&lsqb;5&rsqb; ratios of 15, 40, 60, and 80:1. As shown by Table 2, yields between 88-90% were obtained, and the molecular weight was indeed controlled resulting in bis(methacrylate)-functionalized telechelic poly(butadiene)s with {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>values between 3700 to 17700.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00002">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="28pt" align="center"/>
<colspec colname="2" colwidth="35pt" align="center"/>
<colspec colname="3" colwidth="42pt" align="center"/>
<colspec colname="4" colwidth="28pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="center"/>
<colspec colname="6" colwidth="28pt" align="center"/>
<colspec colname="7" colwidth="21pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="7" rowsep="1"><PTEXT><PDAT>TABLE 2</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>% Cis-</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>% Cis-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Olefin</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lsqb;COD&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>%</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Olefin</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(End</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>/&lsqb;5&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Yield</PDAT><HIL><SP><PDAT>d</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(Backbone)</PDAT><HIL><SP><PDAT>e</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Group)</PDAT><HIL><SP><PDAT>e</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(NMR)</PDAT><HIL><SP><PDAT>f</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(GPC)</PDAT><HIL><SP><PDAT>g</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>PDI</PDAT><HIL><SP><PDAT>h</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT></PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="28pt" align="center"/>
<colspec colname="2" colwidth="35pt" align="center"/>
<colspec colname="3" colwidth="42pt" align="center"/>
<colspec colname="4" colwidth="28pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="char" char="."/>
<colspec colname="6" colwidth="28pt" align="char" char="."/>
<colspec colname="7" colwidth="21pt" align="center"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>15</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>88</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>50</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3700</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>5400</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.74</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>40</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>89</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>55</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>20</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>8000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>10100</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.86</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>60</PDAT><HIL><SP><PDAT>b</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>90</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>60</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>14500</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>11900</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2.02</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>80</PDAT><HIL><SP><PDAT>c</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>90</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>55</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>17700</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>15300</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.99</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00004"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>Polymerizations were run neat at 25&deg; C. for 48 h with &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; &equals; 2000. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00005"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>To ensure better mixing and higher yields, &lsqb;COD&rsqb; &equals; 12.4M in benzene was utilized. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00006"><PTEXT><HIL><SP><PDAT>c</PDAT></SP></HIL><PDAT>To ensure better mixing and higher yields, &lsqb;COD&rsqb; &equals; 9.3M in benzene was utilized. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00007"><PTEXT><HIL><SP><PDAT>d</PDAT></SP></HIL><PDAT>Isolated yields after purification. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00008"><PTEXT><HIL><SP><PDAT>e</PDAT></SP></HIL><PDAT>Determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00009"><PTEXT><HIL><SP><PDAT>f</PDAT></SP></HIL><PDAT>Determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration assuming a number average functionality of 2. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00010"><PTEXT><HIL><SP><PDAT>g</PDAT></SP></HIL><PDAT>Determined by gel permeation chromatography in CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>relative to monodispersed polystyrene standards. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>As illustrated in the plot of {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>versus the &lsqb;COD&rsqb;/&lsqb;5&rsqb; ratio in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, a direct correlation was observed between the &lsqb;COD&rsqb;/&lsqb;5&rsqb; ratio and polymer molecular weight. Although the experimentally observed molecular weights were higher than that calculated for the theoretical molecular weights, this is believed to be due to the incomplete incorporation of the chain transfer agent 5 during the polymerization.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>The resulting telechelic poly(butadiene)s contained between 50-60% cis-olefin in the backbone and between 20-25% cis-olefin at the polymer end groups, and polydispersities (PDIs) of 1.74-2.02 were obtained. Both </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H and </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR indicated a {overscore (F)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>value near 2.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Polymerization of COD in the Presence of 6</PDAT></STEXT></H>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>Polymerization of COD in the presence of the chain transfer agent 6 resulted in bis(epoxide)-functionalized telechelic poly(butadiene) 10 as shown in Scheme </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00028">
<CHEMCDX ID="CHEMCDX-00028" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00028.CDX"/>
<CHEMMOL ID="CHEMMOL-00028" ALT="chemistry mol file" FILE="US06465590-20021015-C00028.MOL"/>
<EMI ID="EMI-C00028" ALT="embedded image" HE="127.94355" WI="215.0631" FILE="US06465590-20021015-C00028.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>The impact of the &lsqb;COD&rsqb;/&lsqb;CTA&rsqb; ratio, reaction time, and temperature on the polymer yield and the incorporation of 6 was examined. All polymerization reactions were run neat according to the conditions described in Table 3.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00003">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="42pt" align="center"/>
<colspec colname="2" colwidth="35pt" align="center"/>
<colspec colname="3" colwidth="35pt" align="center"/>
<colspec colname="4" colwidth="35pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="center"/>
<colspec colname="6" colwidth="35pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="6" rowsep="1"><PTEXT><PDAT>TABLE 3</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>&lsqb;COD&rsqb;/</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Rxn.</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Temp.</PDAT></PTEXT></entry>
<entry></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lsqb;COD&rsqb;/&lsqb;6&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&lsqb;initiator&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Time (h)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(&deg; C.)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>% Yield</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(NMR)</PDAT><HIL><SP><PDAT>b</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>48</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>60</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3700</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>4000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>48</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>51</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3600</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>24</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>45</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>67</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3400</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>48</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>45</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>67</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3400</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>4000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>24</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>45</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>63</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3500</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>4000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>48</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>45</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>61</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3700</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><PTEXT><FOO ID="FOO-00011"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>Isolated yields after purification. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><PTEXT><FOO ID="FOO-00012"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>Determined by (&lsqb;COD&rsqb;/&lsqb;6&rsqb;)(MW of COD) &plus; (MW of 6). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><PTEXT><FOO ID="FOO-00013"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>Determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration assuming a number average functionality of 2. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>Despite similar molecular weight values, a lower yield (51% compared to 60%) was observed at the lower initiator loading. As a result, polymerization reactions in the presence of 6 were run at 25&deg; C. and at a 2000:1 &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; ratio. However, unlike the polymerization of COD in the presence of 5, polymerization reactions could be run at higher temperatures because of the relative stability of 6. Comparing entries 3-6 in Table, similar yields and molecular weights were observed regardless of changes in the reaction time or the &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; ratio. Therefore, based on these results, all COD polymerization reactions in the presence of chain transfer agent 6 were carried out at 45&deg; C. with a &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; ratio of 4000:1 for 24 hours.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>The effect of the &lsqb;COD&rsqb;&lsqb;CTA&rsqb; ratio was also investigated. By varying the &lsqb;COD&rsqb;/&lsqb;6&rsqb; ratio from 15 to 80: 1, {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>values between 3000-16800 were obtained with yields between 71-87% (see Table 4).</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00004">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="28pt" align="center"/>
<colspec colname="2" colwidth="35pt" align="center"/>
<colspec colname="3" colwidth="42pt" align="center"/>
<colspec colname="4" colwidth="28pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="center"/>
<colspec colname="6" colwidth="28pt" align="center"/>
<colspec colname="7" colwidth="21pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="7" rowsep="1"><PTEXT><PDAT>TABLE 4</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>% Cis-</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>% Cis-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Olefin</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lsqb;COD&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>%</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Olefin</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(End</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>{overscore (M)}</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>/&lsqb;6&rsqb;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Yield</PDAT><HIL><SP><PDAT>d</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(Backbone)</PDAT><HIL><SP><PDAT>e</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Group)</PDAT><HIL><SP><PDAT>e</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(NMR)</PDAT><HIL><SP><PDAT>f</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(GPC)</PDAT><HIL><SP><PDAT>g</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>PDI</PDAT><HIL><SP><PDAT>g</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT></PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="28pt" align="center"/>
<colspec colname="2" colwidth="35pt" align="center"/>
<colspec colname="3" colwidth="42pt" align="center"/>
<colspec colname="4" colwidth="28pt" align="center"/>
<colspec colname="5" colwidth="35pt" align="char" char="."/>
<colspec colname="6" colwidth="28pt" align="char" char="."/>
<colspec colname="7" colwidth="21pt" align="center"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>15</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>71</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>60</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>30</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>4000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.55</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>40</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>80</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>65</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>7800</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>6900</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.89</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>60</PDAT><HIL><SP><PDAT>b</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>87</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>50</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>30</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>11000</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>10500</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.87</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>80</PDAT><HIL><SP><PDAT>c</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>84</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>55</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>25</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>16800</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>11600</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.94</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00014"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>Polymerizations were run neat at 45&deg; C. for 24 h with &lsqb;COD&rsqb;/&lsqb;initiator&rsqb; &equals; 4000. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00015"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>To ensure better mixing and higher yields, &lsqb;COD&rsqb; &equals; 12.4M in benzene was utilized. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00016"><PTEXT><HIL><SP><PDAT>c</PDAT></SP></HIL><PDAT>To ensure better mixing and higher yields, &lsqb;COD&rsqb; &equals; 9.3M in benzene was utilized. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00017"><PTEXT><HIL><SP><PDAT>d</PDAT></SP></HIL><PDAT>Isolated yields after purification. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00018"><PTEXT><HIL><SP><PDAT>e</PDAT></SP></HIL><PDAT>Determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00019"><PTEXT><HIL><SP><PDAT>f</PDAT></SP></HIL><PDAT>Determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR integration assuming a number average functionality of 2. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><PTEXT><FOO ID="FOO-00020"><PTEXT><HIL><SP><PDAT>g</PDAT></SP></HIL><PDAT>Determined by gel permeation chromatography in CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>relative to monodispersed polystyrene standards. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>As shown by </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT>, an excellent correlation was observed between the &lsqb;COD&rsqb;/&lsqb;6&rsqb; and polymer molecular weight (M n). The bis(epoxide)-functionalized telechelic poly(butadiene)s 10 contained between 50-65% cis-olefins in the backbone and between 25-30% cis-olefins in the end groups. The observed PDIs ranged from 1.55 to 1.94. Both </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H and </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR indicated a {overscore (F)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>near 2 for these materials.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Cross-linking of the Telechelic Poly(Butadiene)s 9 and 10</PDAT></STEXT></H>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>Crosslinking studies of the telechelic poly(butadiene)s 9 and 10 were conducted. Bis(methacrylate)-functionalized telechelic poly(butadiene)s 9 was crosslinked using both thermal and photochemical methods. For thermal cross-linking, concentrated solutions of polymer 9 (100 mg of polymer 9 in 200 &mgr;L toluene) ({overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>values between 3700 to 17700) were combined with benzoyl peroxide (2 wt %) and heated to 90&deg; C. Within 5 minutes, a tacky insoluble material was observed, and within 15 minutes, a rubbery polymeric solid was formed which was completely insoluble in all common organic solvents including CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CHCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, benzene, toluene, Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, ethyl acetate, and DMSO.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>Photochemical crosslinking was induced by combining either benzoyl peroxide or 2,2-dimethoxy-2-phenylacetophenone (2 wt %) with the concentrated polymer solutions and photolyzing the solutions for 15 minutes using a 450 watt medium pressure mercury Hanovia lamp. As in the thermally-induced cross-linking reactions, a tacky insoluble material was formed within 5 minutes and a highly crosslinked rubbery material was obtained after 15 minute.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>Bis(epoxide)-functionalized telechelic poly(butadiene)s 10 was crosslinked using an acid. Solutions of polymer 10 (100 mg of polymer 10 in 500 gL toluene) {overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>values between 3000 to 16800) were stirred with a magnetic stirrer and treated with H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(cat.). Upon addition of the acid, a rubbery polymeric solid was immediately observed which was insoluble in all common organic solvents including CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CHCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, benzene, toluene, Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, ethyl acetate, and DMSO. Treatment with other acids such as HCl (1 M in Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O) and p-toluenesulfonic acid resulted in no significant cross-linking even at elevated temperatures. Treatment of the polymer solutions with BF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&mdash;Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (cat.) resulted in cross-linking, however the cross-linking required between 2 and 3 hours at room temperature and often gave inconsistent results. Treatment with H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO4 (cat.) was by far the simplest and most rapid method for the cross-linking of the bis(epoxide)-functionalized telechelic poly(butadiene)s 10.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXPERIMENTAL METHODS</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>General Protocols</PDAT></STEXT></H>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>Argon was purified by passage through columns of BASF R-11 catalyst (Chemalog) and 4 &angst; molecular sieves (Linde). NMR spectra were recorded on GE QE-300 Plus (300.1 MHz; 75.49 MHz </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C) spectrometer and a JEOL GX-400 (399.65 MHz </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H; 100 MHz </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C; 161.85 MHz </PDAT><HIL><SP><PDAT>31</PDAT></SP></HIL><PDAT>P) spectrometer. </PDAT><HIL><SP><PDAT>31</PDAT></SP></HIL><PDAT>P NMR spectra were referenced to an external 85% H</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>standard. IR spectra were recorded on a Perkin-Elmer 1600 series FT-IR spectrometer. Gel permeation chromatographs were obtained on a HPLC system using an Altex model 110A pump, a Rheodyne model 7125 injector with a 100 &mgr;L injection loop, two American Polymer Standards 10 micron mixed bed columns, and a Knauer differential-refractometer using CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>as eluent at a 1.0 mL/min flow rate. Molecular weights and polydispersities were reported versus monodispersed polystyrene standards. Photolysis was accomplished with a 450 watt medium pressure mercury Hanovia lamp.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Materials</PDAT></STEXT></H>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>The benzene used in polymerizations was distilled from CaH</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>under vacuum. Dry THF was obtained by distillation under atmospheric pressure from CaH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. All other solvents were reagent grade and used without purification. cis-2-Butene-1,4-diol, methacryloyl chloride, triethylamine, NaOH, Bu</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>N&plus;HSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, epichlorohydrin, p-methoxyphenol, MeOH, benzoyl peroxide, 2,2-dimethoxy-2-phenylacetophenone, BF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, and H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>were purchased from the Aldrich Chemical Company and used without further purification. COD was purchased from the Aldrich Chemical Company and degassed by stirring in vacuo for 2 hours before use in polymerizations.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Preparation of cis-2-Butene-1,4-diol Dimethacrylate (5)</PDAT></STEXT></H>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>cis-2-Butene-1,4-diol (14.04 g, 0.16 mol, 1.0 eq) was mixed with THF (500 mL) and triethylamine (40.34 g, 0.48 mol, 3.0 eq) in a 1 L round bottom flask under argon. To the reaction flask 90% methacryloyl chloride (53.9 g, 0.46 mol, 2.9 eq) was added via an addition funnel over 1 h at 0&deg; C. during which time a white precipitate was observed. The ice bath was then removed, and the reaction was left to stir overnight at room temperature. Deionized water (150 mL) was then added to dissolve the precipitated salts, and the reaction mixture was poured into a 2 L separatory funnel containing petroleum ether (750 mL). The organics were then washed with deionized water (3&times;200 mL), aqueous NaOH (15% w/w, 4&times;200 mL), and deionized water (3&times;200 mL). The organics were dried over MgSO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and concentrated in vacuo. The product was purified by flash column chromatography (silica gel, 5% ethyl acetate/hexanes, R</PDAT><HIL><SB><PDAT>f</PDAT></SB></HIL><PDAT>&equals;0.45) to give 26.5 g (74%) of pure product as a viscous oil. To prevent cross-linking, this material was stored with p-methoxyphenol (20 wt %) at &minus;30&deg; C. in a dry box. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 6.08-6.06 (m, 2H), 5.81-5.71 (m, 2H), 5.54-5.52 (m, 2H), 4.78-4.69 (m, 4H), 1.90-1.89 (m, 6H); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 166.95; 136.03, 128.01, 125.67, 60.26, 18.19; IR (thin film on a NaCl plate) 3105, 3036, 2981, 2959, 2929, 2894, 1719, 1637, 1512, 1452, 1403, 1378, 1348, 1318, 1293, 1152, 1012, 975, 942, 815, 734, 651 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>; HRM S (CI) calcd for C</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(M&plus;H)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> 225.1127, found 225.1129.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Preparation of cis-2-Butene-1,4-diol Diglycidyl Ether (6)</PDAT></STEXT></H>
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>In a 1L Erlenmeyer flask, epichlorohydrin (270 g, 3.00 mol, 10 eq), aqueous NaOH (50% w/w) (240 g, 3.00 mol, 10 eq), and Bu</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>N&plus;HSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> (5.0 g, cat.) were combined at room temperature with magnetic stirring. A thermometer was placed in the flask to monitor the temperature during the reaction. To this flask, cis-2-butene-1,4-diol (26.5 g, 0.30 mol, 1 eq) was added dropwise slowly over 30 min. The reaction was extremely exothermic, and so the temperature was maintained between 30-40&deg; C. by controlling the addition rate as well as by intermittent cooling in an ice bath. At the end of the addition, the reaction temperature remained near 40&deg; C. for approximately 1 h, and when it began to cool, the reaction flask was heated at 40&deg; C. in an oil bath for an additional 1 h. The flask was allowed to cool, and then deionized water was added (200 mL). This mixture was then extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;200 mL), dried over MgSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, and concentrated in vacuo to obtain a yellow oil. This was distilled at 0.2 mm Hg/105-110&deg; C. to give a clear oil (38.0 g, 65% yield). </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 5.8-5.61 (m, 2H), 4.11-4.00 (m, 4H), 3.67 (dd, J</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;3.0 Hz, J</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;11.4 Hz, 2H), 3.30 (dd, J</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;5.7 Hz, J</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;11.4 Hz, 2H), 3.11-3.06 (m, 2H), 2.73 (dd, J</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;4.2 Hz, J</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;4.8 Hz, 2H), 2.54 (dd, J</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>&equals;2.7 Hz, J</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&equals;4.8 Hz, 2H); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 129.13, 70.76, 66.74, 50.61, 44.03; IR (thin film on a NaCl plate) 3055, 2999, 2922, 2867, 1511, 1472, 1439, 1411, 1327, 1253, 1162, 1094, 1016, 968, 947, 901, 855, 762 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>; HRMS (Cl) calcd for C</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>18</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(M&plus;H)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> 201.1127, found 201.1128.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Reaction of CTAs 5 and 6 with the Ruthenium Benzylidene (3)</PDAT></STEXT></H>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>All manipulations were carried out in a dry box. In a 10 mL vial, ruthenium benzylidene 3 (6.0 mg, 7.3e-6 mol, 1.0 eq), CTA (either 5 or 6) (3.7e-4 mol, 50 eq), and C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>D</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>(0.70 mL) were combined to form a homogeneous solution. This solution was transferred to a NMR tube which was capped with a rubber septa and removed from the dry box. The NMR tube was placed in an oil bath at 45&deg; C. for 30 min. After this time, the NMR tube was removed from the oil bath, and the reaction was analyzed by both </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H and </PDAT><HIL><SP><PDAT>31</PDAT></SP></HIL><PDAT>P NMR.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>General Polymerization Procedure.</PDAT></STEXT></H>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>All manipulations were carried out in a dry box. In a 10 mL vial, the correct amount of either 5 or 6 and COD were weighed out. In a separate vial, the initiator was weighed out and a stirbar added, and this was combined with the COD/CTA mixture. The vial was then capped, removed from the dry box, and left to stir for the desired time. For reactions involving the methacrylate CTA 5, aluminum foil was wrapped around the reaction vial to prevent photo-induced crosslinking. At the end of the desired reaction time, ethyl vinyl ether (600 eq relative to initiator) was pipetted into the vial along with an equal volume of toluene. This was left to stir for 1 h followed by precipitation into MeOH to isolate the polymer. The MeOH was decanted away, and the polymer was washed with excess fresh MeOH to remove any remaining COD or CTA. The resulting telechelic poly(butadiene)s were concentrated in vacuo and then characterized by standard methods including </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR, </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR, IR, and GPC.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Bis(methacrylate)-functionalized Telechelic Poly(Butadiene) (9)</PDAT></STEXT></H>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>Spectral data for the polymer derived from a 15:1 &lsqb;COD&rsqb;/&lsqb;5&rsqb; ratio ({overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>(NMR)&equals;3700, DP&equals;32). </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 6.13 (bs), 5.86-5.54 (bm), 4.68 (bd, J&equals;6.0 Hz), 4.57 (bd, J&equals;6.6 Hz), 2.43-1.72 (bm); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 167.224, 167.14, 136.37, 135.49, 135.41, 134.50, 130.66, 130.42, 130.06, 129.94, 129.55, 129.38, 128.95, 128.76, 128.67, 125.34, 124.23, 124.14, 123.84, 123.67, 65.29, 60.60, 60.53, 32.93, 32.65, 32.28, 31.89, 27.66, 27.36, 27.01, 26.67, 18.34; IR (thin film on a NaCl plate) 3005, 2937, 2844, 1721, 1655, 1639, 1446, 1403, 1318, 1294, 1239, 1159, 1079, 1010, 966, 814, 733 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Bis(epoxide)-functionalized Telechelic Poly(Butadiene) (10)</PDAT></STEXT></H>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>Spectral data for the polymer derived from a 15:1 &lsqb;COD&rsqb;/&lsqb;6&rsqb; ratio ({overscore (M)}</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>(NMR)&equals;3000, DP&equals;26). </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 5.77-5.17 (bm), 4.09-3.91 (bm), 3.72-3.61 (bm), 3.41-3.30 (bm), 3.17-3.08 (bm), 2.81-2.72 (bm), 2.62-2.53 (bm), 2.35-1.64 (bm); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>) &dgr; 134.49, 134.43, 133.19, 130.26, 130.03, 129.93, 129.73, 129.52, 129.35, 126.19, 126.06, 125.90. 71.95, 70.65, 70.46, 66.81, 50.72, 44.33, 44.26, 32.91, 32.63, 32.29, 32.04, 27.97, 27.63, 27.35, 27.10, 26.76; IR (thin film on a NaCl plate) 3006, 2918, 2846, 1654, 1437, 1403, 1348, 1312, 1240, 1158, 1101, 966, 845, 732 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Cross-linking of Bis(methacrylate)-functionalized Telechelic Poly(Butadiene)s (9)</PDAT></STEXT></H>
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>In a 2 mL glass vial, polymer 9 (100 mg) was dissolved in toluene (200 &mgr;L) with either benzoyl peroxide or 2,2-dimethoxy-2-phenylacetophenone (2 mg, 2 wt %). This solution was then either subjected to heat in an oil bath at 90&deg; C. (benzoyl peroxide-initiated) or light using a 450 watt medium pressure mercury Hanovia lamp (benzoyl peroxide- or 2,2-dimethoxy-2-phenylacetophenone-initiated) in a photolysis chamber. Although an insoluble material was formed within 5 min under these conditions for each of the different molecular weight polymers synthesized, heating or photolysis for 15 min resulted in a more highly cross-linked rubbery material which was completely insoluble in all common organic solvents including CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CHCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, benzene, toluene, Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, ethyl acetate, and DMSO.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Cross-linking of Bis(epoxide)-functionalized Telechelic Poly(Butadiene)s (10)</PDAT></STEXT></H>
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>In a 2 mL vial, polymer 10 (100 mg) was dissolved in toluene (500 &mgr;L) and a stir bar was added. This solution was then stirred at room temperature and H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(cat.) was added. Immediate formation of an insoluble rubbery solid was observed for each of the different molecular weight polymers synthesized. These materials were completely insoluble in all common organic solvents including CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CHCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, benzene, toluene, Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, ethyl acetate, and DMSO.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00115" LVL="0"><PTEXT><PDAT>1. A linear polymer of the general formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00029">
<CHEMCDX ID="CHEMCDX-00029" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00029.CDX"/>
<CHEMMOL ID="CHEMMOL-00029" ALT="chemistry mol file" FILE="US06465590-20021015-C00029.MOL"/>
<EMI ID="EMI-C00029" ALT="embedded image" HE="17.2935" WI="109.2042" FILE="US06465590-20021015-C00029.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00116" LVL="7"><PTEXT><PDAT>wherein:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>n is an integer; </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00030">
<CHEMCDX ID="CHEMCDX-00030" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00030.CDX"/>
<CHEMMOL ID="CHEMMOL-00030" ALT="chemistry mol file" FILE="US06465590-20021015-C00030.MOL"/>
<EMI ID="EMI-C00030" ALT="embedded image" HE="14.175" WI="52.07895" FILE="US06465590-20021015-C00030.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>&emsp;is an alkadienyl group; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>Y is an alkyl group; and, </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>Z is methacrylate or epoxide. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT>2. A linear polymer of the general formula </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00031">
<CHEMCDX ID="CHEMCDX-00031" ALT="chemistry chemdraw file" FILE="US06465590-20021015-C00031.CDX"/>
<CHEMMOL ID="CHEMMOL-00031" ALT="chemistry mol file" FILE="US06465590-20021015-C00031.MOL"/>
<EMI ID="EMI-C00031" ALT="embedded image" HE="16.3296" WI="185.77755" FILE="US06465590-20021015-C00031.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00118" LVL="7"><PTEXT><PDAT>wherein n is an integer and Z is a crosslinkable end group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>3. The polymer as in </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein Z is selected from the group consisting methacrylate, acylate, cinnamate, epoxide, lactone, cyclic carbonate, tetrahydrofuran, oxetane, lactams, phosphazenes, and alkoxysilanes.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>4. The polymer as in </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT> wherein Z is methacrylate or epoxide.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06465590-20021015-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06465590-20021015-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06465590-20021015-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06465590-20021015-D00003.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06465612-20021015-C00001.CDX SYSTEM "US06465612-20021015-C00001.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00001.MOL SYSTEM "US06465612-20021015-C00001.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00001.TIF SYSTEM "US06465612-20021015-C00001.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00002.CDX SYSTEM "US06465612-20021015-C00002.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00002.MOL SYSTEM "US06465612-20021015-C00002.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00002.TIF SYSTEM "US06465612-20021015-C00002.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00003.CDX SYSTEM "US06465612-20021015-C00003.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00003.MOL SYSTEM "US06465612-20021015-C00003.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00003.TIF SYSTEM "US06465612-20021015-C00003.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00004.CDX SYSTEM "US06465612-20021015-C00004.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00004.MOL SYSTEM "US06465612-20021015-C00004.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00004.TIF SYSTEM "US06465612-20021015-C00004.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00005.CDX SYSTEM "US06465612-20021015-C00005.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00005.MOL SYSTEM "US06465612-20021015-C00005.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00005.TIF SYSTEM "US06465612-20021015-C00005.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00006.CDX SYSTEM "US06465612-20021015-C00006.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00006.MOL SYSTEM "US06465612-20021015-C00006.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00006.TIF SYSTEM "US06465612-20021015-C00006.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00007.CDX SYSTEM "US06465612-20021015-C00007.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00007.MOL SYSTEM "US06465612-20021015-C00007.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00007.TIF SYSTEM "US06465612-20021015-C00007.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00008.CDX SYSTEM "US06465612-20021015-C00008.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00008.MOL SYSTEM "US06465612-20021015-C00008.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00008.TIF SYSTEM "US06465612-20021015-C00008.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00009.CDX SYSTEM "US06465612-20021015-C00009.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00009.MOL SYSTEM "US06465612-20021015-C00009.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00009.TIF SYSTEM "US06465612-20021015-C00009.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00010.CDX SYSTEM "US06465612-20021015-C00010.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00010.MOL SYSTEM "US06465612-20021015-C00010.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00010.TIF SYSTEM "US06465612-20021015-C00010.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00011.CDX SYSTEM "US06465612-20021015-C00011.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00011.MOL SYSTEM "US06465612-20021015-C00011.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00011.TIF SYSTEM "US06465612-20021015-C00011.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00012.CDX SYSTEM "US06465612-20021015-C00012.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00012.MOL SYSTEM "US06465612-20021015-C00012.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00012.TIF SYSTEM "US06465612-20021015-C00012.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00013.CDX SYSTEM "US06465612-20021015-C00013.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00013.MOL SYSTEM "US06465612-20021015-C00013.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00013.TIF SYSTEM "US06465612-20021015-C00013.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00014.CDX SYSTEM "US06465612-20021015-C00014.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00014.MOL SYSTEM "US06465612-20021015-C00014.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00014.TIF SYSTEM "US06465612-20021015-C00014.TIF" NDATA TIF>
<!ENTITY US06465612-20021015-C00015.CDX SYSTEM "US06465612-20021015-C00015.CDX" NDATA CDX>
<!ENTITY US06465612-20021015-C00015.MOL SYSTEM "US06465612-20021015-C00015.MOL" NDATA MOL>
<!ENTITY US06465612-20021015-C00015.TIF SYSTEM "US06465612-20021015-C00015.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06465612</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021015</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09405516</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19990923</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>A61K 3800</PDAT></B511>
<B512><PDAT>C07K 1400</PDAT></B512>
<B512><PDAT>C07K  700</PDAT></B512>
<B512><PDAT>C07K  900</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>530300</PDAT></B521>
<B522><PDAT>530305</PDAT></B522>
<B522><PDAT>530326</PDAT></B522>
<B522><PDAT>530327</PDAT></B522>
<B522><PDAT>514  2</PDAT></B522>
<B522><PDAT>514 12</PDAT></B522>
<B522><PDAT>514 13</PDAT></B522>
<B522><PDAT>514 14</PDAT></B522>
<B522><PDAT>514 23</PDAT></B522>
<B522><PDAT>514 25</PDAT></B522>
<B522><PDAT>514 42</PDAT></B522>
<B522><PDAT>435325</PDAT></B522>
<B522><PDAT>536 186</PDAT></B522>
<B522><PDAT>560 19</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Synthetic peptides, conjugation reagents and methods</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4692439</PDAT></DNUM>
<DATE><PDAT>19870900</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Rideout et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>514185</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B562><NCIT><STEXT><PDAT>Yu, Zhonghua et al. Irreversible Inhibition of the HIV-1 Protease: Targeting Alkylating Agents to the Catalytic Aspartate Groups. J. Am. Chem. Soc, vol. 118, 1996 pp. 5846-5856, see Scheme 3. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Schmidt, Ulrich et al. The Synthesis of Epnemycin. J. Chem. Soc., Chem. Commun., 1992 pp. 529-530, see Scheme 1.</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>27</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>530326</PDAT></B582>
<B582><PDAT>530300</PDAT></B582>
<B582><PDAT>530305</PDAT></B582>
<B582><PDAT>530327</PDAT></B582>
<B582><PDAT>560 19</PDAT></B582>
<B582><PDAT>435325</PDAT></B582>
<B582><PDAT>536 186</PDAT></B582>
<B582><PDAT>514  2</PDAT></B582>
<B582><PDAT>514 12</PDAT></B582>
<B582><PDAT>514 13</PDAT></B582>
<B582><PDAT>514 14</PDAT></B582>
<B582><PDAT>514 23</PDAT></B582>
<B582><PDAT>514 25</PDAT></B582>
<B582><PDAT>514 42</PDAT></B582>
</B580>
<B590><B595><PDAT>0</PDAT></B595><B596><PDAT>0</PDAT></B596></B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/101494</PDAT></DNUM><DATE><PDAT>19980923</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Carolyn R.</PDAT></FNM><SNM><STEXT><PDAT>Bertozzi</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Albany</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Lisa A.</PDAT></FNM><SNM><STEXT><PDAT>Marcaurelle</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Boston</PDAT></CITY>
<STATE><PDAT>MA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Elena C.</PDAT></FNM><SNM><STEXT><PDAT>Rodriguez</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>San Diego</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>The Regents of the University of California</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Oakland</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><FNM><PDAT>Richard Aron</PDAT></FNM><SNM><STEXT><PDAT>Osman</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Karen Cochrane</PDAT></FNM><SNM><STEXT><PDAT>Carlson</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Chih-Min</PDAT></FNM><SNM><STEXT><PDAT>Kam</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>1653</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The invention provides methods and compositions useful for making synthetic peptide conjugates. In one embodiment, the invention provides compositions comprising the structure: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00001">
<CHEMCDX ID="CHEMCDX-00001" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00001.CDX"/>
<CHEMMOL ID="CHEMMOL-00001" ALT="chemistry mol file" FILE="US06465612-20021015-C00001.MOL"/>
<EMI ID="EMI-C00001" ALT="embedded image" HE="54.97065" WI="62.6535" FILE="US06465612-20021015-C00001.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00002" LVL="7"><PTEXT><PDAT>wherein R is selected from lower substituted or unsubstituted alkyl, O, NH and S and P is an amine protection group. In more particular embodiments, the compositions comprise &agr;-amine protected 4,5-dehydroleucine or &agr;-amine protected (2S)-aminolevulinic acid and/or P is F-moc. These compounds may be incorporated into peptides, for example, peptides comprising a substituted or unsubstituted (2S)-aminolevulinic acid residue, such as (2S)-aminolevulinic acid residue is substituted with an O- or N-linked glycoconjugate, or a detectable label.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This application claims priority from provisional patent application No. 60/101,494, filed Sep. 23, 1998, abandoned.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>The research carried out in the subject application was supported in part by grants from the National Science Foundation (No. CHE-9734430). The government may have rights in this invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>FIELD OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>The invention relates to methods and reagents used to make synthetic peptide conjugates.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Glycoprotein pharmaceuticals are major targets of the biotechnology industry and include such widely used therapeutic agents as tissue plasminogen activator (TPA), erythropoietin (EPO) and monoclonal antibodies. Glycosylation presents special challenges in drug discovery and development, largely due to the heterogeneity of oligosaccharide structures obtained from recombinant expression in eukaryotic cell lines. The presence of heterogeneous glycoforms convolutes the characterization of the glycoprotein&apos;s structure and biological activity, which hinders clinical evaluation and approval. New strategies for their production which control oligosaccharide structure and uniformity would facilitate the development of glycoprotein pharmaceutical agents.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>We have developed novel methods for the synthesis of glycopeptides based on the highly selective reaction of nucleophilic carbohydtrate derivatives with ketone-containing peptides. Peptides bearing unnatural ketone side chains can be generated using N-protected (2S)-aminolevulinic acid by standard solid-phase peptide synthesis (SPPS). Oligosaccharides functionalized at their reducing termini with aminooxy, hydrazide or thiosemicarbazide groups can be coupled to keto-peptides in aqueous solvent without need for protecting groups or auxiliary coupling reagents. These methods can be used to prepare glycopeptides of therapeutic interest.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>The invention provides methods and compositions useful for making synthetic peptide conjugates. In one embodiment, the invention provides compositions comprising the structure: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00002">
<CHEMCDX ID="CHEMCDX-00002" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00002.CDX"/>
<CHEMMOL ID="CHEMMOL-00002" ALT="chemistry mol file" FILE="US06465612-20021015-C00002.MOL"/>
<EMI ID="EMI-C00002" ALT="embedded image" HE="54.97065" WI="62.6535" FILE="US06465612-20021015-C00002.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00009" LVL="7"><PTEXT><PDAT>wherein R is selected from lower substituted or unsubstituted alkyl, O, NH and S and P is an amine protection group. In more particular embodiments, the compositions comprise &agr;-amine protected 4,5-dehydroleucine or &agr;-amine protected (2S)-aminolevulinic acid and/or P is F-moc. These compounds may be incorporated into a wide variety of synthetic molecules such as peptides. In a particular embodiment, such peptides comprise a substituted or unsubstituted (2S)-aminolevulinic acid residue, such as (2S)-aminolevulinic acid residue is substituted with an O- or N-linked glycoconjugate, or a detectable label. These peptides may be synthesized in vitro or in vivo and may be incorporated into cells or cellular structures.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>The invention also provides methods for conjugating a molecule to a composition comprising a (2S)-aminolevulinic acid residue comprising the step of reacting the molecule with the residue under conditions whereby the molecule is covalently conjugated to residue. In particular embodiments, the composition comprises a synthetic peptide comprising the (2S)-aminolevulinic acid residue or the molecule is a glycoconjugate or comprises a detectable label.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF PARTICULAR EMBODIMENTS OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>The following descriptions of particular embodiments are offered by way of illustration and not by way of limitation. Unless contraindicated or noted otherwise, in these descriptions and throughout this specification, the terms &ldquo;a&rdquo; and &ldquo;an&rdquo; mean one or more, the term &ldquo;or&rdquo; means and/or.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>EXAMPLE I</PDAT></STEXT></H>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>Direct incorporation of unprotected ketone groups into peptides during solid phase synthesis: application of the one-step modification of peptides with two different biophysical probes for FRET.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>Abstract: An amino acid bearing an unprotected ketone group, (2S)-aminolevulinic acid, was incorporated into a synthetic peptide using standard Fmoc-based solid-phase methods. The ketone group remained unharmed during the synthesis and provided a uniquely reactive functional group for covalent modification of the peptide. The ketone and the sulfhydryl group of a cysteine residue elsewhere in the peptide were reacted simultaneously with two different biophysical probes, enabling the site-specific installation of a donor and acceptor pair for FRET in one step without the need for differential side chain protection. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00003">
<CHEMCDX ID="CHEMCDX-00003" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00003.CDX"/>
<CHEMMOL ID="CHEMMOL-00003" ALT="chemistry mol file" FILE="US06465612-20021015-C00003.MOL"/>
<EMI ID="EMI-C00003" ALT="embedded image" HE="163.21095" WI="215.8002" FILE="US06465612-20021015-C00003.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>The fluoresence resonance energy transfer (FRET) technique has found widespread use in the study of protein structure and dynamics.</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>The technique requires the installation of two biophysical probes, a donor and an acceptor, at defined locations within the peptide of interest. A number of methods are now available for the conjugation of small molecule probes to peptides and proteins. The majority of these methods are based on coupling electrophilic functional groups, such as &agr;-iodoacetamides</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and N-hydroxysuccinimido esters,</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>with exposed cysteine and lysine residues, respectively. However, in order achieve site-specific modification of a peptide in the presence of multiple copies of these nucleophilic residues, differential side chain protection must be employed during the synthesis. To avoid the need for extra protecting group manipulations during the conjugation of a synthetic peptide with two different probes, several groups have exploited selective N-terminal reactions,</PDAT><HIL><SP><PDAT>1f </PDAT></SP></HIL><PDAT>or incorporated non-native amino acids with suitable photophysical properties (e.g., p-nitrotyrosine) in place of their native counterparts.</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>These approaches are somewhat limited with regard to the site of residence and structure of the probe.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>In recent years, the adornment of synthetic peptides with a uniquely reactive electrophile has become an increasingly popular tactic for site-specific modification. For example, ketone or aldehyde groups can be installed in synthetic peptides by conjugating levulinic acid (4-oxopentanoic acid) or masked aldehydes to the &egr;-amino groups of lysine side chains or to the N-terminus of the peptide.</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>Alternatively, aldehyde groups can be generated by the selective oxidation of N-terminal serine residues with periodate.</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>The ketones or aldehydes form stable covalent adducts with a complementary nucleophile, typically an aminooxy, hydrazide or thiosemicarbazide group, in aqueous milieu in the absence of side chain protecting groups. Still, these methods for decorating peptides with ketones and aldehydes require orthogonal side chain or N-terminal protection for site-specific introduction of the electrophile.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>Here we report that (2S)-aminolevulinic acid, an amino acid bearing an unprotected ketone group, can be directly incorporated into synthetic peptides using standard Fmoc-based solid-phase methods. The ketone group survives the synthesis without undergoing any apparent degradation or unwanted side reactions. Furthermore, the ketone is chemically orthogonal to all natural amino acid side chain functional groups. Thus, sulfhydryl groups of cysteine residues, for example, can be modified in the presence of the ketone and vice versa, allowing for the selective labeling of a peptide with two different probes in one synthetic step. The versatility of the ketone group is therefore two-fold: it can be installed at any site along the polypeptide backbone without need for extra protecting group steps, and it does not interfere with reactions involving the nucleophilic functional groups of native amino acid side chains.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>Fmoc-protected (2S)-aminolevulinic acid (3) was synthesized in two steps from commercially available 4,5-dehydroleucine</PDAT><HIL><SP><PDAT>7 </PDAT></SP></HIL><PDAT>(1) as depicted in Scheme 1. The &agr;-amine was first protected with an Fmoc group to afford compound 2,</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>which was then converted to keto-amino acid 3 by reductive ozonolysis.</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>We incorporated compound 3 into a 19-amino acid peptide (4) on an automated peptide synthesizer using standard Fmoc-based solid-phase methods.</PDAT><HIL><SP><PDAT>10 </PDAT></SP></HIL><PDAT>The sequence of peptide 4 was derived from the anti-microbial glycopeptide drosocin, which is produced by insects in response to immune challenge.</PDAT><HIL><SP><PDAT>11 </PDAT></SP></HIL><PDAT>The bacteriostatic potency of drosocin is enhanced five-fold by the presence of an O-linked glycan at Thr11, a feature that may reflect an altered conformational preference due to glycosylation. Thus, drosocin constructs labeled with biophysical probes may be useful tools for analyzing the conformation of the unglycosylated peptide compared to the glycosylated version. We chose to install the (2S)-aminolevulinic acid group in place of Ile17. In addition, a cysteine residue was incorporated in place of Lys2 to provide a second orthogonal site for covalent modification. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00004">
<CHEMCDX ID="CHEMCDX-00004" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00004.CDX"/>
<CHEMMOL ID="CHEMMOL-00004" ALT="chemistry mol file" FILE="US06465612-20021015-C00004.MOL"/>
<EMI ID="EMI-C00004" ALT="embedded image" HE="317.54835" WI="215.8002" FILE="US06465612-20021015-C00004.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>We were concerned that the ketone group might undergo unwanted side reactions, such as condensation with amines to form imines or enamines, or acid- or base-catalyzed aldol condensations, during the process of Fmoc-based solid-phase synthesis. However, the crude product obtained after synthesis and cleavage from the resin was a single peak by reversed-phase HPLC (RP-HPLC) analysis, and its identity as the desired keto-peptide (4) was confirmed by mass spectrometry.</PDAT><HIL><SP><PDAT>12 </PDAT></SP></HIL><PDAT>No other side products were obtained, indicating that the unprotected ketone group is fully compatible with the reagents of Fmoc-based synthesis, including DCC, piperidine and TFA. In essence, keto-amino acid 3 can be treated similarly to an alanine residue.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>To demonstrate the versatility of the ketone group, we modified keto-peptide 4 with two biophysical probes, coumarin iodoacetarnide (5) and fluorescein thiosemicarbazide (6), which are commonly used as a donor and acceptor pair for FRET.</PDAT><HIL><SP><PDAT>13,14 </PDAT></SP></HIL><PDAT>The site-specific labeling of peptide 4 with these probes was achieved in one synthetic step (Scheme 2). Peptide 4 (5 mg) was incubated with 1.2 equivalents each of 5 and 6 in 900 &mgr;L DMF and 100 &mgr;L of 1.0 M sodium phosphate buffer, pH 7.0. The ligation reaction was complete after 24 hours and the fluorescently labeled peptide (7) was isolated by RP-HPLC and its identity confirmed by mass spectrometry.</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>This general strategy for attaching a pair of small molecules to synthetic peptides is applicable to a wide range of targets. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00005">
<CHEMCDX ID="CHEMCDX-00005" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00005.CDX"/>
<CHEMMOL ID="CHEMMOL-00005" ALT="chemistry mol file" FILE="US06465612-20021015-C00005.MOL"/>
<EMI ID="EMI-C00005" ALT="embedded image" HE="264.2787" WI="449.82945" FILE="US06465612-20021015-C00005.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>In summary, N-Fmoc-(2S)-aminolevulinic acid (3) can be incorporated into synthetic peptides in an unprotected form to provide a convenient electrophilic functional group, the ketone, for site-specific conjugation. The chemical orthogonality of the ketone to the sulfhydryl group of cysteine side chains allows for the selective modification of peptides with two different probes and facilitates the synthesis of constructs for FRET experiments. This method is therefore a useful complement to traditional protein modification techniques.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>REFERENCES AND NOTES</PDAT></STEXT></H>
<PARA ID="P-00021" LVL="1"><PTEXT><PDAT>1. (a) Stryer, L. </PDAT><HIL><ITALIC><PDAT>Ann. Rev. Biochem. </PDAT></ITALIC></HIL><PDAT>1978, 47, 819-846. (b) Lee, J. A.; Fortes, P. A. G. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1985, 24, 322-330. (c) Taniguchi, K.; Mardh, S. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>1993, 268a, 15588-15594. (d) Wu, P.; Brand, L. </PDAT><HIL><ITALIC><PDAT>Anal. Biochem. </PDAT></ITALIC></HIL><PDAT>1994, 218, 1-13. (e) Miki, M.; Kouyama, T. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1994, 33, 10171-10177. (f) Imperiali, B.; Rickert, K. W. </PDAT><HIL><ITALIC><PDAT>Proc. Nati. Acad. Sci. </PDAT></ITALIC></HIL><PDAT>1995, 92, 97-101. (g) Xing, J.; Cheung, H. C. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1995, 34, 6475-6487. (h) Mehta, S.; Meldal, M.; Ferro, V.; Duus, J. O.; Bock, K. </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc., Perkins Trans. </PDAT></ITALIC></HIL><PDAT>1 1997, 1365-1374. (i) Slevin, P. R. </PDAT><HIL><ITALIC><PDAT>Meth. Enzynol. </PDAT></ITALIC></HIL><PDAT>1995, 246, 300-334.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="1"><PTEXT><PDAT>2. (a) Sharma, J.; Luduena, R. F.; </PDAT><HIL><ITALIC><PDAT>J. Protein Chem. </PDAT></ITALIC></HIL><PDAT>1994, 13, 165-176. (b) Wong, S. Y. C.; Guile, G.; Dwek, R.; Arsequell, G. </PDAT><HIL><ITALIC><PDAT>Biochem. J. </PDAT></ITALIC></HIL><PDAT>1994, 300, 843-850. (c) Esmann, M.; Sar, P. C.; Hideg, K. Marsh, D. </PDAT><HIL><ITALIC><PDAT>Anal. Biochem. </PDAT></ITALIC></HIL><PDAT>1993, 213, 336-348.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="1"><PTEXT><PDAT>3. (a) Bradburne, J. A.; Godfrey, P.; Choi, J. H.; Mathis, J. N. </PDAT><HIL><ITALIC><PDAT>Appl. Environ. Microbiol, </PDAT></ITALIC></HIL><PDAT>1993, 59, 663-668. (b) Fan, J. G.; Pope, L. E.; Vitols, K. S.; Huennekens, F. M. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1991, 30, 4573-4580.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="1"><PTEXT><PDAT>4. Meldal, M.; Breddamn, K. </PDAT><HIL><ITALIC><PDAT>Anal. Biochem. </PDAT></ITALIC></HIL><PDAT>1991, 195, 141-147.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="1"><PTEXT><PDAT>5. (a) Canne, L. E.; Ferre-D&apos;Amare, A. R.; Burley, S. K.; Kent, S. B. H. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 2998-3007. (b) Shao, J.; Tam, J. P. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 3893-3899.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="1"><PTEXT><PDAT>6. (a) Geoghegan, K. F.; Stroh, J. G. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1992, 3, 138-146. (b) Rose, K. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1994, 116, 30-33. (c) Rose, K.; Zeng, W.; Regamey, P. -O.; Chernushevich, I. V.; Standing, K. G.; Gaertner, H. F. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1996, 7, 552-556.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="1"><PTEXT><PDAT>7. 4,5-Dehydroleucine (1) was purchased from Bachem.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="1"><PTEXT><PDAT>8. Hardy, P. M.; Sheppard, P. W. </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc., Perkin Trans. </PDAT></ITALIC></HIL><PDAT>1 1983, 723-729.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="1"><PTEXT><PDAT>9. Preparation of N-Fmoc-(2S)-aminolevulinic acid (3): A solution of Fmoc-4,5-dehydroleucine (2)</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>(1.1 g, 3.1 mmol) in 9:1 CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/methanol (15 mL) was cooled to &minus;78&deg; C. and purged with N</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>for 10 min. A stream of ozone was passed through the solution until a blue color persisted. The reaction mixture was then purged with N</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(ca. 10 min) until the solution was no longer blue in color. Dimethylsulfide (0.58 mL, 7.9 mmol) was added and the solution was warmed to rt overnight. Excess dimethylsulfide and solvent were removed in vacuo and the resulting yellow syrup was purified by silica gel chromatography (10:1 CHCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>/methanol, 0.1% AcOH) and crystallized from CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/hexanes to afford 0.89 g (81%) of compound 3 as a white solid: mp 136-138_C; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (300 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;7.76 (d, 2 H, J&equals;7.4), 7.58 (d, 2 H, J&equals;5.1), 7.39 (t, 2 H, J&equals;7.0), 7.30 (dt, 2H, J&equals;6.2, 1.2), 5.85 (d, 1 H, J&equals;7.8, N-H), 4.60 (m, 1H), 4.43-4.34 (m, 1H), 4.22 (t, 1 H, J&equals;6.9), 3.25 (dd, 1H, J&equals;18.3, 4.0), 2.99 (dd, 1H J&equals;15.5, 4.0), 2.19 (s, 3H, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>); C</PDAT><HIL><SP><PDAT>13 </PDAT></SP></HIL><PDAT>NMR (100 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;175.5, 156.2, 143.7, 143.6, 141.2, 127.7, 127.0, 125.0, 120.0, 119.8, 67.3, 49.5, 47.0, 45.0; FAB-HRMS calcd for C</PDAT><HIL><SB><PDAT>20</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>20</PDAT></SB></HIL><PDAT>NO</PDAT><HIL><SB><PDAT>5 </PDAT></SB></HIL><PDAT>(M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) 354.1341, found 354.1334.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="1"><PTEXT><PDAT>10. Fields, G. B.; Noble, R. L. </PDAT><HIL><ITALIC><PDAT>Int. J. Peptide Protein Res. </PDAT></ITALIC></HIL><PDAT>1990, 35, 161-214.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="1"><PTEXT><PDAT>11. (a) Bulet, P.; Dimarcaq, J.-L.; Hetru, C.; Lagueux, M.; Charlet, M.; Hegy, G.; Dorsselar, A. V.; Hoffman, J. A. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>1993, 268, 14893-14897. (b) Bulet, P.; Urge, L.; Ohresser, S.; Hetru, C.; Otvos, L. </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem. </PDAT></ITALIC></HIL><PDAT>1996, 238, 64-69.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="1"><PTEXT><PDAT>12. ES-MS: calcd for peptide 4 (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) 2173, found m/z 2173.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="1"><PTEXT><PDAT>13. Coumarin iodoacetamide and flourescein thiosemicarbazide were purchased from Molecular Probes (cat. &num; C-404 and F-121, respectively).</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="1"><PTEXT><PDAT>14. (a) Haugland, R. </PDAT><HIL><ITALIC><PDAT>Molecular Probes Handbook of Fluorescent Probes and Research Chemicals; </PDAT></ITALIC></HIL><PDAT>6th ed. 1996. (b) Theilen, T. P. G. M.; Maassen, J. A.; Kriek, J.; Moller, W. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1984, 23, 6668-6674. (c) Odom, O. W.; Deng, H. Y.; Dabbs, E. R.; Hardesty, B. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1984, 23, 5069-5076.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="1"><PTEXT><PDAT>15. Reversed-phase (C</PDAT><HIL><SB><PDAT>18</PDAT></SB></HIL><PDAT>) HPLC conditions: Elution gradient: CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN (B) in H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (A), both with 0.1% TFA (10&oslash;60% B, over 50 min). ES-MS: calcd for peptide 7 (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) 2939, found m/z 2939.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE II</PDAT></STEXT></H>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>Synthesis of an oxime-linked neoglycopeptide with glycosylation-dependent activity similar to its native counterpart.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>Abstract: Neoglycopeptides containing an oxime sugar-peptide linkage can be generated by coupling an aminooxy sugar with a peptide bearing a keto-amino acid. The coupling reaction can be executed in aqueous milieu without need for protecting groups on the peptide or saccharide, or auxiliary coupling reagents. Using this method, an oxime-linked analog of an antimicrobial peptide with glycosylation-dependent function was prepared and found to have similar bioactivity to the native glycopeptide. Thus, replacement of the sugar-peptide bond with an unnatural but synthetically facile linkage can produce functional neoglycopeptides. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00006">
<CHEMCDX ID="CHEMCDX-00006" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00006.CDX"/>
<CHEMMOL ID="CHEMMOL-00006" ALT="chemistry mol file" FILE="US06465612-20021015-C00006.MOL"/>
<EMI ID="EMI-C00006" ALT="embedded image" HE="282.28095" WI="215.8002" FILE="US06465612-20021015-C00006.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>An appealing strategy for the assembly of glycopeptides is the convergent coupling of an oligosaccharide with a pre-formed peptide. While this strategy has been implemented in the synthesis of N-linked glycopeptides,</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>O-linked glycopeptides have been prohibitive due to the difficulty in forming a glycosidic bond in the presence of multifunctional proteins and carbohydrates. However, if the native glycosidic linkage between the sugar and the peptide backbone were replaced with an alternate non-native linkage, a convergent synthesis of O-linked glycopeptides could be realized. To date, this strategy has not been widely explored, perhaps due to the suggestion that the proximal GalNAc residue of O-linked glycoproteins plays a role in modulating local peptide conformnation.</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>However, the importance of the native sugar-peptide linkage for the bioactivity of O-linked glycopeptides, especially those with glycosylation-dependent function, has yet to be addressed. It may be that in some cases this linkage can be substituted without dramatically altering global structure or function. The complexity of glycopeptide synthesis could certainly be reduced by replacing the sugar-peptide linkage with a more facile bond.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>We synthesized an O-linked glycopeptide with glycosylation-dependent activity (1) and a neoglycopeptide analog (2) in which the sugar and peptide are linked by an oxime (Formulae 1 a). Glycopeptide 1, named drosocin, is an antimicrobial substance produced by insects in response to immune challenge, and its potency in blocking bacterial growth is enhanced approximately five-fold by the presence of a GalNAc residue at Thr11.</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>A similar glycosylation-induced enhancement in potency is observed for other drosocin glycoforms,</PDAT><HIL><SP><PDAT>3,4 </PDAT></SP></HIL><PDAT>suggesting that the glycan exerts a conformational influence on the peptide. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00007">
<CHEMCDX ID="CHEMCDX-00007" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00007.CDX"/>
<CHEMMOL ID="CHEMMOL-00007" ALT="chemistry mol file" FILE="US06465612-20021015-C00007.MOL"/>
<EMI ID="EMI-C00007" ALT="embedded image" HE="300.51" WI="210.7539" FILE="US06465612-20021015-C00007.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00040" LVL="7"><PTEXT><PDAT>Formulae 1a. Native drosocin (1), bearing a proximal GalNAc residue attached in an &agr;-glycosidic linkage to Thr11, and a drosocin neoglycopeptide (2) bearing an oxime-linked &agr;-GalNAc residue. The recited amino acid sequence, &ldquo;GKPRPYSPRP&rdquo;, is SEQ ID NO:2, and the sequence &ldquo;SHPRPIRV&rdquo; is SEQ ID NO:3.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>We envisioned that the oxime-linked neoglycopeptide (2) could be obtained from the highly selective reaction of an aminooxy sugar with a peptide bearing an unnatural ketone side chain. The ketone group is chemically orthogonal to all natural amino acid side chains and reacts with aminooxy groups in a highly specific manner, allowing site-specific conjugation without the requirement for protecting groups on the sugar or peptide. While methods for the synthesis of neoglycopeptides bearing other nominative linkages are well known,</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>the majority of these methods involve the coupling of electrophilic carbohydrate derivatives with nucleophilic amino acids. For example, bromoacetamides</PDAT><HIL><SP><PDAT>5d </PDAT></SP></HIL><PDAT>or isothiocyanates</PDAT><HIL><SP><PDAT>5e </PDAT></SP></HIL><PDAT>can be coupled with exposed cysteine or lysine residues, respectively. However, in the presence of several copies of these nucleophilic residues, such methods are not site selective.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>As described elsewhere herein, unprotected ketone groups can be incorporated into a peptide using Fmoc-protected (2S)-aminolevulinic acid (3) by solid-phase peptide synthesis (SPPS) (Scheme 1a). We generated keto-drosocin (4) in this fashion, in which the (2S)-aminolevulinic acid residue replaced Thr11, the natural site of glycosylation. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00008">
<CHEMCDX ID="CHEMCDX-00008" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00008.CDX"/>
<CHEMMOL ID="CHEMMOL-00008" ALT="chemistry mol file" FILE="US06465612-20021015-C00008.MOL"/>
<EMI ID="EMI-C00008" ALT="embedded image" HE="197.5428" WI="215.8002" FILE="US06465612-20021015-C00008.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>The aminooxy sugar, &agr;-GalNAc derivative 7 (Scheme 2), was generated from glycosyl chloride 5</PDAT><HIL><SP><PDAT>7 </PDAT></SP></HIL><PDAT>using a method similar to that reported by Roy and coworkers.</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>Compound 5 was reacted with N-hydroxysuccinimide (NHS) to afford the &agr;-NHS glycoside 6. Reductive acetylation of the azide, followed by deprotection of the acetyl esters and succinimido group provided the desired aminooxy sugar (7).</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00009">
<CHEMCDX ID="CHEMCDX-00009" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00009.CDX"/>
<CHEMMOL ID="CHEMMOL-00009" ALT="chemistry mol file" FILE="US06465612-20021015-C00009.MOL"/>
<EMI ID="EMI-C00009" ALT="embedded image" HE="197.316" WI="215.8002" FILE="US06465612-20021015-C00009.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00044" LVL="7"><PTEXT><PDAT>Reagents and conditions: (a) N-hydroxysuccinimide, Bu</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>N(HSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>), 1:1 CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/1 M Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, 52%; (b) H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, 10% Pd/C, Ac</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 100%; (c) H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>&sup;H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 71%.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>The coupling reaction of keto-drosocin (4) with aminooxy GalNAc (7) was carried out in 1.0 M NaOAc buffer, pH 5.5 at 37&deg; C. (Formulae 2a). The progress of the reaction was monitored by reversed-phase HPLC. The reaction was essentially complete after eight hours, as indicated by the presence of a single peak in the HPLC trace. No significant byproducts were observed. and the identity of the drosocin neoglycopeptide (2) was confirmed by electrospray ionization mass spectrometry (ESI-MS).</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>In order to evaluate the functional consequences of replacing the glycosidic linkage at Thr11 with an unnatural oxime linkage, we evaluated the bacteriostatic activity of neoglycopeptide 2 and compared its activity to both native (1) and unglycosylated drosocin.</PDAT><HIL><SP><PDAT>10 </PDAT></SP></HIL><PDAT>The oxime-linked neoglycopeptide (2) was found to be four-fold more potent in blocking bacterial growth (IC</PDAT><HIL><SB><PDAT>50</PDAT></SB></HIL><PDAT>&equals;0.16&plusmn;0.04 &mgr;M) than unglycosylated drosocin (IC</PDAT><HIL><SB><PDAT>50</PDAT></SB></HIL><PDAT>&equals;0.63&plusmn;0.05 &mgr;M), and similar in potency to native drosocin (1) (IC</PDAT><HIL><SB><PDAT>50</PDAT></SB></HIL><PDAT>&equals;0.10&plusmn;0.02 &mgr;M). These results indicate that the native sugar-peptide linkage in drosocin is not essential to achieve glycosylation-dependent enhancement in potency. Analagous results are obtained with other O-linked glycopeptides. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00010">
<CHEMCDX ID="CHEMCDX-00010" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00010.CDX"/>
<CHEMMOL ID="CHEMMOL-00010" ALT="chemistry mol file" FILE="US06465612-20021015-C00010.MOL"/>
<EMI ID="EMI-C00010" ALT="embedded image" HE="184.81365" WI="205.22565" FILE="US06465612-20021015-C00010.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00047" LVL="7"><PTEXT><PDAT>Formulae 2a. Coupling reaction of keto-drosocin (4) with aminooxy GalNAc (7) to give oxime-linked neoglycopeptide 2. The recited amino acid sequence, &ldquo;GKPRPYSPRP&rdquo;, is SEQ ID NO:2, and the sequence &ldquo;SHPRPIRV&rdquo; is SEQ ID NO:3.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>In summary, we have shown that a functional neoglycopeptide can be synthesized by the condensation of an aminooxy sugar with a keto-peptide. There are several convenient features of this approach. First, this method obviates the need for the cunibsersome assembly of glycosylated amino acids typically used in the synthesis of native O-linked glycopeptides.</PDAT><HIL><SP><PDAT>11 </PDAT></SP></HIL><PDAT>Second, the carbohydrate can be installed at a user-defined location within any given peptide without concern for differential protection of amino acid side chains. Third, the highly selective coupling reaction is carried out under aqueous conditions without use of auxiliary coupling reagents. Furthermore, the only byproduct of the reaction is water, minimizing the need for purification. Finally, a variety of neoglycopeptides can be obtained from a single keto-peptide using this convergent synthetic strategy.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>REFERENCES AND NOTES</PDAT></STEXT></H>
<PARA ID="P-00049" LVL="1"><PTEXT><PDAT>1. (a) Anisfeld, S. T.; Lansbury, J. P. T. </PDAT><HIL><ITALIC><PDAT>J. Org. Chem. </PDAT></ITALIC></HIL><PDAT>1990, 55, 5560-5562. (b) Cohen-Anisfeld, S. T.; Lansbury, J. P. T. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1993, 115, 10531-10537. (c) Roberge, J.; Beebe, X.; Danishefsky, S. J.; </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1995, 269, 202-204. (d) Danishefsky, S. J.; Hu, S.; Cirillo, P. F.; Eckhardt, M.; Seeberger, P. </PDAT><HIL><ITALIC><PDAT>Chem. Eur. J. </PDAT></ITALIC></HIL><PDAT>1997, 3, 1617-1628.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="1"><PTEXT><PDAT>2. (a) Andreotti, A. H.; Kahne, D. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1993, 115, 3352-3353. (b) Liang, R.; Andreotti, A. H.; Kahne, D. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 10395-10396. (c) Maeji, N. J.; Inoue, Y.; Ch&ucirc;j&ocirc;, R. </PDAT><HIL><ITALIC><PDAT>Biopolymers </PDAT></ITALIC></HIL><PDAT>1987, 26, 1753-1767.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="1"><PTEXT><PDAT>3. (a) Bulet, P.; Urge, L.; Ohresser, S.; Hetru, C.; Otvos, L. </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem. </PDAT></ITALIC></HIL><PDAT>1996, 238, 64-69. (b) Bulet, P.; Dimarcq, J.-L.; Hetru, C.; Languex, M.; Charlet, M.; Hegy, G.; Dorsselar, A. V.; Hoffman, J. A. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>1993, 268, 14893-14897.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="1"><PTEXT><PDAT>4. Rodriguez, E. C.; Winans, K. A.; King, D. S.; Bertozzi, C. R. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1997, 119, 9905-9906.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="1"><PTEXT><PDAT>5. (a) Stowell, C. P.; Lee, Y. C. </PDAT><HIL><ITALIC><PDAT>Neoglycoproteins: The Preparation and Application of Synthetic Glycoproteins; </PDAT></ITALIC></HIL><PDAT>Academic Press: San Francisco, 1980; Vol. 37, pp 225-281. (b) Mangusson, G.; Chemack, A. Y.; Kihlberg, J.; Kononov, L. O. </PDAT><HIL><ITALIC><PDAT>Synthesis of Neoglycoconjugates; </PDAT></ITALIC></HIL><PDAT>Academic Press: San Diego, 1994. (c) Lee, Y. C.; Lee, R. T. </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol. </PDAT></ITALIC></HIL><PDAT>1994, 242, 3-123. (d) Wong, S. Y. C.; Guile, G.; Dwek, R.; Arsequell, G. </PDAT><HIL><ITALIC><PDAT>Biochem. J. </PDAT></ITALIC></HIL><PDAT>1994, 300, 843-850. (e) Mulins, R. E.; Langdon, R. G. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1980, 19, 1199-1205.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="1"><PTEXT><PDAT>6. Marcaurelle, L. A.; Bertozzi, C. R., preceeding paper.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="1"><PTEXT><PDAT>7. Lemieux, R. U.; Ratcliffe, R. M. </PDAT><HIL><ITALIC><PDAT>Can. J. Chem. </PDAT></ITALIC></HIL><PDAT>1979, 57, 1244-1251.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="1"><PTEXT><PDAT>8. Cao, S.; Tropper, F. D.; Roy, R. </PDAT><HIL><ITALIC><PDAT>Tetrahedron </PDAT></ITALIC></HIL><PDAT>1995, 51, 6679-6686.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="1"><PTEXT><PDAT>9. Characterization of aminooxy-2-acetamido-2-deoxy-&agr;-D-galactopyranoside (7): </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (300 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;4.97 (d, 1 H, J&equals;4.0), 4.23 (dd, 1 H, J&equals;11.3, 4.0), 4.00 (m, 2 H), 3.81 (m, 3 H), 2.06 (s, 3 H); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (100 MHz,): &dgr;174.55, 100.55, 70.93, 68.34, 67.49, 61.07, 49.11, 21.83; FAB-HRMS calcd for C</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>(M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) 237.1087, found 237.1084.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="1"><PTEXT><PDAT>10. The growth inhibition assay was performed essentially as described by Bulet et al.</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>Sterile 96-well plates were used, with a final volume of 100 &mgr;L per well. This volume consisted of 90 &mgr;L of mid-logarithmnic phase culture of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>D22 in LB media containing streptomycin (50 &mgr;g/mL), added to 10 &mgr;L of serially diluted peptide (native drosocin (1), unglycosylated drosocin or neoglycopeptide 2) in water. Final peptide concentrations ranged from 10</PDAT><HIL><SP><PDAT>&minus;8 </PDAT></SP></HIL><PDAT>to 10</PDAT><HIL><SP><PDAT>&minus;5 </PDAT></SP></HIL><PDAT>M. Plates were incubated for 24 h at rt. Bacterial growth was determined by measuring the absorbance at 415 nm on a BioRad 550 microplate reader. Measurements were taken at t&equals;0 h and t&equals;24 h, and the change in absorbance (optical density) was recorded.</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="1"><PTEXT><PDAT>11. (a) Meldal, M.; St. Hiliare, P. M. </PDAT><HIL><ITALIC><PDAT>Curr. Opin. Chem. Biol. </PDAT></ITALIC></HIL><PDAT>1997, 1, 552-563. (b) Mathieux, N.; Paulsen, H.; Meldal, M.; Block, K. </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc., Perkin Trans. </PDAT></ITALIC></HIL><PDAT>1 1997, 2259-2364. (c) Sames, D.; Chen, X.-T.; Danishefsky, S. J. </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>1997, 389, 587-591.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE III</PDAT></STEXT></H>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>Aminooxy, hydrazide and theosemicarbazide-functionalized saccharides: versatile reagents for glycoconjugate synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>ABSTRACT: Saccharides functionalized at their reducing termini with aminooxy, hydrazide or thiosemicarbazide groups are versatile reagents for the synthesis of glycoconjugates using chemoselective ligation reactions. They can be prepared from aminoglycosides without the requirement for protecting groups on the saccharide. Novel neoglycopeptides were constructed by the condensation of aminooxy and thiosemicarbazide-functionalized oligosaccharides with ketone groups on an unprotected peptide scaffold. In this fashion, we synthesized neoglycopeptides bearing the chitobiosyl moiety found in N-linked glycopeptides, or a sialyl Lewis x motif found in O-linked glycopeptides.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>Organic chemists have exercised significant creativity in the construction of glycoconjugate assemblies as tools for studying carbohydrate recognition and as potential therapeutic agents.</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>These synthetic accomplishments, which include neoglycoproteins</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>, glycodendrimers</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>, glycoliposomes</PDAT><HIL><SP><PDAT>4 </PDAT></SP></HIL><PDAT>and glycopolymers</PDAT><HIL><SP><PDAT>5</PDAT></SP></HIL><PDAT>, have been sparked by the growing realization that glycoconjugates participate in a wide range of normal and pathophysiological processes.</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>Given the importance of glycoconjugates as tools for glycobiology and as emerging pharmaceutical reagents, new methods for attaching sugars to scaffolds are of significant current interest.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>The highly selective condensation reactions of ketones or aldehydes with aminooxy, hydrazide or thiosemicarbazide groups (forming oximes, hydrazones and thiosemicarbazones, respectively) are popular for the conjugation of peptides and proteins.</PDAT><HIL><SP><PDAT>7,8 </PDAT></SP></HIL><PDAT>The reactions proceed in aqueous solvent and their high selectivity obviates the requirement for protection of other functional groups on the coupling partners. Despite the utility of these &lsquo;chemoselective ligation&rsquo; reactions</PDAT><HIL><SP><PDAT>7,8 </PDAT></SP></HIL><PDAT>in the assembly of peptide-based macromolecules, their implementation in glycoconjugate synthesis is limited to a few examples.</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>The majority of current methods for attaching sugars to scaffolds involve the coupling of electrophilic carbohydrate derivatives with exposed thiol or amino groups. The electrophilic derivatives include &agr;-haloacetamides,</PDAT><HIL><SP><PDAT>10 </PDAT></SP></HIL><PDAT>bromoethyl glycosides,</PDAT><HIL><SP><PDAT>11 </PDAT></SP></HIL><PDAT>maleimides,</PDAT><HIL><SP><PDAT>12 </PDAT></SP></HIL><PDAT>and isothiocyanates.</PDAT><HIL><SP><PDAT>13 </PDAT></SP></HIL><PDAT>Here we report an alternate ligation strategy based on the coupling of nucleophilic carbohydrate derivatives to synthetic scaffolds. We synthesized carbohydrates bearing aminooxy, hydrazide or thiosemicarbazide groups at their reducing termini, and coupled two of these derivatives to ketone groups on a peptide scaffold. The novel neoglycopeptides produced in this fashion have structural motifs shared by native N-linked or O-linked glycopeptides.</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>The direct attachment of an aminooxy group to the reducing terminus of a mono- or disaccharide can be accomplished by formation of the N-hydroxysuccinimido (NHS) glycoside</PDAT><HIL><SP><PDAT>15 </PDAT></SP></HIL><PDAT>followed by cleavage of the succinimide group with hydrazine, a strategy first reported by Roy and coworkers.</PDAT><HIL><SP><PDAT>15b </PDAT></SP></HIL><PDAT>Accordingly, we synthesized &bgr;-linked aminooxy analogs of galactose (4), N-acetylglucosamine (GlcNAc) (5) and lactose (6) from the corresponding protected NHS glycosides 1, 2 and 3, respectively (Scheme 1b). In addition, we prepared an &agr;-aminooxy GalNAc derivative (8) to mimic of the peptide-proximal &agr;-GalNAc residue found in O-linked glycoproteins. This was achieved by first generating the &agr;-NHS glycoside of peracetylated 2-azido-2-deoxy galactose by reaction of azido chloride 7</PDAT><HIL><SP><PDAT>16 </PDAT></SP></HIL><PDAT>with NHS. Subsequent reductive acetylation of the azide and deprotection with hydrazine furnished the desired analog.</PDAT><HIL><SP><PDAT>17 </PDAT></SP></HIL></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>The simple aminooxy sugars 4-6 and 8 can be transformed into more complex oligosaccharides using established enzymatic methods.</PDAT><HIL><SP><PDAT>18 </PDAT></SP></HIL><PDAT>As an example, we synthesized an aminooxy-functionalized analog of the tetrasaccharide sialyl Lewis x (NeuAc&agr;2&oslash;3Gal&bgr;1&oslash;4(Fuc&agr;1&oslash;3)GlcNAc), a motif recognized by the selectin family of adhesion molecules that has been explored as a selectin inhibitorin the form of many different conjugated assemblies.</PDAT><HIL><SP><PDAT>19 </PDAT></SP></HIL><PDAT>Aminooxy lactose (6) was converted to the corresponding sialyllactose analog using an &agr;(2,3)-sialyltransferase (&agr;(2,3)-ST) and the glycosyl donor CMP-sialic acid. Without isolation, aminooxy sialyllactose was fucosylated using an &agr;(1,3)-fucosyltransferase (&agr;(1,3)-FucT) with GDP-fucose as the glycosyl donor affording sialyl Lewis x analog 9 (Scheme 2b).</PDAT><HIL><SP><PDAT>20,21 </PDAT></SP></HIL><PDAT>The presence of the aminooxy group did not adversely affect the course of the enzymatic reactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>In order to generate complex oligosaccharide coupling partners without the use of glycosyltransferases, we required a strategy for functionalizing the reducing terminus with minimal protecting group manipulations. We therefore developed methods for the synthesis of aminooxy, hydrazide and thiosemicarbazide-functionalized sugars that employ the well-known Kochetkov procedure</PDAT><HIL><SP><PDAT>22 </PDAT></SP></HIL><PDAT>for generating glycosylamines from unprotected free-reducing sugars. &bgr;-Amino lactose (10) was prepared by stirring the free disaccharide in a concentrated solution of NH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>HCO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>.</PDAT><HIL><SP><PDAT>22b </PDAT></SP></HIL><PDAT>Aminooxy and hydrazide groups were then introduced as depicted in Scheme 3b. Compound 10 was coupled with N-(t-butoxycarbonyl)aminooxyacetic acid and subsequently deprotected with TFA to give aminooxy sugar 12. The coupling reaction of 10 with monomethyl succinate, followed by treatment with hydrazine gave hydrazide 14.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>The most efficiently prepared saccharide derivatives for chemoselective ligation reactions were glycosyl thiosemicarbazides, prepared from the corresponding isothiocyanates</PDAT><HIL><SP><PDAT>23 </PDAT></SP></HIL><PDAT>as shown in Scheme3b. &bgr;-Amino lactose (10) was reacted with thiophosgene</PDAT><HIL><SP><PDAT>24 </PDAT></SP></HIL><PDAT>in aqueous solution to give the corresponding isothiocyanate (16). Without isolation, the isothiocyanate (16) was immediately converted to thiosemicarbazide 18 by treatment with hydrazine. The same procedure when applied to &bgr;-amino chitobiose (15)</PDAT><HIL><SP><PDAT>24a </PDAT></SP></HIL><PDAT>furnished thiosemicarbazide 19. The overall yields of the isolated thiosemicarbazides ranged from 50-70%. The synthesis of compound 19 highlights the utility of this procedure for transforming small amounts of precious oligosaccharides into suitable coupling partners.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>Finally, we constructed neoglycopeptides containing motifs found in naturally occurring N- and O-linked glycopeptides by coupling the nucleophilic sugars to a synthetic peptide fashioned with a ketone group (20, Formulae 1b). Keto-peptide 20 was synthesized by the direct incorporation of (2S)-aminolevulinic acid into the peptide during Fmoc-based solid-phase synthesis, a procedure we have recently reported.</PDAT><HIL><SP><PDAT>24 </PDAT></SP></HIL><PDAT>We reacted keto-peptide 20 with chitobiose thiosemicarbazide (19) to afford neoglycopeptide 21, a structure that resembles the core chitobiosyl-asparagine motif shared by all N-linked glycoproteins (Formulae 1b).</PDAT><HIL><SP><PDAT>25 </PDAT></SP></HIL><PDAT>The coupling reaction of keto-peptide 20 with aminooxy sialyl Lewis x analog 9 produced neoglycopeptide 22, which resembles the O-linked glycopeptides that function as native selectin ligands.</PDAT><HIL><SP><PDAT>26 </PDAT></SP></HIL><PDAT>It should be emphasized that these condensation reactions proceed in aqueous solvent without need for auxiliary reagents. In addition, subsequent purification is straightforward as the only other product of the reaction is water. The facile construction of neoglycopeptides related to native N- and O-linked structures underscores the utility of this approach for glycoconjugate synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>Synthetic procedures for compounds 4-6, 8, 9, 12, 14, 18 and 19:</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>General methods: All chemical reagents were obtained from commercial suppliers and used without further purification. &agr;(2,3)-Sialyltransferase, &agr;(1,3)-ficosyltransferase, CMP-sialic acid and GDP-fucose were purchased from Calbiochem. Flash chromatography was performed using 230-400 mesh silica gel 60 (E. Merck No 9385). Analytical thin layer chromatography (tlc) was conducted on Analtech Uniplate silica gel plates with detection by ceric ammonium molybdate, p-anisaldehyde, ninhydrin and/or UV light. Unless otherwise specified, all reactions were conducted at rt. High-pressure liquid chromatography (HPLC) was performed on a Rainin Dynamax SD-200 system using Microsorb and Dynamax aminopropyl and C</PDAT><HIL><SB><PDAT>18 </PDAT></SB></HIL><PDAT>columns (particle size 5 &mgr;m; analytical column: 4.6 mm ID&times;25 cm, 1 mL/min; semi-preparative column: 10 mm ID&times;25 cm, 3 mL/min), and UV detection (200 or 230 nm) was performed with a Rainin Dynamax UV-1 detector. It is important to note that use of low wavelengths (200 nm) was important for detecting aminooxy sugar derivatives which have very low extinction coefficients. The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H- and </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR spectra were obtained at either 400 or 500 MHz with Bruker AMX-400 and DRX-500 spectrometers. Chemical shifts are reported in &dgr; values downfield from tetramethylsilane (TMS) and coupling constants are reported in Hz.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>Aminooxy-&bgr;-D-galactopyranoside (4). Compound 1 (1.0 g, 2.2 mmol) was dissolved in 25 mL of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>(55%) and the solution was stirred at rt overnight. The reaction mixture was concentrated in vacuo, filtered and purified by HPLC on aminopropyl silica gel (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (100:0&oslash;55:45 over 60 min) to provide 0.38 g (86%) of 4. (The product has low UV absorbtivity relative to the other products, butanedioic hydrazide and acetyl hydrazide, and tends to elute closely following butanedioic hydrazide during HPLC purification). </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (400 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;3.50 (app t, 1 H, J&equals;9.0), 3.65 (dd, 1 H, J&equals;6.8,9.9), 3.70 (m, 3 H), 3.90 (d, 1 H, J&equals;3.3), 4.50 (d, 1 H, J&equals;8.1); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (100 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;63.58, 71.14, 71.89, 75.35, 77.65, 108.11; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>14</PDAT></SB></HIL><PDAT>NO</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>196.0821, found 196.0819.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>Aminooxy-2-acetamido-2-deoxy-&bgr;-D-glucopyranoside (5). Compound 2 (100 mg, 0.2 mmol) was dissolved in 20 mL of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>(55%) and the solution was stirred at rt overnight. The reaction mixture was concentrated in vacuo, filtered and purified by aminopropyl silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (100:0&oslash;60:40 over 75 min) to provide 29 mg (55%) of 5. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;2.01 (s, 3 H), 3.43 (m, 2 H), 3.52 (app t, 1 H, J&equals;8.6), 3.69 (dd, 1 H, J&equals;9.1, 10.5), 3.73 (dd, 1 H, J&equals;5.5, 12.3), 3.91 (dd, 1 H, J&equals;1.8, 12.2), 4.75 (d, 1 H, J&equals;8.8); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;22.01, 53.74, 60.58, 69.67, 73.69, 75.71, 103.55, 174.69; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>6 </PDAT></SB></HIL><PDAT>237.1087, found 237.1082.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>Aminooxy-&bgr;-D-lactoside (6). Compound 3 (0.50 g, 0.68 mmol) was dissolved in 6.8 mL of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>(55%) and the solution was stirred at rt overnight. The reaction was concentrated in vacuo, filtered and purified by aminopropyl silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (100:0&oslash;50:50 over 90 min) to provide 0.20 g (81%) of 6. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;3.33 (app t, 1 H, J&equals;9.2), 3.52 (dd, 1 H, J&equals;7.8, 9.9), 3.81-3.60 (m, 8 H), 3.90 (d, 1 H, J&equals;3.3), 3.98 (dd, 1 H, J&equals;2.1, 12.3), 4.42 (d, 1 H, J&equals;7.8), 4.57 (d, 1 H, J&equals;8.3); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (100 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;60.15, 61.12, 68.65, 71.05, 71.46, 72.62, 74.53, 74.81, 75.45, 78.30, 103.03, 104.94; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>24</PDAT></SB></HIL><PDAT>NO</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>358.1349, found 358.1350.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>2-Azido-2-deoxy-3,4,6-tri-O-acetyl-&agr;-D-galactopyranosyl hydroxysuccin-imide (8a). To a solution of N-hydroxysuccinimide (1.3 g, 7.5 mmol) and tetrabutylammonium hydrogensulfate (0.79 g, 2.3 mmol) in 1 M Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(11.5 mL) was added a solution of 7 (0.81 g, 2.3 mmol) in CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(11.5 mL). The biphasic mixture was stirred vigorously for 24 h, diluted with CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(50 mL), and washed with H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2&times;25 mL) and brine (40 mL). The aqueous layers were extracted with CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, and the combined organic layers were dried (Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>) and concentrated in vacuo. The crude product was purified by silica gel chromatography (100:1 CHCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>/MeOH) to yield 0.41 g (52%) of 8a as mixture of anomers (4:1 &agr;/&bgr;)._The &agr;-anomer was isolated as a white solid upon trituration with CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/hexanes. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;2.05 (s, 3 H), 2.07 (s, 3 H), 2.15 (s, 3 H), 2.77 (s, 4 H), 3.92 (m, 2 H), 4.21 (dd, 1 H, J&equals;6.5, 11.3), 5.09 (app t, 1 H, J&equals;7.2), 5.45 (dd, 1 H, J&equals;3.2, 11.5), 5.52 (d, 1 H, J&equals;3.7), 5.56 (dd, 1 H, J&equals;1.4, 3.1); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;22.11, 22.22, 26.81, 57.10, 61.59, 67.56, 67.91, 69.18, 101.51, 167.00, 167.32, 167.80, 167.86; FAB-MS: Calcd. for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>20</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>428, found m/z 429 (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>). Anal. Calcd. for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>20</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>: C, 44.86; H, 4.71; N, 13.08. Found: C, 44.82; H, 4.54; N, 13.03.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>2-Acetamido-2-deoxy-3,4,6,-tri-O-acetyl-&agr;-D-galactopyranosyl hydroxy-succinimide (8b). To a solution of 8a (56 mg, 0.13 mmol) and 10% Pd/C (11 mg) in 1:1 MeOH/CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(3 mL) was added acetic anhydride (25 &mgr;L, 0.26 mmol). The mixture was stirred under an atmosphere of H</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>gas at rt. After 3.5 h, the reaction mixture was filtered through Celite and concentrated in vacuo to give 58 mg (100%) of compound 8b. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;2.00 (s, 3 H), 2.04 (s, 3 H), 2.07 (s, 3 H), 2.15 (s, 3 H), 2.73 (s, 4 H), 3.93 (dd, 1 H, J&equals;6.7, 11.4), 4.25 (dd, 1 H, J&equals;5.9, 11.4), 4.73 (td, 1 H, J&equals;3.7, 9.6), 4.97 (t, 1 H, J&equals;6.0), 5.28 (m, 2 H), 5.51 (d, 1 H, J&equals;1.9), 6.10 (d, 1 H, J&equals;9.5); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;20.66, 20.72, 23.14, 25.37, 47.15, 61.59, 67.12, 67.31, 69.21, 104.20, 170.11, 170.44, 170.58, 170.61, 170.86; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd. for C</PDAT><HIL><SB><PDAT>18</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>24</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>445.1458, found 445.1467.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>Aminooxy 2-acetamido-2-deoxy-&agr;-D-galactopyranoside (8). Compound 8b (57 mg, 0.13 mmol) was dissolved in 5 mL of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>(55%) and the solution was stirred at rt overnight. The solution was concentrated in vacuo, filtered and purified by aminopropyl silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (90:10&oslash;65:35 over 60 min) to provide 26 mg (85%) of 8. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;2.06 (s, 3 H), 3.81 (m, 3 H), 4.00 (m, 2 H), 4.23 (dd, 1 H, J&equals;4.0, 11.3), 4.97 (d, 1 H, J&equals;4.0); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;21.83, 49.11, 61.07, 67.49,68.35, 70.93, 100.54, 174.56; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>30 </PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>237.1087, found 237.1084.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>Aminooxy sialyl Lewis x analog (9). To 5 mg of 7 (0.014 mmol) was added in succession water (105 &mgr;L), 0.5 M HEPES (14 &mgr;L, pH 7.4), 25% Triton CF-54 (2.8 &mgr;L), and 5% BSA (2.2 &mgr;L). To this solution was added CMP-sialic acid (10 mg, 0.014 mmol) followed by &agr;(2,3)-sialyltransferase (12.5 &mgr;L, 1 mU/&mgr;L), and calf intestinal alkaline phosphatase (CIAP) (2.9 &mgr;L, 1 U/&mgr;L, Sigma). The reaction was incubated for 5 d at rt. To the reaction mixture was then added water (18 &mgr;L), 0.5 M HEPES (5 &mgr;L, pH 7.4), 1.0 M MnCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(1 &mgr;L), and GDP-fucose (9 mg, 0.014 mmol). &agr;(2-3)-Fucosyltransferase (E.C. 2.4.1.65) (25 mL, 0.5 mU/mL) and CIAP (1 &mgr;L) were added and the reaction was incubated at rt for an additional 5 d. The solution was filtered through an Amicon 3 kDa membrane and purified by aminopropyl silica gel HPLC (195 nm detection) eluting with 74:26 CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN/15 mM KH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, pH 5.2, to provide compound 9. Due to the presence of buffer salts in the eluant, an isolated yield could not be accurately determined, but HPLC analysis of the enzymatic reactions indicated approximately 60% conversion to 9. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;1.17 (d, 1 H, J&equals;6.7), 1.79 (t, 1 H, J&equals;12.1), 2.03 (s, 3 H, NHCOCH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>), 2.76 (dd, 1 H, H-3&Prime;</PDAT><HIL><SB><PDAT>eq</PDAT></SB></HIL><PDAT>, J</PDAT><HIL><SB><PDAT>3&Prime;eq,4&Prime;</PDAT></SB></HIL><PDAT>&equals;4.6, J</PDAT><HIL><SB><PDAT>3&Prime;eq,3&Prime;ax</PDAT></SB></HIL><PDAT>&equals;12.5), 3.34 (br t, 1 H, H-2), 3.94 (d, 1 H, H-4&prime;, J</PDAT><HIL><SB><PDAT>4&prime;,3&prime;</PDAT></SB></HIL><PDAT>&equals;3.3) 4.02 (dd, 1 H, H-6</PDAT><HIL><SB><PDAT>a</PDAT></SB></HIL><PDAT>, J</PDAT><HIL><SB><PDAT>6a,5</PDAT></SB></HIL><PDAT>&equals;2.1, J</PDAT><HIL><SB><PDAT>6a,6b</PDAT></SB></HIL><PDAT>&equals;12.3), 4.08 (dd, 1 H, H-3&prime;, J&equals;3.2, J</PDAT><HIL><SB><PDAT>3&prime;,2&prime;</PDAT></SB></HIL><PDAT>&equals;10.0), 4.49 (d, 1 H, H-1, J</PDAT><HIL><SB><PDAT>1,2</PDAT></SB></HIL><PDAT>&equals;7.8), 4.59 (d, 1 H, H-1&prime;, J</PDAT><HIL><SB><PDAT>1&prime;,2&prime;</PDAT></SB></HIL><PDAT>&equals;8.3), 5.43 (d, 1 H, J&equals;4.0).</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>Compound 11. To a solution of N-(t-butoxycarbonyl)aminooxyacetic acid (31 mg, 0.16 mmol) in DMSO (1 mL) was added DIEA (76 mL, 0.44 mmol), compound 10 (50 mg, 0.15 mmol), and BOP (80 mg, 0.17 mmol) in succession. The clear yellow solution was stirred at rt for 2 h. The crude product was precipitated from solution by the addition of 1:2 acetone/ether (12 mL), incubation at &minus;20&deg; C. for 15 min and centrifugation. A second batch of product was obtained by precipitation from the concentrated supernatant. The pooled precipitate was purified by aminopropyl silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (100:0&oslash;35:65 over 60 min) to provide 31 mg (41%) of compound 11. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;1.48 (s, 9 H), 3.54 (m, 2 H), 3.75 (m, 9 H), 3.94 (m, 2 H), 4.47 (m, 3 H), 5.07 (d, 1 H, J&equals;9.2); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;27.30, 58.78, 60.98, 68.42, 70.86, 71.43, 72.42, 74.54, 74.90, 75.29, 76.43, 77.66, 78.77, 84.02, 84.02, 102.79, 158.60, 172.34; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>19</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>35</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>14 </PDAT></SB></HIL><PDAT>515.2088, found 515.2090.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>Compound 12. Compound 11 (27 mg, 0.053 mmol) was dissolved in 3:2 CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/TFA (2 mL) and stirred at rt for 1.5 h. The solvent was removed under vacuum and crude product was dissolved in water, neutralized using weak anion exchange resin (Amberlyst) and concentrated to afford 21 mg (100%) of 12. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;3.56 (m, 2 H), 3.77 (m, 11 H), 3.94 (m, 2 H), 4.29 (d, 2 H, J&equals;0.8), 4.47 (d, 1 H, J&equals;2.6) 5.08 (d, 1 H, J&equals;9.2); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;59.71, 60.96, 68.46, 70.84, 71.29, 72.39, 73.47, 74.90, 75.26, 76.40, 77.58, 78.79, 102.77, 173.82; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>14</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>27</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>12 </PDAT></SB></HIL><PDAT>415.1564, found 415.1559.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>Compound 13. To a solution of monomethylsuccinate (22 mg, 0.16 mmol) in DMSO (1 mL) was added DIEA (76 mL, 0.44 mmol), glycosylamine 10 (50 mg, 0.15 mmol), and BOP (80 mg, 0.17 mmol) in succession. The clear yellow solution was stirred at rt for 2 h. The crude product was precipitated from solution by the addition of 1:2 acetone/ether (12 mL), incubation at &minus;20&deg; C. for 15 min and centrifugation. The pooled precipitate was purified by aminopropyl silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (100:0&oslash;35:65 over 60 min) to provide 32 mg (48%) of compound 13. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;2.68 (m, 4 H), 3.45 (app t, 1 H, J&equals;9.1), 3.56 (dd, 1 H, J&equals;7.8, 9.8), 3.74 (m, 14 H), 3.94 (m, 2 H), 4.46 (d, 1 H. J&equals;7.8) 4.99 (d, 1 H, J&equals;9.2); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;28.71, 30.08, 52.27, 59.81, 60.98, 68.49, 70.88, 71.41, 72.44, 75.00, 75.29, 76.28, 77.72, 79.04, 102.80, 175.58, 176.01; HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>15</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>28</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>12 </PDAT></SB></HIL><PDAT>456.1704, found 456.1708.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>Lactose succinic hydrazide (14). Compound 13 (31 mg, 0.67 mmol) was dissolved in 2 mL of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>(55%) and the solution was stirred at rt overnight. The reaction was concentrated in vacuo, filtered and purified by aminopropyl silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (90:10&oslash;65:35 over 60 min) to provide 18 mg (59%) of 14. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;2.52 (app t, 2 H, J&equals;6.9), 2.64 (m, 2 H), 3.44 (app t, 1 H, J&equals;9.0), 3.56 (dd, 1 H, J&equals;7.9, 8.8), 3.75 (m, 14 H), 3.94 (m, 3 H), 4.46 (d, 1 H, J&equals;7.7) 4.98 (d, 1 H, J&equals;9.2); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;28.54, 30.63, 59.78, 60.97, 68.47, 70.86, 71.39, 72.42, 74.96, 75.28, 76.28, 77.67, 79.01, 102.78, 173.62, 175.85; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>16</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>30</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>12 </PDAT></SB></HIL><PDAT>456.1829, found 456.1826.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>Lactose thiosemicarbazide (18). To a solution of 10 (50 mg, 0.15 mmol) in 3 mL of 0.3 M NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>was added thiophosgene (33 &mgr;L, 0.44 mmol). The orange solution was stirred at rt for 20 min during which the glycosyl isothiocyanate (16) was produced in quantitative yield as determined by tic analysis. To this solution was added 26 &mgr;L (0.45 mmol) of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>(55%) resulting in a bright yellow solution. This solution was stirred for 20 min at rt then concentrated in vacuo. Subsequent HPLC purification on aminopropyl silica gel &lsqb;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (90:10&oslash;65:35 over 60 min)&rsqb; afforded 29 mg (48%) of thiosemicarbazide 18. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;3.57 (dd, 1 H, J&equals;7.8, 9.9), 3.76 (m, 9 H), 3.95 (m, 2 H), 4.48 (d, 1 H, J&equals;7.8) 5.54 (br d, 1 H, J&equals;8.5); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;59.71, 60.98, 68.49, 70.87, 71.58, 72.42, 74.92, 75.28, 76.20, 77.79, 83.24, 102.82; HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>13</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>26</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>S 416.1339, found 416.1338. Appropriate precautions should be taken to avoid contact with thiophosgene; it is a highly toxic and corrosive reagent.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>Chitobiose thiosemicarbazide (19). To a solution of &bgr;-amino chitobiose 15 (9.0 mg, 0.021 mmol) in 0.3 M NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(0.5 mL) was added thiophosgene (5.1 &mgr;L, 0.067 mmol). The orange solution was stirred at rt for 30 min to give the glycosyl isothiocyanate (17) in quantitative yield as determined by tlc analysis. To the solution was then added 3.9 &mgr;L (0.070 mmol) of N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, (55% ) resulting in a bright yellow solution. This solution was stirred for 10 min at rt then concentrated in vacuo. Subsequent HPLC purification on aminopropyl silica gel &lsqb;CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (90:10&oslash;65:35 over 60 min)&rsqb; afforded 6.6 mg (62%) of thiosemicarbazide 19. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;2.00 (s, 3 H), 2.07 (s, 3 H), 3.72 (m, 12 H), 4.61 (d, 1 H, J&equals;8.5) 5.52 (d, 1 H, J&equals;9.6); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;21.79, 22.01, 53.76, 55.50, 59.91, 60.44, 69.62, 72.34, 73.34, 75.80, 75.93, 78.95, 82.52, 101.36, 174.55, 174.86; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>32</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>S 498.1870, found 498.1869. Appropriate precautions should be taken to avoid contact with thiophosgene; it is a highly toxic and corrosive reagent</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>Synthesis of neoglycopeptides 21 and 22. To 50 &mgr;L of keto-peptide 20 (50 mM) was added 10 &mgr;L of 1 M NaOAc buffer (pH 5.5) and 40 &mgr;L of 19 or 9 (100 mM). The reaction mixture was incubated at 37C. for 24 h and the corresponding product (21 or 22, respectively) was isolated by RP-HPLC with a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN: H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, both with 0.1%. TFA (10:90&oslash;30:60 over 30 min). ESI-MS: Glycopeptide 21: calcd 2690.0 (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 2986.9. Glycopeptide 22: calcd 2987.3 (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 2986.9, calcd 3009.3 (M&plus;Na</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 3009.1.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>Compound 11. To a solution of N-(t-butoxycarbonyl)aminooxyacetic acid (31 mg, 0.16 mmol) in DMSO (1 mL) was added DIEA (76 mL, 0.44 mmol), compound 10 (50 mg, 0.15 mmol), and BOP (80 mg, 0.17 mmol) in succession. The clear yellow solution was stirred at rt for 2 h. The crude product was precipated from solution by the addition of 1:2 acetone/ether (12 mL), incubation at &minus;20&deg;C. for 15 min and centrifugation. A second batch of product was obtained by precipitation from the concentrated supernatant. The pooled precipate was purified by aminopropy silica gel HPLC (200 nm detection) using a gradient of CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (100:0&oslash;35:65 over 60 min) to provide 31 mg (41%) of compound 11. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H-NMR (500 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;1.48 (s, 9 H), 3.54 (m, 2 H), 3.75 (m, 9 H), 3.94 (m, 2 H), 4.47 (m, 3 H), 5.07 (d, 1 H, J&equals;9.2); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR (125 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;27.30, 58.78, 60.98, 68.42, 70.86, 71.43, 72.42, 74.54, 74.90, 75.29, 76.43, 77.66, 78.77, 84.02, 84.02, 102.79, 158.60, 172.34; FAB-HRMS (M&plus;H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>) calcd for C</PDAT><HIL><SB><PDAT>19</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>35</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>14 </PDAT></SB></HIL><PDAT>515.2088, found 515.2090.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>REFERENCES</PDAT></STEXT></H>
<PARA ID="P-00086" LVL="1"><PTEXT><PDAT>1. (a) Roy, R. </PDAT><HIL><ITALIC><PDAT>Curr. Opin. Struct. Biol. </PDAT></ITALIC></HIL><PDAT>1996, 6, 696. (b) Roy, R. Sialoside Mimetics and Conjugates as Anti-Inflammatory Agents and Inhibitors of Flu Virus Infections. </PDAT><HIL><ITALIC><PDAT>In Carbohydrates in Drug Design; </PDAT></ITALIC></HIL><PDAT>Witczak, Z. J.; Nieforth, K. A., Eds.; Marcel Dekker: New York, 1997; Chapter 3, pp 83-135.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="1"><PTEXT><PDAT>2. Lee, Y. C.; Lee, R. T. </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol. </PDAT></ITALIC></HIL><PDAT>1994, 242, 3 and references cited therein.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="1"><PTEXT><PDAT>3. (a) Palcic, M. M.; Hong, L.; Zanini, D.; Bhella, R. S.; Roy, R. </PDAT><HIL><ITALIC><PDAT>Carbohydr. Res. </PDAT></ITALIC></HIL><PDAT>1998, 305, 433. (b) Zanini, D.; Roy, R. </PDAT><HIL><ITALIC><PDAT>J. Org. Chem. </PDAT></ITALIC></HIL><PDAT>1998, 63, 3486 and references cited therein.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="1"><PTEXT><PDAT>4. (a) Reichert, A.; Nagy, J. O.; Spevak, W.; Charych, D. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 829. (b) Spevak, D.; Foxall, C.; Charych, D. H.; Dasgupta, F.; Nagy, J. O. </PDAT><HIL><ITALIC><PDAT>J. Med. Chem. </PDAT></ITALIC></HIL><PDAT>1996, 39, 1018.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="1"><PTEXT><PDAT>5. (a) Manning, D. D.; Strong, L. E.; Hu, X.; Beck, P. J.; Kiessling, L. L. </PDAT><HIL><ITALIC><PDAT>Tetrahedron </PDAT></ITALIC></HIL><PDAT>1997, 53, 11937. (b) Roy, R.; Tropper, F. D.; Romanowski, A. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1992, 3, 265.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="1"><PTEXT><PDAT>6. Varki, A. </PDAT><HIL><ITALIC><PDAT>Glycobiol. </PDAT></ITALIC></HIL><PDAT>1993, 3, 97 and references cited therein.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="1"><PTEXT><PDAT>7. Muir, T. W. </PDAT><HIL><ITALIC><PDAT>Structure </PDAT></ITALIC></HIL><PDAT>1995, 3, 649.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="1"><PTEXT><PDAT>8. Lemieux, G. A.; Bertozzi, C. R. </PDAT><HIL><ITALIC><PDAT>Trends Biotechnol. </PDAT></ITALIC></HIL><PDAT>1998, 16(12):506-13.</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="1"><PTEXT><PDAT>9. (a) Rodriguez, E. C.; Winans, K. A.; King, D. S.; Bertozzi, C. R. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1997, 119, 9905; (b) Cervigni, S. E.; Dumy, P.; Mutter, M. </PDAT><HIL><ITALIC><PDAT>Angew. Chem., Int. Ed. Engl. </PDAT></ITALIC></HIL><PDAT>1996, 35, 1230; (c) Zhao, Y.; Kent, S. B. H.; Chait, B. T. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. U.S.A. </PDAT></ITALIC></HIL><PDAT>1997, 94, 1629.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="1"><PTEXT><PDAT>10. (a) Wong, S. Y. C.; Guile, G. R.; Dwek, R. A.; Arsequell, G. </PDAT><HIL><ITALIC><PDAT>Biochem. J. </PDAT></ITALIC></HIL><PDAT>1994, 300, 843; (b) Davis, N. J.; Flitsch, S. L. </PDAT><HIL><ITALIC><PDAT>Tetrahedron Lett. </PDAT></ITALIC></HIL><PDAT>1991, 32, 6793.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="1"><PTEXT><PDAT>11. Bengtsson, M.; Broddefalk, J.; Dahmen, J.; Henriksson, K.; Kihlberg, J.; Lonn, H.; Srinivasa, B. R.; Stenvall, K. </PDAT><HIL><ITALIC><PDAT>Glycoconjugate J. </PDAT></ITALIC></HIL><PDAT>1998, 15, 223.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="1"><PTEXT><PDAT>12. Hansen, P. R.; Olsen, C. E.; Holm, A. </PDAT><HIL><ITALIC><PDAT>Biooconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1998, 9, 126.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="1"><PTEXT><PDAT>13. (a) Mullins, R. E.; Langdon, R. G. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1980, 19, 1199; (b) For a review on glycosyl isothiocyanates see, Witczak, Z. J. </PDAT><HIL><ITALIC><PDAT>Adv. Carbohydr. Chem. Biochem. </PDAT></ITALIC></HIL><PDAT>1986, 44, 91.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="1"><PTEXT><PDAT>14. For a review on the synthesis of native glycopeptides see, Large, D. G.; Warren, C. D. </PDAT><HIL><ITALIC><PDAT>Glycopeptides and Related Compounds: Synthesis, Analysis, and Applications; </PDAT></ITALIC></HIL><PDAT>Marcel Dekker: New York, 1997.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="1"><PTEXT><PDAT>15. (a) Andersson, M.; Oscarson, S. </PDAT><HIL><ITALIC><PDAT>Glycocnjugate J. </PDAT></ITALIC></HIL><PDAT>1992, 9, 122; (b) Cao, S.; Tropper, F. D.; Roy, R. </PDAT><HIL><ITALIC><PDAT>Tetrahedron </PDAT></ITALIC></HIL><PDAT>1995, 51, 6679.</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="1"><PTEXT><PDAT>16. Lemieux, R. U.; Ratcliffe, R. M. </PDAT><HIL><ITALIC><PDAT>Can. J. Chem. </PDAT></ITALIC></HIL><PDAT>1979, 57, 1244.</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="1"><PTEXT><PDAT>17. Saccharides with hydrazine attached at the reducing terminus, or glycosylhydrazines, have also been reported. They react with aldehydes to form hydrazones, but the glycosidic linkage hydrolyzes in water after several hours. By contrast, we have found aminooxy sugars to be stable for months in aqueous solution. (a) Takasaki, S.; Mizuochi, T.; Kobata, A. </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol. </PDAT></ITALIC></HIL><PDAT>1982, 83, 263; (b) Tolvanen, M.; Gahmberg, C. G. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>1986, 261, 9546.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="1"><PTEXT><PDAT>18. (a) Palcic, M. M. </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol. </PDAT></ITALIC></HIL><PDAT>1994, 230, 300; (b) McGarvey, G. J.; Glenn, J.; Wong, C. -H. </PDAT><HIL><ITALIC><PDAT>Liebigs Ann. </PDAT></ITALIC></HIL><PDAT>1997, 1059.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="1"><PTEXT><PDAT>19. Simanek, E. E.; McGarvey, G. J.; Jablonowski, J. A.; Wong, C. -H. </PDAT><HIL><ITALIC><PDAT>Chem. Rev. </PDAT></ITALIC></HIL><PDAT>1998, 98, 833.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="1"><PTEXT><PDAT>20. The enzymatic reactions were executed essentially as described in Ichikawa, Y.; Lin, Y.-C.; Dumas, D. P.; Shen, G.-J.; Garcia-Junceda, E.; Williams, M. A.; Bayer, R.; Ketcham, C.; Walker, L. E.; Paulson, J. C.; Wong, C. -H. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1992, 114, 9283.</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="1"><PTEXT><PDAT>21. The &agr;(2,3)-ST and &agr;(1,3)-FucT were purchased from Calbiochem.</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="1"><PTEXT><PDAT>22. (a) Likhosherstov, L. M.; Novikova, O. S.; Derevitskaja, V. A.; Kochetkov, N. K. </PDAT><HIL><ITALIC><PDAT>Carbohydr. Res. </PDAT></ITALIC></HIL><PDAT>1986, 146, C1; (b) Vetter, D.; Gallop, M. A. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1995, 6, 316; (c) Meinjohanns, E.; Meldal, M.; Paulsen, H.; Dwek, R. A. </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc., Perkin Trans. </PDAT></ITALIC></HIL><PDAT>1 1998, 549.</PDAT></PTEXT></PARA>
<PARA ID="P-00108" LVL="1"><PTEXT><PDAT>23. Unprotected glycosyl isothiocyanates have been used for protein modification (ref. 13), but their conversion to glycosyl thiosemicarbazides has not to our knowledge been reported.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="1"><PTEXT><PDAT>24. Marcaurelle, L. A.; Bertozzi, C. R., </PDAT><HIL><ITALIC><PDAT>Tetrahedron Lett., </PDAT></ITALIC></HIL><PDAT>in press.</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="1"><PTEXT><PDAT>25. Coupling reactions were performed in 1 M NaOAc buffer, pH 5.5, 37&deg; C. The neoglycopeptide products were purified by RP-HPLC and characterized by ES-MS. The yields of the coupling reactions ranged from 85 to 95%.</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="1"><PTEXT><PDAT>26. Rosen, S. D.; Bertozzi, C. R. </PDAT><HIL><ITALIC><PDAT>Curr. Biol. </PDAT></ITALIC></HIL><PDAT>1996, 6, 261.</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="7"><PTEXT><PDAT>Scheme 1b </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00011">
<CHEMCDX ID="CHEMCDX-00011" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00011.CDX"/>
<CHEMMOL ID="CHEMMOL-00011" ALT="chemistry mol file" FILE="US06465612-20021015-C00011.MOL"/>
<EMI ID="EMI-C00011" ALT="embedded image" HE="309.4119" WI="215.8002" FILE="US06465612-20021015-C00011.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00113" LVL="2"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>(a) N</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 14 h; (b) HPLC on arninopropyl silica gei;</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="2"><PTEXT><PDAT>(c) NHS, Bu</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>N(HSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>), 1:1 CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CI</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/1M Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, 24 h;</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="2"><PTEXT><PDAT>(d) H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, 10% Pd/C, Ac</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 4 h.</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="7"><PTEXT><PDAT>Scheme 2b </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00012">
<CHEMCDX ID="CHEMCDX-00012" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00012.CDX"/>
<CHEMMOL ID="CHEMMOL-00012" ALT="chemistry mol file" FILE="US06465612-20021015-C00012.MOL"/>
<EMI ID="EMI-C00012" ALT="embedded image" HE="220.81815" WI="214.58115" FILE="US06465612-20021015-C00012.TIF"/>
</CHEM-US>
</CWU>
<PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00013">
<CHEMCDX ID="CHEMCDX-00013" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00013.CDX"/>
<CHEMMOL ID="CHEMMOL-00013" ALT="chemistry mol file" FILE="US06465612-20021015-C00013.MOL"/>
<EMI ID="EMI-C00013" ALT="embedded image" HE="460.6308" WI="449.3475" FILE="US06465612-20021015-C00013.TIF"/>
</CHEM-US>
</CWU>
<PDAT></PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00014">
<CHEMCDX ID="CHEMCDX-00014" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00014.CDX"/>
<CHEMMOL ID="CHEMMOL-00014" ALT="chemistry mol file" FILE="US06465612-20021015-C00014.MOL"/>
<EMI ID="EMI-C00014" ALT="embedded image" HE="450.28305" WI="351.39825" FILE="US06465612-20021015-C00014.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE IV</PDAT></STEXT></H>
<PARA ID="P-00117" LVL="0"><PTEXT><PDAT>A strategy for the chemoselective synthesis of )-linked glycopeptides with native sugar-peptide linkages.</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>ABSTRACT: The convergent coupling of oligosaccharides to a protein scaffold is an attractive approach to the synthesis of complex glycopeptides. Here we describe a strategy for the convergent assembly of O-linked glycopeptide analogs using the principle of chemoselective ligation. A single GalNAc residue was incorporated into a glycopeptide by solid phase methods, and then oxidized to the corresponding aldehyde with the enzyme galactose oxidase. Hydroxylamine-fimctionalized sugars were ligated onto the glycopeptide aldehyde affording oxime-linked products with native sugar-peptide linkages. This strategy was demonstrated in the synthesis of chemoselectively ligated analogs of the antibacterial glycopeptide drosocin.</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>The critical role of specific oligosaccharide structures in the biological fimction of many glycoproteins is now well appreciated.</PDAT><HIL><SP><PDAT>1 </PDAT></SP></HIL><PDAT>The importance of protein-bound oligosaccharides in cell-cell recognition events,</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and in modulating protein folding and stability</PDAT><HIL><SP><PDAT>3 </PDAT></SP></HIL><PDAT>has been highlighted in a number of recent landmark studies, inspiring the development of new synthetic methods for the construction of glycoproteins with defined, homogeneous glycoforms. Many of the difficulties inherent to the synthesis of such complex molecules, including the requirement for extensive protecting group manipulations and the chemical sensitivity of glycosidic linkages, have been elegantly addressed by several groups.</PDAT><HIL><SP><PDAT>4,5 </PDAT></SP></HIL><PDAT>Yet, the convergent coupling of tailor-made oligosaccharides to a protein scaffold, an appealing strategy for the synthesis of complex glycoproteins, has been successful only in the construction of the amide sugar-peptide linkage found in N-linked glycopeptides. The extension of this approach to O-linked glycopeptides has been hindered by the difficulties endemic to the formation of a sugar-peptide glycosidic bond.</PDAT></PTEXT></PARA>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>Here we report a strategy for the convergent synthesis of O-linked glycopeptide analogs with native sugar-peptide linkages using the principle of chemoselective ligation.</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>At the heart of this approach is the introduction of mutually and uniquely reactive functional groups (e.g., an aldehyde group and a hydroxylamino group) onto unprotected fragments and the coupling of these fragments in an aqueous environment. First, building block 1 &lsqb;N</PDAT><HIL><SP><PDAT>&agr;</PDAT></SP></HIL><PDAT>-Fmoc-Thr/Ser(Ac</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-&agr;-D-GalNAc)&rsqb; is incorporated into a glycopeptide by solid phase peptide synthesis (SPPS).</PDAT><HIL><SP><PDAT>4c-j </PDAT></SP></HIL><PDAT>Next, a chemically unique functional group for chemoselective ligation is introduced using the commercially available enzyme galactose oxidase,</PDAT><HIL><SP><PDAT>7 </PDAT></SP></HIL><PDAT>which selectively converts galactose or GalNAc residus to the corresponding C-6 aldehydes. The aldehyde groups are reacted with an unprotected oligosaccharide bearing a hydroxylamino group at the reducing end, affording an oxime-linked analog of the &bgr;1&oslash;6 glycosidic linkage that is frequently observed in naturally occurring O-linked glycans.</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>This approach allows flexibility in the elaboration of outlying glycoforms while retaining the native proximal GalNAc-&agr;-Ser/Thr linkage.</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>Our focus on preserving the sugar-peptide linkage was motivated by several studies suggesting a major role for the proximal GalNAc residue in modulating local peptide conformation.</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>In some glycopeptide targets, perturbation of this linkage might result in loss of native conformation and therefore function. Several methods are available for the covalent attachment of oligosaccharides to peptides through non-native linkages,</PDAT><HIL><SP><PDAT>10 </PDAT></SP></HIL><PDAT>including chemoselective ligation of the reducing terminal aldehyde of an oligosaccharide to an N-terminal hydroxylarnino group.</PDAT><HIL><SP><PDAT>11 </PDAT></SP></HIL><PDAT>These methods may not be suitable, however, for the synthesis of glycoproteins with glycosylation-dependent active conformations.</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>To demonstrate this methodology we selected the insect-derived, antibacterial 19-amino acid glycopeptide drosocin, the biological activity of which is influenced by glycosylation.</PDAT><HIL><SP><PDAT>12 </PDAT></SP></HIL><PDAT>Drosocin&apos;s potency in blocking bacterial growth is enhanced 2-8 fold (depending on the target bacterial strain) by a single O-linked disaccharide (Gal&oslash;GalNAc) at Thr11.</PDAT><HIL><SP><PDAT>13 </PDAT></SP></HIL><PDAT>Threonine derivative 1</PDAT><HIL><SP><PDAT>4h </PDAT></SP></HIL><PDAT>was incorporated into drosocin using Fmoc-based solid-phase methods to give GalNAc-drosocin 2, which was oxidized with galactose oxidase (Sigma) to the corresponding C-6 aldehyde (isolated yields were &gt;70%). Hydroxylamino derivatives of galactose (3) and GlcNAc (4) were prepared from the corresponding N-hydroxysuccinimidoglycosides using the method of Roy and coworkers.</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>Compounds 3 and 4 were coupled with the glycopeptide aldehyde to give chemoselectively ligated products 5 and 6, respectively (isolated yields were &gt;80%). The glycosylation sequence of glycopeptide 5 mimics that of native drosocin. The glycan in glycopeptide 6 mimics the naturally occurring GlcNAc&bgr;1&oslash;6GalNAc (&ldquo;core 6&rdquo;) structure; an oxime group substitutes for the natural glycosidic bond and the linkage is extended by one atom.</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>Unprotected oligosaccharides, either synthetic or derived from natural sources, can be converted to the corresponding glycosylamines via Kochetkov amination.</PDAT><HIL><SP><PDAT>4k,4l,15 </PDAT></SP></HIL><PDAT>Functionalization of these derivatives with a hydroxylamino group would provide access to a wide variety of oligosaccharide coupling partners. In order to demonstrate this approach we synthesized lactose hydroxylamine 7 by aminooxyacetylation</PDAT><HIL><SP><PDAT>16 </PDAT></SP></HIL><PDAT>of a glycosylamine derivative. Compound 7 was coupled with the aldehyde derived from enzymatic oxidation of 2 to give chemoselectively ligated glycopeptide 8.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="0"><PTEXT><PDAT>We also applied the enzymatic oxidation and chemoselective ligation reactions to the simple monosaccharide &agr;-benzyl GalNAc to obtain oxime-linked disaccharide 9 for spectroscopic comparison with oxime-linked glycopeptides. Both the trans and cis isomers of the compound 9 were obtained in a ratio of 2.5:1 (trans/cis).</PDAT><HIL><SP><PDAT>17 1</PDAT></SP></HIL><PDAT>H NMR analysis of drosocin analog 6, bearing an identical oxime-linked disaccharide, revealed only a single isomer which was assigned the trans configuration based on the chemical shift of the oxime proton (HC&boxH;NOR, 7.69 ppm). Thus, the C-1 substituent of GalNAc appears to affect the trans/cis ratio of oximes formed at C-6. Conformational analysis of oligosaccharides possessing the native GlcNAc&bgr;1&oslash;6GalNAc&agr;1&oslash;OR structure has exposed interactions between the C-1 sustituent of GalNAc and the GlcNAc residue that affect the conformational preference of the &bgr;1&oslash;6 linkage.</PDAT><HIL><SP><PDAT>18 </PDAT></SP></HIL></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>Finally, we compared the relative potencies of unglycosylated drosocin and chemoselectively ligated analog 5 (the closest structural mimic to native Gal&oslash;GalNAc-drosocin) to determine the functional consequences of the unnatural oxime-linked glycan at Thr11. Glycopeptide 5 was found to be 3 to 4-fold more potent in blocking bacterial growth (IC</PDAT><HIL><SB><PDAT>50</PDAT></SB></HIL><PDAT>&equals;0.12&plusmn;0.02 &mgr;M) than unglycosylated drosocin (IC</PDAT><HIL><SB><PDAT>50</PDAT></SB></HIL><PDAT>&equals;0.40&plusmn;0.05 &mgr;M), similar to the trend observed with native glycosylated drosocin. This observation indicates that flexibility in the structure of the outlying glycoform is permitted as long as the native sugar-peptide linkage is maintained. Glycoproteins that follow this paradigm are well suited synthetic targets for this chemoselective ligation approach.</PDAT></PTEXT></PARA>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>General methods: Galactose oxidase (EC 1.1.3.9) (450 units/mg) was purchased from Sigma. All chemical reagents were obtained from commercial suppliers and used without further purification. For flash chromatography, 230-400 mesh silica gel 60 (E. Merck No. 9385) was employed. Analytical thin layer chromatography (tlc) was conducted on Analtech Uniplate silica gel plates with detection by ceric ammonium molybdate and/or by UV light. Reversed-phase high pressure liquid chromatography (RP-HPLC) was performed on a Rainin Dynamax SD-200 system using Microsorb and Dynamax C</PDAT><HIL><SB><PDAT>18 </PDAT></SB></HIL><PDAT>reversed-phase columns (analytical: 4.6 mm ID&times;25 cm, 1 mL/min; semi-preparative: 10 mm ID&times;25 cm, 3 mL/min), and ultraviolet detection (230 nm) was performed with a Rainin Dynamax UV-1 detector. The </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strain D22 used in bacterial growth inhibition assays was obtained from the </PDAT><HIL><ITALIC><PDAT>E. Coli </PDAT></ITALIC></HIL><PDAT>Genetic Stock Center at Yale University.</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="0"><PTEXT><PDAT>Unless otherwise noted, all air and moisture sensitive reactions were performed under a nitrogen atmosphere. All solvents were distilled under a nitrogen atmosphere prior to use. THF was dried and deoxygenated over Na/benzophenone; CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN, and benzene were dried over CaH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>; toluene was dried over Na. Unless otherwise specified, extracts were dried over MgSO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>and solvents were removed with a rotary vacuum evaporator. The </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H- and </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C-NMR spectra were obtained with Bruker AMX-300 and AMX-400 MHz spectrometers. Chemical shifts are reported in &dgr; values downfield from tetramethylsilane (TMS) and coupling constants are reported in Hz. Low resolution FAB mass spectra were obtained by the Mass Spectrometry Laboratory at the University of California at Berkeley on a AE1 M512 mass spectrometer using m-nitrobenzyl alcohol or glycerol as the matrix solvent. Electrospray ionization mass spectrometry (ESI-MS) was performed on a Hewlett-Packard 5989A mass spectrometer equipped with an electrospray ion source. The synthesis of compound 5S is show in Scheme 1c.</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="7"><PTEXT><PDAT>Scheme 1c </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00015">
<CHEMCDX ID="CHEMCDX-00015" ALT="chemistry chemdraw file" FILE="US06465612-20021015-C00015.CDX"/>
<CHEMMOL ID="CHEMMOL-00015" ALT="chemistry mol file" FILE="US06465612-20021015-C00015.MOL"/>
<EMI ID="EMI-C00015" ALT="embedded image" HE="454.8474" WI="449.82945" FILE="US06465612-20021015-C00015.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>4-O-(2,3,4,6-Tetra-O-acetyl-&bgr;-D-galactopyranosyl)-2,3,6-tri-O-acetyl-&bgr;-D-glucopyranosyl azide (1S). To a suspension of 0.033 g (0.147 mmol) of AgClO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>in 7 mL of CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>was added 0.147 mL of a 1 M solution of SnCl</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>in CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. The solution was stirred for 1 h in the dark at rt. A solution of &bgr;-lactose octaacetate (0.500 g, 0.737 mmol) and azidotrimethylsilane (0.117 mL, 0.884 mmol) in CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(7 mL) was added to the suspension and the reaction was stirred for 5.5 h. The mixture was diluted with 50 mL CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and washed with 25 mL saturated aqueous NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and water (3&times;15 mL). The organic layer was dried and concentrated directly onto silica gel for chromatography. The column was eluted with 2:1 hexanes/ethyl acetate to give 0.262 g (54%) of a pale yellow foam; R</PDAT><HIL><SB><PDAT>f </PDAT></SB></HIL><PDAT>0.54 (1:3 hexanes/ethyl acetate); IR (KBr pellet): 3446, 2121, 1751,1371, 1232, 1059 cm</PDAT><HIL><SP><PDAT>&minus;1</PDAT></SP></HIL><PDAT>; </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (300 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;1.97 (s, 3 H), 2.05 (s, 3 H), 2.06 (s, 3 H), 2.07 (s, 3 H), 2.09 (s, 3 H), 2.14 (s, 3 H), 2.15 (s, 3 H), 3.79 (m, 3 H), 4.11 (m, 3 H), 4.50 (m, 2 H), 4.86 (t, 1 H, J&equals;8.84), 4.95 (dd, 1 H, J&equals;10.45, 3.40), 5.11 (m, 1 H), 5.21 (t, 1 H, J&equals;9.09), 5.35 (d, 1 H, J&equals;2.64); </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (100 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;20.46, 20.60, 20.69, 20.76, 60.76, 61.71, 66.57, 69.06, 70.76, 70.91, 72.52, 74.80, 75.76, 77.21, 87.69, 101.09, 169.02, 169.44, 169.56, 170.00, 170.06, 170.24, 170.29; FAB-MS: Calcd. for C</PDAT><HIL><SB><PDAT>26</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>36</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>662 (M&plus;H), found 662. Anal. Calcd. for C</PDAT><HIL><SB><PDAT>26</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>35</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>17</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>: C, 47.20; H, 5.33; N, 6.35. Found: C, 47.49; H, 5.60; N, 6.31.</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>4-O-(2,3,4,6-Tetra-O-acetyl-&bgr;-D-galactopyranosyl)-2,3,6-tri-O-acetyl-&bgr;-D-glucopyranosyl amine (2S). A solution of 1S (430 mg, 0.65 mmol) and 10% Pd/C (80 mg) in methanol (20 ml) was stirred under a hydrogen atmosphere for 30 min. The mixture was filtered through Celite and concentrated to give 413 mg (100%) of unstable glycosylamine 2S which was used without further purification in the next reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>N</PDAT><HIL><SP><PDAT>&agr;</PDAT></SP></HIL><PDAT>-&lsqb;4-O-(2,3,4,6-Tetra-O-acetyl-&bgr;-D-galactopyranosyl)-2,3,6-tri-O-acetyl-&bgr;-D-glucopyranosyl&rsqb;-tert-butoxycarbonylaminooxyacetamide (3S). Crude compound 2S (413, 0.65 mmol) was dissolved in 15 ml of freshly distilled CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>along with t-butoxycarbonylaminooxy acetic acid (157 mg, 0.80 mmol), 1-hydroxybenzotriazole hydrate (108 mg, 0.80 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (153 mg, 0.80 mmol) and stirred at rt for 4.5 h. The reaction solution was diluted with 100 mL of CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and washed with 0.1 M HCl (3&times;25 mL), water (3&times;25 mL) and saturated aqueous NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(3&times;25 mL). The organic layer was dried and concentrated directly onto silica gel for chromatography. The column was eluted with 1:1 hexanes/ethyl acetate to give 400 mg (76%) of a white foam. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (400 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;1.47 (s, 9 H), 1.96 (s, 3 H), 2.02 (s, 3 H), 2.04 (s, 3 H), 2.05 (s, 3 H), 2.06 (s, 3 H), 2.10 (s, 3 H), 2.15 (s, 3 H), 3.82 (m, 3H), 4.11 (m, 3H), 4.33 (dd, 2H, J&equals;25.43, 16.41), 4.47 (m, 2H), 4.94 (m, 2H), 5.10 (dd, 1H, J&equals;7.78, 10.36), 5.28 (m, 2H), 5.34 (d, 1H, J&equals;3.20). </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (100 MHz, CDCl</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>): &dgr;820.50, 20.60, 20.64, 20.72, 20.80, 20.85, 28.09, 60.86, 62.08, 66.63, 69.02, 70.73, 71.02, 71.10, 72.75, 74.60, 75.97, 77.50, 83.14, 100.95, 157.38, 168.99, 169.55, 170.07, 170.15, 170.36, 170.94. FAB-MS: Calcd. for C</PDAT><HIL><SB><PDAT>33</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>49</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>21</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>809 (M&plus;H), found 809.</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>N</PDAT><HIL><SP><PDAT>&agr;</PDAT></SP></HIL><PDAT>-&lsqb;(4-O-&bgr;-D-galactopyranosyl)-&bgr;-D-glucopyranosyl&rsqb;-tert-butoxycarbonylaminooxyacetamide (4S). To a solution of compound 3S (32 mg, 0.040 mmol) in 3.6 mL MeOH was added 0.40 mL of NaOMe in MeOH (100 mM). The reaction mixture was stirred at rt for 7.5 h, neutralized on H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> resin and concentrated to give 21 mg (100%) of compound 4S. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (400 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;3.71 (m, 14 H), 4.51 (app d, 3H), 5.06 (d, 1 H, J&equals;9.16). </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (100 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;29.94, 30.05, 32.15, 62.37, 63.58, 71.07, 73.47, 74.02, 75.02, 77.16, 77.52, 77.88, 79.02, 80.26, 81.38, 105.4, 161.2, 174.9.</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>N</PDAT><HIL><SP><PDAT>&agr;</PDAT></SP></HIL><PDAT>-&lsqb;(4-O-&bgr;-D-galactopyranosyl)-&bgr;-D-glucopyranosyl&rsqb;-aminooxyacetamide (5S). Compound 4S (21 mg, 0.040 mmol) was dissolved in 3:2 CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>/TFA and stirred at rt for 30 min. The solvent was removed under vacuum and the residue was coevaporated twice with toluene. The crude product was dissolved in water, neutralized on anion exchange resin (hydroxide form) and concentrated to afford 17 mg (100%) of free hydroxylamine 5S. </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (400 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;3.73 (m, 14 H), 4.27 (s, 2 H), 4.45 (d, 1 H, J&equals;7.40), 5.07 (d, 1 H, J&equals;9.16). </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C NMR (100 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;62.36, 63.59, 71.10, 73.48, 73.94, 75.04, 76.12, 77.54, 77.90, 79.04, 80.26, 81.42, 105.41, 176.4. FAB-MS: Calcd. for C</PDAT><HIL><SB><PDAT>14</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>27</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>12</PDAT></SB></HIL><PDAT>N</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(M&plus;H) 415, found 415.</PDAT></PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>N-Gly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr(&agr;-D-GalNAc)-Ser-His-Pro-Arg-Pro-Ile-Arg-Val-OH (GalNAc-drosocin) (SEQ ID NO:4). The GalNAc-drosocin glycopeptide was synthesized on HMP resin using N</PDAT><HIL><SP><PDAT>&agr;</PDAT></SP></HIL><PDAT>-Fmoc-protected amino acids and DCC-mediated HOBT ester activation in NMP (ABI 431A synthesizer, user-devised cycles). The glycosylated amino acid N</PDAT><HIL><SP><PDAT>&agr;</PDAT></SP></HIL><PDAT>-Fmoc-Thr(Ac</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-&agr;-D-GalNAc, 1) (&tilde;2&times;molar excess) was activated with HBTU in the presence of HOBt and DIEA; acylation was complete within 6 h. After completion of peptide synthesis, the sugar moiety was deacetylated by treating the resin with 5.5% hydrazine hydrate in MeOH for 18 h at rt and washing with methanol and diethyl ether. Peptide resin cleavage/deprotection was accomplished with reagent K (4 h, rt) (King, D. S.; Fields, C.; Fields, G. Int. </PDAT><HIL><ITALIC><PDAT>J. Pep. Prot. Res. </PDAT></ITALIC></HIL><PDAT>1990, 36, 225). The purity of the resulting crude glycopeptide was &tilde;95% as assessed by RP-HPLC and ESI-MS: Calcd. 2401.78 (M</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 2402.13. The drosocin glycopeptide was used without further purification in subsequent reactions. The chemical synthesis of unglycosylated drosocin was accomplished using similar methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00135" LVL="0"><PTEXT><PDAT>Galactose oxidase reactions. A solution of GalNAc-drosocin (1 mM) in Dulbecco&apos;s phosphate buffer saline, pH 7.3, and galactose oxidase (50 units) was incubated at 37&deg; C. for 1.5 h. Oxidized GalNAc-drosocin was purified by semi-preparative RP-HPLC. Elution was accomplished by a gradient of acetonitrile in water, both with 0.1% TFA: CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (85:15-70:30) (55 min). The aldehyde product was analyzed by ESI-MS: Calcd. 2399.76, found 2418.29 (M&plus;H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, hydrated aldehyde).</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>Chemoselective ligation reactions. A solution of drosocin glycopeptide aldehyde (0.50 mM) in NaOAc buffer (100 mM, pH 5.5) was incubated with compound 3, 4 or 7 (final concentration&equals;1.25 mM) at 37&deg; C. for 24 h. The reactions were monitored by RP-HPLC: elution was accomplished by a gradient of acetonitrile in water, both with 0.1% TFA: CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN:H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (85:15-70:30) (28 min). The respective products 5, 6 and 8 were analyzed by ESI-MS and glycopeptide 6 was further characterized by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR analysis. Glycopeptide 5: Calcd. 2576.92 (M</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 2577.20. Glycopeptide 6: Calcd. 2618.22 (M</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 2617.70. Characteristic peak in the </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H MMR spectrum (400 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O): &dgr;7.69 (d, J&equals;3.2) (HC&boxH;NOR). Glycopeptide 8: Calcd. 2796.12 (M</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>), found 2796.22.</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>Bacterial growth inhibition assays. Growth inhibition assays were performed essentially as described by Bulet et al. (</PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem. </PDAT></ITALIC></HIL><PDAT>1996, 238, 64). Sterile 96 well plates (Corning &num;25860) were used, with a final volume of 40 &mgr;l per well. This volume comprised 35 &mgr;l of a mid-logarithmic phase culture of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>D22 at an initial A</PDAT><HIL><SB><PDAT>595</PDAT></SB></HIL><PDAT>&equals;0.001 in Luria-Bertani (LB) media containing streptomycin (50 &mgr;g/ml), added to 5 &mgr;l serially diluted peptide (unglycosylated drosocin or GalGalNAc-drosocin) in water. Peptide concentrations were determined by measuring dry weight, and assuming 80% of that weight was peptide and the remainder water and salts. Final concentrations ranged from 10</PDAT><HIL><SP><PDAT>&minus;11 </PDAT></SP></HIL><PDAT>to 10</PDAT><HIL><SP><PDAT>&minus;2 </PDAT></SP></HIL><PDAT>M; the precise range used for a given peptide depended on its potency. Plates were incubated for 6 h at 25&deg; C. with periodic shaking. Growth was determined by measuring the absorbance at 595 nm on a BioRad 550 microplate reader. Percent inhibition was defined as ((A</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>&minus;A</PDAT><HIL><SB><PDAT>x</PDAT></SB></HIL><PDAT>)/A</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>)*100), where A</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>was the absorbance of a control well lacking peptide and A</PDAT><HIL><SB><PDAT>x </PDAT></SB></HIL><PDAT>was the absorbance of a well with peptide.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>REFERENCES</PDAT></STEXT></H>
<PARA ID="P-00138" LVL="1"><PTEXT><PDAT>1. (a) Bill, R. M.; Flitsch, S. L. </PDAT><HIL><ITALIC><PDAT>Chem. Biol. </PDAT></ITALIC></HIL><PDAT>1996, 3, 145. (b) Lis, H.; Sharon, N. </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem. </PDAT></ITALIC></HIL><PDAT>1993, 218, 1. (c) Cumming, D. A. </PDAT><HIL><ITALIC><PDAT>Glycobiology </PDAT></ITALIC></HIL><PDAT>1991, 1, 115.</PDAT></PTEXT></PARA>
<PARA ID="P-00139" LVL="1"><PTEXT><PDAT>2. (a) Varki, A. </PDAT><HIL><ITALIC><PDAT>Glycobiology </PDAT></ITALIC></HIL><PDAT>1993, 3, 97. (b) Snell, W. J.; White, J. M. </PDAT><HIL><ITALIC><PDAT>Cell </PDAT></ITALIC></HIL><PDAT>1996, 85, 629. (c) Lasky, L. A. </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Biochem. </PDAT></ITALIC></HIL><PDAT>1995, 64, 113. (d) Sears, P.; Wong, C. -H. </PDAT><HIL><ITALIC><PDAT>Proc. NatL. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>1996, 93, 12086.</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="1"><PTEXT><PDAT>3. (a) O&apos;Connor, S. E.; Imperiali, </PDAT><HIL><ITALIC><PDAT>B. Chem. Biol. </PDAT></ITALIC></HIL><PDAT>1996, 3, 803. (b) Rickert, K. W.; Imperiali, B. </PDAT><HIL><ITALIC><PDAT>Chem. Biol. </PDAT></ITALIC></HIL><PDAT>1995, 2, 751. (c) Wyss, D. F.; Choi, J. S.; Li, J.; Knoppers, M. H.; Willis, K. J.; Arulanandam, A. R. N.; Smolyar, A.; Reinherz, E. L.; Wagner, G. </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1995, 269, 1273. (d) Gowda, D. C.; Jackson, C. M.; Kurzban, G. P.; McPhie, P.; Davidson, E. A. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1996, 35, 5833. (e) Garone, L.; Edmunds, T.; Hanson, E.; Bernasconi, R.; Huntington, J. A.; Meagher, J. L.; Fan, B.; Gettins, P. G. W. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1996, 35, 8881. (f) Live, D. H.; Kumar, R. A.; Beebe, X.; Danishefsky, S. J. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>1996, 93, 12759.</PDAT></PTEXT></PARA>
<PARA ID="P-00141" LVL="1"><PTEXT><PDAT>4. (a) Roberge, J. Y.; Beebe, X.; Danishefsky, S. J. </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>1995, 269, 202. (b) Cohen-Anisfeld, S. T.; Lansbury, P. T., Jr. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1993, 115, 10531. (c) Meldal, M.; Bock, K. </PDAT><HIL><ITALIC><PDAT>Glycoconjugate J. </PDAT></ITALIC></HIL><PDAT>1994, 11, 59. (d) Meldal, M. </PDAT><HIL><ITALIC><PDAT>Curr. Opin. Struct. Biol. </PDAT></ITALIC></HIL><PDAT>1994, 4, 710. (e) Paulsen, H.; Schleyer, A.; Mathieux, N.; Meldal, M.; Bock, K. </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc., Perkin Trans. </PDAT></ITALIC></HIL><PDAT>1 1997, 281. (f) Bielfeldt, T.; Peters, S.; Meldal, M.; Bock, K.; Paulsen, H. </PDAT><HIL><ITALIC><PDAT>Angew. Chem. Int. Ed. Engl. </PDAT></ITALIC></HIL><PDAT>1992, 31, 857. (g) Meinjohanns, E.; Meldal, M.; Schleyer, A.; Paulsen, H.; Bock, K. </PDAT><HIL><ITALIC><PDAT>J. Chem. Soc., Perkin Trans. </PDAT></ITALIC></HIL><PDAT>1 1996, 9985. (h) Ciommer, M.; Kunz, H. </PDAT><HIL><ITALIC><PDAT>Synlett </PDAT></ITALIC></HIL><PDAT>1991, 593. (i) Nakahara, Y.; Nakahara, Y.; Ogawa, T. </PDAT><HIL><ITALIC><PDAT>Carbohydr. Res. </PDAT></ITALIC></HIL><PDAT>1996, 292, 71. (j) Polt, R.; Szab&oacute;, L.; Treiberg, J.; Li, Y.; Hruby, V. J. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1992, 114, 10249. (k) Anisfeld, S. T.; Lansbury, P. T., Jr. </PDAT><HIL><ITALIC><PDAT>J. Org. Chem. </PDAT></ITALIC></HIL><PDAT>1990, 55, 5560. (l) Vetter, D.; Gallop, M. A. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1995, 6, 316.</PDAT></PTEXT></PARA>
<PARA ID="P-00142" LVL="1"><PTEXT><PDAT>5. (a) Witte, K.; Sears, P.; Martin, R.; Wong, C. -H. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1997, 119, 2114. (b) Schuster, M.; Wang, P.; Paulson, J. C.; Wong, C.-H. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1994, 116, 1135. (c) Wong, C.-H.; Schuster, M.; Wang, P.; Sears, P. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1993, 115, 5893. (d) Wang, L. -X.; Fan, J. -Q.; Lee, Y. C. </PDAT><HIL><ITALIC><PDAT>Tetrahedron Lett. </PDAT></ITALIC></HIL><PDAT>1996, 37, 1975. (e) Imperiali, B.; Rickert, K. W. </PDAT><HIL><ITALIC><PDAT>Proc. NatL. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>1995, 92, 97.</PDAT></PTEXT></PARA>
<PARA ID="P-00143" LVL="1"><PTEXT><PDAT>6. (a) Muir, T. W. </PDAT><HIL><ITALIC><PDAT>Structure </PDAT></ITALIC></HIL><PDAT>1995, 3, 649. (b) Hilvert, D. </PDAT><HIL><ITALIC><PDAT>Chem. Biol. </PDAT></ITALIC></HIL><PDAT>1994, 1, 201. (c) Canne, L. E.; Ferr&eacute;-D&apos;Amar&eacute;, A. R.; Burley, S. K.; Kent, S. B. H. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 2998. (d) Lu, W.; Qasim, M. A.; Kent, S. B. H. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1996, 118, 8518. (e) Shao, J.; Tam, J. P. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 3893. (f) Liu, C. -F.; Rao, C.; Tan, J. P. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1996, 118, 307. (g) Rose, K. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1994, 116, 30. (h) Rose, K.; Zeng, W.; Regamey, P. -O.; Chernushevich, I. V.; Standing, K. G.; Gaertner, H. F. </PDAT><HIL><ITALIC><PDAT>Bioconjugate Chem. </PDAT></ITALIC></HIL><PDAT>1996, 7, 552.</PDAT></PTEXT></PARA>
<PARA ID="P-00144" LVL="1"><PTEXT><PDAT>7. (a) Amaral, D.; Bernstein, L.; Morse, D.; Horecker, B. L. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>1963, 238, 2281. (b) Gahmberg, C. G.; Tolvanen, M. </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol. </PDAT></ITALIC></HIL><PDAT>1994, 230, 32.</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="1"><PTEXT><PDAT>8. </PDAT><HIL><ITALIC><PDAT>Molecular Glycobiology; </PDAT></ITALIC></HIL><PDAT>Fukuda, M. and Hindsgaul, O., Eds.; Oxford University: Oxford, 1994.</PDAT></PTEXT></PARA>
<PARA ID="P-00146" LVL="1"><PTEXT><PDAT>9. (a) Andreotti, A. H.; Kahne, D. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1993, 115, 3352. (b) The second sugar attached to a glycopeptide may also play an important role in defining the local conformation. Liang, R.; Andreotti, A. H.; Kahne, D. </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>1995, 117, 10395. (c) Gerken, T. A.; Butenhof, K. J.; Shogren, R. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1989, 28, 5536. (d) Shogren, R.; Gerken, T. A.; Jentoft, N. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>1989, 28, 5525.</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="1"><PTEXT><PDAT>10. (a) Stowell, C. P.; Lee, Y. C. </PDAT><HIL><ITALIC><PDAT>Adv. Carbohydr. Chem. Biochem. </PDAT></ITALIC></HIL><PDAT>1980, 37, 225. (b) Wong, S. Y. C.; Guile, G. R.; Dwek, R. A.; Arsequell, G. </PDAT><HIL><ITALIC><PDAT>Biochem. J. </PDAT></ITALIC></HIL><PDAT>1994, 300, 843.</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="1"><PTEXT><PDAT>11. (a) Cervigni, S. E.; Dumy, P.; Mutter, M. </PDAT><HIL><ITALIC><PDAT>Angew. Chem. Int. Ed. Engl. </PDAT></ITALIC></HIL><PDAT>1996, 35, 1230. (b) Zhao, Y.; Kent, S. B. H.; Chait, B. T. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>1997, 94, 1629.</PDAT></PTEXT></PARA>
<PARA ID="P-00149" LVL="1"><PTEXT><PDAT>12. (a) Bulet, P.; Dimarcq, J. -L.; Hetru, C.; Lagueux, M.; Charlet, M.; Hegy, G.; Van Dorsselaer, A.; Hoffinan, J. A. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>1993, 268, 14893. (b) Bulet, P.; Urge, L.; Ohresser, S.; Hetru, C.; Otvos, L., Jr. </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem. </PDAT></ITALIC></HIL><PDAT>1996, 238, 64.</PDAT></PTEXT></PARA>
<PARA ID="P-00150" LVL="1"><PTEXT><PDAT>13. The position of the linkage has not been directly determined but is suggested to be 1&oslash;3 (ref. 12b).</PDAT></PTEXT></PARA>
<PARA ID="P-00151" LVL="1"><PTEXT><PDAT>14. Cao, S.; Tropper, F. D.; Roy, R. </PDAT><HIL><ITALIC><PDAT>Tetrahedron </PDAT></ITALIC></HIL><PDAT>1995, 51, 6679.</PDAT></PTEXT></PARA>
<PARA ID="P-00152" LVL="1"><PTEXT><PDAT>15. Likhosherstov, L. M.; Novikova, O. S.; Derevitskaja, V. A.; Kochetkov, N. K. </PDAT><HIL><ITALIC><PDAT>Carbohydr. Res. </PDAT></ITALIC></HIL><PDAT>1986, 146, C1.</PDAT></PTEXT></PARA>
<PARA ID="P-00153" LVL="1"><PTEXT><PDAT>16. Kurth, M.; Pelegrin, A.; Rose, K.; Offord, R. E.; Pochon, S.; Mach, J. -P.; Buchegger, F. </PDAT><HIL><ITALIC><PDAT>J. Med. Chem. </PDAT></ITALIC></HIL><PDAT>1993, 36, 1255.</PDAT></PTEXT></PARA>
<PARA ID="P-00154" LVL="1"><PTEXT><PDAT>17. The trans and cis isomers of compound 9 were assigned based on the chemical shift of the oxime proton (HC&boxH;NOR) in the </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR spectrum (400 MHz, D</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O) (Karabatsos, G. J.; Hsi, N. </PDAT><HIL><ITALIC><PDAT>Tetrahedron </PDAT></ITALIC></HIL><PDAT>1967,23,1079). Trans isomer: 7.56 ppm(doublet, J&equals;4.2 Hz); Cis isomer: 6.95 ppm (doublet, J&equals;4.4 Hz).</PDAT></PTEXT></PARA>
<PARA ID="P-00155" LVL="1"><PTEXT><PDAT>18. Pollex-Krfiger, A.; Meyer, B.; Stuike-Prill, R.; Sinnwell, V.; Matta, K. L.; Brockhausen, I. </PDAT><HIL><ITALIC><PDAT>Glycoconjugate J. </PDAT></ITALIC></HIL><PDAT>1993, 10, 365.</PDAT></PTEXT></PARA>
<PARA ID="P-00156" LVL="0"><PTEXT><PDAT>All publications and patent applications cited in this specification and all references cited therein are herein incorporated by reference as if each individual publication or patent application or reference were specifically and individually indicated to be incorporated by reference. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.</PDAT></PTEXT></PARA>
<CWU>
<SEQLST-US ID="SEQLST-1">
<SEQ-LST-NEW>
<S100>
<S160>
<PDAT>4</PDAT>
</S160>
</S100>
<S200>
<S210>
<PDAT>1</PDAT>
</S210>
<S211>
<PDAT>16</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Artificial Sequence</PDAT>
</S213>
<S220>
<S223><STEXT><PDAT>Description of Artificial Sequence Synthetic
      Sequence Peptide</PDAT></STEXT></S223>
</S220>
</S200>
<S400>
<PDAT> 1
Gly Cys Pro Arg Pro Tyr Ser Pro Arg Pro Thr Ser His Pro Arg Pro
  1               5                  10                  15
</PDAT>
</S400>
<S200>
<S210>
<PDAT>2</PDAT>
</S210>
<S211>
<PDAT>10</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Artificial Sequence</PDAT>
</S213>
<S220>
<S223><STEXT><PDAT>Description of Artificial Sequence Synthetic
      Sequence Peptide</PDAT></STEXT></S223>
</S220>
</S200>
<S400>
<PDAT> 2
Gly Lys Pro Arg Pro Tyr Ser Pro Arg Pro
  1               5                  10
</PDAT>
</S400>
<S200>
<S210>
<PDAT>3</PDAT>
</S210>
<S211>
<PDAT>8</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Artificial Sequence</PDAT>
</S213>
<S220>
<S223><STEXT><PDAT>Description of Artificial Sequence Synthetic
      Sequence Peptide</PDAT></STEXT></S223>
</S220>
</S200>
<S400>
<PDAT> 3
Ser His Pro Arg Pro Ile Arg Val
  1               5
</PDAT>
</S400>
<S200>
<S210>
<PDAT>4</PDAT>
</S210>
<S211>
<PDAT>19</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Artificial Sequence</PDAT>
</S213>
<S220>
<S223><STEXT><PDAT>Description of Artificial Sequence Synthetic
      Sequence Peptide</PDAT></STEXT></S223>
</S220>
</S200>
<S400>
<PDAT> 4
Gly Lys Pro Arg Pro Tyr Ser Pro Arg Pro Xaa Ser His Pro Arg Pro
  1               5                  10                  15
Ile Arg Val
</PDAT>
</S400>
</SEQ-LST-NEW>
</SEQLST-US>
</CWU>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00157" LVL="0"><PTEXT><PDAT>1. A peptide comprising a (2S)-aminolevulinic acid residue comprising a substituted or unsubstituted ketone group.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>2. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>3. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a detectable label.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>4. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a detectable label comprising a fluorescent resonance energy transfer (FRET) donor or acceptor.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>5. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with an O- or N-linked glycosyl group to yield glycoconjugate.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00162" LVL="0"><PTEXT><PDAT>6. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with an aminooxy sugar to yield corresponding oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00163" LVL="0"><PTEXT><PDAT>7. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with an aminooxy sugar consisting of aminooxy N-acetyl glucosamine (GalNAc).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00164" LVL="0"><PTEXT><PDAT>8. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with an aminooxy sugar consisting of aminooxy lactose.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00165" LVL="0"><PTEXT><PDAT>9. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a hydrazide sugar to yield a corresponding hydrazone.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00166" LVL="0"><PTEXT><PDAT>10. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a hydrazide sugar consisting of lactose succinic hydrazide.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00167" LVL="0"><PTEXT><PDAT>11. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a thiosemicarbazide-functionalized sugar to yield a corresponding thiosemicarbazone.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00168" LVL="0"><PTEXT><PDAT>12. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a thiosemicarbazide-functionalized sugar consisting of chitobiose thiosemicarbazide.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00169" LVL="0"><PTEXT><PDAT>13. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the ketone group of the residue is substituted with a thiosemicarbazide-functionalized sugar consisting of lactose thiosemicarbazide.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>14. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00171" LVL="0"><PTEXT><PDAT>15. The peptide according to </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00172" LVL="0"><PTEXT><PDAT>16. The peptide according to </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00173" LVL="0"><PTEXT><PDAT>17. The peptide according to </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00174" LVL="0"><PTEXT><PDAT>18. The peptide according to </PDAT><CLREF ID="CLM-00005"><PDAT>claim 5</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00175" LVL="0"><PTEXT><PDAT>19. The peptide according to </PDAT><CLREF ID="CLM-00006"><PDAT>claim 6</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00176" LVL="0"><PTEXT><PDAT>20. The peptide according to </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00177" LVL="0"><PTEXT><PDAT>21. The peptide according to </PDAT><CLREF ID="CLM-00008"><PDAT>claim 8</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00022">
<PARA ID="P-00178" LVL="0"><PTEXT><PDAT>22. The peptide according to </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00023">
<PARA ID="P-00179" LVL="0"><PTEXT><PDAT>23. The peptide according to </PDAT><CLREF ID="CLM-00010"><PDAT>claim 10</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00024">
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>24. The peptide according to </PDAT><CLREF ID="CLM-00011"><PDAT>claim 11</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00025">
<PARA ID="P-00181" LVL="0"><PTEXT><PDAT>25. The peptide according to </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00026">
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>26. The peptide according to </PDAT><CLREF ID="CLM-00013"><PDAT>claim 13</PDAT></CLREF><PDAT>, wherein the peptide is in vitro.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00027">
<PARA ID="P-00183" LVL="0"><PTEXT><PDAT>27. The peptide according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the peptide is in incorporated into a cell or cellular structure.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06465631-20021015-D00001.TIF SYSTEM "US06465631-20021015-D00001.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00002.TIF SYSTEM "US06465631-20021015-D00002.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00003.TIF SYSTEM "US06465631-20021015-D00003.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00004.TIF SYSTEM "US06465631-20021015-D00004.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00005.TIF SYSTEM "US06465631-20021015-D00005.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00006.TIF SYSTEM "US06465631-20021015-D00006.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00007.TIF SYSTEM "US06465631-20021015-D00007.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00008.TIF SYSTEM "US06465631-20021015-D00008.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00009.TIF SYSTEM "US06465631-20021015-D00009.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00010.TIF SYSTEM "US06465631-20021015-D00010.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00011.TIF SYSTEM "US06465631-20021015-D00011.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00012.TIF SYSTEM "US06465631-20021015-D00012.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00013.TIF SYSTEM "US06465631-20021015-D00013.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00014.TIF SYSTEM "US06465631-20021015-D00014.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00015.TIF SYSTEM "US06465631-20021015-D00015.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00016.TIF SYSTEM "US06465631-20021015-D00016.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00017.TIF SYSTEM "US06465631-20021015-D00017.TIF" NDATA TIF>
<!ENTITY US06465631-20021015-D00018.TIF SYSTEM "US06465631-20021015-D00018.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06465631</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021015</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09080205</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19980518</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C07H 2104</PDAT></B511>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>536 232</PDAT></B521>
<B522><PDAT>536 237</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Lipid a 4&prime; kinase</PDAT></STEXT></B540>
<B560>
<B562><NCIT><STEXT><PDAT>A. Kermouni et.al.; The IL-9 Receptor gene (IL9R): Genomic Structure, Chromosomal LOcalization in the Pseudoautosomal Region of the Long Arm of the Sex Chromosomes, and Identification of IL9R Pseudogenes at 9qter, 16pter, and 18pter, Genomics 29, 371-382.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>R. Ingalls et al.; Membrane Expression of Soluble Endotoxin-binding Proteins Permits Lipopolysaccharide Signaling in Chinese Hamster Ovary Fibroblasts Independently of CD14; May 1999, The Journal of Biological Chemistry, vol. 274, 13993-13998.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>S. Orkin et al.; Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy; 1995, Targeted Genetics, 1-38.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>W. Anderson; Human gene therapy; Apr. 1998 Nature, vol. 392. ; 25-30.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>I. Verma et.al.; Gene therapy- promises, problems and prospects, Sep. 1997, Nature vol. 389, 239-242.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>J. Rudinger; Characteristics of the amino acids as components of a peptide hormone sequence; Jun. 1976, Biological Council ,4-7.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Gencore 4.5; U.S. 09-080-205-4, Nov. 2000.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>B. Alberts et.al.; Molecular Biology of The Cell; 441-444.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>C. Lam et.al; Immunostimulatory, but not Antiendotoxin, Activity of Lipid X is due to Small Amounts of Contaminating N, O-Acylated Disccharide-1-Phosphate: In Vitro and In Vivo Reevaluation of the Biological Activity of Synthetic Lipid X; Jul. 1991 Infecti.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Ray et al, &ldquo;The Biosynthesis of Gram-negative Endotoxin: A Novel Kinase In </PDAT><HIL><ITALIC><PDAT>Escherichia Coli </PDAT></ITALIC></HIL><PDAT>Membranes That Incorporates The 4&prime;-Phosphate of Lipid A&rdquo;, The Journal of Biological Chemistry 202(3):1122-1128 (1987). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hampton et al, &ldquo;Lipid A 4&prime;-Kinase form </PDAT><HIL><ITALIC><PDAT>Escherichia coli</PDAT></ITALIC></HIL><PDAT>: Enzyme Assay and Preparation of 4&prime;-32P-Labeled Probes of High Specific Radioactivity&rdquo;, Methods in Enzymology 209:466-475 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Garrett et al, &ldquo;Identification of the Gene Encoding the </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>Lipid A 4&prime;-Kinase&rdquo;, The Journal of Biological Chemistry 272(35):2185521864 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Karow et al, &ldquo;The essential </PDAT><HIL><ITALIC><PDAT>Escherichia coli msbA </PDAT></ITALIC></HIL><PDAT>gene, a multicopy suppressor of null mutations in the </PDAT><HIL><ITALIC><PDAT>htrB </PDAT></ITALIC></HIL><PDAT>gene, is related to the univesally conserved family of ATP-dependent translocators&rdquo;, Molecular Microbiology 7(1):69-79 (1993).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>5</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>435  6</PDAT></B582>
<B582><PDAT>435 641</PDAT></B582>
<B582><PDAT>4352523</PDAT></B582>
<B582><PDAT>4353201</PDAT></B582>
<B582><PDAT>435325</PDAT></B582>
<B582><PDAT>514 44</PDAT></B582>
<B582><PDAT>536 232</PDAT></B582>
<B582><PDAT>536 237</PDAT></B582>
<B582><PDAT>536 2432</PDAT></B582>
<B582><PDAT>536 2433</PDAT></B582>
</B580>
<B590><B595><PDAT>18</PDAT></B595><B596><PDAT>18</PDAT></B596></B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/046947</PDAT></DNUM><DATE><PDAT>19970519</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Christian R. H.</PDAT></FNM><SNM><STEXT><PDAT>Raetz</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Rougemont</PDAT></CITY>
<STATE><PDAT>NC</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Teresa A.</PDAT></FNM><SNM><STEXT><PDAT>Garrett</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Durham</PDAT></CITY>
<STATE><PDAT>NC</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Julie L.</PDAT></FNM><SNM><STEXT><PDAT>Kadrmas</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Centerville</PDAT></CITY>
<STATE><PDAT>UT</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Duke University</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Durham</PDAT></CITY><STATE><PDAT>NC</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Nixon &amp; Vanderhye P.C.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>James</PDAT></FNM><SNM><STEXT><PDAT>Ketter</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Richard</PDAT></FNM><SNM><STEXT><PDAT>Schnizer</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>1635</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention relates, in general, to lipid A 4&prime; kinase and, in particular, to a nucleic acid encoding lipid A 4&prime; kinase and to a method of producing lipid A 4&prime; kinase recombinantly using same. The invention further relates to methods of producing 4&prime; phosphorylated lipid A analogs using the recombinantly produced lipid A 4&prime; kinase.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application claims benefit of priority to provisional appplicaiton No. 60/046,947, filed May 19, 1997.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This application was made with Government support under Grant Nos. 5RO1 GM51310 and 5RO1 GM51796 awarded by the National Institutes of Health and Grant No. DBE092-53851 awarded by the National Science Foundation. The Government has certain rights in the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>TECHNICAL FIELD</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>The present invention relates, in general, to lipid A 4&prime; kinase and, in particular, to a nucleic acid encoding lipid A 4&prime; kinase and to a method of producing lipid A 4&prime; kinase recombinantly using same. The invention further relates to methods of producing 4&prime; phosphorylated lipid A analogs using the recombinantly produced lipid A 4&prime; kinase.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>Lipopolysaccharide (LPS) is the major glycolipid of the outer membrane of gram-negative bacteria. Lipid A, or endotoxin, is the hydrophobic anchor of LPS, and it is a potent immunostimulant. It appears to be responsible for many of the features of septic shock that can accompany severe gram-negative infections. Lipid A is a disaccharide of glucosamine that is phosphorylated at the 1 and 4&prime; positions and is acylated with R-3 hydroxymyristate at the 2, 3, 2&prime;, and 3&prime; positions. In </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>, two additional fatty acyl chains are also esterified to the 2&prime; and 3&prime; R-3 hydroxymyristate groups to form acyloxyacyl units.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Lipid A biosynthesis begins with the acyl-ACP dependent acylation of UDP-N-acetylglucosamine (Anderson et al, J. Biol. Chem. 260:15536 (1985), Anderson et al, J. Biol. Chem. 262:5159 (1987), Anderson et al, J. Biol. Chem. 268:19858 (1993), Williamson et al, J. Bacteriol. 173:3591 (1991), Raetz et al, Science 270:997 (1995)). Nine enzymes are required for the complete synthesis of Kdo</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid A (Raetz, J. Bacteriol. 175:5745 (1993), Raetz, </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 1, Second Ed., pp. 1035-1063, American Society for Microbiology, Washington, D.C. (1996), Raetz et al, J. Biol. Chem. 265:1235 (1990)). Seven of the nine structural genes coding for the enzymes of lipid A biosynthesis in </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>have been identified, however, the lipid A 4&prime; kinase gene has remained elusive (Raetz, </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 1, Second Ed., pp. 1035-1063, American Society for Microbiology, Washington, D.C. (1996)). The 4&prime; kinase catalyzes the sixth step of the pathway (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>) (Ray et al, J. Biol. Chem. 262:1122 (1987)). It phosphorylates the 4&prime; position of a tetraacyldisaccharide-1-phosphate intermediate (termed DS-1-P) to form tetraacyldisaccharide 1, 4&prime; bis-phosphate, also known as lipid IVA (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>) (Ray et al, J. Biol. Chem. 262:1122 (1987), Raetz et al, J. Biol. Chem. 260:16080 (1985), Strain et al, J. Biol. Chem. 260:16089 (1985)).</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>Identification of the 4&prime; kinase gene has been hampered because mutants lacking the 4&prime; kinase have not been identified (Raetz, </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 1, Second Ed., pp. 1035-1063, American Society for Microbiology, Washington, D.C. (1996)). Attempts to purify the kinase to homogeneity have been thwarted by the protein&apos;s association with membranes and its instability in the presence of detergents (Ray et al, J. Biol. Chem. 262:1122 (1987), Hampton et al, Methods in Enzymology 209:466 (1992)).</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>The lipid A 4&prime; kinase can be used to make 4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P labeled lipid A precursors, such as &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IVA and Kdo</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-&lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IVA, for biochemical analyses of late pathway reactions. The 4&prime; kinase activity found in wild type </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>membranes, however, is relatively inefficient and unstable, especially in the presence of low chemical concentrations of ATP. The inability to achieve high levels of </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P transfer makes it virtually impossible to use the 4&prime; kinase for phosphorylating DS-1-P analogs that are utilized less rapidly. Identification and overexpression of the 4&prime; kinase gene would facilitate the synthesis of 4&prime; phosphorylated lipid A analogs with activity as endotoxin antagonists or mimetics (Raetz, J. Bacteriol. 175:5745 (1993), Raetz, </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 1, Second Ed., pp. 1035-1063, American Society for Microbiology, Washington, D.C. (1996)). The present invention provides a nucleic acid encoding lipid A 4&prime; kinase and a method of producing 4&prime; kinase using same.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>OBJECTS AND SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>It is a general object of the invention to provide a nucleic acid encoding lipid A 4&prime; kinase.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>It is another object of the invention to provide a method of producing lipid A 4&prime; kinase recombinantly.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>It is a further object of the invention to provide a recombinantly produced lipid A 4&prime; kinase.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>It is a further object of the invention to provide a method of producing lipid A analogs suitable for use as endotoxin mimetics or endotoxin antagonists, using lipid A 4&prime; kinase.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>The foregoing objects are met by the present invention which relates to a nucleic acid encoding 4&prime; kinase, to an expression construct comprising that nucleic acid and to a host cell into which the construct has been introduced. The invention further relates to a method of producing 4&prime; kinase using such host cells and to the 4&prime; kinase produced thereby. In addition, the invention relates to the production of 4&prime; phosphorylated lipid A analogs using the recombinantly produced 4&prime; kinase.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>Further objects and advantages of the invention will be clear from the description that follows.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>A and B: (A) is a DNA sequence encoding </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>lipid A 4&prime; kinase orfE (SEQ ID NO:3) and (B) is the encoded amino acid sequence (SEQ ID NO:4) (see also Karow et al, Mol. Microbiol. 7:69 (1993)).</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>A and B: (A) is a DNA sequence encoding </PDAT><HIL><ITALIC><PDAT>Haemophilus influenzae, </PDAT></ITALIC></HIL><PDAT>orfE (SEQ ID NO:5) and (B) is the encoded amino acid sequence (SEQ ID NO:6).</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>A and B: (A) is a DNA sequence encoding </PDAT><HIL><ITALIC><PDAT>Francisella novcida </PDAT></ITALIC></HIL><PDAT>orfE (SEQ ID NO:7) and (B) is the encoded amino acid sequence (SEQ ID NO:8).</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>: Construction of pJK2.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>A and </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>B: Biosynthetic pathway for </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>Kdo</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid A. Five enzymes, LpxA, LpxC, LpxD, a UDP-diacylglucosamine pyrophosphatase, and LpxB are required for the synthesis of DS-1-P, the substrate for the 4&prime; kinase. The 4&prime; phosphorylation of DS-1-P yields lipid A. The Kdo transferase, encoded by kdtA, then transfers two Kdo sugars to lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>to form Kdo</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>. The late acyltransferases, HtrB and MsbB, add laurate and myristate, respectively, to form Kdo</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid A. Kdo</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid A is sufficient to support the growth of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>and is fully active as an immunostimulant and as an endotoxin during gram-negative sepsis. Whole cells of mutants lacking MsbB are many orders of magnitude less immunostimulatory than wild type (Somerville Jr. et al, J. Clin. Invest. 97:359-365 (1996)).</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>: Assays of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>lysates generated with individual hybrid &lgr; bacteriophages &lsqb;201&rsqb;4H7 to &lsqb;280&rsqb;22E3 for 4&prime; kinase activity. The &lgr; bacteriophages &lsqb;201&rsqb;4H7 to &lsqb;280&rsqb;22E3 represent one sixth of the Kohara miniset library (Kohara et al, Cell 50:495 (1987), Borodovsky et al, Trends Biochem. Sci. 19:309 (1994)). The 4&prime; kinase activity was assayed in a 10 &mgr;l reaction mixture containing 100 &mgr;M DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P (1000 cpm/nmol), 1 mg/ml cardiolipin, 50 mM Tris, pH 8.5, 5 mM ATP, 5 mM MgCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, 1% NP-40, and 5 &mgr;l of lysate. After 60 minutes at 30&deg; C., the reaction was stopped by spotting 5 &mgr;l onto a Silica Gel 60 TLC plate. The plates were developed in chloroform:methanol:water:acetic acid (25:15:4:2, v/v). After chromatography, the plate was dried under a cold air stream, exposed to a Phosphorlmager screen, and visualized using ImageQuant software (Molecular Dynamics). The histogram shows the % conversion of DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P to &lsqb;1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>for 80 of the 476 lysates tested. The asterisk highlights &lgr; clone &lsqb;218&rsqb;E1D1. The mean and standard deviation for the 80 lysates of this set were determined. The solid line shows the mean value, and the dashed line shows the mean plus two standard deviations. Any lysates showing activity above the dashed line were re-assayed.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>: </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>DNA contained on Kohara library &lgr; clones used to verify the overexpression of 4&prime; kinase associated with &lsqb;218&rsqb;E1D1. The bold bar depicts the relevant </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>genomic DNA with the minutes designated (Berlyn et al, in </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 2, Second Ed., pp. 1715-1902, American Society for Microbiology, Washington, D.C. (1996)). Four different Kohara clones, &lsqb;216&rsqb;13E3, &lsqb;217&rsqb;6D12, &lsqb;218&rsqb;E1D1, and &lsqb;320&rsqb;15G10, are shown with the genomic DNA included on each. The dashed lines lead to an enlargement of the overlap region between clones &lsqb;217&rsqb;6D12 and &lsqb;218&rsqb;E1D1. The locations of the msbA, orfE, and kdsB genes are shown.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT>: Re-assay of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>lysates generated with selected hybrid &lgr; bacteriophages of the Kohara library for 4&prime; kinase activity. Plaque forming units (pfu) were determined for the lysates made from &lgr; clones &lsqb;216&rsqb;13E3, &lsqb;217&rsqb;6D12, &lsqb;218&rsqb;E1D1, and &lsqb;320&rsqb;15G10. Matched lysates were made by infecting </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>W3110 with 4&times;10</PDAT><HIL><SP><PDAT>&minus;3 </PDAT></SP></HIL><PDAT>pfu as described in the Examples that follow. Lysis occurred 7 to 8 hours after infection. At lysis, the lysates were transferred to fresh tubes and frozen overnight at &minus;80&deg; C. The 4&prime; kinase activity was assayed as described above with reference to FIG. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>. The histogram shows the % conversion of DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P to &lsqb;1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>. The lysate generated with &lgr; clone &lsqb;218&rsqb;E1D1 is 2.5 fold more active than the other lysates.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>: Massive over-expression of 4&prime; kinase activity on a hybrid plasmid bearing orfE. Washed membranes from BLR(DE3)pLysS/pET3a (lanes 1 and 2), BLR(DE3)pLysS/pJK2 (lanes 3 and 4), and strain BR7 (lane 5) were assayed for 4&prime; kinase activity in a reaction mixture containing 100 &mgr;M DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P (1000 cpm/nmol), 1 mg/ml cardiolipin, 50 mM Tris, pH 8.5, 5 mM ATP, 5 mM MgCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, 1% NP-40, and 0.5 mg/ml washed-membranes. After 10 minutes at 30&deg; C., the reaction was stopped by spotting 5 &mgr;l onto Silica Gel 60 TLC plate and developing in chloroform:methanol:water:acetic acid (25:15:4:2, v/v). After chromatography, the plate was dried, exposed to a Phosphorlmager screen, and visualized using ImageQuant software. The membranes used in lanes 2 and 4 are from cells that were induced with 1 mM IPTG during the growth of the cells. BLR/pET 3a and BLR/pJK2 are abbreviations for BLR(DE3)pLysS/pET 3a and BLR(DE3)pLysS/pJK2 respectively. NE (lane 6) indicates the no enzyme control. Arrows indicate where the substrate, DS-1-P, and the product, lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>, of the reaction migrate on the TLC plate.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>: SDS-polyacrylamide gel analysis of various fractions from wild-type and 4&prime; kinase over-producing strains. Lanes 1-4 are from BLR(DE3)pLysS/pET3a and lanes 5-8 are from BLR(DE3)pLysS/pJK2. Ten &mgr;g of protein from whole cells (lanes 1 and 5), cell-free extract (lanes 2 and 6), twice centrifuged cytosol (lanes 3 and 7) and washed membranes (lanes 4 and 8) were subjected to electrophoresis on a 10% SDS-polyacrylamide gel in 1&times;Laemmli buffer for 45 minutes at 200 V, and then stained with Coomassie Brillant Blue. The migration of the molecular weight standard (in kDa) is indicated on both sides of the gel. The arrow indicates the migration of a protein band specifically elevated in OrfE over-producing extracts. The migration of this band is consistent with the predicted molecular weight of 36 kDa. It is present in whole cells, cell-free extract, and washed membranes of BLR(DE3)pLysS/pJK2 but not in comparable fractions of the same cells harboring vector alone.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>11</PDAT></BOLD></HIL><PDAT>: Chemical structure of DS-1-P analogs tested as 4&prime; kinase substrates. The chemical structures of DS-1-P and three analogs are shown. The 3-aza-DS-1-P has an amide linked hydroxymyristate group at the 3 position instead of an ester linked group (relevant NH indicated in bold). Mild base hydrolysis of these compounds results in removal of the ester linked hydroxymyristate groups. The resulting compounds, base-treated DS-1-P and base-treated 3-aza-DS-1-P, are also shown.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>: Effective phosphorylation of DS-1-P and DS-1-P analogs with recombinant, overproduced 4&prime; kinase. Washed membranes from strain BR7 and BLR(DE3)pLysS/pJK2 were used, as indicated, in 4&prime; kinase assays containing 100 &mgr;M of the indicated DS-1-P analog, 0.6 &mgr;M &lsqb;&ggr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb; ATP, 50 mM Tris, pH 8.5, 5 mM MgCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, 1% NP-40, 1 mg/ml cardiolipin and 0.5 mg/ml washed membranes. After a 10 minute incubation at 30&deg; C., 5 &mgr;l of the reaction was spotted onto a Silica Gel 60 TLC plate and developed in chloroform:pyridine:formic acid:water (30:70:16:10 v/v). The plate was dried, exposed to a PhosphorImager screen and visualized using ImageQuant software. Arrows indicate the products of the reactions. If the native substrate DS-1-P is present in the reaction, &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>is formed. When 3-aza-DS-1-P, base-treated DS-1-P, or base-treated 3-aza-DS-1-P are present, 4&prime; phosphorylated products a, b and c are formed, respectively. The migration of each of these products is slower than the non-phosphorylated substrate analog, consistent with the phosphate incorporation. As in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT>, BLR/pJK2 is an abbreviation for BLR(DE3)pLysS/pJK2, and NE indicates the no enzyme control. Formation of 4&prime; phosphorylated products is 100-1000 fold more effective with membranes from BLR/pJK2 than with BR7 membranes. Minor </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P containing lipids generated by membranes of BLR(DE3)pLysS/pJK2 in the absence of any acceptor substrate arise by the action of diglyceride kinase on endogenous glycerophospholipids (see especially Lane 6). The diglyceride kinase is inactivated by mutation in strain BR7 (Hampton et al, Methods in Enzymology 209:466 (1992)).</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>13</PDAT></BOLD></HIL><PDAT>: Proposed reaction catalyzed by the 4&prime; kinase with compound 505 as substrate to form &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid A. Overexpressed, recombinant 4&prime; kinase is able to catalyze measurable 4&prime; phosphorylation of compound 505 (45-47) to form &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid A.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>: Generation of &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid A (endotoxin) from compound 505 using recombinant, overexpressed 4&prime; kinase. Kinase assays were performed exactly as in the legend to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, except that DS-1-P and compound 505 were the acceptor lipids used, as indicated. Arrows indicate &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>, the product when DS-1-P is present, and &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid A, the product when compound 505 is present. The migration of lipid A formed in this reaction is the same as labeled lipid A isolated after pH 4.5 hydrolysis (Karibian et al, J. Bacteriol 175:2988 (1993)) from wild type cells of </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>. The yield of the 4&prime;-phosphorylated product represented about 5% of the input &lsqb;&ggr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb; ATP when membranes of BLR/pJK2 were employed, but </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P incorporation was not detectable with BR7 membranes.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>The present invention relates to lipid A 4&prime; kinase and to a nucleic acid sequence encoding same (see for example, FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>A and B). The invention further relates to a method of preparing 4&prime; phosphorylated lipid A analogs with activity as endotoxin mimetics or antagonists.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>In one embodiment, the invention relates to gram-negative bacterial lipid A 4&prime; kinase, for example, </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>4&prime; kinase. In a specific embodiment, the 4&prime; kinase has the amino acid sequence shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1B</PDAT></FGREF><PDAT> or an allelic variation thereof (eg a naturally occurring allelic variant) or a variant of the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1B</PDAT></FGREF><PDAT> sequence from a bacterial species other than </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>. The variant sequences retain the functional characteristics of the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1B</PDAT></FGREF><PDAT> sequence. Variant sequences can be identified using a complementation assay such as that described in Examples that follow. Examples of variant sequences include the protein encoded in an open reading frame identified in the Haemophilus influenzae Rd genome (Fleischmann et al, Science 269:496 (1995) (see </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 2A and B</PDAT></FGREF><PDAT>) and the protein encoded in the valB gene (Mdluli et al, Microbiology 140:3309 (1994)) from </PDAT><HIL><ITALIC><PDAT>Francisella novicida </PDAT></ITALIC></HIL><PDAT>(see FIGS. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>A and B).</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>The present invention relates not only to the entirety of the 4&prime; kinase protein, for example, the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1B</PDAT></FGREF><PDAT> sequence or variations thereof as defined above, but to portions thereof as well. The term &ldquo;portions&rdquo; relates to peptides and polypeptides of at least 6 or at least 10 amino acids in length, preferably, at least 25, at least 50, at least 100 or at least 300 amino acids. One such portion is an N-terminal truncated form (eg truncated to remove the putative transmembrane domain) of 4&prime; kinase (eg the FIG </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>B sequence from which amino acids 1-70 have been removed).</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>In addition to the 4&prime; kinase protein, the present invention also relates to a nucleic acid sequence (DNA or RNA) encoding the 4&prime; kinase, eg gram-negative bacterial 4&prime; kinase, and to fragments thereof suitable for use, for example, as probes or primers, of at least 18, preferably at least 30, more preferably at least 75, 150, 300, or 900 bases in length, that encode the &ldquo;portions&rdquo; described above. In a specific embodiment, the invention relates to a nucleic acid sequence encoding the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1B</PDAT></FGREF><PDAT> amino acid sequence, or portion or variant thereof as defined above. In particular, the present invention relates to the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1A</PDAT></FGREF><PDAT> nucleic acid sequence or fragments thereof. The nucleic acid can be present in isolated form, for example, free of nucleic acids with which it is normally associated (eg free of the msbA encoding sequence in the case of the </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1A</PDAT></FGREF><PDAT> sequence). The present invention also relates to a nucleic acid sequence substantially identical to the nucleic acid sequence of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1A. A</PDAT></FGREF><PDAT> &ldquo;substantially identical&rdquo; sequence is one the complement of which hybridizes to the nucleic acid sequence of FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>A. An example of stringency conditions that can be used to identify &ldquo;substantially identical&rdquo; sequences by Southern hybridization is as follows: hybridization at 42&deg; C. for 24 hours in 20% formamide, 5&times;SSC (1&times; is 0.15 M NaCl, 0.015 M NaCitrate), 5&times;Denhardt&apos;s solution, 1% SDS, 150 &mgr;g/ml salmon sperm DNA, and 1.5&times;10</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>cpm/ml </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P random primed lpxK probe; two washes are carried out using 2&times;SSC, 0.1% SDS &commat; 42&deg; C., once with same buffer for 10 minutes at room temperature. (See Hyland et al, J. Bacteriology 179:2029 (1997)). (For details of reagent preparation, etc, see Sambrook et al, Molecular Cloning, A Laboratory Manual, 2nd Edition). The invention also relates to nucleic acids complementary to those described above.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>The present invention also relates to a recombinant molecule (a construct) comprising a nucleic acid sequence as described above and to a host cell transformed therewith. Using methodologies well known in the art, a recombinant molecule comprising a vector and a nucleic acid sequence encoding a 4&prime; kinase of the invention, or portion or variant thereof as defined above, can be constructed. Vectors suitable for use in the present invention include plasmid and viral vectors (for example, lambda, pET, pUC18 or 19, pACYC 184, pT7, pING (procayotic vectors) and, pcDNA 1, 2 or 3, adenovirus, adeno-associated virus, retrovirus (eucaryotic vectors)). Appropriate vectors can be selected based on their compatibility with transformation into a selected host cell. The nucleotide sequence of the invention can be present in the vector operably linked to regulatory elements, for example, a promoter. Suitable promoters include, but are not limited to the T7, lac, tac, ara, CMV and SV40 promoters. Preferably, the nucleic acid of </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1A</PDAT></FGREF><PDAT> is not operably linked (via msbA) to the msbA promoter.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>As indicated above, the recombinant molecule of the invention can be constructed so as to be suitable for transforming a host cell. Suitable host cells include prokaryotic cells, such as bacteria, particularly gram negative bacteria such as </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>. Gram positve bacteria are also suitable hosts, as are eucaryotic cells such as yeast and insect cells. The recombinant molecule of the invention can be introduced into appropriate host cells using a variety of known methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>The present invention further relates to a method of producing the 4&prime; kinase of the invention, or portion or variant thereof as defined above. The method comprises culturing the above-described transformed host cells under conditions such that the encoding sequence is expressed and the protein thereby produced. The protein can be isolated as described in the Examples that follow. The protein can be further purified using standard procedures, advantageously, in the presence of a non-ionic detergent (such as Triton X100). (See, for example, Belunis and Raetz, J. Biol. Chem. 267:9988 (1992).)</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>The 4&prime; kinase of the invention, or portion or variant thereof as defined above, can be present in isolated form, for example, substantially free of proteins with which it is normally associated. Quantitative Western blotting as described by Pardridge et al (J. Biol. Chem. 265:18035 (1990)) can be used to determine the ratio of lipid A 4&prime; kinase present relative to, for example, Msb. Advantageously, the protein is at least 5% pure, as determined, for example, by gel electrophoresis. The proteins, polypeptides and peptides of the invention can be produced recombinantly using the nucleic acid sequences as described above, or chemically using known methods. When prepared recombinantly, the protein of the invention can be produced alone or as a fusion product, for example, fused with a protein such as the maltose binding protein, glutathione-S-transferase or &bgr;-galactosidase. For example, the coding sequence of the invention (eg the sequence encoding the </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>4&prime; kinase) can be cloned in frame with a sequence encoding another protein (such as those referenced above) and the fusion product expressed in an appropriate host cell. The coding sequence of the invention can also be expressed as a C- or N-terminal histidine or epitope tagged product in order to facilitate purification (a C-terminal histidine tagged product (for example, tagged with 6 histidine residues) retains activity).</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The proteins, polypeptides and peptides of the invention can be used as antigens to generate 4&prime; kinase specific antibodies, particularly, antibodies specific for </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>4&prime; kinase. Methods of antibody generation are well known in the art. Both monoclonal and polyclonal antibodies are contemplated, as are antigen binding fragments thereof. Such antibodies can be used, for example to, effect purification of the protein using, for instance, affinity chromatography.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>The 4&prime; kinase of the invention, present either in purified form or in a lysate of a cell in which it has been overexpressed, can be used to produce lipid A analogs that are phosphorylated. In the case of disaccharides, phosphorylation at the 4&prime; is preferred. In certain substrate analogs, phosphorylation can occur at other available hydroxyl groups. Lipid A analogs with the greatest potency (either as endotoxin mimetics or endotoxin antagonists) are those that are phosphorylated both at positions 1 and 4&prime; (Golenbock et al, J. Biol. Chem. 266:19490 (1991) and references cited therein; Raetz, </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 1, Second Ed., pp. 1035-1063, American Society for Microbiology, Washington, D.C. (1996), Golenbock et al, J. Biol. Chem. 266:19490 (1991), Christ et al, J. Am. Chem. Soc. 116:3637 (1994), Christ et al, Science 265:80 (1995), Takayama et al, Infect. Immun. 57:1336 (1989)). Examples of lipid A-like molecules suitable as substrates for the 4&prime; kinase of the invention include disaccharides (eg 2 glucosamines) with preferably 2-7 (more preferably 4-6) acyl (preferably a C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>acyl, more preferably a C</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>16 </PDAT></SB></HIL><PDAT>acyl) or alkyl (preferably, a C</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>20 </PDAT></SB></HIL><PDAT>alkyl, more preferably a C</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>16 </PDAT></SB></HIL><PDAT>alkyl) chains. Lipid A-like molecules that display either endotoxin agonist or antagonist activity can contain 5 or 6 acyl (or alkyl) chains (see also suitable substrates described in DE 3834876, DE 3834877 and WO 8700174). Advantageously, a phosphate is present at the 1 position of the substrate and &mdash;OH at the 4&prime; position. The phosphate donor used in the reactions can be unlabelled or labeled, for example, radiolabelled, or labelled with a heavy isotope such as (</PDAT><HIL><SP><PDAT>18</PDAT></SP></HIL><PDAT>O).</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>Endotoxin antagonists produced in accordance with the invention can be used for treating complications of gram-negative sepsis as well the diseases/disorders enumerated in U.S. Pat. No. 4,918,061. The endotoxin mimetics produced in accordance with the invention can be used as adjuvants or as immunostimulants.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>Immunostimulation of a patient can be effected using the lipid A 4&prime; kinase encoding sequence of the invention. The lipid A 4&prime; kinase encoding sequence can, for example, be introduced into macrophages (or other immune cell types (eg dendritic cells or stem cells)) under conditions such that the encoding sequence is expressed. The lipid A 4&prime; kinase encoding sequence can be introduced, for example, using a vector, eg a viral (eg a retroviral, adenoviral or adeno-associated viral) vector. The immune cells can be transfected with the lipid A 4&prime; kinase sequence ex vivo and subsequently (re)introduced into the patient. Immunostimulation is can be effected by administering to the patient a precursor of lipid A agonist (eg a substrate of lipid A 4&prime; kinase that, upon 4&prime; phosphorylation, is activated to a lipid A agonist). Activation of the precursor by the expression product of the lipid A 4&prime; kinase encoding sequence results in immunostimulation. Various precursors can be used and optimum transfection and dosing regimens can be established by one skilled in the art without undue experimentation. Candidates for immunostimulation as described above include immunodeficient or otherwise compromised patients (eg HIV patents and cancer patients). The immunostimulatory approach described can be used alone or in combination with other therapies (eg anti-infective therapies), depending on the effect sought.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>Certain aspects of the present invention are described in greater detail in the non-limiting Examples that follow.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLES</PDAT></STEXT></H>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>The following experimental details are relevant to the specific Examples that follow.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Bacterial strains and growth conditions. Table I lists the strains used. Cells were cultured at 37&deg; in Luria Broth (LB) consisting of 5 g of NaCl, 5 g of yeast extract, and 10 g tryptone/liter (Miller, Exp. Mol. Genet., Cold Spring Harbor Lab. Cold Spring Harbor, N.Y. (1972)). Antibiotics were added, when required, at 50 &mgr;g/ml for ampicillin, 12 &mgr;g/ml for tetracycline and 30 &mgr;g/ml for chloramphenicol.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE I</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Plasmids and </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strains used in this study</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="70pt" align="left"/>
<colspec colname="2" colwidth="98pt" align="left"/>
<colspec colname="3" colwidth="49pt" align="left"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>Strain or plasmid</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Relevant genotype</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Reference</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>W3110</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Wild-type, F-, &lgr;-</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>CGSC, Yale</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>University</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>BR7</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>dgk-6-zjb-729::Tn10, &Dgr;uncBC</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(55)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>BLR(DE3)pLysS</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>cm&prime;, tet&prime;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Novagen</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pET3a</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>vector, amp&prime;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Novagen</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pJK2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>pET 3a containing orfE</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>This Work</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>coding region</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00044" LVL="7"><PTEXT><PDAT>DNA techniques. </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>chromosomal DNA was isolated as described by Ausbel et al, Current Prot. Mol. Biol., John Wiley &amp; Sons, N.Y. (1989). Mini preparations of plasmid DNA were made using the Promega Wizard mini purification system. Large scale preparations of plasmid DNA were made using the 5&prime;-3&prime; Bigger Prep kit. PCR reactions were optimized using the Stratagene Optiprime Kit. DNA fragments were isolated from agarose gels using the Qiagen Qiaex 11 gel extraction kit.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>Restriction enzymes and T4 ligase were used according to the manufacturer&apos;s directions. Transformation of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>with plasmid DNAs was done using salt competent cells (Maniatis et al, Mol. Cloning: A Lab. Manual, Cold Spring Harbor, Cold Spring Harbor, N.Y. (1982)).</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>Lipid substrates. DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P was made according to Radika et al, (J. Biol. Chem. 263:14859 (1988)). Milligram quantities DS-1-P were enzymatically synthesized from UDP-2,3-diacyl-glucosamine and 2,3-diacyl-glucosamine-1-phosphate (lipid X) using a partially purified </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>disaccharide synthase preparation (Radika et al, J. Biol. Chem. 263:14859 (1988)). 3-aza-DS-1-P was made in the same manner except that 3-aza-lipid X (Haselberger et al, Triangle 26:33 (1987)) was used in place of lipid X. Base-treated DS-1-P was made by treating 2 mg of DS-1-P for 30 minutes with 0.2 M NaOH in 1 ml chloroform:methanol (2:1, v/v). The mixture was diluted 10 fold with chloroform:methanol (95:5) and loaded onto a 5 ml silica column equilibrated with 50 ml chloroform:methanol (95:5). The column was washed with 25 ml of each of the following ratios (v/v) of chloroform:methanol: 95:5, 90:10, 70:30, 1:1, 30:70 and 20:80. Thirty 5 ml fractions were collected. The resolved hydroxy fatty acids and the deacylated DS-1-P were detected by spotting 5 &mgr;l of each fraction onto a thin layer chromatography plate, developing the plate in chloroform:methanol:water:acetic acid (25:15:4:2, v/v), and charring with sulfuric acid. The hydroxy fatty acid eluted with the 70:30 v/v solvent mixture. The base-treated, deacylated DS-1-P eluted with the 1:1 solvent ratio. The relevant fractions were pooled, and the solvent removed by rotary evaporation. The base-treated, deacylated 3-aza-DS-1-P was prepared in the same manner. The elution profile for this compound was the same as for the base-treated, deacylated DS-1-P. For use as substrates in 4&prime; kinase assays, all lipid substrates were dispersed in 50 mM Hepes, pH 7.4, by sonic irradiation for 2 minutes.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>Kohara &lgr; library preparation and screen for 4&prime; kinase activity. Fresh lysates of the Kohara &lgr; library were made following the method of Clementz et al with slight modifications (J. Biol. Chem. 271:12095 (1996)). The host </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strain, W3110, was grown overnight at 37&deg; C. in LB medium, supplemented with 0.2% maltose and 10 mM MgSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>. The culture was diluted 1:1 with 10 mM CaCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, 10 mM MgCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. The &lgr; lysates used by Clementz et al (J. Biol. Chem. 271:12095 (1996)), were diluted 1:100 and 1:100 in SM buffer (5.8 g NaCl, 2 g MgSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 50 ml 1 M Tris, pH 7.5 per liter). Using 96-well microtiter plates, 5 &mgr;l of the individual diluted lysates and 10 &mgr;l of the diluted host cell suspension were mixed and incubated at 37&deg; C. for 15 minutes. LB medium supplemented with 10 mM MgSO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(150 &mgr;l) was added to each well and incubation continued at 37&deg; C. After 4 hours, the OD</PDAT><HIL><SB><PDAT>600 </PDAT></SB></HIL><PDAT>of each well was measured using a Molecular Dynamics Spectramax 250 microplate reader. When the cell suspension had cleared to an OD</PDAT><HIL><SB><PDAT>600 </PDAT></SB></HIL><PDAT>less than 0.1, it was considered lysed, and was transferred to a fresh microtiter plate at 4&deg; C. Lysis was evaluated every hour until 8 hours after infection. The lysates originating from the 1:1000 dilution of the originals were chosen for assay. Any hybrid &lgr; bacteriophages that did not yield fresh suitable lysates with the 1:1000 dilutions of the original stock were generally obtained from the 1:100 dilutions of the original stock. The final lysates were stored at &minus;80&deg; C. overnight. The 4&prime; kinase activity of each lysate was assayed in a 10 &mgr;l reaction mixture containing 5 &mgr;l of lysate, 100 &mgr;M DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P (1000 cpm/nmol), 1 mg/ml cardiolipin, 50 mM Tris, pH 8.5, 5 mM ATP, 1% NP-40, and 5 mM MgCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. After incubation at 30&deg; C. for 60 minutes, the reaction was stopped by spotting 5 &mgr;l onto a Silica Gel 60 TLC plate. The plates were developed in chloroform:methanol:water:acetic acid (25:15:4:2, v/v), dried, and exposed to a Molecular Dynamics PhosphorImager screen. Conversion of DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P to &lsqb;1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>was quantified using ImageQuant software (Molecular Dynamics).</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>Construction of pJK2 bearing orfE under the control of a T7 promoter. The gene encoded by the open reading frame orfE was cloned into pET3a cloning vector (Novagen). orfE was amplified by PCR of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>genomic DNA using pfu DNA polymerase (according to manufacturer&apos;s specification) and the following primers: 5&prime;GTTTGGCATATGATCGAAAAAATCTGG 3&prime; (SEQ ID NO:1) and 5&prime;ATTCATGGATCCATCAATCGAACGCTG 3&prime; (SEQ ID NO:2). The first primer introduces a Nde I site at the start codon of orfE, and the second primer introduces a BamHl site downstream of the stop codon. The PCR product was digested with Nde I and BamHl, and ligated into a similarly cut pET3a vector. A portion of the ligation reaction was transformed into </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>SURE cells (Stratagene, La Jolla, Calif.), and colonies resistant to ampicillin were selected. Plasmid DNA was isolated from ampicillin resistant clones and was digested with BamHl and Ndel to identify those constructs that contained the desired 1 kb insert. This plasmid is called pJK2 (see FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>Expression of the orfE gene product: pJK2 was transformed into BLR(DE3)pLysS cells and grown at 37&deg; C. in 2 liters of LB. When the cultures reached an A</PDAT><HIL><SB><PDAT>600 </PDAT></SB></HIL><PDAT>of 0.6, IPTG was added (final concentration of 1 mM) to induce expression of the orfE gene product. After 3 hours of induction, the cells were collected by centrifugation at 10,000&times;g for 15 minutes at 4&deg; C., washed with 1 liter of 50 mM Hepes, pH 7.5, and resuspended in 30 ml of the wash buffer. Cells were broken in a cold french pressure cell at 20,000 psi, and unbroken cells were removed by centrifugation at 3,500&times; g to form the cell-free extract. The membrane and soluble fractions were isolated by centrifugation of the entire cell-free extract at 150,000&times;g for 60 minutes. After centrifugation, the soluble fraction was removed to a fresh tube, and the membrane pellet resuspended in 50 ml 50 mM Hepes, pH 7.5. The soluble fraction and the resuspended membranes were both centrifuged a second time. The final membrane pellet was resuspended by homogenization in 10 ml of the Hepes buffer and stored frozen in aliquots at &minus;80&deg; C. The membrane free cytosol was also stored in aliquots at &minus;80&deg; C. The protein concentration was determined using the BioRad protein assay kit with bovine serum albumin as a standard.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>Assays for 4&prime; kinase activity. Two methods for analyzing 4&prime; kinase activity of various protein fractions were employed. The first (method I) utilizes DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P as the labeled substrate. Typically, 100 &mgr;M DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P (1000 cpm/nmol), 1 mg/ml cardiolipin, 50 mM Tris, pH 8.5, 5 mM ATP, 1% NP-40, and 5 mM MgCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>are mixed with 0.5-500 &mgr;g/ml protein fraction and incubated at 30&deg; C. for various times. Reactions were stopped by spotting a portion of the reaction onto a Silica Gel 60 thin layer chromatography plate. Plates were developed in chloroform:methanol:water:acetic acid (25:15:4:2, v/v) and analyzed as described above. Method II (which is not intended for the quantitative determination of specific activities) utilizes &lsqb;&ggr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb; ATP (&tilde;8&times;10</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>cpm/nmol) as the labeled substrate. The reaction conditions are exactly the same as for method I except that the ATP concentration is lowered to 0.6 &mgr;M and only non-radioactive DS-1-P (final concentration of 100 &mgr;M) is added. The reactions were stopped as described above, and plates were developed in chloroform:pyridine:formic acid:water (30:70:16:10, v/v).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example I</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Screening for Overproduction of Lipid A 4&prime; Kinase in Kohara Library &lgr; Lysates</PDAT></STEXT></H>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>Kohara et al (Cell 50:495 (1987)) have generated a library of 3400 mapped hybrid &lgr;, bacteriophage clones which cover the </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>genome. A subset of this library containing 476 &lgr; clones is available which covers 99% of the genome with some overlap between the clones (Clementz et al, J. Biol. Chem. 271:12095 (1996), Borodovsky et al, Trends Biochem. Sci. 19:309 (1994)). Clementz et al showed that enzymatic activity could be detected in </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>lysates produced by these hybrid &lgr; clones. Activities of several enzymes involved in LPS biosynthesis were detected, and lysates generated from the &lgr; clones containing the gene coding for the enzymes of interest displayed 5 to 10 fold overproduction of the activities.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>The same approach was employed to identify the gene for the lipid A 4&prime; kinase. The 4&prime; kinase activity was assayed in the lysates using method I (DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P and 5 mM ATP). Under these conditions, product formation was linear with respect to time and protein concentration, there were no side products, and the results were reproducible for a given lysate.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>Fresh &lgr; lysates of W3110 were prepared and assayed for 4&prime; kinase activity in 6 sets of 80. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT> shows the assay results for one set, hybrid &lgr; clones &lsqb;201&rsqb;4H7 to &lsqb;280&rsqb;22E3. No single lysate in the collection gave the 5 to 10 fold overproduction seen with other enzymes of lipid A biosynthesis. However, there were several lysates with significantly higher activity than their neighboring lysates (FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>). In order to choose lysates for further analysis, the mean and standard deviation for each set of 80 was calculated. Fifteen clones, the activity of which surpassed the mean by more than two standard deviations, were reassayed. One lysate, &lsqb;218&rsqb;E1D1 (marked by bold asterisk in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT>) consistently displayed 2-2.5 fold more kinase activity than the other lysates.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>Differences in lysis time could account for some of the variation of the activities seen in the lysates. The original lysates used to make the library were not generated from a fixed titer. To control for this variation among lysates, the plaque forming units (pfu) for lysates derived from &lgr; clones &lsqb;216&rsqb;13E3, &lsqb;217&rsqb;6D12, and &lsqb;218&rsqb;E1D1, and &lsqb;320&rsqb;15G10 were determined (FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>). Matched lysates were then made by infecting </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>W3110 with 4&times;10</PDAT><HIL><SP><PDAT>&minus;3 </PDAT></SP></HIL><PDAT>pfu. After 7-8 hours, lysis occurred in each case, and the lysates were again assayed for 4&prime; kinase activity as before. The result is shown in FIG. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT>. The lysate of &lgr;&lsqb;218&rsqb;E1D1 persisted in having 2-2.5 fold overproduction of 4&prime; kinase activity, compared to controls. This finding led to the further investigation of the genes on &lgr;&lsqb;218&rsqb;E1D1.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>The &lgr; clone &lsqb;218&rsqb;E1D1 contains a 20 kb fragment of the </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>genome spanning minutes 20.8-21.3 (Berlyn et al, in </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 2, Second Ed., pp. 1715-1902, American Society for Microbiology, Washington, D.C. (1996)). Two genes in this region, msbA and kdsB, are related to the lipopolysaccharide system. kdsB encodes the CMP-Kdo synthase, and msbA encodes a putative LPS transporter (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>) with homology to mammalian Mdr proteins. msbA was first identified by Karow and Georgopoulos (Karow et al, Mol. Microbiol. 7:69 (1993), Polissi et al, Mol. Microbiol. 20:1221 (1996)) as a multicopy suppressor of htrB (Karow et al, J. Bacteriol. 173:741 (1991), Karow et al, Mol. Microbiol. 5:2285 (1991), Karow et al, J. Bacteriol. 174:7407 (1992)), the gene encoding the Kdo-dependent lauroyl transferase (FIG. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>). msbA forms an operon with an essential downstream open reading frame, orfE, of unknown function (Karow et al, Mol. Microbiol. 7:69 (1993). Insertion of an &OHgr; chloramphenicol resistance cassette into the msbA gene blocks transcription of both msbA and orfE. Complementation of this msbA/orfE knockout only occurred with hybrid plasmids encoding both msbA and orfE, supporting the view that both genes are essential. As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 7</PDAT></FGREF><PDAT>, only about half of the msbA coding region is on &lgr; clone &lsqb;218&rsqb;E1D1. In this clone, orfE is missing its native msbA promoter and expression of this gene would be from readthrough of &lgr; genes. Given the relatively low overproduction of the 4&prime; kinase activity found in lysates generated with &lsqb;218&rsqb;E1D1 and the indication that orfE does not have its own endogenous promoter, a plasmid was constructed to overexpress orfE using the T7 RNA polymerase system.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example II</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Massive Over-Expression of 4&prime; Kinase Activity on a Hybrid Plasmid Bearing orfE</PDAT></STEXT></H>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>The gene encoding orfE was cloned behind the T7 promoter of pET3a to form pJK2. Plasmid pJK2 was transformed into BLR(DE3)pLysS cells, an </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strain that carries the T7 RNA polymerase as a &lgr; lysogen (Table I). The expression of T7 RNA polymerase is induced with IPTG and leads to the expression of genes from the T7 promoter. Washed membranes from BR7, an </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strain deficient for diglyceride kinase (Ray et al, J. Biol. Chem. 262:1122 (1987), Hampton et al, Methods in Enzymology 209:466 (1992)), BLR(DE3)pLysS/pJK2, and BLR(DE3)pLysS/pET3a were assayed for 4&prime; kinase activity using DS-1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P as the phosphate acceptor. The result of this assay is shown in FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>. The 4&prime; kinase activity was highly over-expressed in cells with pJK2 versus strain BR7 or cells with pET3a vector alone (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT>, lanes 3 and 4, versus lanes 1, 2, and 5). When assayed at a protein dilution in which product-formation is linear with respect to time, expression of orfE led to several thousand fold overproduction of 4&prime; kinase activity. Table II shows the specific activities of the 4&prime; kinase in cell-free extracts, membrane free cytosols (subjected to two ultracentrifugations), and washed membranes.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00002">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE III</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Conversion of DS-&lsqb;1-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>by various fractions of</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>BLR(DE3)pLysS/pET3a and BLR (DE3)pLysS/pJK2</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="77pt" align="left"/>
<colspec colname="2" colwidth="56pt" align="left"/>
<colspec colname="3" colwidth="84pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>Specific Activity</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Strain</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Cellular fraction</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>nmol/min/mg (30&deg; C.)</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="77pt" align="left"/>
<colspec colname="2" colwidth="56pt" align="left"/>
<colspec colname="3" colwidth="84pt" align="char" char="."/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>BLR(DE3)pLysS/pE</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>cell-free extract</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>0.34</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>T3a</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>membranes</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>1.75</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>cytosol</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>ND</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>BLR(DE3)pLysS</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>cell-free extract</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.17 &times; 10</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>membranes</PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>3.17 &times; 10</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>cytosol</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>30.7</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00001"><PTEXT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>Washed membranes were used. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00002"><PTEXT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>Cytosol subjected to two ultracentrifugations was used. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00003"><PTEXT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>The activity was too low to measure accurately </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>orfE encodes a 328 amino acid protein with a predicted molecular weight of 36 kDa (Karow et al, Mol. Microbiol. 7:69 (1993)). Analysis of protein fractions from BLR(DE3)pLysS/pJK2 cells by SDS-PAGE shows an over-expressed protein that is not present in protein fractions from BLR(DE3)pLysS/pET3a cells (FIG. </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>). The over-expressed protein migrates with the molecular weight predicted from the sequence of orfE and is associated with the membranes (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, lane 8). This is consistent with the hydropathy profile of orfE, which predicts 1 or 2 transmembrane helices in the N-terminal region of the protein. Like the protein, the 4&prime; kinase activity is also associated with the membranes consistent with the hypothesis that orfE encodes the enzyme (Table II).</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>Database searches identified only two open reading frames of unknown function from other gram-negative bacteria with significant homology to orfE. The predicted amino acid sequence of an open reading frame identified in the Haemophilus influenzae Rd genome (Fleischmann et al, Science 269:496 (1995)) is 70.2% similar and 48.4% identical to the predicted amino acid sequence of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>orfE. The valB gene (Mdluli et al, Microbiology 140:3309 (1994)) from </PDAT><HIL><ITALIC><PDAT>Francisella novicida </PDAT></ITALIC></HIL><PDAT>encodes a protein that is 66.8% similar and 41.4% identical to orfE. This strongly suggests that the </PDAT><HIL><ITALIC><PDAT>H. influenzae </PDAT></ITALIC></HIL><PDAT>open reading frame and </PDAT><HIL><ITALIC><PDAT>Francisella novicida </PDAT></ITALIC></HIL><PDAT>valb may also be genes encoding lipid A 4&prime; kinase variants. orfE and its homologues do not display significant sequence similarity to any other type of kinase, including those involved in carbohydrate, lipid, nucleic acid or protein phosphorylation.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example III</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Analysis of Substrate Specificity and Generation of Novel Analogs with the Overproduced Kinase</PDAT></STEXT></H>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>The 4&prime; kinase is a useful tool for making </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-labeled substrates for the biochemical analysis of the enzymes catalyzing the late steps of the lipid A pathway (Hampton et al, Methods in Enzymology 209:466 (1992), Brozek et al, J. Biol. Chem. 264:6956 (1989), Brozek et al, J. Biol. Chem. 265:15410 (1990), Clementz et al, J. Biol. Chem. 271:12095 (1996)). </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-labeled lipid A precursors and substructures are also useful for studying the interactions of lipid A-like molecules with mammalian cells (Hampton et al, Nature 266:19499 (1991), Hampton et al, Nature 352:342 (1991). To demonstrate the synthetic utility of the overexpressed 4&prime; kinase, several DS-1-P analogs were analyzed as 4&prime; kinase substrates (FIG. </PDAT><HIL><BOLD><PDAT>11</PDAT></BOLD></HIL><PDAT>). DS-1-P is the physiological substrate for the 4&prime; kinase. 3-aza-DS-1-P has an amide-linked hydroxymyristate group at the 3 position instead of an ester-linked group (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, NH indicated in bold). Mild alkaline hydrolysis of these compounds results in removal of the ester-linked hydroxymyristate moieties. The structures of the resulting compounds, designated base-treated DS-1-P and base-treated 3-aza-DS-1-P, are also shown.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>Each lipid analog was tested as a 4&prime; kinase substrate using recombinant, overexpressed 4&prime; kinase in conjunction with the method II assay conditions (0.6 &mgr;M &lsqb;&ggr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-ATP as the phosphate donor and 100 &mgr;M lipid acceptor). DS-1-P becomes phosphorylated to form &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>by BR7 membranes (containing wild-type kinase levels), but only with a yield of &tilde;0.5% (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, lane 2). When BLR(DE3)pLysS/pJK2 membranes are used (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, lane 7) more than 50% of the </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P is incorporated into &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>. The 3-aza-DS-1-P, the base-treated DS-1-P, and the base-treated 3-aza-DS-1-P, were also well utilized substrates for the recombinant, over-expressed 4&prime; kinase. Product (a) is formed efficiently from 3-aza-DS-1-P in the presence of BLR(DE3)pLysS/pJK2 membranes, but not BR7 membranes (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, lane 8 versus lane 3). Products (b) and (c) are formed from base-treated DS-1-P and base treated 3-aza-DS-1-P, respectively. In each case, the reaction is 100-1000 fold more effective with membranes from BLR(DE3)pLysS/pJK2 membranes than with membranes from BR7 (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12</PDAT></FGREF><PDAT>, lanes 9 and 10 versus lanes 4 and 5).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example IV</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Enzymatic Synthesis of &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-Lipid A</PDAT></STEXT></H>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>The results using the DS-1-P analogs show that the 4&prime; kinase can efficiently phosphorylate disaccharides with 2, 3 or 4 acyl chains. However, some of the most important lipid A-like molecules that display either endotoxin agonist or antagonist activity contain 5 or 6 acyl (or alkyl) chains (Raetz, </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed) Vol. 1, Second Ed., pp. 1035-1063, American Society for Microbiology, Washington, D.C. (1996), Golenbock et al, J. Biol. Chem. 266:19490 (1991), Christ et al, J. Am. Chem. Soc. 116:3637 (1994), Christ et al, Science 265:80 (1995), Takayama et al, Infect. Immun. 57:1336 (1989)). In order to address whether the recombinant, overexpressed 4&prime; kinase would be useful for making </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-endotoxin agonists or antagonists, an attempt was made to phosphorylate compound 505, a synthetic hexaacyldisaccharide-1-phosphate (Imoto et al, Bull. Chem. Soc. Jpn. 60:2205 (1987), Loppnow et al, J. Immunol. 142:3229 (1989), Kusumoto et al in Bacterial Endotoxic Lipopolysaccharides, Vol. I: Molecular Biochemistry and Cellular Biology. (Morrison et al, eds), pp. 81-105, CRC Press, Boca Raton (1992)). The 4&prime; phosphorylation of this compound yields the major molecular species that constitutes </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>K-12 lipid A (endotoxin) (Karibian et al, J. Bacteriol. 175:2988 (1993)), as shown in FIG. </PDAT><HIL><BOLD><PDAT>13</PDAT></BOLD></HIL><PDAT>. Compound 505 was tested in a 4&prime; kinase assay system using membranes from BR7 and BLR(DE3)pLysS/pJK2. The results are shown in FIG. </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>. When BR7 membranes are used with DS-1-P, a small amount of &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid IVA product (representing &tilde;0.5% of the input &lsqb;&ggr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-ATP) is formed (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14</PDAT></FGREF><PDAT>, lane 2). Use of BLR(DE3)pLysS/pJK2 membranes leads to formation of a large amount of lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>(</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14</PDAT></FGREF><PDAT>, lane 5). If compound 505 is assayed with BR7 membranes, no detectable product (&lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid A) was formed (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14</PDAT></FGREF><PDAT>, lane 3). However, with BLR(DE3)pLysS/pJK2 membranes, about 5% of the input </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P from &lsqb;&ggr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-ATP is incorporated into &lsqb;4&prime;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-lipid A (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14</PDAT></FGREF><PDAT>, lane 6). The migration of this novel, enzymatically labeled product has the same migration as lipid A isolated by pH 4.5 hydrolysis from wild-type </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>cells. Thus, when greatly over-expressed, the 4&prime; kinase is capable of phosphorylating glucosamine disaccharides that are more or less acylated than the native substrate, DS-1-P. Lipid X and UDP-diacylglucosamine were not substrates for the 4&prime; kinase, even when the enzyme was highly overexpressed. The enzyme apparently has a strong preference for glucosamine disaccharides.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>Membranes from </PDAT><HIL><ITALIC><PDAT>Rhizobium etli </PDAT></ITALIC></HIL><PDAT>strain CE3, contain an unusual phosphatase that removes the 4&prime; phosphate from the lipid A precursor, KdO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>. Solubilized CE3 membranes were used to make 4&prime; de-phosphorylated KdO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid IV</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>. The 4&prime; dephosphorylated KdO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-lipid IV</PDAT><HIL><SB><PDAT>A </PDAT></SB></HIL><PDAT>is not a substrate for the over-expressed 4&prime; kinase. The Kdo disaccharide may interfere with the presentation of the 4&prime;&mdash;OH of the glucosamine disaccharide to the kinase.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example IV</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Construction of Plasmids for Generation of lpxK Knockout</PDAT></STEXT></H>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>The lpxK gene was cloned into pMAK705, a vector with a temperature sensitive origin of replication (Hamilton et al, J. Bacteriol. 171:4617 (1989)). pJK2 and pMAK705 were digested with XbaI and BamHI. The 1 kb lpxK gene from pJK2 and the 6 kb linearized pMAK705 were gel purified from a 1% agarose gel. pMAK705 was dephosphorylated with shrimp alkaline phosphatase (USB). The lpxK gene was ligated into pMAK705. A portion of the ligation mixture was transformed into CaCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. competent XL1-Blue </PDAT><HIL><ITALIC><PDAT>E. coli, </PDAT></ITALIC></HIL><PDAT>and colonies resistant to chloramphenicol were selected. Plasmid DNA was isolated from chloramphenicol resistant clones, and digested with XbaI and BamHI to identify those constructs with the desired insert. This plasmid is called pTAG1. To verify that pTAG1 expressed the lpxK gene using the lac promoter, a cell-free extract was prepared and assayed as indicated above. Extracts of cells containing pTAG1 displayed &tilde;5 fold overexpression of 4&prime; kinase activity versus extracts of cells with vector alone.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>A plasmid analogous to pTAG1 was constructed with a kanamycin cassette inserted into the NsiI site of lpxK gene. pJK2 was digested with NsiI and pUC-4K (Pharmacia) was digested with PstI. The 5.5 kb linearized pJK2 and the 1.2 kb kanamycin cassette from pUC-4K were gel purified and ligated together. A portion of the ligation was transformed into </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>XL1-Blue (Stratagene) and colonies resistant to ampicillin were selected. Plasmids were isolated from ampicillin resistant colonies and digested with NdeI and BamHI to verify the presence of the correct 2.2 kb insert. The lpxK::kan construct described above was digested with XbaI and BamHI and cloned into pMAK705 exactly as for pTAG1, yielding pTAG2.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Construction of Strain TG1/pTAG1,</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Mutant with Insertion in Chromosomal Copy of lpxK Covered by Plasmid Bearing lpxK</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> and Temperature Sensitive Replicon</PDAT></STEXT></H>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>TG1/pTAG1 was constructed following the method of Hamilton et al. (1989). Competent MC1061 were transformed with pTAG2 and grown at 30&deg; C. to an A</PDAT><HIL><SB><PDAT>600 </PDAT></SB></HIL><PDAT>of 0.6. Next, 1&times;10</PDAT><HIL><SP><PDAT>5 </PDAT></SP></HIL><PDAT>cells were plated on prewarmed LB plates containing 30 &mgr;g/ml chloramphenicol and incubated at 44&deg; C. This selects for cells in which pTAG2 has integrated into the genome. A single colony was used to inoculate 1 ml LB containing chloramphenicol and grown at 30&deg; C. for 6 hours. This culture was diluted into 100 ml of LB containing chloramphenicol and grown to stationary phase. A portion of the culture was diluted 1:1000 into fresh LB containing chloramphenicol and grown to stationary phase again. The above outgrowth was repeated once more. During this outgrowth, the integrated plasmid will occasionally excise carrying either the wild-type lpxK gene or the lpxK::kan allele (Hamilton et al., J. Bacteriology. 171:4617 (1989)). The cells were plated on LB containing chloramphenicol at 30&deg; C. Cells in which the plasmid had excised were identified by their inability to grow at 44&deg; C. in the presence of chloramphenicol. Plasmids were then isolated from 14 temperature sensitive strains and digested with XbaI and BamHI. Of the 14 colonies, 11 contained the pTAG2 insert. Three, however, had the pTAG1 insert, indicating that the lpxK::kan insertion of pTAG2 had replaced the wild-type lpxK gene on the chromosome (Hamilton et al., J. Bacteriology. 171:4617 (1989)). One of these strains was made recA</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> by PI transduction using BLR(DE3) as the donor. The presence of the recA</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> -phenotype was verified by the strain&apos;s sensitivity to UV light.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>This strain (designated TG1/pTAG</PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>1) is temperature sensitive for growth, accumulates DS-1-P at the non-permissive temperature and is rescued at 44&deg; C. by the introduction into cells of non-temperature sensitive plasmids bearing lpxK</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>or various lpxK homologs from other bacterial species.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Temperature Sensitivity of TG1/pTAG1</PDAT></STEXT></H>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>Strain TG1/pTAG1 is a mutant with a kanamycin cassette inserted into the chromosomal copy of orfE/lpxK (orfe is the original gene name, however, given its newly identified function it has been renamed lpxK). This insertion is covered by a plasmid, pTAG1, bearing lpxK&plus; and a temperature sensitive origin of replication. pTAG1 contains the chloramphenicol resistance gene and cells containing pTAG1 are resistant to chloramphenicol at 30&deg; C. but not at 44&deg; C. At higher temperature the origin of replication on pTAG1 does not function and leads to loss of the plasmid. Strain TG1/pTAG1 was tested for its ability to grow with a chromosomal insertion in the lpxK gene in the absence of pTAG1 by growth at 44&deg; C. A single colony was streaked to two LBV plates containing kanamycin and tetracycline. One plate was incubated at 30&deg; C. and the other at 44&deg; C. TG1/pTAG1 was able to grow and form single colonies at 30&deg; C. but not at 44&deg; C. indicating that the insertional inactivation of lpxK is lethal. This result is consistent with Karow and Georgopolous&apos;s finding that orfE was an essential gene (Karow et al, Mol. Microbiol. 7:69 (1993)).</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>Construction of pTAG6</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>pNGH1-amp was constructed from pNGH1 (T. Odegaard et al, J. Biol. Chem., submitted). pNGHI was digested with BamHI and SalI yielding 3.9 kb and 1.6 kb fragments. pACYC177 was digested with BamHI and XhoI yielding 2.5 kb and 1.4 kb fragments. The 2.5 kb pACYC177 fragment which contains the &bgr;-lactamase gene and 1.6 kb pNGH1 fragment which contains the lac promoter were ligated together to form pNGH1-amp. pJK2 was digested with NdeI and the 5&prime; overhang filled in with Klenow DNA Polymerase (New England Biolabs). The lpxK gene was excised by further digestion with BamHI, yielding a 985 base pair fragment with one blunt end and one BamHI sticky end. pNGH1-amp was digested with SmaI and BamHI. The lpxK fragment was ligated into the digested pNGH1-amp. A portion of the ligation was transformed into XLI-Blue competent cells and colonies resistant to ampicillin were selected. Plasmid DNA was isolated from ampicillin resistant clones and was digested with BamHI and SacI to verify the presence of the correct insert. This plasmid was called pTAG6.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>A Complementation Assay for Functional lpxK Genes</PDAT></STEXT></H>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>A mutant rescue experiment was performed using the </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>lpxK gene to illustrate the use of TG1/pTAG1 for identification of 4&prime; kinase variants. pTAG6 is a plasmid which contains the lpxK gene on a low copy ampicillin resistant vector, pNGH1-amp. Unlike pTAG1, this vector is not temperature sensitive for replication and will be maintained at 44&deg; C. Salt competent TG1/pTAG1 cells were made (Sambrook et al, Molecular Cloning, A laboratory Manual, 2nd Edition), and transformed with pTAG6. Transformed cells were plated on LB plates containing ampicillin and grown overnight at 30&deg; C. Transformants, called TG1/pTAG1/pTAG6, were cured of pTAG1 by growth on plates at 44&deg; C. Unlike strain TG1/pTAG1, TG1/pTAG6 is able to grow and form single colonies at 44&deg; C. TG1/pTAG6 is chloramphenicol sensitive at 30&deg; C. and 44&deg; C. consistent with loss of pTAG1. pTAG6 contains a functional 4&prime; kinase gene and is able to cover the lpxK insertion mutation.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>All documents cited above are hereby incorporated in their entirety by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>One skilled in the art will appreciate from a reading of this disclosure that various changes in form and detail can be made without departing from the true scope of the invention.</PDAT></PTEXT></PARA>
<CWU>
<SEQLST-US ID="SEQLST-1">
<SEQ-LST-NEW>
<S100>
<S160>
<PDAT>8</PDAT>
</S160>
</S100>
<S200>
<S210>
<PDAT>1</PDAT>
</S210>
<S211>
<PDAT>27</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Artificial Sequence</PDAT>
</S213>
<S220>
<S223><STEXT><PDAT>Description of Artificial Sequenceprimer</PDAT></STEXT></S223>
</S220>
</S200>
<S400>
<PDAT> 1
gtttggcata tgatcgaaaa aatctgg                                         27
</PDAT>
</S400>
<S200>
<S210>
<PDAT>2</PDAT>
</S210>
<S211>
<PDAT>27</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Artificial Sequence</PDAT>
</S213>
<S220>
<S223><STEXT><PDAT>Description of Artificial Sequenceprimer</PDAT></STEXT></S223>
</S220>
</S200>
<S400>
<PDAT> 2
attcatggat ccatcaatcg aacgctg                                         27
</PDAT>
</S400>
<S200>
<S210>
<PDAT>3</PDAT>
</S210>
<S211>
<PDAT>987</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Escherichia coli</PDAT>
</S213>
</S200>
<S400>
<PDAT> 3
atgatcgaaa aaatctggtc tggtgaatcc cctttgtggc ggctattgct gccactctcc     60
tggttgtatg gcctggtgag tggcgcgatc cgtctttgct ataaactaaa actgaagcgc    120
gcctggcgtg cccccgtacc ggttgtcgtg gttggtaatc tcaccgcagg cggcaacgga    180
aaaaccccgg tcgttgtctg gctggtggaa cagttgcaac agcgcggtat tcgcgtgggg    240
gtcgtatcgc ggggatatgg tggtaaggct gaatcttatc cgctgttatt gtcggcagat    300
accacaacag cacaggcggg tgatgaacct gtgttgattt atcaacgcac tgatgcgcct    360
gttgcggttt ctcccgttcg ttctgatgcg gtaaaagcca ttctggcgca acaccctgat    420
gtgcagatca tcgtaaccga cgacggttta cagcattacc gtctggcgcg tgatgtggaa    480
attgtcgtta ttgatggtgt gcgtcgcttt ggcaatggct ggtggttgcc ggcggggcca    540
atgcgtgagc gagcggggcg cttaaagtcg gttgatgcgg taatcgtcaa cggcggtgtc    600
cctcgcagcg gtgaaatccc catgcatctg ctgccgggtc aggcggtgaa tttacgtacc    660
ggtacgcgtt gtgacgttgc tcagcttgaa catgtagtgg cgatggcggg gattgggcat    720
ccgccgcgct tttttgccac gctgaagatg tgtggcgtac aaccggaaaa atgtgtaccg    780
ctggccgatc atcagtcttt gaaccatgcg gatgtcagtg cgttggtaag cgccgggcaa    840
acgctggtaa tgactgaaaa agatgcggtg aaatgccggg cctttgcaga agaaaattgg    900
tggtatttgc ctgtagacgc acagctttca ggtgatgaac cagcgaaact gcttacgcaa    960
ctaaccttgc tggcttctgg caactag                                        987
</PDAT>
</S400>
<S200>
<S210>
<PDAT>4</PDAT>
</S210>
<S211>
<PDAT>328</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Escherichia coli</PDAT>
</S213>
</S200>
<S400>
<PDAT> 4
Met Ile Glu Lys Ile Trp Ser Gly Glu Ser Pro Leu Trp Arg Leu Leu
  1               5                  10                  15
Leu Pro Leu Ser Trp Leu Tyr Gly Leu Val Ser Gly Ala Ile Arg Leu
             20                  25                  30
Cys Tyr Lys Leu Lys Leu Lys Arg Ala Trp Arg Ala Pro Val Pro Val
         35                  40                  45
Val Val Val Gly Asn Leu Thr Ala Gly Gly Asn Gly Lys Thr Pro Val
     50                  55                  60
Val Val Trp Leu Val Glu Gln Leu Gln Gln Arg Gly Ile Arg Val Gly
 65                  70                  75                  80
Val Val Ser Arg Gly Tyr Gly Gly Lys Ala Glu Ser Tyr Pro Leu Leu
                 85                  90                  95
Leu Ser Ala Asp Thr Thr Thr Ala Gln Ala Gly Asp Glu Pro Val Leu
            100                 105                 110
Ile Tyr Gln Arg Thr Asp Ala Pro Val Ala Val Ser Pro Val Arg Ser
        115                 120                 125
Asp Ala Val Lys Ala Ile Leu Ala Gln His Pro Asp Val Gln Ile Ile
    130                 135                 140
Val Thr Asp Asp Gly Leu Gln His Tyr Arg Leu Ala Arg Asp Val Glu
145                 150                 155                 160
Ile Val Val Ile Asp Gly Val Arg Arg Phe Gly Asn Gly Trp Trp Leu
                165                 170                 175
Pro Ala Gly Pro Met Arg Glu Arg Ala Gly Arg Leu Lys Ser Val Asp
            180                 185                 190
Ala Val Ile Val Asn Gly Gly Val Pro Arg Ser Gly Glu Ile Pro Met
        195                 200                 205
His Leu Leu Pro Gly Gln Ala Val Asn Leu Arg Thr Gly Thr Arg Cys
    210                 215                 220
Asp Val Ala Gln Leu Glu His Val Val Ala Met Ala Gly Ile Gly His
225                 230                 235                 240
Pro Pro Arg Phe Phe Ala Thr Leu Lys Met Cys Gly Val Gln Pro Glu
                245                 250                 255
Lys Cys Val Pro Leu Ala Asp His Gln Ser Leu Asn His Ala Asp Val
            260                 265                 270
Ser Ala Leu Val Ser Ala Gly Gln Thr Leu Val Met Thr Glu Lys Asp
        275                 280                 285
Ala Val Lys Cys Arg Ala Phe Ala Glu Glu Asn Trp Trp Tyr Leu Pro
    290                 295                 300
Val Asp Ala Gln Leu Ser Gly Asp Glu Pro Ala Lys Leu Leu Thr Gln
305                 310                 315                 320
Leu Thr Leu Leu Ala Ser Gly Asn
                325
</PDAT>
</S400>
<S200>
<S210>
<PDAT>5</PDAT>
</S210>
<S211>
<PDAT>996</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Haemophilus influenzae</PDAT>
</S213>
</S200>
<S400>
<PDAT> 5
atgcccttct ggtattccaa ctccaaactt atttggctct tatcgccttt ttctttattg     60
ttttggttga ttagccaact tcgtcgcgcc ttattctctt tggggctgaa gtcttcttat    120
cgcgcaccaa aaccagtgat aattgtggga aatttgtctg tgggtggaaa tggcaaaacg    180
cctgtggttg tttggcttat ggaagaatta aaaaaacgag gtctgcgtgt aggtgtgatt    240
tctcgtggtt acggcagtaa atctaaaact tatccgttat tcgtcactaa aaatacaaat    300
ccaattgaag gtggcgatga gcctgtattg atcgctaaac gtactaatgc gccagttgtg    360
atttccccga atcgccagca agcgattgaa ttactcttaa gccaagcaga gtgcgatatt    420
attatttctg atgatggttt gcagcattat caattacaac gtgatttaga aattgtcgta    480
atggacgctg agcgcgcatt gggaaatggt tttgtattgc cagcaggtcc attgcgtgaa    540
ttaccaagtc gattaaaatc tgtcgatttt gtgatcacta atggtggaaa aaatcagtat    600
tcagatgcag ttatgcgtct tgtgcctcat ttcgcgatta atttaaaaac caatgaaaaa    660
cgccaattaa atgaatttca atctggtgtt gccatcgcag ggattggcaa tccacagcgt    720
ttttttacta tgttagaaaa gttagggatt cagttaaagc aaactcaagc atttcaagat    780
catcaacatt ttgaagcgtc tcaattagaa aaacttgctg aaaatcaacc gctctttatg    840
acggaaaaag atgccgtaaa atgccaatct tttgctaaag ataattggtg gtatgtccct    900
gtggatgcgg agattattga ggctgaaaaa caacgtgaaa atttaccgca cttttgggcc    960
aaaatagaca aacttgtgga gcaatacaga aatggc                              996
</PDAT>
</S400>
<S200>
<S210>
<PDAT>6</PDAT>
</S210>
<S211>
<PDAT>332</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Haemophilus influenzae</PDAT>
</S213>
</S200>
<S400>
<PDAT> 6
Met Pro Phe Trp Tyr Ser Asn Ser Lys Leu Ile Trp Leu Leu Ser Pro
  1               5                  10                  15
Phe Ser Leu Leu Phe Trp Leu Ile Ser Gln Leu Arg Arg Ala Leu Phe
             20                  25                  30
Ser Leu Gly Leu Lys Ser Ser Tyr Arg Ala Pro Lys Pro Val Ile Ile
         35                  40                  45
Val Gly Asn Leu Ser Val Gly Gly Asn Gly Lys Thr Pro Val Val Val
     50                  55                  60
Trp Leu Met Glu Glu Leu Lys Lys Arg Gly Leu Arg Val Gly Val Ile
 65                  70                  75                  80
Ser Arg Gly Tyr Gly Ser Lys Ser Lys Thr Tyr Pro Leu Phe Val Thr
                 85                  90                  95
Lys Asn Thr Asn Pro Ile Glu Gly Gly Asp Glu Pro Val Leu Ile Ala
            100                 105                 110
Lys Arg Thr Asn Ala Pro Val Val Ile Ser Pro Asn Arg Gln Gln Ala
        115                 120                 125
Ile Glu Leu Leu Leu Ser Gln Ala Glu Cys Asp Ile Ile Ile Ser Asp
    130                 135                 140
Asp Gly Leu Gln His Tyr Gln Leu Gln Arg Asp Leu Glu Ile Val Val
145                 150                 155                 160
Met Asp Ala Glu Arg Ala Leu Gly Asn Gly Phe Val Leu Pro Ala Gly
                165                 170                 175
Pro Leu Arg Glu Leu Pro Ser Arg Leu Lys Ser Val Asp Phe Val Ile
            180                 185                 190
Thr Asn Gly Gly Lys Asn Gln Tyr Ser Asp Ala Val Met Arg Leu Val
        195                 200                 205
Pro His Phe Ala Ile Asn Leu Lys Thr Asn Glu Lys Arg Gln Leu Asn
    210                 215                 220
Glu Phe Gln Ser Gly Val Ala Ile Ala Gly Ile Gly Asn Pro Gln Arg
225                 230                 235                 240
Phe Phe Thr Met Leu Glu Lys Leu Gly Ile Gln Leu Lys Gln Thr Gln
                245                 250                 255
Ala Phe Gln Asp His Gln His Phe Glu Ala Ser Gln Leu Glu Lys Leu
            260                 265                 270
Ala Glu Asn Gln Pro Leu Phe Met Thr Glu Lys Asp Ala Val Lys Cys
        275                 280                 285
Gln Ser Phe Ala Lys Asp Asn Trp Trp Tyr Val Pro Val Asp Ala Glu
    290                 295                 300
Ile Ile Glu Ala Glu Lys Gln Arg Glu Asn Leu Pro His Phe Trp Ala
305                 310                 315                 320
Lys Ile Asp Lys Leu Val Glu Gln Tyr Arg Asn Gly
                325                 330
</PDAT>
</S400>
<S200>
<S210>
<PDAT>7</PDAT>
</S210>
<S211>
<PDAT>969</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Francisella novcida</PDAT>
</S213>
</S200>
<S400>
<PDAT> 7
atgctagata agatttggta cagatcaaaa ccaaacttgc ttagtcgggt gctacaacca     60
atatctttgg tttttataga tattgcaaat aaacgtaaaa taaaacagca actcaagcaa    120
tataaatcaa aaattcctat aatagttgtt ggcaatatct ctgttggcgg tactggcaaa    180
actccagttg ttagaatgtt ggctcagcaa tatttagcac aaggtaaaaa accagctata    240
attagtcgtg gatatggtgc aaaggctgat aattatcctt ttgaagtaac aagtggtact    300
ctagcaactc aatgtggcga tgagcctgcg atgttatttg atgctttgca agcacaggtt    360
cctattgtta ttgctccaga gagagttcag gctgttaaat acattgaaaa gaattttcct    420
gatacagata taattatatc tgatgatggc ttgcaacatt ataaattagc tcgagataag    480
gaaatagtgg tcgtagatgc tattagaatg tttggcaata aattatgttt gcctgctggt    540
ccattgagag aaccgattga gagattaaaa gaagtagatc aaattatagt tataggtaat    600
tgctcagata aagataaaga gttactcaaa aactataaaa atgtgactta tgcaaaagtc    660
gtagctactg aatttgttaa tatattaaca gctaaaaaag tagctaagac tgaatttaat    720
catcaaaatg taatagctat agcagggatt ggcaatccaa caaaattttt taagacttta    780
gaagagagtg ctataaacat aacagctaaa aaagttttta aagatcacca taagtttact    840
cagagtgatt ttgagggtat agatagtgac ataactgtag tgatgacata taaagatgct    900
attaaatgca aaaattttgc taaagctaat tggtggtatc tggatatagc tttagatatc    960
aatgtttaa                                                            969
</PDAT>
</S400>
<S200>
<S210>
<PDAT>8</PDAT>
</S210>
<S211>
<PDAT>322</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Francisella novcida</PDAT>
</S213>
</S200>
<S400>
<PDAT> 8
Met Leu Asp Lys Ile Trp Tyr Arg Ser Lys Pro Asn Leu Leu Ser Arg
  1               5                  10                  15
Val Leu Gln Pro Ile Ser Leu Val Phe Ile Asp Ile Ala Asn Lys Arg
             20                  25                  30
Lys Ile Lys Gln Gln Leu Lys Gln Tyr Lys Ser Lys Ile Pro Ile Ile
         35                  40                  45
Val Val Gly Asn Ile Ser Val Gly Gly Thr Gly Lys Thr Pro Val Val
     50                  55                  60
Arg Met Leu Ala Gln Gln Tyr Leu Ala Gln Gly Lys Lys Pro Ala Ile
 65                  70                  75                  80
Ile Ser Arg Gly Tyr Gly Ala Lys Ala Asp Asn Tyr Pro Phe Glu Val
                 85                  90                  95
Thr Ser Gly Thr Leu Ala Thr Gln Cys Gly Asp Glu Pro Ala Met Leu
            100                 105                 110
Phe Asp Ala Leu Gln Ala Gln Val Pro Ile Val Ile Ala Pro Glu Arg
        115                 120                 125
Val Gln Ala Val Lys Tyr Ile Glu Lys Asn Phe Pro Asp Thr Asp Ile
    130                 135                 140
Ile Ile Ser Asp Asp Gly Leu Gln His Tyr Lys Leu Ala Arg Asp Lys
145                 150                 155                 160
Glu Ile Val Val Val Asp Ala Ile Arg Met Phe Gly Asn Lys Leu Cys
                165                 170                 175
Leu Pro Ala Gly Pro Leu Arg Glu Pro Ile Glu Arg Leu Lys Glu Val
            180                 185                 190
Asp Gln Ile Ile Val Ile Gly Asn Cys Ser Asp Lys Asp Lys Glu Leu
        195                 200                 205
Leu Lys Asn Tyr Lys Asn Val Thr Tyr Ala Lys Val Val Ala Thr Glu
    210                 215                 220
Phe Val Asn Ile Leu Thr Ala Lys Lys Val Ala Lys Thr Glu Phe Asn
225                 230                 235                 240
His Gln Asn Val Ile Ala Ile Ala Gly Ile Gly Asn Pro Thr Lys Phe
                245                 250                 255
Phe Lys Thr Leu Glu Glu Ser Ala Ile Asn Ile Thr Ala Lys Lys Val
            260                 265                 270
Phe Lys Asp His His Lys Phe Thr Gln Ser Asp Phe Glu Gly Ile Asp
        275                 280                 285
Ser Asp Ile Thr Val Val Met Thr Tyr Lys Asp Ala Ile Lys Cys Lys
    290                 295                 300
Asn Phe Ala Lys Ala Asn Trp Trp Tyr Leu Asp Ile Ala Leu Asp Ile
305                 310                 315                 320
Asn Val
</PDAT>
</S400>
</SEQ-LST-NEW>
</SEQLST-US>
</CWU>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>1. An isolated nucleic acid consisting of a nucleic acid sequence that encodes an amino acid sequence consisting of SEQ ID NO:4.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>2. An isolated nucleic acid consisting of SEQ ID NO:3, or a portion of SEQ ID NO:3 of at least 30 consecutive bases, or the complement of SEQ ID NO:3 or of said portion of at least 30 consecutive bases.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>3. The isolated nucleic acid according to </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein the nucleic acid consists of SEQ ID NO:3, or said portion of at least 30 consecutive bases.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>4. The isolated nucleic acid according to </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein said nucleic acid consists of SEQ ID NO:3, or a portion of SEQ ID NO:3 of at least 75 consecutive bases.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>5. The isolated nucleic acid according to </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> wherein the nucleic acid consists of SEQ ID NO:3.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06465631-20021015-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06465631-20021015-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06465631-20021015-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06465631-20021015-D00004.TIF"/>
<EMI ID="EMI-D00005" ALT="embedded image" FILE="US06465631-20021015-D00005.TIF"/>
<EMI ID="EMI-D00006" ALT="embedded image" FILE="US06465631-20021015-D00006.TIF"/>
<EMI ID="EMI-D00007" ALT="embedded image" FILE="US06465631-20021015-D00007.TIF"/>
<EMI ID="EMI-D00008" ALT="embedded image" FILE="US06465631-20021015-D00008.TIF"/>
<EMI ID="EMI-D00009" ALT="embedded image" FILE="US06465631-20021015-D00009.TIF"/>
<EMI ID="EMI-D00010" ALT="embedded image" FILE="US06465631-20021015-D00010.TIF"/>
<EMI ID="EMI-D00011" ALT="embedded image" FILE="US06465631-20021015-D00011.TIF"/>
<EMI ID="EMI-D00012" ALT="embedded image" FILE="US06465631-20021015-D00012.TIF"/>
<EMI ID="EMI-D00013" ALT="embedded image" FILE="US06465631-20021015-D00013.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00014" ALT="embedded image" FILE="US06465631-20021015-D00014.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00015" ALT="embedded image" FILE="US06465631-20021015-D00015.TIF"/>
<EMI ID="EMI-D00016" ALT="embedded image" FILE="US06465631-20021015-D00016.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00017" ALT="embedded image" FILE="US06465631-20021015-D00017.TIF"/>
<EMI ID="EMI-D00018" ALT="embedded image" FILE="US06465631-20021015-D00018.TIF" TYPE="HALFTONE"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06465693-20021015-C00001.CDX SYSTEM "US06465693-20021015-C00001.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00001.MOL SYSTEM "US06465693-20021015-C00001.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00001.TIF SYSTEM "US06465693-20021015-C00001.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00002.CDX SYSTEM "US06465693-20021015-C00002.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00002.MOL SYSTEM "US06465693-20021015-C00002.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00002.TIF SYSTEM "US06465693-20021015-C00002.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00003.CDX SYSTEM "US06465693-20021015-C00003.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00003.MOL SYSTEM "US06465693-20021015-C00003.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00003.TIF SYSTEM "US06465693-20021015-C00003.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00004.CDX SYSTEM "US06465693-20021015-C00004.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00004.MOL SYSTEM "US06465693-20021015-C00004.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00004.TIF SYSTEM "US06465693-20021015-C00004.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00005.CDX SYSTEM "US06465693-20021015-C00005.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00005.MOL SYSTEM "US06465693-20021015-C00005.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00005.TIF SYSTEM "US06465693-20021015-C00005.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00006.CDX SYSTEM "US06465693-20021015-C00006.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00006.MOL SYSTEM "US06465693-20021015-C00006.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00006.TIF SYSTEM "US06465693-20021015-C00006.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00007.CDX SYSTEM "US06465693-20021015-C00007.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00007.MOL SYSTEM "US06465693-20021015-C00007.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00007.TIF SYSTEM "US06465693-20021015-C00007.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00008.CDX SYSTEM "US06465693-20021015-C00008.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00008.MOL SYSTEM "US06465693-20021015-C00008.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00008.TIF SYSTEM "US06465693-20021015-C00008.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00009.CDX SYSTEM "US06465693-20021015-C00009.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00009.MOL SYSTEM "US06465693-20021015-C00009.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00009.TIF SYSTEM "US06465693-20021015-C00009.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00010.CDX SYSTEM "US06465693-20021015-C00010.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00010.MOL SYSTEM "US06465693-20021015-C00010.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00010.TIF SYSTEM "US06465693-20021015-C00010.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00011.CDX SYSTEM "US06465693-20021015-C00011.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00011.MOL SYSTEM "US06465693-20021015-C00011.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00011.TIF SYSTEM "US06465693-20021015-C00011.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00012.CDX SYSTEM "US06465693-20021015-C00012.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00012.MOL SYSTEM "US06465693-20021015-C00012.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00012.TIF SYSTEM "US06465693-20021015-C00012.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00013.CDX SYSTEM "US06465693-20021015-C00013.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00013.MOL SYSTEM "US06465693-20021015-C00013.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00013.TIF SYSTEM "US06465693-20021015-C00013.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00014.CDX SYSTEM "US06465693-20021015-C00014.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00014.MOL SYSTEM "US06465693-20021015-C00014.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00014.TIF SYSTEM "US06465693-20021015-C00014.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00015.CDX SYSTEM "US06465693-20021015-C00015.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00015.MOL SYSTEM "US06465693-20021015-C00015.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00015.TIF SYSTEM "US06465693-20021015-C00015.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00016.CDX SYSTEM "US06465693-20021015-C00016.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00016.MOL SYSTEM "US06465693-20021015-C00016.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00016.TIF SYSTEM "US06465693-20021015-C00016.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00017.CDX SYSTEM "US06465693-20021015-C00017.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00017.MOL SYSTEM "US06465693-20021015-C00017.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00017.TIF SYSTEM "US06465693-20021015-C00017.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00018.CDX SYSTEM "US06465693-20021015-C00018.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00018.MOL SYSTEM "US06465693-20021015-C00018.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00018.TIF SYSTEM "US06465693-20021015-C00018.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00019.CDX SYSTEM "US06465693-20021015-C00019.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00019.MOL SYSTEM "US06465693-20021015-C00019.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00019.TIF SYSTEM "US06465693-20021015-C00019.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00020.CDX SYSTEM "US06465693-20021015-C00020.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00020.MOL SYSTEM "US06465693-20021015-C00020.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00020.TIF SYSTEM "US06465693-20021015-C00020.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00021.CDX SYSTEM "US06465693-20021015-C00021.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00021.MOL SYSTEM "US06465693-20021015-C00021.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00021.TIF SYSTEM "US06465693-20021015-C00021.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00022.CDX SYSTEM "US06465693-20021015-C00022.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00022.MOL SYSTEM "US06465693-20021015-C00022.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00022.TIF SYSTEM "US06465693-20021015-C00022.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00023.CDX SYSTEM "US06465693-20021015-C00023.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00023.MOL SYSTEM "US06465693-20021015-C00023.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00023.TIF SYSTEM "US06465693-20021015-C00023.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00024.CDX SYSTEM "US06465693-20021015-C00024.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00024.MOL SYSTEM "US06465693-20021015-C00024.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00024.TIF SYSTEM "US06465693-20021015-C00024.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00025.CDX SYSTEM "US06465693-20021015-C00025.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00025.MOL SYSTEM "US06465693-20021015-C00025.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00025.TIF SYSTEM "US06465693-20021015-C00025.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00026.CDX SYSTEM "US06465693-20021015-C00026.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00026.MOL SYSTEM "US06465693-20021015-C00026.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00026.TIF SYSTEM "US06465693-20021015-C00026.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00027.CDX SYSTEM "US06465693-20021015-C00027.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00027.MOL SYSTEM "US06465693-20021015-C00027.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00027.TIF SYSTEM "US06465693-20021015-C00027.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00028.CDX SYSTEM "US06465693-20021015-C00028.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00028.MOL SYSTEM "US06465693-20021015-C00028.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00028.TIF SYSTEM "US06465693-20021015-C00028.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00029.CDX SYSTEM "US06465693-20021015-C00029.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00029.MOL SYSTEM "US06465693-20021015-C00029.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00029.TIF SYSTEM "US06465693-20021015-C00029.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00030.CDX SYSTEM "US06465693-20021015-C00030.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00030.MOL SYSTEM "US06465693-20021015-C00030.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00030.TIF SYSTEM "US06465693-20021015-C00030.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00031.CDX SYSTEM "US06465693-20021015-C00031.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00031.MOL SYSTEM "US06465693-20021015-C00031.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00031.TIF SYSTEM "US06465693-20021015-C00031.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00032.CDX SYSTEM "US06465693-20021015-C00032.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00032.MOL SYSTEM "US06465693-20021015-C00032.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00032.TIF SYSTEM "US06465693-20021015-C00032.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00033.CDX SYSTEM "US06465693-20021015-C00033.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00033.MOL SYSTEM "US06465693-20021015-C00033.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00033.TIF SYSTEM "US06465693-20021015-C00033.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00034.CDX SYSTEM "US06465693-20021015-C00034.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00034.MOL SYSTEM "US06465693-20021015-C00034.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00034.TIF SYSTEM "US06465693-20021015-C00034.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00035.CDX SYSTEM "US06465693-20021015-C00035.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00035.MOL SYSTEM "US06465693-20021015-C00035.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00035.TIF SYSTEM "US06465693-20021015-C00035.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00036.CDX SYSTEM "US06465693-20021015-C00036.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00036.MOL SYSTEM "US06465693-20021015-C00036.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00036.TIF SYSTEM "US06465693-20021015-C00036.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00037.CDX SYSTEM "US06465693-20021015-C00037.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00037.MOL SYSTEM "US06465693-20021015-C00037.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00037.TIF SYSTEM "US06465693-20021015-C00037.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00038.CDX SYSTEM "US06465693-20021015-C00038.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00038.MOL SYSTEM "US06465693-20021015-C00038.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00038.TIF SYSTEM "US06465693-20021015-C00038.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00039.CDX SYSTEM "US06465693-20021015-C00039.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00039.MOL SYSTEM "US06465693-20021015-C00039.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00039.TIF SYSTEM "US06465693-20021015-C00039.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00040.CDX SYSTEM "US06465693-20021015-C00040.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00040.MOL SYSTEM "US06465693-20021015-C00040.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00040.TIF SYSTEM "US06465693-20021015-C00040.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00041.CDX SYSTEM "US06465693-20021015-C00041.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00041.MOL SYSTEM "US06465693-20021015-C00041.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00041.TIF SYSTEM "US06465693-20021015-C00041.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00042.CDX SYSTEM "US06465693-20021015-C00042.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00042.MOL SYSTEM "US06465693-20021015-C00042.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00042.TIF SYSTEM "US06465693-20021015-C00042.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00043.CDX SYSTEM "US06465693-20021015-C00043.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00043.MOL SYSTEM "US06465693-20021015-C00043.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00043.TIF SYSTEM "US06465693-20021015-C00043.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00044.CDX SYSTEM "US06465693-20021015-C00044.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00044.MOL SYSTEM "US06465693-20021015-C00044.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00044.TIF SYSTEM "US06465693-20021015-C00044.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00045.CDX SYSTEM "US06465693-20021015-C00045.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00045.MOL SYSTEM "US06465693-20021015-C00045.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00045.TIF SYSTEM "US06465693-20021015-C00045.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00046.CDX SYSTEM "US06465693-20021015-C00046.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00046.MOL SYSTEM "US06465693-20021015-C00046.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00046.TIF SYSTEM "US06465693-20021015-C00046.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00047.CDX SYSTEM "US06465693-20021015-C00047.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00047.MOL SYSTEM "US06465693-20021015-C00047.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00047.TIF SYSTEM "US06465693-20021015-C00047.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00048.CDX SYSTEM "US06465693-20021015-C00048.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00048.MOL SYSTEM "US06465693-20021015-C00048.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00048.TIF SYSTEM "US06465693-20021015-C00048.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00049.CDX SYSTEM "US06465693-20021015-C00049.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00049.MOL SYSTEM "US06465693-20021015-C00049.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00049.TIF SYSTEM "US06465693-20021015-C00049.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00050.CDX SYSTEM "US06465693-20021015-C00050.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00050.MOL SYSTEM "US06465693-20021015-C00050.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00050.TIF SYSTEM "US06465693-20021015-C00050.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00051.CDX SYSTEM "US06465693-20021015-C00051.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00051.MOL SYSTEM "US06465693-20021015-C00051.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00051.TIF SYSTEM "US06465693-20021015-C00051.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00052.CDX SYSTEM "US06465693-20021015-C00052.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00052.MOL SYSTEM "US06465693-20021015-C00052.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00052.TIF SYSTEM "US06465693-20021015-C00052.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00053.CDX SYSTEM "US06465693-20021015-C00053.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00053.MOL SYSTEM "US06465693-20021015-C00053.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00053.TIF SYSTEM "US06465693-20021015-C00053.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00054.CDX SYSTEM "US06465693-20021015-C00054.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00054.MOL SYSTEM "US06465693-20021015-C00054.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00054.TIF SYSTEM "US06465693-20021015-C00054.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00055.CDX SYSTEM "US06465693-20021015-C00055.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00055.MOL SYSTEM "US06465693-20021015-C00055.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00055.TIF SYSTEM "US06465693-20021015-C00055.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00056.CDX SYSTEM "US06465693-20021015-C00056.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00056.MOL SYSTEM "US06465693-20021015-C00056.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00056.TIF SYSTEM "US06465693-20021015-C00056.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00057.CDX SYSTEM "US06465693-20021015-C00057.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00057.MOL SYSTEM "US06465693-20021015-C00057.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00057.TIF SYSTEM "US06465693-20021015-C00057.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00058.CDX SYSTEM "US06465693-20021015-C00058.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00058.MOL SYSTEM "US06465693-20021015-C00058.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00058.TIF SYSTEM "US06465693-20021015-C00058.TIF" NDATA TIF>
<!ENTITY US06465693-20021015-C00059.CDX SYSTEM "US06465693-20021015-C00059.CDX" NDATA CDX>
<!ENTITY US06465693-20021015-C00059.MOL SYSTEM "US06465693-20021015-C00059.MOL" NDATA MOL>
<!ENTITY US06465693-20021015-C00059.TIF SYSTEM "US06465693-20021015-C00059.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06465693</PDAT></DNUM></B110>
<B130><PDAT>B2</PDAT></B130>
<B140><DATE><PDAT>20021015</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09765072</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20010118</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C07C20900</PDAT></B511>
<B512><PDAT>C07C24100</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>564386</PDAT></B521>
<B522><PDAT>564250</PDAT></B522>
<B522><PDAT>564251</PDAT></B522>
<B522><PDAT>564389</PDAT></B522>
<B522><PDAT>564391</PDAT></B522>
<B522><PDAT>564405</PDAT></B522>
<B522><PDAT>564407</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>3867452</PDAT></DNUM>
<DATE><PDAT>19750200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Wilcox</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>260569</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4374271</PDAT></DNUM>
<DATE><PDAT>19830200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Hunter et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>564310</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5576460</PDAT></DNUM>
<DATE><PDAT>19961100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Buchwald et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>0 078 768</PDAT></DNUM>
<DATE><PDAT>19830500</PDAT></DATE>
<CTRY><PDAT>EP</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>0 187 285</PDAT></DNUM>
<DATE><PDAT>19860700</PDAT></DATE>
<CTRY><PDAT>EP</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>0 224 831</PDAT></DNUM>
<DATE><PDAT>19870600</PDAT></DATE>
<CTRY><PDAT>EP</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>0 790 233</PDAT></DNUM>
<DATE><PDAT>19970800</PDAT></DATE>
<CTRY><PDAT>EP</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 95/25090</PDAT></DNUM>
<DATE><PDAT>19950900</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 97/41177</PDAT></DNUM>
<DATE><PDAT>19971100</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>WO 98/06725</PDAT></DNUM>
<DATE><PDAT>19980200</PDAT></DATE>
<CTRY><PDAT>WO</PDAT></CTRY>
</DOC>
</PCIT>
<CITED-BY-OTHER/>
</B561>
<B562><NCIT><STEXT><PDAT>Barton, H.R. Derek, et al., &ldquo;Metallic Copper Catalysis of N-Arylation of Amines By Triarylbismuth Diacylates&rdquo;, </PDAT><HIL><ITALIC><PDAT>Tetraherdon Letters</PDAT></ITALIC></HIL><PDAT>, vol. 27, No. 31, pp. 3615-3618, (1986). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cristau, H. J., et al., &ldquo;Arylation Catalytique D&apos;OrganoPhosphores. Produits De L&apos;Arylation, Catalysee Par Les Sels De Nickel (II), De Composes Du Phosphore Tricoordine&rdquo;, </PDAT><HIL><ITALIC><PDAT>Journal of Organometallic Chemistry</PDAT></ITALIC></HIL><PDAT>, 185, pp. 283-295, (1980). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Driver, Michael S., et al., &ldquo;A Second-Generation Catalyst for Aryl Halide Amination: Mixed Secondary Amines from Aryl Halides and Primary Amines Catalyzed by (DPPF) PdC12&rdquo;, </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc.</PDAT></ITALIC></HIL><PDAT>, vol. 118, pp. 7217-7218, (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Goodson, Felix, E., et al., &ldquo;Regiodefined Poly (N-arylaniline)s and Donor-Acceptor Copolymers via Palladium-Mediated Animation Chemistry&rdquo;, </PDAT><HIL><ITALIC><PDAT>Macromolecules</PDAT></ITALIC></HIL><PDAT>, vol. 31, pp. 1700-1703, (1998). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Greiner, Alfred, &ldquo;An Improvement of the N-Arylation of Amides; Application to the Synthesis of Substituted 3-(N-Acetyl-N-phenylamino)-pyridines&rdquo;, </PDAT><HIL><ITALIC><PDAT>Synthesis</PDAT></ITALIC></HIL><PDAT>, pp. 312-313, (Apr. 1989). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Guram, Anil S., et al., &ldquo;A Simple Catalytic Method for the Conversion of Aryl Bromides to Arylamines&rdquo;, </PDAT><HIL><ITALIC><PDAT>Angew. Chem. Int. Ed. Engl</PDAT></ITALIC></HIL><PDAT>. vol. 34, No. 12, (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hamann, Blake C., et al., &ldquo;Palladium-Catalyzed Direct a-Arylation of Ketones, Rate Acceleration by Sterically Hindered Chelating Ligands and Reductive Elimination from a transition Metal Enolate Complex&rdquo;, </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc.</PDAT></ITALIC></HIL><PDAT>, vol. 119, pp. 12382-12383, (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kang, Suk-Ku, et al., &ldquo;Palladium-Catalyzed Synthesis of Arylamines From Diphenyliodonium Tetrafluoroborate and Secondary Amine&rdquo;, </PDAT><HIL><ITALIC><PDAT>Synthetic Communications</PDAT></ITALIC></HIL><PDAT>, vol. 26(22), pp. 4219-4224, (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Louie, Janis, et al., &ldquo;Palladium-Catalyzed Synthesis of Arylamines from Aryl Halides. Mechanistic Studies Lead to Coupling in the Absence of Tin Reagents&rdquo;, </PDAT><HIL><ITALIC><PDAT>Tetrahedron Letters</PDAT></ITALIC></HIL><PDAT>, vol. 36, No. 21, pp. 3609-3612, (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Perry, Robert J., et al., &ldquo;Synthesis of 2-Arylbenzoxazoles via the Palladium-Catalyzed Carbonylation and Condensation of Aromatic Halides and o-Aminophenols&rdquo;, </PDAT><HIL><ITALIC><PDAT>J. Org. Chem.</PDAT></ITALIC></HIL><PDAT>, vol. 57, pp. 2883-2887, (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sonesson, Clas, et al., &ldquo;Regioselective Synthesis of 3-Aryl Substituted Pyrrolidines Via Palladium Catalyzed Arylation: Pharmacological Evaluation For Central Dopaminergic and Serotoergic Activity&rdquo;, </PDAT><HIL><ITALIC><PDAT>Bioorganic </PDAT></ITALIC></HIL><PDAT>&amp; </PDAT><HIL><ITALIC><PDAT>Medicinal Chemistry Letters</PDAT></ITALIC></HIL><PDAT>, vol. 7, No. 3, pp. 241-246, (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Wagaw, S., et al., &ldquo;The Synthesis of Aminopyridines: A Method Employing Palladium-Catalyzed Carbon-Nitrogen Bond Formation&rdquo;, </PDAT><HIL><ITALIC><PDAT>J. Org. Chem.</PDAT></ITALIC></HIL><PDAT>, vol. 61, pp. 7240-7241, (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Wagaw, S., et al., &ldquo;Palladium-Catalyzed Coupling of Optically Active Amines with Aryl Bromides&rdquo;, </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc.</PDAT></ITALIC></HIL><PDAT>, vol. 119, pp. 8451-8458, (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Wolfe, John P., et al., &ldquo;Improved Functional Group Compatibility in the Palladium-Catalyzed Amination of Aryl Bromides&rdquo;, </PDAT><HIL><ITALIC><PDAT>Tetrahedron Letters</PDAT></ITALIC></HIL><PDAT>, vol. 38, No. 36, pp. 6359-6362, (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Wolfe, John P., et al., &ldquo;Room Temperature Catalytic Amination of Aryl Iodides&rdquo;, </PDAT><HIL><ITALIC><PDAT>J. Org Chem.</PDAT></ITALIC></HIL><PDAT>, vol. 62, pp. 6066-6068, (1997).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>20</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>564250</PDAT></B582>
<B582><PDAT>564251</PDAT></B582>
<B582><PDAT>564386</PDAT></B582>
<B582><PDAT>564389</PDAT></B582>
<B582><PDAT>564391</PDAT></B582>
<B582><PDAT>564405</PDAT></B582>
<B582><PDAT>564407</PDAT></B582>
</B580>
<B590><B595><PDAT>0</PDAT></B595><B596><PDAT>0</PDAT></B596></B590>
</B500>
<B600>
<B620><PARENT-US><CDOC><DOC><DNUM><PDAT>09/765072</PDAT></DNUM></DOC></CDOC><PDOC><DOC><DNUM><PDAT>09/030936</PDAT></DNUM><DATE><PDAT>19980226</PDAT></DATE><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>00</PDAT></KIND></DOC></PDOC><PSTA><PDAT>01</PDAT></PSTA><PPUB><DOC><DNUM><PDAT>6235936</PDAT></DNUM><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>A </PDAT></KIND></DOC></PPUB></PARENT-US></B620>
<B690US>
<DOC>
<DNUM><PDAT>20010031894</PDAT></DNUM>
<DATE><PDAT>20011018</PDAT></DATE>
<CTRY><PDAT>US</PDAT></CTRY>
<KIND><PDAT>A1</PDAT></KIND>
</DOC>
</B690US></B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Stephen L.</PDAT></FNM><SNM><STEXT><PDAT>Buchwald</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Newton</PDAT></CITY>
<STATE><PDAT>MA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Seble</PDAT></FNM><SNM><STEXT><PDAT>Wagaw</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Cambridge</PDAT></CITY>
<STATE><PDAT>MA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>O.</PDAT></FNM><SNM><STEXT><PDAT>Geis</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Berlin</PDAT></CITY>
<CTRY><PDAT>DE</PDAT></CTRY>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Massachusetts Institute of Technology</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Cambridge</PDAT></CITY><STATE><PDAT>MA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><FNM><PDAT>Dana M.</PDAT></FNM><SNM><STEXT><PDAT>Gordon</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B741>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Foley Hoag LLP</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>James O.</PDAT></FNM><SNM><STEXT><PDAT>Wilson</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1623</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>A method is provided for the transition metal-catalyzed arylation, or vinylation, of hydrazines, hydrazones, and the like. Additionally, the invention provides a conceptually novel strategy, the cornerstone of which is the transition metal-catalyzed arylation or vinylation method, for the synthesis of indoles, carbazoles, and the like. The methods and strategies of the invention may be utilized in standard, parallel, and combinatorial synthetic protocols.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>RELATED APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application is a division of U.S. patent application Ser. No. 09/030,936, filed Feb. 26, 1998, now U.S. Pat. No. 6,235,936.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>GOVERNMENT SUPPORT</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention was made with government support under Grant No. 9421982-CHE awarded by the National Science Foundation. The government has certain rights in the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>The present invention relates to improved methods for preparing aryl hydrazines, aryl hydrazones, O-aryl hydroxylamines, N-aryl hydroxylamines, O-aryl oximes and the like which are useful intermediates and end products in pharmaceutical and agricultural applications. Certain products of the present invention are utilized in a novel entry into the classical Fischer indole synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>Despite the recent successes with palladium-catalyzed cross-coupling reactions of Ar&mdash;X with amines, comparable couplings of aryl halides with hydrazines and the like have not been reported. Existing methods for the conversion of Ar&mdash;X to the corresponding aryl hydrazines often require harsh or restrictive reaction conditions and/or the presence of activating groups on the aromatic ring.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Thus there remains a need for an effective method of preparing a wide range of aryl hydrazines and the like under mild conditions and in high yields. There is a further need for an efficient catalytic system with high efficiencies and turnover numbers for the synthesis of these compounds.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>The present invention provides general and attractive routes to a wide range of aryl hydrazines, aryl hydrazones, O-aryl hydroxylamines, N-aryl hydroxylamines, O-aryl oximes and the like. The methods provide several improvements over methods known heretofore, namely, the efficient synthesis of these compounds under mild conditions and in high yields. In particular, the method of the invention may be used in coupling reactions between aryl halides or sulfonates and ketone or aldehyde hydrazones; the products of these coupling reactions provide indoles via the Fischer indole synthesis. In other aspects of the invention, the invention provides a means of synthesizing combinatorial libraries of indoles, carbazoles and the like.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00008" LVL="7"><PTEXT><PDAT>Overview</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>In one aspect of the invention, an aryl hydrazine is prepared by reacting hydrazine, or a substituted hydrazine, or a hydrazide salt, with an activated aromatic compound in the presence of a base and a metal catalyst that includes a Group VIII metal atom such as iron, cobalt, nickel, ruthenium, rhodium, palladium, iridium and platinum; Group 10 metals&mdash;platinum, palladium and nickel&mdash;are the most preferred metals. The activated aromatic compound comprises an activated substituent, X, which generally is selected from the group comprising halides and sulfonate esters. When the reaction takes place using an hydrazide salt, an additional base may not be required.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>In preferred embodiments, the subject synthetic reaction can be characterized by the general reaction scheme shown below: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00001">
<CHEMCDX ID="CHEMCDX-00001" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00001.CDX"/>
<CHEMMOL ID="CHEMMOL-00001" ALT="chemistry mol file" FILE="US06465693-20021015-C00001.MOL"/>
<EMI ID="EMI-C00001" ALT="embedded image" HE="54.4887" WI="194.1975" FILE="US06465693-20021015-C00001.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00011" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>Ar represents an aromatic group (which may be furthered substituted beyond X);</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>X represents an activated group (such as a halide or a sulfonate), which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed arylation reaction;</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>Y represents NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, OR, N&boxH;CR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, N(R)S(O)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>R, or N(R)C(O)NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>R represents independently for each occurrence, as valence and stability permit, H, a substituted or unsubstituted alkyl or alkenyl moiety, a formyl, acyl, or sulfonyl moiety, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>,</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>m is an integer in the range 0 to 8 inclusive.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>In additional preferred embodiments, the subject synthetic reaction can be characterized by the general reaction scheme shown below: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00002">
<CHEMCDX ID="CHEMCDX-00002" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00002.CDX"/>
<CHEMMOL ID="CHEMMOL-00002" ALT="chemistry mol file" FILE="US06465693-20021015-C00002.MOL"/>
<EMI ID="EMI-C00002" ALT="embedded image" HE="40.3137" WI="201.6252" FILE="US06465693-20021015-C00002.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00019" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>Ar represents an aromatic group (which may be furthered substituted beyond X);</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>X represents an activated group (such as a halide or a sulfonate), which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed arylation reaction;</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>Y represents O, S, or Se;</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>R independently for each occurrence is absent or represents, as valence and stability permit, H, a substituted or unsubstituted alkyl or alkenyl moiety, an alkylidene moiety, a formyl, acyl, or sulfonyl moiety, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>,</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>m is an integer in the range 0 to 8 inclusive.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>In further preferred embodiments, the subject reaction may be an intramolecular reaction. In this instance, it will be realized that, with reference to Scheme 1, YNHR is covalently attached to Ar via T which represents a tether between Ar and Y. The intramolecular reaction results in a product containing at least one more ring than the substrate and said reaction can be represented as follows in Scheme 3: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00003">
<CHEMCDX ID="CHEMCDX-00003" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00003.CDX"/>
<CHEMMOL ID="CHEMMOL-00003" ALT="chemistry mol file" FILE="US06465693-20021015-C00003.MOL"/>
<EMI ID="EMI-C00003" ALT="embedded image" HE="64.5813" WI="184.3317" FILE="US06465693-20021015-C00003.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00027" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>Ar represents an aromatic group (which may be furthered substituted beyond X and T&mdash;Y&mdash;NHR);</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>X represents an activated group (such as a halide or a sulfonate), which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed arylation reaction;</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>Y represents NR, O, sp</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>-hybridized N in a &pgr;-bond to T, NS(O)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>R, or NC(O)NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>T represents a covalent tether connecting Y and Ar, said tether comprising between 0 and 4 backbone atoms; the backbone of said tether may comprise a r-bond, provided that the configuration of said &pgr;-bond is such that the described intramolecular reaction is geometrically feasible, or that said &pgr;-bond can adopt a configuration under the reaction conditions that renders the intramolecular reaction geometrically feasible; said tether additionally may itself be either unsubstituted or bear any number of substituents of any type permitted by stability and the rules of valence;</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>R independently for each occurrence represents, as valence and stability permit, H, a substituted or unsubstituted alkyl or alkenyl moiety, a formyl, acyl, or sulfonyl moiety, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>m is an integer in the range 0 to 8 inclusive.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>In additional preferred embodiments, the subject reaction may be another form of intramolecular reaction. In this instance, it will be realized that, with reference to Scheme 2, N(R)YH is covalently attached to Ar via T which represents a tether between Ar and N. The intramolecular reaction results in a product containing at least one more ring than the substrate and said reaction can be represented as follows in Scheme 4: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00004">
<CHEMCDX ID="CHEMCDX-00004" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00004.CDX"/>
<CHEMMOL ID="CHEMMOL-00004" ALT="chemistry mol file" FILE="US06465693-20021015-C00004.MOL"/>
<EMI ID="EMI-C00004" ALT="embedded image" HE="64.5813" WI="184.3317" FILE="US06465693-20021015-C00004.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00036" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>Ar represents an aromatic group (which may be furthered substituted beyond X and T&mdash;NR&mdash;YH);</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>X represents an activated group (such as a halide or a sulfonate), which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed arylation reaction;</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>Y represents O, S, or Se;</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>T represents a covalent tether connecting NR and Ar, said tether comprising between 0 and 4 backbone atoms; the backbone of said tether may comprise a &pgr;-bond, provided that the configuration of said &pgr;-bond is such that the described intramolecular reaction is geometrically feasible, or that said &pgr;-bond can adopt a configuration under the reaction conditions that renders the intramolecular reaction geometrically feasible; said tether additionally may itself be either unsubstituted or bear any number of substituents of any type permitted by stability and the rules of valence;</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>R represents independently for each occurrence, as valence and stability permit, H, a substituted or unsubstituted alkyl or alkenyl moiety, a formyl, acyl, or sulfonyl moiety, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>m is an integer in the range 0 to 8 inclusive.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>In another embodiment, the subject synthetic reaction can be characterized by the general reaction scheme shown below in Scheme 5: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00005">
<CHEMCDX ID="CHEMCDX-00005" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00005.CDX"/>
<CHEMMOL ID="CHEMMOL-00005" ALT="chemistry mol file" FILE="US06465693-20021015-C00005.MOL"/>
<EMI ID="EMI-C00005" ALT="embedded image" HE="113.0598" WI="214.0992" FILE="US06465693-20021015-C00005.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00045" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>X represents an activated group (such as a halide or a sulfonate), which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed vinylation reaction;</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>Y represents NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, OR, N&boxH;CR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, N(R)S(O)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>R, or N(R)C(O)NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>R represents independently for each occurrence, as valence and stability permit, H, a substituted or unsubstituted alkyl or alkenyl moiety, a formyl, acyl, or sulfonyl moiety, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>R&prime; represents independently for each occurrence, as valence and stability permit, H, halogen, lower alkyl, lower alkenyl, lower alkynyl, carbonyl group (e.g. ester, carboxylate, or formate), thiocarbonyl (e.g. thiolester, thiolcarboxylate, or thiolformate), ketone, aldehyde, amino, acylamino, amido, amidino, cyano, nitro, azido, sulfonyl, sulfoxido, sulfate, sulfonate, sulfamoyl, sulfonamido, phosphoryl, phosphonate, phosphinate, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;OH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O-lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O-lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;SH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S-lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S-lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, or protecting groups of the above, or a solid or polymeric support;</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>n and m are integers independently for each occurrence selected from the range of 0 to 8 inclusive.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>In yet another embodiment, the subject synthetic reaction can be characterized by the general reaction scheme shown below in Scheme 6: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00006">
<CHEMCDX ID="CHEMCDX-00006" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00006.CDX"/>
<CHEMMOL ID="CHEMMOL-00006" ALT="chemistry mol file" FILE="US06465693-20021015-C00006.MOL"/>
<EMI ID="EMI-C00006" ALT="embedded image" HE="96.98535" WI="214.58115" FILE="US06465693-20021015-C00006.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00053" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>X represents an activated group (such as a halide or a sulfonate), which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed vinylation reaction;</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>Y represents O, S, or Se;</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>R independently for each occurrence is absent or represents, as valence and stability permit, H, a substituted or unsubstituted alkyl or alkenyl moiety, an alkylidene moiety, a formyl, acyl, or sulfonyl moiety, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>;</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>R&prime; represents independently for each occurrence, as valence and stability permit, H, halogen, lower alkyl, lower alkenyl, lower alkynyl, carbonyl group (e.g. ester, carboxylate, or formate), thiocarbonyl (e.g. thiolester, thiolcarboxylate, or thiolformate), ketone, aldehyde, amino, acylamino, amido, amidino, cyano, nitro, azido, sulfonyl, sulfoxido, sulfate, sulfonate, sulfamoyl, sulfonamido, phosphoryl, phosphonate, phosphinate, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;OH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O-lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O-lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;SH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S-lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S-lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, or protecting groups of the above, or a solid or polymeric support;</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>n and m are integers independently for each occurrence selected from the range of 0 to 8 inclusive.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>Artisans of ordinary skill will recognize the potential for intramolecular variants of the vinylation reactions presented in Schemes 5 and 6. Specifically, a comparison of the embodiment of the subject method depicted in Scheme 1 with that in Scheme 3, and a similar comparison of the embodiments depicted in Schemes 2 and 4, will serve to teach the embodiments that comprise an intramolecular vinylation reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>While not being bound by any particular mode of operation, it is hypothesized that the mechanism of the preferred Pd-catalyzed arylation of hydrazines and the like may proceed via a pathway similar to that depicted in Scheme 7. Scheme 7 presents a proposed reaction pathway for the synthesis of an aryl hydrazine via an intermolecular reaction. Any ligands that may be present on the palladium atom during this process have been omitted for clarity. With reference to Scheme 7, oxidative addition of the Pd(0) complex to the C&mdash;X bond of the activated aryl moiety (ArX) affords the Pd(II) organometallic intermediate A. The hydrazine could then displace X</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> from A and thereby generate cation B. Cation B would then suffer deprotonation to afford charge neutral intermediate C, which would subsequently undergo reductive elimination to yield the product aryl hydrazine and regenerate the active catalyst. The reaction sequence is likely to be similar for intramolecular reactions. Alternatively, and particularly for nickel catalysts, the active transition metal species in the oxidative addition step may involve the metal in the &plus;1 oxidation state. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00007">
<CHEMCDX ID="CHEMCDX-00007" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00007.CDX"/>
<CHEMMOL ID="CHEMMOL-00007" ALT="chemistry mol file" FILE="US06465693-20021015-C00007.MOL"/>
<EMI ID="EMI-C00007" ALT="embedded image" HE="206.18955" WI="177.8679" FILE="US06465693-20021015-C00007.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>In preferred embodiments of the invention, there is no need to use large excesses of either reactant&mdash;hydrazine and the like or aromatic compound. The reaction proceeds quickly and in high yield to the reaction product using substantially stoichiometric amounts of reagents. Thus, the hydrazine may be present in as little as a two-fold excess and preferably in no greater than a 20% excess relative to the aromatic compound. Alternatively, the aromatic compound may be present in as little as a two-fold excess and preferably in no greater than a 20% excess relative to the hydrazine.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>The reaction can proceed at mild temperatures and pressures to give high yields of the product aryl hydrazine or the like. Thus, yields of greater than 45%, preferably greater than 75% and even more preferably greater than 80% may be obtained by reaction at mild temperatures according to the invention. The reaction may be carried out at temperature less than 120&deg; C., and preferably in the range of 50-120&deg; C. In one preferred embodiment, the reaction is carried out at a temperature in the range of 80-100&deg; C.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>The reaction can be run in a wide range of solvent systems, including polar aprotic solvents. Alternatively, in certain embodiments, the subject reactions may be carried in the absence of added solvent.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>The ability to provide a synthesis scheme for hydrazines and the like which can be carried out under mild conditions and/or with non-polar solvents has broad application, especially in the agricultural and pharmaceutical industries, as well as in the polymer industry. In this regard, the subject reaction is more amenable to use of reactants or products which include sensitive functionalities, e.g., which would otherwise be labile under harsh reaction conditions.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>The subject hydrazine arylation reactions can be used as part of a combinatorial synthesis scheme to yield libraries of aryl hydrazines and the like. Accordingly, another aspect of the present invention relates to use of the subject method to generate variegated libraries of aryl hydrazines and the like, and to the libraries themselves. The libraries can be soluble or linked to insoluble supports, e.g., either through substituents of the aryl group or the hydrazine etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="7"><PTEXT><PDAT>Definitions</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>For convenience, before further description of the present invention, certain terms employed in the specification, examples, and appended claims are collected here.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>The term &ldquo;substrate aryl group&rdquo; refers to an aryl group containing an electrophilic atom which is susceptible to the subject cross-coupling reaction, e.g., the electrophilic atom bears a leaving group. In reaction scheme 1, the substrate aryl is represented by ArX, and X is the leaving group. The aryl group, Ar, is said to be substituted if, in addition to X, it is substituted at yet other positions. The substrate aryl group can be a single ring molecule, or can be a component of a larger molecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>The terms &ldquo;hydrazine and/or the like&rdquo; refer to a hydrazine, hydrazone, hydroxylamine, oxime etc. which can attack the electrophilic atom of the substrate aryl group and displace the leaving group in the subject cross-coupling reaction. In Schemes 1 and 2, the nucleophilic hydrazine and/or the like are represented by HN(R)&mdash;Y, and HY&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, respectively. The hydrazine and/or the like can be a component of a molecule separate from the substrate aryl group, or a substituent of the same molecule (e.g., for intramolecular cross couplings).</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>The term &ldquo;nucleophile&rdquo; is recognized in the art, and as used herein means a chemical moiety having a reactive pair of electrons.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>The term &ldquo;electrophile&rdquo; is art-recognized and refers to chemical moieties which can accept a pair of electrons from a nucleophile as defined above. Electrophilic moieties useful in the method of the present invention include halides and sulfonates.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>The terms &ldquo;electrophilic atom&rdquo;, &ldquo;electrophilic center&rdquo; and &ldquo;reactive center&rdquo; as used herein refer to the atom of the substrate aryl moiety which is attacked by, and forms a new bond to the nucleophilic heteroatom of the hydrazine and the like. In most (but not all) cases, this will also be the aryl ring atom from which the leaving group departs.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>The term &ldquo;electron-withdrawing group&rdquo; is recognized in the art, and denotes the tendency of a substituent to attract valence electrons from neighboring atoms, i.e., the substituent is electronegative with respect to neighboring atoms. A quantification of the level of electron-withdrawing capability is given by the Hammett sigma (s) constant. This well known constant is described in many references, for instance, J. March, </PDAT><HIL><ITALIC><PDAT>Advanced Organic Chemistry, </PDAT></ITALIC></HIL><PDAT>McGraw Hill Book Company, New York, (1977 edition) pp. 251-259. The Hammett constant values are generally negative for electron donating groups (s&lsqb;P&rsqb;&equals;&minus;0.66 for NH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>) and positive for electron withdrawing groups (s&lsqb;P&rsqb;&equals;0.78 for a nitro group), s&lsqb;P&rsqb; indicating para substitution. Exemplary electron-withdrawing groups include nitro, ketone, aldehyde, sulfonyl, trifluoromethyl, &mdash;CN, chloride, and the like. Exemplary electron-donating groups include amino, methoxy, and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>The term &ldquo;reaction product&rdquo; means a compound which results from the reaction of the hydrazine or the like and the substrate aryl group. In general, the term &ldquo;reaction product&rdquo; will be used herein to refer to a stable, isolable aryl ether adduct, and not to unstable intermediates or transition states.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>The term &ldquo;catalytic amount&rdquo; is recognized in the art and means a substoichiometric amount of reagent relative to a reactant. As used herein, a catalytic amount means from 0.0001 to 90 mole percent reagent relative to a reactant, more preferably from 0.001 to 50 mole percent, still more preferably from 0.01 to 10 mole percent, and even more preferably from 0.1 to 5 mole percent reagent to reactant.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>The term &ldquo;alkyl&rdquo; refers to the radical of saturated aliphatic groups, including straight-chain alkyl groups, branched-chain alkyl groups, cycloalkyl (alicyclic) groups, alkyl substituted cycloalkyl groups, and cycloalkyl substituted alkyl groups. In preferred embodiments, a straight chain or branched chain alkyl has 30 or fewer carbon atoms in its backbone (e.g., C</PDAT><HIL><SB><PDAT>1</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>30 </PDAT></SB></HIL><PDAT>for straight chain, C</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>-C</PDAT><HIL><SB><PDAT>30 </PDAT></SB></HIL><PDAT>for branched chain), and more preferably 20 or fewer. Likewise, preferred cycloalkyls have from 3-10 carbon atoms in their ring structure, and more preferably have 5, 6 or 7 carbons in the ring structure.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>Moreover, the term &ldquo;alkyl&rdquo; (or &ldquo;lower alkyl&rdquo;) as used throughout the specification and claims is intended to include both &ldquo;unsubstituted alkyls&rdquo; and &ldquo;substituted alkyls&rdquo;, the latter of which refers to alkyl moieties having substituents replacing a hydrogen on one or more carbons of the hydrocarbon backbone. Such substituents can include, for example, a halogen, a hydroxyl, a carbonyl (such as a carboxyl, an ester, a formyl, or a ketone), a thiocarbonyl (such as a thioester, a thioacetate, or a thiolformate), an alkoxyl, a phosphoryl, a phosphonate, a phosphinate, an amino, an amido, an amidine, an imine, a cyano, a nitro, an azido, a sulfhydryl, an alkylthio, a sulfate, a sulfonate, a sulfamoyl, a sulfonamido, a sulfonyl, a heterocyclyl, an aralkyl, or an aromatic or heteroaromatic moiety. It will be understood by those skilled in the art that the moieties substituted on the hydrocarbon chain can themselves be substituted, if appropriate. For instance, the substituents of a substituted alkyl may include substituted and unsubstituted forms of amino, azido, imino, iamido, phosphoryl (including phosphonate and phosphinate), sulfonyl (including sulfate, sulfonamido, sulfamoyl and sulfonate), and silyl groups, as well as ethers, alkylthios, carbonyls (including ketones, aldehydes, carboxylates, and esters), &mdash;CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;CN and the like. Exemplary substituted alkyls are described below. Cycloalkyls can be further substituted with alkyls, alkenyls, alkoxys, alkylthios, aminoalkyls, carbonyl-substituted alkyls, &mdash;CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;CN, and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>The term &ldquo;aralkyl&rdquo;, as used herein, refers to an alkyl group substituted with an aryl group (e.g., an aromatic or heteroaromatic group).</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>The terms &ldquo;alkenyl&rdquo; and &ldquo;alkynyl&rdquo; refer to unsaturated aliphatic groups analogous in length and possible substitution to the alkyls described above, but that contain at least one double or triple bond respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>Unless the number of carbons is otherwise specified, &ldquo;lower alkyl&rdquo; as used herein means an alkyl group, as defined above, but having from one to ten carbons, more preferably from one to six carbon atoms in its backbone structure. Likewise, &ldquo;lower alkenyl&rdquo; and &ldquo;lower alkynyl&rdquo; have similar chain lengths. Preferred alkyl groups are lower alkyls. In preferred embodiments, a substituent designated herein as alkyl is a lower alkyl.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>The term &ldquo;aryl&rdquo; as used herein includes 5-, 6- and 7-membered single-ring aromatic groups that may include from zero to four heteroatoms, for example, benzene, pyrrole, furan, thiophene, imidazole, oxazole, thiazole, triazole, pyrazole, pyridine, pyrazine, pyridazine and pyrimidine, and the like. Those aryl groups having heteroatoms in the ring structure may also be referred to as &ldquo;aryl heterocycles&rdquo; or &ldquo;heteroaromatics&rdquo;. The aromatic ring can be substituted at one or more ring positions with such substituents as described above, for example, halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamido, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, &mdash;CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;CN, or the like. The term &ldquo;aryl&rdquo; also includes polycyclic ring systems having two or more cyclic rings in which two or more carbons are common to two adjoining rings (the rings are &ldquo;fused rings&rdquo;) wherein at least one of the rings is aromatic, e.g., the other cyclic rings can be cycloalkyls, cycloalkenyls, cycloalkynyls, aryls and/or heterocyclyls.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>The abbreviations Me, Et, Ph, Tf, Nf, Ts, Ms represent methyl, ethyl, phenyl, trifluoromethanesulfonyl, nonafluorobutanesulfonyl, p-toluenesulfonyl and methanesulfonyl, respectively. A more comprehensive list of the abbreviations utilized by organic chemists of ordinary skill in the art appears in the first issue of each volume of the </PDAT><HIL><ITALIC><PDAT>Journal of Organic Chemistry; </PDAT></ITALIC></HIL><PDAT>this list is typically presented in a table entitled </PDAT><HIL><ITALIC><PDAT>Standard List of Abbreviations. </PDAT></ITALIC></HIL><PDAT>The abbreviations contained in said list, and all abbreviations utilized by organic chemists of ordinary skill in the art are hereby incorporated by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>The terms ortho, meta and para apply to 1,2-, 1,3- and 1,4-disubstituted benzenes, respectively. For example, the names 1,2-dimethylbenzene and ortho-dimethylbenzene are synonymous.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>The terms &ldquo;heterocyclyl&rdquo; or &ldquo;heterocyclic group&rdquo; refer to 3- to 10-membered ring structures, more preferably 3- to 7-membered rings, whose ring structures include one to four heteroatoms. Heterocycles can also be polycycles. Heterocyclyl groups include, for example, thiophene, thianthrene, furan, pyran, isobenzofuran, chromene, xanthene, phenoxathiin, pyrrole, imidazole, pyrazole, isothiazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, indolizine, isoindole, indole, indazole, purine, quinolizine, isoquinoline, quinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, pteridine, carbazole, carboline, phenanthridine, acridine, pyrimidine, phenanthroline, phenazine, phenarsazine, phenothiazine, furazan, phenoxazine, pyrrolidine, oxolane, thiolane, oxazole, piperidine, piperazine, morpholine, lactones, lactams such as azetidinones and pyrrolidinones, sultams, sultones, and the like. The heterocyclic ring can be substituted at one or more positions with such substituents as described above, as for example, halogen, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, ketone, aldehyde, ester, a heterocyclyl, an aromatic or heteroaromatic moiety, &mdash;CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;CN, or the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>The terms &ldquo;polycyclyl&rdquo; or &ldquo;polycyclic group&rdquo; refer to two or more rings (e.g., cycloalkyls, cycloalkenyls, cycloalkynyls, aryls and/or heterocyclyls) in which two or more carbons are common to two adjoining rings, e.g., the rings are &ldquo;fused rings&rdquo;. Rings that are joined through non-adjacent atoms are termed &ldquo;bridged&rdquo; rings. Each of the rings of the polycycle can be substituted with such substituents as described above, as for example, halogen, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, amino, nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, ketone, aldehyde, ester, a heterocyclyl, an aromatic or heteroaromatic moiety, &mdash;CF</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, &mdash;CN, or the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>The term &ldquo;carbocycle&rdquo;, as used herein, refers to an aromatic or non-aromatic ring in which each atom of the ring is carbon.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>The term &ldquo;heteroatom&rdquo; as used herein means an atom of any element other than carbon or hydrogen. Preferred heteroatoms are nitrogen, oxygen, sulfur and phosphorous.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;nitro&rdquo; means &mdash;NO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>; the term &ldquo;halogen&rdquo; designates &mdash;F, &mdash;Cl, &mdash;Br or &mdash;I; the term &ldquo;sulfhydryl&rdquo; means &mdash;SH; the term &ldquo;hydroxyl&rdquo; means &mdash;OH; and the term &ldquo;sulfonyl&rdquo; means &mdash;SO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&mdash;.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>The terms &ldquo;amine&rdquo; and &ldquo;amino&rdquo; are art recognized and refer to both unsubstituted and substituted amines, e.g., a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00008">
<CHEMCDX ID="CHEMCDX-00008" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00008.CDX"/>
<CHEMMOL ID="CHEMMOL-00008" ALT="chemistry mol file" FILE="US06465693-20021015-C00008.MOL"/>
<EMI ID="EMI-C00008" ALT="embedded image" HE="40.3137" WI="103.7043" FILE="US06465693-20021015-C00008.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00091" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>and R&prime;</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>each independently represent a hydrogen, an alkyl, an alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, or R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>taken together with the N atom to which they are attached complete a heterocycle having from 4 to 8 atoms in the ring structure; R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents an aryl, a cycloalkyl, a cycloalkenyl, a heterocycle or a polycycle; and m is zero or an integer in the range of 1 to 8. In preferred embodiments, only one of R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>or R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>can be a carbonyl, e.g., R</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>and the nitrogen together do not form an imide. In even more preferred embodiments, R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>(and optionally R&prime;</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>) each independently represent a hydrogen, an alkyl, an alkenyl, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>. Thus, the term &ldquo;alkylamine&rdquo; as used herein means an amine group, as defined above, having a substituted or unsubstituted alkyl attached thereto, i.e., at least one of R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>is an alkyl group.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>The term &ldquo;acylamino&rdquo; is art-recognized and refers to a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00009">
<CHEMCDX ID="CHEMCDX-00009" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00009.CDX"/>
<CHEMMOL ID="CHEMMOL-00009" ALT="chemistry mol file" FILE="US06465693-20021015-C00009.MOL"/>
<EMI ID="EMI-C00009" ALT="embedded image" HE="40.0869" WI="59.535" FILE="US06465693-20021015-C00009.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00093" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>is as defined above, and R&prime;</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>represents a hydrogen, an alkyl, an alkenyl or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, where m and R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>are as defined above.</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>The term &ldquo;amido&rdquo; is art recognized as an amino-substituted carbonyl and includes a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00010">
<CHEMCDX ID="CHEMCDX-00010" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00010.CDX"/>
<CHEMMOL ID="CHEMMOL-00010" ALT="chemistry mol file" FILE="US06465693-20021015-C00010.MOL"/>
<EMI ID="EMI-C00010" ALT="embedded image" HE="48.2517" WI="49.2156" FILE="US06465693-20021015-C00010.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00095" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>9</PDAT></SB></HIL><PDAT>, R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>are as defined above. Preferred embodiments of the amide will not include imides which may be unstable.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>The term &ldquo;alkylthio&rdquo; refers to an alkyl group, as defined above, having a sulfur radical attached thereto. In preferred embodiments, the &ldquo;alkylthio&rdquo; moiety is represented by one of &mdash;S-alkyl, &mdash;S-alkenyl, &mdash;S-alkynyl, and &mdash;S&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, wherein m and R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>are defined above. Representative alkylthio groups include methylthio, ethyl thio, and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>The term &ldquo;carbonyl&rdquo; is art recognized and includes such moieties as can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00011">
<CHEMCDX ID="CHEMCDX-00011" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00011.CDX"/>
<CHEMMOL ID="CHEMMOL-00011" ALT="chemistry mol file" FILE="US06465693-20021015-C00011.MOL"/>
<EMI ID="EMI-C00011" ALT="embedded image" HE="25.6851" WI="150.255" FILE="US06465693-20021015-C00011.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00098" LVL="7"><PTEXT><PDAT>wherein X is a bond or represents an oxygen or a sulfur, and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>represents a hydrogen, an alkyl, an alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>or a pharmaceutically acceptable salt, R&prime;</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>represents a hydrogen, an alkyl, an alkenyl or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, where m and R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>are as defined above. Where X is an oxygen and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>or R&prime;</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is not hydrogen, the formula represents an &ldquo;ester&rdquo;. Where X is an oxygen, and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is as defined above, the moiety is referred to herein as a carboxyl group, and particularly when R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is a hydrogen, the formula represents a &ldquo;carboxylic acid&rdquo;. Where X is an oxygen, and R&prime;</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is hydrogen, the formula represents a &ldquo;formate&rdquo;. In general, where the oxygen atom of the above formula is replaced by sulfur, the formula represents a &ldquo;thiolcarbonyl&rdquo; group. Where X is a sulfur and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>or R&prime;</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is not hydrogen, the formula represents a &ldquo;thiolester.&rdquo; Where X is a sulfur and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is hydrogen, the formula represents a &ldquo;thiolcarboxylic acid.&rdquo; Where X is a sulfur and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is hydrogen, the formula represents a &ldquo;thiolformate.&rdquo; On the other hand, where X is a bond, and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is not hydrogen, the above formula represents a &ldquo;ketone&rdquo; group. Where X is a bond, and R</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>is hydrogen, the above formula represents an &ldquo;aldehyde&rdquo; group.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>The terms &ldquo;alkoxyl&rdquo; or &ldquo;alkoxy&rdquo; as used herein refers to an alkyl group, as defined above, having an oxygen radical attached thereto. Representative alkoxyl groups include methoxy, ethoxy, propyloxy, tert-butoxy and the like. An &ldquo;ether&rdquo; is two hydrocarbons covalently linked by an oxygen. Accordingly, the substituent of an alkyl that renders that alkyl an ether is or resembles an alkoxyl, such as can be represented by one of &mdash;O-alkyl, &mdash;O-alkenyl, &mdash;O-alkynyl, &mdash;O&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, where m and R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>are described above.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>The term &ldquo;sulfonate&rdquo; is art recognized and includes a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00012">
<CHEMCDX ID="CHEMCDX-00012" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00012.CDX"/>
<CHEMMOL ID="CHEMMOL-00012" ALT="chemistry mol file" FILE="US06465693-20021015-C00012.MOL"/>
<EMI ID="EMI-C00012" ALT="embedded image" HE="38.41425" WI="46.3239" FILE="US06465693-20021015-C00012.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00101" LVL="7"><PTEXT><PDAT>in which R</PDAT><HIL><SB><PDAT>41 </PDAT></SB></HIL><PDAT>is an electron pair, hydrogen, alkyl, cycloalkyl, or aryl.</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>The terms triflyl, tosyl, mesyl, and nonaflyl are art-recognized and refer to trifluoromethanesulfonyl, p-toluenesulfonyl, methanesulfonyl, and nonafluorobutanesulfonyl groups, respectively. The terms triflate, tosylate, mesylate, and nonaflate are art-recognized and refer to trifluoromethanesulfonate ester, p-toluenesulfonate ester, methanesulfonate ester, and nonafluorobutanesulfonate ester functional groups and molecules that contain said groups, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>The term &ldquo;sulfate&rdquo; is art recognized and includes a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00013">
<CHEMCDX ID="CHEMCDX-00013" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00013.CDX"/>
<CHEMMOL ID="CHEMMOL-00013" ALT="chemistry mol file" FILE="US06465693-20021015-C00013.MOL"/>
<EMI ID="EMI-C00013" ALT="embedded image" HE="38.41425" WI="62.39835" FILE="US06465693-20021015-C00013.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00104" LVL="7"><PTEXT><PDAT>in which R</PDAT><HIL><SB><PDAT>41 </PDAT></SB></HIL><PDAT>is as defined above.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>The term &ldquo;sulfonamido&rdquo; is art recognized and includes a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00014">
<CHEMCDX ID="CHEMCDX-00014" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00014.CDX"/>
<CHEMMOL ID="CHEMMOL-00014" ALT="chemistry mol file" FILE="US06465693-20021015-C00014.MOL"/>
<EMI ID="EMI-C00014" ALT="embedded image" HE="40.0869" WI="59.05305" FILE="US06465693-20021015-C00014.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00106" LVL="7"><PTEXT><PDAT>in which R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R&prime;</PDAT><HIL><SB><PDAT>11 </PDAT></SB></HIL><PDAT>are as defined above.</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>The term &ldquo;sulfamoyl&rdquo; is art-recognized and includes a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00015">
<CHEMCDX ID="CHEMCDX-00015" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00015.CDX"/>
<CHEMMOL ID="CHEMMOL-00015" ALT="chemistry mol file" FILE="US06465693-20021015-C00015.MOL"/>
<EMI ID="EMI-C00015" ALT="embedded image" HE="38.41425" WI="50.1795" FILE="US06465693-20021015-C00015.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00108" LVL="7"><PTEXT><PDAT>in which R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>are as defined above.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>The terms &ldquo;sulfoxido&rdquo; or &ldquo;sulfinyl&rdquo;, as used herein, refers to a moiety that can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00016">
<CHEMCDX ID="CHEMCDX-00016" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00016.CDX"/>
<CHEMMOL ID="CHEMMOL-00016" ALT="chemistry mol file" FILE="US06465693-20021015-C00016.MOL"/>
<EMI ID="EMI-C00016" ALT="embedded image" HE="32.40405" WI="130.09815" FILE="US06465693-20021015-C00016.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00110" LVL="7"><PTEXT><PDAT>in which R</PDAT><HIL><SB><PDAT>44 </PDAT></SB></HIL><PDAT>is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aralkyl, or aryl.</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>A &ldquo;phosphoryl&rdquo; can in general be represented by the formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00017">
<CHEMCDX ID="CHEMCDX-00017" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00017.CDX"/>
<CHEMMOL ID="CHEMMOL-00017" ALT="chemistry mol file" FILE="US06465693-20021015-C00017.MOL"/>
<EMI ID="EMI-C00017" ALT="embedded image" HE="40.0869" WI="36.0045" FILE="US06465693-20021015-C00017.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00112" LVL="7"><PTEXT><PDAT>wherein Q</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>represented S or O, and R</PDAT><HIL><SB><PDAT>46 </PDAT></SB></HIL><PDAT>represents hydrogen, a lower alkyl or an aryl. When used to substitute, e.g., an alkyl, the phosphoryl group of the phosphorylalkyl can be represented by the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00018">
<CHEMCDX ID="CHEMCDX-00018" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00018.CDX"/>
<CHEMMOL ID="CHEMMOL-00018" ALT="chemistry mol file" FILE="US06465693-20021015-C00018.MOL"/>
<EMI ID="EMI-C00018" ALT="embedded image" HE="40.0869" WI="162.729" FILE="US06465693-20021015-C00018.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00113" LVL="7"><PTEXT><PDAT>wherein Q</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>represented S or O, and each R</PDAT><HIL><SB><PDAT>46 </PDAT></SB></HIL><PDAT>independently represents hydrogen, a lower alkyl or an aryl, Q</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>represents O, S or N. When Q</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>is an S, the phosphoryl moiety is a &ldquo;phosphorothioate&rdquo;.</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>A &ldquo;phosphoramidite&rdquo; can be represented in the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00019">
<CHEMCDX ID="CHEMCDX-00019" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00019.CDX"/>
<CHEMMOL ID="CHEMMOL-00019" ALT="chemistry mol file" FILE="US06465693-20021015-C00019.MOL"/>
<EMI ID="EMI-C00019" ALT="embedded image" HE="40.0869" WI="162.729" FILE="US06465693-20021015-C00019.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00115" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>are as defined above, and Q</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>represents O, S or N.</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>A &ldquo;phosphoramidite&rdquo; can be represented in the general formula: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00020">
<CHEMCDX ID="CHEMCDX-00020" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00020.CDX"/>
<CHEMMOL ID="CHEMMOL-00020" ALT="chemistry mol file" FILE="US06465693-20021015-C00020.MOL"/>
<EMI ID="EMI-C00020" ALT="embedded image" HE="40.0869" WI="162.729" FILE="US06465693-20021015-C00020.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00117" LVL="7"><PTEXT><PDAT>wherein R</PDAT><HIL><SB><PDAT>9 </PDAT></SB></HIL><PDAT>and R</PDAT><HIL><SB><PDAT>10 </PDAT></SB></HIL><PDAT>are as defined above, Q</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>represents O, S or N, and R</PDAT><HIL><SB><PDAT>48 </PDAT></SB></HIL><PDAT>represents a lower alkyl or an aryl, Q</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>represents O, S or N.</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>A &ldquo;selenoalkyl&rdquo; refers to an alkyl group having a substituted seleno group attached thereto. Exemplary &ldquo;selenoethers&rdquo; which may be substituted on the alkyl are selected from one of &mdash;Se-alkyl, &mdash;Se-alkenyl, &mdash;Se-alkynyl, and &mdash;Se&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, m and R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>being defined above.</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>Analogous substitutions can be made to alkenyl and alkynyl groups to produce, for example, aminoalkenyls, aminoalkynyls, amidoalkenyls, amidoalkynyls, iminoalkenyls, iminoalkynyls, thioalkenyls, thioalkynyls, carbonyl-substituted alkenyls or alkynyls.</PDAT></PTEXT></PARA>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>The phrase &ldquo;protecting group&rdquo; as used herein means temporary modifications of a potentially reactive functional group which protect it from undesired chemical transformations. Examples of such protecting groups include esters of carboxylic acids, silyl ethers of alcohols, and acetals and ketals of aldehydes and ketones, respectively. The field of protecting group chemistry has been reviewed (Greene, T. W.; Wuts, P. G. M. </PDAT><HIL><ITALIC><PDAT>Protective Groups in Organic Synthesis, </PDAT></ITALIC></HIL><PDAT>2</PDAT><HIL><SP><PDAT>nd </PDAT></SP></HIL><PDAT>ed.; Wiley: New York, 1991).</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>It will be understood that &ldquo;substitution&rdquo; or &ldquo;substituted with&rdquo; includes the implicit proviso that such substitution is in accordance with permitted valence of the substituted atom and the substituent, and that the substitution results in a stable compound, e.g., which does not spontaneously undergo transformation such as by rearrangement, cyclization, elimination, etc.</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;substituted&rdquo; is contemplated to include all permissible substituents of organic compounds. In a broad aspect, the permissible substituents include acyclic and cyclic, branched and unbranched, carbocyclic and heterocyclic, aromatic and nonaromatic substituents of organic compounds. Illustrative substituents include, for example, those described hereinabove. The permissible substituents can be one or more and the same or different for appropriate organic compounds. For purposes of this invention, the heteroatoms such as nitrogen may have hydrogen substituents and/or any permissible substituents of organic compounds described herein which satisfy the valencies of the heteroatoms. This invention is not intended to be limited in any manner by the permissible substituents of organic compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>A &ldquo;polar solvent&rdquo; means a solvent which has a dipole moment (&egr;) of 2.9 or greater, such as DMF, THF, ethylene gylcol dimethyl ether, DMSO, acetone, acetonitrile, methanol, ethanol, isopropanol, n-propanol, t-butanol or 2-methoxyethyl ether. Preferred solvents are DMF, diglyme, and acetonitrile.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="0"><PTEXT><PDAT>A &ldquo;polar, aprotic solvent&rdquo; means a polar solvent as defined above which has no available hydrogens to exchange with the compounds of this invention during reaction, for example DMF, acetonitrile, diglyme, DMSO, or THF.</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>An &ldquo;aprotic solvent&rdquo; means a non-nucleophilic solvent having a boiling point range above ambient temperature, preferably from about 25&deg; C. to about 190&deg; C., more preferably from about 80&deg; C. to about 160&deg; C., most preferably from about 80&deg; C. to 150&deg; C., at atmospheric pressure. Examples of such solvents are acetonitrile, toluene, DMF, diglyme, THF or DMSO.</PDAT></PTEXT></PARA>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>For purposes of this invention, the chemical elements are identified in accordance with the Periodic Table of the Elements, CAS version, Handbook of Chemistry and Physics, 67th Ed., 1986-87, inside cover. Also for purposes of this invention, the term &ldquo;hydrocarbon&rdquo; is contemplated to include all permissible compounds having at least one hydrogen and one carbon atom. In a broad aspect, the permissible hydrocarbons include acyclic and cyclic, branched and unbranched, carbocyclic and heterocyclic, aromatic and nonaromatic organic compounds which can be substituted or unsubstituted.</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="7"><PTEXT><PDAT>II. Exemplary Catalyzed Reactions</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="0"><PTEXT><PDAT>As described above, one invention of the Applicants&apos; features a transition metal-catalyzed cross-coupling reaction which comprises combining a hydrazine with an aryl group (a &ldquo;substrate aryl&rdquo;) bearing an activated group X. The reaction includes at least a catalytic amount of a transition metal catalyst and the combination is maintained under conditions appropriate for the metal catalyst to catalyze the nucleophilic addition of the reactive hydrazine to the electrophilic atom of the substrate aryl.</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>In an illustrative embodiment, the subject method can be used for the intermolecular reaction between an activated aryl substrate and a hydrazine to give an aryl hydrazine: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00021">
<CHEMCDX ID="CHEMCDX-00021" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00021.CDX"/>
<CHEMMOL ID="CHEMMOL-00021" ALT="chemistry mol file" FILE="US06465693-20021015-C00021.MOL"/>
<EMI ID="EMI-C00021" ALT="embedded image" HE="108.0135" WI="214.8363" FILE="US06465693-20021015-C00021.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>In a second illustrative embodiment, the subject method can be used to bring about an intramolecular arylation of a hydrazine; said arylation yields a diazaheterocycle. In some cases, including the case illustrated below, the initially-formed diazaheterocycle can be oxidized to yield a new diazaaromatic compound: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00022">
<CHEMCDX ID="CHEMCDX-00022" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00022.CDX"/>
<CHEMMOL ID="CHEMMOL-00022" ALT="chemistry mol file" FILE="US06465693-20021015-C00022.MOL"/>
<EMI ID="EMI-C00022" ALT="embedded image" HE="149.77305" WI="214.35435" FILE="US06465693-20021015-C00022.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>Another aspect of the Applicants&apos; invention features a transition metal-catalyzed cross-coupling reaction which comprises combining a hydroxylamine with an aryl group (a &ldquo;substrate aryl&rdquo;) being an activated group X. The reaction includes at least a catalytic amount of a transition metal catalyst and the combination is maintained under conditions appropriate for the metal catalyst to catalyze the nucleophilic addition of a reactive nitrogen or oxygen of a hydroxylamine, depending upon substrates and conditions selected, or a reactive oxygen of an oxime to the electrophilic atom of the substrate aryl.</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>In an embodiment illustrative of this aspect of the invention, the subject method can be exploited for the preparation of an O-alkenyl oxime from a vinyl halide and an oxime: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00023">
<CHEMCDX ID="CHEMCDX-00023" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00023.CDX"/>
<CHEMMOL ID="CHEMMOL-00023" ALT="chemistry mol file" FILE="US06465693-20021015-C00023.MOL"/>
<EMI ID="EMI-C00023" ALT="embedded image" HE="99.6219" WI="211.9446" FILE="US06465693-20021015-C00023.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>In an second embodiment illustrative of this aspect of the invention, the subject method can be exploited in the arylation of an O-alkyl hydroxylamine to give an N-aryl-O-alkyl hydroxylamine: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00024">
<CHEMCDX ID="CHEMCDX-00024" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00024.CDX"/>
<CHEMMOL ID="CHEMMOL-00024" ALT="chemistry mol file" FILE="US06465693-20021015-C00024.MOL"/>
<EMI ID="EMI-C00024" ALT="embedded image" HE="139.45365" WI="212.42655" FILE="US06465693-20021015-C00024.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>Intramolecular variants are available of the aspects of the invention that center on hydroxyl amines. An illustrative embodiment is shown below: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00025">
<CHEMCDX ID="CHEMCDX-00025" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00025.CDX"/>
<CHEMMOL ID="CHEMMOL-00025" ALT="chemistry mol file" FILE="US06465693-20021015-C00025.MOL"/>
<EMI ID="EMI-C00025" ALT="embedded image" HE="127.94355" WI="212.19975" FILE="US06465693-20021015-C00025.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00135" LVL="0"><PTEXT><PDAT>A second illustrative embodiment of an intramolecular arylation of a hydroxyl amine is shown below. Also illustrated below is the potential for the preparation of 1,n-amino alcohols via a subsequent reduction of the nitrogen-oxygen single bond in products of the subject arylation. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00026">
<CHEMCDX ID="CHEMCDX-00026" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00026.CDX"/>
<CHEMMOL ID="CHEMMOL-00026" ALT="chemistry mol file" FILE="US06465693-20021015-C00026.MOL"/>
<EMI ID="EMI-C00026" ALT="embedded image" HE="117.369" WI="295.0101" FILE="US06465693-20021015-C00026.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>The subject method can be applied to the synthesis of N-arylhydrazones. A preferred embodiment, illustrated below, involves the transition metal catalyzed arylation of benzophenone hydrazone: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00027">
<CHEMCDX ID="CHEMCDX-00027" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00027.CDX"/>
<CHEMMOL ID="CHEMMOL-00027" ALT="chemistry mol file" FILE="US06465693-20021015-C00027.MOL"/>
<EMI ID="EMI-C00027" ALT="embedded image" HE="84.2562" WI="212.42655" FILE="US06465693-20021015-C00027.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>In still another illustrative embodiment, the subject reaction between a hydrazone and an activated aryl substrate, followed by reduction of the resulting N-aryl hydrazone, can be utilized for the synthesis of anilines: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00028">
<CHEMCDX ID="CHEMCDX-00028" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00028.CDX"/>
<CHEMMOL ID="CHEMMOL-00028" ALT="chemistry mol file" FILE="US06465693-20021015-C00028.MOL"/>
<EMI ID="EMI-C00028" ALT="embedded image" HE="244.12185" WI="212.19975" FILE="US06465693-20021015-C00028.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00138" LVL="0"><PTEXT><PDAT>In a highly preferred illustrative embodiment, the subject arylation of benzophenone hydrazone is the initial step in a conceptually novel entry into the Fischer indole synthesis. The entire sequence of events in this novel strategy for indole synthesis is illustrated below. The second step in this strategy involves two discrete events: 1) an acid-catalyzed exchange of a new aldehyde or ketone for benzophenone to form a new hydrazone&mdash;labeled &ldquo;not isolated&rdquo;&mdash;and benzophenone (not shown); and 2) the acid-catalyzed formation of an indole from the second hydrazone via what is known in the art as the Fischer Indole synthesis: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00029">
<CHEMCDX ID="CHEMCDX-00029" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00029.CDX"/>
<CHEMMOL ID="CHEMMOL-00029" ALT="chemistry mol file" FILE="US06465693-20021015-C00029.MOL"/>
<EMI ID="EMI-C00029" ALT="embedded image" HE="195.3882" WI="349.7256" FILE="US06465693-20021015-C00029.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>In another highly preferred illustrative embodiment, the subject arylation of benzophenone hydrazone is followed by a second subject arylation to give an N,N-diaryl benzophenone hydrazone. The subsequent step of this embodiment is the acid-catalyzed &ldquo;exchange in&rdquo; of a new carbonyl component to produce benzophenone and a new hydrazone (refer to the teachings of the preceding illustrative example); the new hydrazone then undergoes an acid-catalyzed Fischer indole synthesis reaction to give the product indole. The Fischer indole synthesis step in this embodiment is highly selective; the more electron-rich aryl moiety of the intermediate N,N-diaryl hydrazone is selectively incorporated into the indole nucleus of the product, and the less electron-rich aryl moiety appears as a substituent at the 1-position of the indole product. </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00030">
<CHEMCDX ID="CHEMCDX-00030" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00030.CDX"/>
<CHEMMOL ID="CHEMMOL-00030" ALT="chemistry mol file" FILE="US06465693-20021015-C00030.MOL"/>
<EMI ID="EMI-C00030" ALT="embedded image" HE="217.2177" WI="295.2369" FILE="US06465693-20021015-C00030.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>In an additional highly preferred embodiment, the arylation-Fischer Indole synthesis strategy is carried out on a solid support: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00031">
<CHEMCDX ID="CHEMCDX-00031" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00031.CDX"/>
<CHEMMOL ID="CHEMMOL-00031" ALT="chemistry mol file" FILE="US06465693-20021015-C00031.MOL"/>
<EMI ID="EMI-C00031" ALT="embedded image" HE="289.9638" WI="293.79105" FILE="US06465693-20021015-C00031.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>In a further highly preferred embodiment, a combinatorial approach to the arylation-Fischer Indole synthesis strategy on a solid support is pursued to yield a library of indoles: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00032">
<CHEMCDX ID="CHEMCDX-00032" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00032.CDX"/>
<CHEMMOL ID="CHEMMOL-00032" ALT="chemistry mol file" FILE="US06465693-20021015-C00032.MOL"/>
<EMI ID="EMI-C00032" ALT="embedded image" HE="283.47165" WI="274.8249" FILE="US06465693-20021015-C00032.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>In another highly preferred embodiment, the subject arylation of an oxime can be followed by a step analogous to the Fischer indole synthesis to provide a benzofuran: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00033">
<CHEMCDX ID="CHEMCDX-00033" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00033.CDX"/>
<CHEMMOL ID="CHEMMOL-00033" ALT="chemistry mol file" FILE="US06465693-20021015-C00033.MOL"/>
<EMI ID="EMI-C00033" ALT="embedded image" HE="160.3476" WI="214.58115" FILE="US06465693-20021015-C00033.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>In a highly preferred embodiment, the subject vinylation of a hydrazone can be followed by a step analogous to the Fischer indole synthesis to provide a pyrrole: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00034">
<CHEMCDX ID="CHEMCDX-00034" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00034.CDX"/>
<CHEMMOL ID="CHEMMOL-00034" ALT="chemistry mol file" FILE="US06465693-20021015-C00034.MOL"/>
<EMI ID="EMI-C00034" ALT="embedded image" HE="198.25155" WI="212.42655" FILE="US06465693-20021015-C00034.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>The substrate aryl compounds include compounds derived from simple aromatic rings (single or polycylic) such as benzene, naphthalene, anthracene and phenanthrene; or heteroaromatic rings (single or polycyclic), such as pyrrole, thiophene, thianthrene, furan, pyran, isobenzofluran, chromene, xanthene, phenoxathiin, pyrrole, imidazole, pyrazole, thiazole, isothiazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, indolizine, isoindole, indole, indazole, purine, quinolizine, isoquinoline, quinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, pteridine, carbazole, carboline, phenanthridine, acridine, perimidine, phenanthroline, phenazine, phenarsazine, phenothiazine, furazan, phenoxazine, pyrrolidine, oxolane, thiolane, oxazole, piperidine, piperazine, morpholine and the like. In preferred embodiment, the reactive group, X, is substituted on a five, six or seven membered ring (though it can be part of a larger polycyle).</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>In preferred embodiments, the aryl substrate may be selected from the group consisting of phenyl and phenyl derivatives, heteroaromatic compounds, polycyclic aromatic and heteroaromatic compounds, and functionalized derivatives thereof. Suitable aromatic compounds derived from simple aromatic rings and heteroaromatic rings, include but are not limited to, pyridine, imidizole, quinoline, furan, pyrrole, thiophene, and the like. Suitable aromatic compounds derived from fused ring systems, include but are not limited to naphthalene, anthracene, tetralin, indole and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>Suitable aromatic compounds may have the formula Z</PDAT><HIL><SB><PDAT>p</PDAT></SB></HIL><PDAT>ArX, where X is an activated substituent. An activated substituent, X, is characterized as being a good leaving group. In general, the leaving group is a group such as a halide or sulfonate. For the purposes of the present invention, an activated substituent is that moiety whose conjugate acid, HX, has a pKa of less than 5.0. Suitable activated substituents include, by way of example only, halides such as chloride, bromide and iodide, and sulfonate esters such as triflate, mesylate, nonaflate and tosylate. In certain embodiments, the leaving group is a halide selected from iodine and bromine. Chlorine and fluorine can also be used as leaving groups, though other electronegative substitution on the aryl group may be required to activate those halogens as leaving groups in the subject metal cross-coupling reactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>Z represents one or more optional substituents on the aromatic ring, though each occurence of Z (p&gt;1) is independently selected. By way of example only, each incidence of substitution independently can be, as valence and stability permit, a halogen, a lower alkyl, a lower alkenyl, a lower alkynyl, a carbonyl (e.g., an ester, a carboxylate, or a formate), a thiocarbonyl (e.g., a thiolester, a thiolcarboxylate, or a thiolformate), a ketyl, an aldehyde, an amino, an acylamino, an amido, an amidino, a cyano, a nitro, an azido, a sulfonyl, a sulfoxido, a sulfate, a sulfonate, a sulfamoyl, a sulfonamido, a phosphoryl, a phosphonate, a phosphinate, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;OH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O-lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O-lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;SH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S-lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S-lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, or protecting groups of the above or a solid or polymeric support; R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents a substituted or unsubstituted aryl, aralkyl, cycloalkyl, cycloalkenyl, or heterocycle; and n and m are independently for each occurrence zero or an integer in the range of 1 to 6. P is preferably in the range of 0 to 5. For fused rings, where the number of substitution sites on the aryl group increases, p may be adjusted appropriately.</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="0"><PTEXT><PDAT>In certain embodiments, suitable substituents Z include alkyl, aryl, acyl, heteroaryl, amino, carboxylic ester, carboxylic acid, hydrogen group, ether, thioether, amide, carboxamide, nitro, phosphonic acid, hydroxyl, sulfonic acid, halide, pseudohalide groups, and substituted derivatives thereof, and p is in the range of 0 to 5. In particular, the reaction has been found compatible with acetals, amides and silyl ethers as functional groups. For fused rings, where the number of substitution sites on the aromatic ring increases, p may be adjusted appropriately. In addition, the above mentioned moieties may be covalently linked to an alcohol moiety in intramolecular reactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>In preferred embodiments, the resonance structure of the aryl group Ar, or at least one substituent Z, is electron-withdrawing from the substituted position of X.</PDAT></PTEXT></PARA>
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>A wide variety of substrate aryl groups are useful in the methods of the present invention. The choice of substrate will depend on factors such as the hydrazine or the like to be employed and the desired product, and an appropriate aryl substrate will be apparent to the skilled artisan. It will be understood that the aryl substrate preferably will not contain any interfering functionalities. It will further be understood that not all activated aryl substrates will react with every alcohol.</PDAT></PTEXT></PARA>
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>The reactive hydrazine group or the like can be a molecule separate from the substrate aryl group, or a substituent of the same molecule (e.g., for intramolecular condensation).</PDAT></PTEXT></PARA>
<PARA ID="P-00152" LVL="0"><PTEXT><PDAT>The hydrazine or the like is selected to provide the desired reaction product. In general, the hydrazine or the like may be selected from the set comprising hydrazines, hydrazones, hydroxylamines and the like. The hydrazine or the like may be functionalized. The hydrazine or the like may be selected from a wide variety of structural types, including but not limited to, acyclic, cyclic or heterocyclic compounds, fused ring compounds or phenol derivatives. The aromatic compound and the hydrazine or the like may be included as moieties of a single molecule, whereby the arylation reaction proceeds as an intramolecular reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00153" LVL="0"><PTEXT><PDAT>In certain embodiments, the reactive hydrazine group or the like which is used in the subject coupling reaction can be represented by general formula RHN&mdash;Y or HY&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. R represents, as valence and stability permit, a substituted or unsubstituted alkyl or alkenyl group, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, wherein R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents a substituted or unsubstituted aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle, and m is zero or an integer in the range of 1 to 8. In other embodiments, R is linker to a solid support.</PDAT></PTEXT></PARA>
<PARA ID="P-00154" LVL="0"><PTEXT><PDAT>In certain embodiments, the hydrazine or the like is generated in situ by conversion of a precursor under the reaction conditions, e.g. by deprotonation of a hydrohalide salt of the hydrazine or the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00155" LVL="0"><PTEXT><PDAT>Alternatively, the corresponding hydrazide or the like salt, e.g., NaN(R)&mdash;Y, LiN(R)&mdash;Y, KN(R)&mdash;Y, NaY&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, LiY&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, KY&mdash;NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, etc., may be prepared and used in place of the hydrazine or the like. When the corresponding hydrazide or the like is used in the reaction, an additional base may not be required.</PDAT></PTEXT></PARA>
<PARA ID="P-00156" LVL="0"><PTEXT><PDAT>The active form of the transition metal catalyst is not well characterized. Therefore, it is contemplated that the &ldquo;transition metal catalyst&rdquo; of the present invention, as that term is used herein, shall include any catalytic transition metal and/or catalyst precursor as it is introduced into the reaction vessel and which is, if necessary, converted in situ into the active form, as well as the active form of the catalyst which participates in the reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00157" LVL="0"><PTEXT><PDAT>In preferred embodiments, the transition metal catalyst complex is provided in the reaction mixture is a catalytic amount. In certain embodiments, that amount is in the range of 0.0001 to 20 mol %, and preferably 0.05 to 5 mol %, and most preferably 1-3 mol %, with respect to the limiting reagent, which may be either the aromatic compound or the hydrazine or the like (or corresponding hydrazide etc.) or both, depending upon which reagent is in stoichiometric excess. In the instance where the molecular formula of the catalyst complex includes more than one metal, the amount of the catalyst complex used in the reaction may be adjusted accordingly. By way of example, Pd</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(dba)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>has two metal centers; and thus the molar amount of Pd</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(dba)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>used in the reaction may be halved without sacrifice to catalytic activity.</PDAT></PTEXT></PARA>
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>Additionally, heterogeneous catalysts containing forms of these elements are also suitable catalysts for any of the transition metal catalyzed reactions of the present invention. Catalysts containing palladium and nickel are preferred. It is expected that these catalysts will perform similarly because they are known to undergo similar reactions, namely oxidative-addition reactions and reductive-elimination reactions, which are thought to be involved in the formation of the aryl hydrazines etc. of the present invention. However, the different ligands are thought to modify the catalyst performance by, for example, modifying reactivity and preventing undesirable side reactions.</PDAT></PTEXT></PARA>
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>As suitable, the catalysts employed in the subject method involve the use of metals which can mediate cross-coupling of the aryl groups ArX and the hydrazine or the like as defined above. In general, any transition metal (e.g., having d electrons) may be used to form the catalyst, e.g., a metal selected from one of Groups 3-12 of the periodic table or from the lanthanide series. However, in preferred embodiments, the metal will be selected from the group of late transition metals, e.g. preferably from Groups 5-12 and even more preferably Groups 7-11. For example, suitable metals include platinum, palladium, iron, nickel, ruthenium and rhodium. The particular form of the metal to be used in the reaction is selected to provide, under the reaction conditions, metal centers which are coordinately unsaturated and not in their highest oxidation state. The metal core of the catalyst should be a zero valent transition metal, such as Pd or Ni with the ability to undergo oxidative addition to Ar-X bond. The zero-valent state, M</PDAT><HIL><SP><PDAT>0</PDAT></SP></HIL><PDAT>, may be generated in situ from M</PDAT><HIL><SP><PDAT>&plus;2</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>To further illustrate, suitable transition metal catalysts include soluble or insoluble complexes of platinum, palladium and nickel. Nickel and palladium are particularly preferred and palladium is most preferred. A zero-valent metal center is presumed to participate in the catalytic carbon-heteroatom bond forming sequence. Thus, the metal center is desirably in the zero-valent state or is capable of being reduced to metal(0). Suitable soluble palladium complexes include, but are not limited to, tris(dibenzylideneacetone) dipalladium &lsqb;Pd</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(dba)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&rsqb;, bis(dibenzylideneacetone) palladium &lsqb;Pd(dba)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rsqb; and palladium acetate. Suitable catalysts for a heterogeneous arylation reaction include, but are not limited to, palladium on carbon (Pd/C). Alternatively, particularly for nickel catalysts, the active species for the oxidative-addition step may be in the metal (&plus;1) oxidative-addition state.</PDAT></PTEXT></PARA>
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>Catalysts containing palladium and nickel are preferred. It is expected that these catalysts will perform comparably because they are known to undergo similar reactions, namely cross-coupling reactions, which may be involved in the formation of the aryl hydrazines etc. of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00162" LVL="0"><PTEXT><PDAT>The coupling can be catalyzed by a palladium catalyst which may take the form of, to illustrate, PdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Pd(OAc)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, (CH</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>CN)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Pd&lsqb;P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&rsqb;</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, and polymer supported Pd(0). In other embodiments, the reaction can be catalyzed by a nickel catalyst, such as Ni(acac)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, NiCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&lsqb;P(C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>5</PDAT></SB></HIL><PDAT>)&rsqb;</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Ni(1,5-cyclooctadiene)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Ni(1,10-phenanthroline)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, Ni(dppf)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, NiC</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(dppf), NiCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(1,10-phenanthroline), Raney nickel and the like, wherein &ldquo;acac&rdquo; represents acetylacetonate.</PDAT></PTEXT></PARA>
<PARA ID="P-00163" LVL="0"><PTEXT><PDAT>The catalyst will preferably be provided in the reaction mixture as metal-ligand complex comprising a bound supporting ligand, that is, a metal-supporting ligand complex. The ligand effects can be key to favoring, inter alia, the reductive elimination pathway or the like which produces the hydrazine or the like, over such side reactions as &bgr;-hydride elimination. In particular, the use of bulky and less electron-donating ligands (but probably still chelating ligands) should favor the reductive elimination process. In preferred embodiments, the subject reaction employs bulky bidentate ligands such as bisphosphines.</PDAT></PTEXT></PARA>
<PARA ID="P-00164" LVL="0"><PTEXT><PDAT>The ligand, as described in greater detail below, may include chelating ligands, such as by way of example only, alkyl and aryl derivatives of phosphines and bisphosphines, amines, diamines, imines, arsines, and hybrids thereof, including hybrids of phosphines with amines. Weakly or non-nucleophilic stabilizing ions are preferred to avoid complicating side reaction of the counter ion attacking or adding to the electrophilic center of the substrate aryl. This catalyst complex may include additional ligands as is necessary to obtain a stable complex. Moreover, the ligand can be added to the reaction mixture in the form of a metal complex, or added as a separate reagent relative to the addition of the metal. By way of example, PdC</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(BINAP) may be prepared in a separate step and used as the catalyst complex set forth in Schemes 1-7.</PDAT></PTEXT></PARA>
<PARA ID="P-00165" LVL="0"><PTEXT><PDAT>The ligand, if chiral can be provided as a racemic mixture or a purified stereoisomer.</PDAT></PTEXT></PARA>
<PARA ID="P-00166" LVL="0"><PTEXT><PDAT>The supporting ligand may be added to the reaction solution as a separate compound or it may be complexed to the metal center to form a metal-supporting ligand complex prior to its introduction into the reaction solution. Supporting ligands are compounds added to the reaction solution which are capable of binding to the catalyst metal center, although an actual metal-supporting ligand complex has not been identified in each and every synthesis. In some preferred embodiments, the supporting ligand is a chelating ligand. Although not bound by any theory of operation, it is hypothesized that the supporting ligands prevent unwanted side reactions as well as enhancing the rate and efficiency of the desired process. Additionally, they typically prevent precipitation of the catalytic transition metal. Although the present invention does not require the formation of a metal-supporting ligand complex, such complexes have been shown to be consistent with the postulate that they are intermediates in these reactions and it has been observed the selection of the supporting ligand has an affect on the course of the reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00167" LVL="0"><PTEXT><PDAT>The supporting ligand is present in the range of 0.0001 to 40 mol% relative to the limiting reagent, i.e., hydrazine etc. or aromatic compound. The ratio of the supporting ligand to catalyst complex is typically in the range of about 1 to 20, and preferably in the range of about 1 to 4 and most preferably 2. These ratios are based upon a single metal complex and a single binding site ligand. In instances where the ligand contains additional binding sites (i.e., a chelating ligand) or the catalyst contains more than one metal, the ratio is adjusted accordingly. By way of example, the supporting ligand BINAP contains two coordinating phosphorus atoms and thus the ratio of BINAP to catalyst is adjusted downward to about 1 to 10, preferably about 1 to 2 and most preferably 1. Conversely, Pd</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(dba)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>contains two palladium metal centers and the ratio of a non-chelating ligand to Pd</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(dba)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>is adjusted upward to 1 to 40, preferably 1 to 8 and most preferably 4.</PDAT></PTEXT></PARA>
<PARA ID="P-00168" LVL="0"><PTEXT><PDAT>In certain embodiments of the subject method, the transition metal catalyst includes one or more phosphine ligands, e.g., as a Lewis basic ligand that controls the stability and electron transfer properties of the transition metal catalyst, and/or stabilizes the metal intermediates. Phosphine ligands are commercially available or can be prepared by methods similar to processes known per se. The phosphines can be monodentate phosphine ligands, such as trimethylphosphine, triethylphosphine, tripropylphosphine, triisopropylphosphine, tributylphosphine, tricyclohexylphosphine, trimethyl phosphite, triethyl phosphite, tripropyl phosphite, triisopropyl phosphite, tributyl phosphite and tricyclohexyl phosphite, in particular triphenylphosphine, tri(o-tolyl)phosphine, triisopropylphosphine or tricyclohexylphosphine; or a bidentate phosphine ligand such as 2,2&prime;-bis(diphenylphosphino)-1,1&prime;-binaphthyl (BINAP), 1,2-bis(dimethylphosphino)ethane, 1,2-bis(diethylphosphino)ethane, 1,2-bis(dipropylphosphino)ethane, 1,2-bis(diisopropylphosphino)ethane, 1,2-bis(dibutyl-phosphino)ethane, 1,2-bis(dicyclohexylphosphino)ethane, 1,3-bis(dicyclohexylphosphino)propane, 1,3-bis(diiso-propylphosphino)propane, 1,4-bis(diisopropylphosphino)-butane and 2,4-bis(dicyclohexylphosphino)pentane.</PDAT></PTEXT></PARA>
<PARA ID="P-00169" LVL="0"><PTEXT><PDAT>In preferred embodiments, the phosphine ligand is one (or a mix of) of P(o-tolyl)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. Bis(phosphine) ligands are particularly preferred chelating supporting ligands. Suitable bis(phosphine) compounds include but are in no way limited to (&plusmn;)-2,2&prime;-bis(diphenylphosphino)-1,1&prime;-binaphthyl (and separate enantiomers), (&plusmn;)-2,2&prime;-bis(di-p-tolylphosphino)-1,1&prime;-binaphthyl (and separate enantiomers), 1-1&prime;-bis(diphenylphosphino)ferrocene (dppf), 1,3-bis(diphenylphosphino)propane (dppp), 1,2-bis(diphenylphosphino)benzene, 2,2&prime;-bis(diphenylphosphino)diphenyl ether, and 1,2-bis(diphenylphosphino)ethane (dppe). Hybrid chelating ligands such as (&plusmn;)-N,N-dimethyl-1-&lsqb;2-(diphenylphosphino) ferrocenyl&rsqb;ethylamine (and separate enantiomers), and (&plusmn;)-(R)-1-&lsqb;(S)-2-(diphenylphosphino)-ferrocenyl&rsqb;ethyl methyl ether (and separate enantiomers) are also within the scope of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>In some instances, it may be necessary to include additional reagents in the reaction to promote reactivity of either the transition metal catalyst or activated aryl nucleus. In particular, it may be advantageous to include a suitable base. In general, a variety of bases may be used in practice of the present invention. It has not been determined if deprotonation occurs prior to or after heteroatom coordination to the transition metal of the active catalyst. The base may optionally be sterically hindered to discourage metal coordination of the base in those circumstances where such coordination is possible, i.e., alkali metal alkoxides. Exemplary bases include such as, for example: an alkoxides such as sodium tert-butoxide, an alkali metal amide such as sodium amide, lithium diisopropylamide or an alkali metal bis(trialkylsilyl)amides, e.g., such as lithium bis(trimethylsilyl)amide or sodium bis(trimethylsilyl) amide, a tertiary amine (e.g. triethylamine, trimethylamine, 4-(dimethylamino)pyridine (DMAP), 1,5-diazabicycl&lsqb;4.3.0&rsqb;non-5-ene (DBN), 1,5-diazabicyclo&lsqb;5.4.0&rsqb;undec-5-ene (DBU), alkali, alkaline earth carbonate, bicarbonate or hydroxide (e.g. sodium, magnesium, calcium, barium, potassium carbonate, hydroxide and bicarbonate). By way of example only, suitable bases include NaH, LiH, KH, K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Tl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, Cs</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, K(OtBu), Li(OtBu), Na(OtBu) K(OPh), Na(OPh), triethylamine or mixtures thereof NaH, Na(OtBu) and K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>have been found useful in a wide variety of aryl ether bond forming reactions. Preferred bases include Cs</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, DBU, NaH, KOt-Bu, LiN(i-Pr)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(LDA), KN(SiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, NaN(SiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, and LiN(SiMe</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00171" LVL="0"><PTEXT><PDAT>Base is used in approximately stoichiometric proportions in reactions using hydrazines etc. The present invention has demonstrated that there is no need for large excesses of base in order to obtain good yields of aryl hydrazines etc. under mild reaction conditions. No more than four equivalents and preferably no more than two equivalents are needed. Further, in reactions using the corresponding hydrazide etc. as the reagent, there may be no need for additional base.</PDAT></PTEXT></PARA>
<PARA ID="P-00172" LVL="0"><PTEXT><PDAT>In this way a wide range of aryl hydrazines, aryl hydrazones, and N- and O-aryl hydroxylamines may be prepared from available hydrazines, hydrazones and hydroxylamines and the corresponding hydrohalide salts. The reaction can be accomplished using a wide range of hydrazines and the like, which are either commercially available or obtainable from conventional syntheses using a variety of methods known in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00173" LVL="0"><PTEXT><PDAT>As is clear from the above discussion, the products which may be produced by the arylation reaction of this invention can undergo further reaction(s) to afford desired derivatives thereof. Such permissible derivatization reactions can be carried out in accordance with conventional procedures known in the art. For example, potential derivatization reactions include esterification, oxidation of alcohols to aldehydes and acids, N-alkylation of amides, nitrile reduction, acylation of alcohols by esters, acylation of amines and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00174" LVL="7"><PTEXT><PDAT>III. Reaction Conditions</PDAT></PTEXT></PARA>
<PARA ID="P-00175" LVL="0"><PTEXT><PDAT>The arylation reactions of the present invention may be performed under a wide range of conditions, though it will be understood that the solvents and temperature ranges recited herein are not limitative and only correspond to a preferred mode of the process of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00176" LVL="0"><PTEXT><PDAT>In general, it will be desirable that reactions are run using mild conditions which will not adversely affect the reactants, the catalyst, or the product. For example, the reaction temperature influences the speed of the reaction, as well as the stability of the reactants and catalyst. The reactions will usually be run at temperatures in the range of 25&deg; C. to 300&deg; C., more preferably in the range 25&deg; C. to 150&deg; C.</PDAT></PTEXT></PARA>
<PARA ID="P-00177" LVL="0"><PTEXT><PDAT>In general, the subject reactions are carried out in a liquid reaction medium. The reactions may be run without addition of solvent. Alternatively, the reactions may be run in an inert solvent, preferably one in which the reaction ingredients, including the catalyst, are substantially soluble. Suitable solvents include ethers such as diethyl ether, 1,2-dimethoxyethane, diglyme, t-butyl methyl ether, tetrahydrofuran and the like; halogenated solvents such as chloroform, dichloromethane, dichloroethane, chlorobenzene, and the like; aliphatic or aromatic hydrocarbon solvents such as benzene, xylene, toluene, hexane, pentane and the like; esters and ketones such as ethyl acetate, acetone, and 2-butanone; polar aprotic solvents such as acetonitrile, dimethylsulfoxide, dimethylformamide and the like; or combinations of two or more solvents.</PDAT></PTEXT></PARA>
<PARA ID="P-00178" LVL="0"><PTEXT><PDAT>The invention also contemplates reaction in a biphasic mixture of solvents, in an emulsion or suspension, or reaction in a lipid vesicle or bilayer. In certain embodiments, it may be preferred to perform the catalyzed reactions in the solid phase with one of the reactants anchored to a solid support.</PDAT></PTEXT></PARA>
<PARA ID="P-00179" LVL="0"><PTEXT><PDAT>In certain embodiments it is preferable to perform the reactions under an inert atmosphere of a gas such as nitrogen or argon.</PDAT></PTEXT></PARA>
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>The reaction processes of the present invention can be conducted in continuous, semi-continuous or batch fashion and may involve a liquid recycle operation as desired. The processes of this invention are preferably conducted in batch fashion. Likewise, the manner or order of addition of the reaction ingredients, catalyst and solvent are also not generally critical and may be accomplished in any conventional fashion. In a preferred order of events that leads to an enhancement of the reaction rate, the base, e.g. t-BuONa, is the last ingredient to be added to the reaction mixture.</PDAT></PTEXT></PARA>
<PARA ID="P-00181" LVL="0"><PTEXT><PDAT>The reaction can be conducted in a single reaction zone or in a plurality of reaction zones, in series or in parallel or it may be conducted batchwise or continuously in an elongated tubular zone or series of such zones. The materials of construction employed should be inert to the starting materials during the reaction and the fabrication of the equipment should be able to withstand the reaction temperatures and pressures. Means to introduce and/or adjust the quantity of starting materials or ingredients introduced batchwise or continuously into the reaction zone during the course of the reaction can be conveniently utilized in the processes especially to maintain the desired molar ratio of the starting materials. The reaction steps may be effected by the incremental addition of one of the starting materials to the other. Also, the reaction steps can be combined by the joint addition of the starting materials to the metal catalyst. When complete conversion is not desired or not obtainable, the starting materials can be separated from the product and then recycled back into the reaction zone.</PDAT></PTEXT></PARA>
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>The processes may be conducted in either glass lined, stainless steel or similar type reaction equipment. The reaction zone may be fitted with one or more internal and/or external heat exchanger(s) in order to control undue temperature fluctuations, or to prevent any possible &ldquo;runaway&rdquo; reaction temperatures.</PDAT></PTEXT></PARA>
<PARA ID="P-00183" LVL="0"><PTEXT><PDAT>Furthermore, one or more of the reactants can be immobilized or incorporated into a polymer or other insoluble matrix by, for example, derivativation with one or more of substituents of the aryl group.</PDAT></PTEXT></PARA>
<PARA ID="P-00184" LVL="7"><PTEXT><PDAT>IV. Combinatorial Libraries</PDAT></PTEXT></PARA>
<PARA ID="P-00185" LVL="0"><PTEXT><PDAT>The subject arylation reaction readily lends itself to the creation of combinatorial libraries of aryl hydrazines, aryl hydrazones, N- and O-aryl hydroxylamines, and indoles for the screening of pharmaceutical, agrochemical or other biological or medically-related activity or material-related qualities. A combinatorial library for the purposes of the present invention is a mixture of chemically related compounds which may be screened together for a desired property; said libraries may be in solution or covalently linked to a solid support. The preparation of many related compounds in a single reaction greatly reduces and simplifies the number of screening processes which need to be carried out. Screening for the appropriate biological, pharmaceutical, agrochemical or physical property is done by conventional methods.</PDAT></PTEXT></PARA>
<PARA ID="P-00186" LVL="0"><PTEXT><PDAT>Diversity in the library can be created at a variety of different levels. For instance, the substrate aryl groups used in the combinatorial reactions can be diverse in terms of the core aryl moiety, e.g., a variegation in terms of the ring structure, and/or can be varied with respect to the other substituents.</PDAT></PTEXT></PARA>
<PARA ID="P-00187" LVL="0"><PTEXT><PDAT>A variety of techniques are available in the art for generating combinatorial libraries of small organic molecules such as the subject aryl hydrazines etc. and indoles. See, for example, Blondelle et al. (1995) </PDAT><HIL><ITALIC><PDAT>Trends Anal. Chem. </PDAT></ITALIC></HIL><PDAT>14:83; the Affymax U.S. Pat. Nos. 5,359,115 and 5,362,899: the Ellman U.S. Pat. No. 5,288,514: the Still et al. PCT publication WO 94/08051; Chen et al. (1994) </PDAT><HIL><ITALIC><PDAT>JACS </PDAT></ITALIC></HIL><PDAT>116:2661: Kerr et al. (1993) </PDAT><HIL><ITALIC><PDAT>JACS </PDAT></ITALIC></HIL><PDAT>115:252; PCT publications WO92/10092, WO93/09668 and WO91/07087; and the Lemer et al. PCT publication WO93/20242). Accordingly, a variety of libraries on the order of about 16 to 1,000,000 or more diversomers of the subject aryl hydrazines etc. or indoles can be synthesized and screened for particular activity or property.</PDAT></PTEXT></PARA>
<PARA ID="P-00188" LVL="0"><PTEXT><PDAT>In an exemplary embodiment, a library of substituted diversomers can be synthesized using the subject cross-coupling reaction adapted to the techniques described in the Still et al. PCT publication WO 94/08051, e.g., being linked to a polymer bead by a hydrolyzable or photolyzable group e.g., located at one of the positions of the aryl group or a substituent of the hydrazine and the like. According to the Still et al. technique, the library is synthesized on a set of beads, each bead including a set of tags identifying the particular diversomer on that bead. In one embodiment, which is particularly suitable for discovering enzyme inhibitors, the beads can be dispersed on the surface of a permeable membrane, and the diversomers released from the beads by lysis of the bead linker. The diversomer from each bead will diffuse across the membrane to an assay zone, where it will interact with an enzyme assay.</PDAT></PTEXT></PARA>
<PARA ID="P-00189" LVL="7"><PTEXT><PDAT>Exemplification</PDAT></PTEXT></PARA>
<PARA ID="P-00190" LVL="0"><PTEXT><PDAT>The invention may be understood with reference to the following examples, which are presented for illustrative purposes only and which are non-limiting. Hydrazines, hydrazones, ketones and aromatic halides utilized as substrates in these examples were either commercially available or were prepared in three or less steps from commercially available reagents. Palladium catalysts were all commercially available.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>EXAMPLE 1</PDAT></STEXT></H>
<PARA ID="P-00191" LVL="7"><PTEXT><PDAT>Synthesis of N-Phenyl-N-4-tolyl-N&prime;-trifluoroacetichydrazide </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00035">
<CHEMCDX ID="CHEMCDX-00035" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00035.CDX"/>
<CHEMMOL ID="CHEMMOL-00035" ALT="chemistry mol file" FILE="US06465693-20021015-C00035.MOL"/>
<EMI ID="EMI-C00035" ALT="embedded image" HE="104.41305" WI="96.98535" FILE="US06465693-20021015-C00035.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00192" LVL="0"><PTEXT><PDAT>Phenylhydrazine (1.2 equiv., 0.6 mmol, 0.06 mL), 4-bromotoluene (1.0 equiv., 0.5 mmol, 0.06 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv., 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), NaOtBu (1.4 equiv., 0.7 mmol, 67 mg) and diisopropylamine (2 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.), and then heated to 80&deg; C. under argon for 1 hour. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. Trifluoroacetic anhydride (5 equiv., 2.5 mmol, 0.35 mL), triethylamine (5 equiv., 2.5 mmol, 0.35 mL), and CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>were added to the crude reaction mixture and allowed to stir at room temperature for 1 hour. The reaction solution was then washed with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution (2&times;10 mL), dried over MgSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum. The crude mixture was purified by flash column chromatography (10% EtOAc/Hex) to give the title product as a white solid (97 mg, 0.35 mmol, 70% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 2</PDAT></STEXT></H>
<PARA ID="P-00193" LVL="7"><PTEXT><PDAT>Synthesis of N-(4-Fluorophenyl)-N-(4-phenylphenyl)hydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00036">
<CHEMCDX ID="CHEMCDX-00036" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00036.CDX"/>
<CHEMMOL ID="CHEMMOL-00036" ALT="chemistry mol file" FILE="US06465693-20021015-C00036.MOL"/>
<EMI ID="EMI-C00036" ALT="embedded image" HE="117.369" WI="65.29005" FILE="US06465693-20021015-C00036.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00194" LVL="0"><PTEXT><PDAT>4-Fluorophenylhydrazine hydrochloride (1-2 equiv., 0.6 mmol, 98 mg), 4-bromobiphenyl (1.0 equiv., 0.5 mmol, 117 mg), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv., 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), NaOtBu (1.4 equiv., 0.7 mmol, 67 mg) and diisopropylamine (2 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&minus;1 min.), and then heated to 50&deg; C. under argon for 7 hours. The reaction was then cooled to room temperature, diluted with Et2O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (10% EtOAc/Hex) to give the title product as a white solid (110 mg, 0.39 mmol, 79% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 3</PDAT></STEXT></H>
<PARA ID="P-00195" LVL="7"><PTEXT><PDAT>Synthesis of N-(4-Chlorophenyl)-N-phenylhydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00037">
<CHEMCDX ID="CHEMCDX-00037" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00037.CDX"/>
<CHEMMOL ID="CHEMMOL-00037" ALT="chemistry mol file" FILE="US06465693-20021015-C00037.MOL"/>
<EMI ID="EMI-C00037" ALT="embedded image" HE="102.25845" WI="65.29005" FILE="US06465693-20021015-C00037.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00196" LVL="0"><PTEXT><PDAT>Phenylhydrazine (1.2 equiv., 0.6 mmol, 0.06 mL), 4-chlorobromobenzene (1.0 equiv., 0.5 mmol, 96 mg), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv., 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), NaOtBu (1.4 equiv., 0.7 mmol, 67 mug) and dilsopropylamine (2 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.), and then heated to 80&deg; C. under argon for 2.5 hours. The reaction was then cooled to room temperature, diluted with Et2O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (10% EtOAc/Hex) to give the title product as a yellow oil (42 mg, 0.19 mmol, 39% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 4</PDAT></STEXT></H>
<PARA ID="P-00197" LVL="7"><PTEXT><PDAT>Synthesis of N-4-Benzotrifluoro-N-t-butyl carbazate </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00038">
<CHEMCDX ID="CHEMCDX-00038" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00038.CDX"/>
<CHEMMOL ID="CHEMMOL-00038" ALT="chemistry mol file" FILE="US06465693-20021015-C00038.MOL"/>
<EMI ID="EMI-C00038" ALT="embedded image" HE="89.5293" WI="68.40855" FILE="US06465693-20021015-C00038.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00198" LVL="0"><PTEXT><PDAT>t-Butyl carbazate (1.2 equiv., 0.6 mmol, 79 mg), 4-bromobenzotrifluoride (1.0 equiv., 0.5 mmol, 0.07 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv., 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), Cs</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(1.4 equiv., 0.7 mmol, 228 mg) and toluene (2 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.), and then heated to 100&deg; C. under argon for 8 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (10% EtOAc/Hex) to give the title product as a yellow oil (50 mg, 0.18 mmol, 36% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 5</PDAT></STEXT></H>
<PARA ID="P-00199" LVL="7"><PTEXT><PDAT>Synthesis of N,N-dimethyl-N&prime;-phenylhydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00039">
<CHEMCDX ID="CHEMCDX-00039" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00039.CDX"/>
<CHEMMOL ID="CHEMMOL-00039" ALT="chemistry mol file" FILE="US06465693-20021015-C00039.MOL"/>
<EMI ID="EMI-C00039" ALT="embedded image" HE="63.36225" WI="65.51685" FILE="US06465693-20021015-C00039.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00200" LVL="0"><PTEXT><PDAT>N,N-Dimethylhydrazine (2.0 equiv., 1.0 mmol, 0.075 mL), bromobenzene (1 equiv., 0.5 mmol, 0.05 mL), Pd</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>(DBA)</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>(0.025 equiv., 0.0125 mmol, 12 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), LiOtBu (1.2 equiv., 0.6 mmol, 48 mg) and toluene (5 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.), and then heated to 80&deg; C. under argon for 18 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (10% EtOAc/Hex) to give the title product as a yellow oil (17 mg, 0.12 mmol, 24% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 6</PDAT></STEXT></H>
<PARA ID="P-00201" LVL="7"><PTEXT><PDAT>Synthesis of Triphenylhydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00040">
<CHEMCDX ID="CHEMCDX-00040" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00040.CDX"/>
<CHEMMOL ID="CHEMMOL-00040" ALT="chemistry mol file" FILE="US06465693-20021015-C00040.MOL"/>
<EMI ID="EMI-C00040" ALT="embedded image" HE="87.11955" WI="84.00105" FILE="US06465693-20021015-C00040.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00202" LVL="0"><PTEXT><PDAT>1,1-Diphenylhydrazine hydrochloride (1.2 equiv., 0.6 mmol, 135 mg), bromobenzene (1.0 equiv., 0.5 mmol, 0.05 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.01 equiv, 0.005 mmol, 2 mg), BINAP (0.01 equiv., 0.005 mmol, 3 mg), and NaOtBu (2.8 equiv., 1.4 mmol, 134 mg) and toluene (3 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.) and then heated to 80&deg; C. for 4 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (5% EtOAc/Hex) to give the title product as a white solid (123 mg, 0.47 mmol, 95% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 7</PDAT></STEXT></H>
<PARA ID="P-00203" LVL="7"><PTEXT><PDAT>Synthesis of N-(4-Benzophenone)-N&prime;, N&prime;-Diphenylhydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00041">
<CHEMCDX ID="CHEMCDX-00041" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00041.CDX"/>
<CHEMMOL ID="CHEMMOL-00041" ALT="chemistry mol file" FILE="US06465693-20021015-C00041.MOL"/>
<EMI ID="EMI-C00041" ALT="embedded image" HE="115.92315" WI="132.02595" FILE="US06465693-20021015-C00041.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00204" LVL="0"><PTEXT><PDAT>1,1-Diphenylhydrazine hydrochloride (1.2 equiv., 0.6 mmol, 135 mg), 4-bromobenzophenone (1.0 equiv., 0.5 mmol, 131 mg), Pd(OAc)2 (0.05 equiv, 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), and NaOtBu (2.8 equiv., 1.4 mmol, 134 mg) and diisopropylamine (2 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.) and then heated to 80&deg; C. for 2 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (5% EtOAc/Hex) to give the title product as a white solid (141 mg, 0.39 mmol, 77% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 8</PDAT></STEXT></H>
<PARA ID="P-00205" LVL="7"><PTEXT><PDAT>Synthesis of N,N-Diphenyl-N&prime;-(2-chlorophenyl)hydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00042">
<CHEMCDX ID="CHEMCDX-00042" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00042.CDX"/>
<CHEMMOL ID="CHEMMOL-00042" ALT="chemistry mol file" FILE="US06465693-20021015-C00042.MOL"/>
<EMI ID="EMI-C00042" ALT="embedded image" HE="87.11955" WI="86.89275" FILE="US06465693-20021015-C00042.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00206" LVL="0"><PTEXT><PDAT>1,1-Diphenylhydrazine hydrochloride (1.2 equiv., 0.6 mmol, 135 mg), 2-chlorobromobenzene (1.0 equiv., 0.5 mmol, 0.06 mL), Pd(OAC)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv, 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), and NaOtBu (1.4 equiv., 0.7 mmol, 67 mg) and diisopropylamine (2 mL) were added to an oven dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.) and then heated to 80&deg; C. for 5 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (2% EtOAc/Hex) to give the title product as a white solid (109 mg, 0.37 mmol, 74% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 9</PDAT></STEXT></H>
<PARA ID="P-00207" LVL="7"><PTEXT><PDAT>Synthesis of N,N&prime;-Diphenyl-N-(4-benzotrifluoro)hydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00043">
<CHEMCDX ID="CHEMCDX-00043" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00043.CDX"/>
<CHEMMOL ID="CHEMMOL-00043" ALT="chemistry mol file" FILE="US06465693-20021015-C00043.MOL"/>
<EMI ID="EMI-C00043" ALT="embedded image" HE="102.0033" WI="91.20195" FILE="US06465693-20021015-C00043.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00208" LVL="0"><PTEXT><PDAT>1,2-Diphenylhydrazine (1.2 equiv., 0.6 mmol, 110 mg), 4-bromobenzotrifluoride (1.0 equiv., 0.5 mmol, 0.07 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv, 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), and NaOtBu (1.4 equiv., 0.7 mmol, 67 mg) and diisopropylamine (2 mL) were added to a flame dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.) and then heated to 80&deg; C. for 5 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (5% EtOAc/Hex) to give the title product as a viscous yellow oil (90 mg, 0.27 mmol, 55% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 10</PDAT></STEXT></H>
<PARA ID="P-00209" LVL="7"><PTEXT><PDAT>Synthesis of N&prime;,N&prime;-Diethyl-N-phenylhydrazine </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00044">
<CHEMCDX ID="CHEMCDX-00044" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00044.CDX"/>
<CHEMMOL ID="CHEMMOL-00044" ALT="chemistry mol file" FILE="US06465693-20021015-C00044.MOL"/>
<EMI ID="EMI-C00044" ALT="embedded image" HE="51.3702" WI="72.71775" FILE="US06465693-20021015-C00044.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00210" LVL="0"><PTEXT><PDAT>1,2-Diethylhydrazine dihydrochloride (1.2 equiv., 0.6 mmol, 97 mg), bromobenzene (1.0 equiv., 0.5 mmol, 0.05 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv, 0.025 mmol, 6 mg), BINAP (0.05 equiv., 0.025 mmol, 16 mg), and NaOtBu (3.8 equiv., 1.9 mmol, 183 mg) and diisopropylamine (2 mL) were added to a flame dried test tube which was capped with a septum and purged briefly with argon (&tilde;1 min.) and then heated to 80&deg; C. for 4 hours. The reaction was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 mL), filtered through Celite and concentrated under vacuum. The crude mixture was purified by flash column chromatography (2% EtOAc/Hex) to give the title product as a viscous yellow oil (27 mg, 0.16 mmol, 33% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 11</PDAT></STEXT></H>
<PARA ID="P-00211" LVL="7"><PTEXT><PDAT>N-(4-Phenylphenyl)cyclohexylhydrazone </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00045">
<CHEMCDX ID="CHEMCDX-00045" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00045.CDX"/>
<CHEMMOL ID="CHEMMOL-00045" ALT="chemistry mol file" FILE="US06465693-20021015-C00045.MOL"/>
<EMI ID="EMI-C00045" ALT="embedded image" HE="61.20765" WI="119.04165" FILE="US06465693-20021015-C00045.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00212" LVL="0"><PTEXT><PDAT>Cyclohexylhydrazone (1.0 equiv., 1.0 mmol, 112 mg), 4-bromobiphenyl (1.0 equiv., 1.0 mmol, 234 mg), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv., 0.05 mmol, 11 mg), (S)-(&minus;)-BINAP (0.05 equiv., 0.05 mmol, 31 mg), NaOt-Bu (1.4 equiv., 1.4 mmol, 134 mg), and toluene (0.2 M, 5 mL) were added to an oven dried test tube, which was then capped and briefly purged with argon and heated to 80&deg; C. under argon for 9 hours The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, filtered through Celite, and concentrated under vacuum. Purification by flash column chromatography (10% EtOAc/Hex) gave the title product as a white solid (72 mg, 0.27 mmol, 27% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 12</PDAT></STEXT></H>
<PARA ID="P-00213" LVL="7"><PTEXT><PDAT>6-Phenyl-1,2,3,4-tetrahydrocarbazole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00046">
<CHEMCDX ID="CHEMCDX-00046" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00046.CDX"/>
<CHEMMOL ID="CHEMMOL-00046" ALT="chemistry mol file" FILE="US06465693-20021015-C00046.MOL"/>
<EMI ID="EMI-C00046" ALT="embedded image" HE="44.3961" WI="105.37695" FILE="US06465693-20021015-C00046.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00214" LVL="0"><PTEXT><PDAT>N-(4-Phenylphenyl) cyclohexylhydrazone (52 mg, 0.20 mmol) was heated to reflux in a 4% H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>/H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O solution with 1 mL EtOH under argon for 4 hours. The reaction mixture was then cooled to room temperature, and neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, and then extracted with CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>Cl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(2&times;15 mL). The organic layer was then dried over Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum. Purification by flash column chromatography (2% EtOAc/Hex) gave the title product as a white solid (22 mg, 0.09 mmol, 45% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 13</PDAT></STEXT></H>
<PARA ID="P-00215" LVL="7"><PTEXT><PDAT>Synthesis of N-(4-Chlorophenyl)benzophenone hydrazone </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00047">
<CHEMCDX ID="CHEMCDX-00047" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00047.CDX"/>
<CHEMMOL ID="CHEMMOL-00047" ALT="chemistry mol file" FILE="US06465693-20021015-C00047.MOL"/>
<EMI ID="EMI-C00047" ALT="embedded image" HE="102.7404" WI="49.92435" FILE="US06465693-20021015-C00047.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00216" LVL="0"><PTEXT><PDAT>Benzophenone hydrazone (1 equiv., 10 mmol, 2.04 g), 4-chlorobromobenzene (1.0 equiv., 10 mmol, 1.915 g), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.01 equiv., 0.1 mmol, 23 mg), BINAP (0.01 equiv., 0.1 mmol, 63 mg), and toluene (5 mL) were added to an oven dried Schlenk flask and stirred at room temperature for 2 minutes, NaOtBu (1.4 equiv., 14 mmol, 1.345 g) and an additional 5 mL of toluene were then added. The flask was capped with a septum and purged briefly with argon (&tilde;1 min.) and heated to 80&deg; C. under argon for 13 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (10 mL), and concentrated under vacuum to give the crude product as a brown solid. Recrystallization of the crude product from hot isopropanol (100 mL) gave the desired product as a yellow solid (1.971 g, 6.4 mmol, 64% yield). The mother liquor was concentrated under vacuum and purified by column chromatography (5% EtOAc/Hex) to give an additional 550 mg of the desired product (1.79 mmol, 18% yield), to give an 82% overall yield of the title product.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 14</PDAT></STEXT></H>
<PARA ID="P-00217" LVL="7"><PTEXT><PDAT>Synthesis of 6-Chloro-1,2,3,4-tetrahydrocarbazole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00048">
<CHEMCDX ID="CHEMCDX-00048" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00048.CDX"/>
<CHEMMOL ID="CHEMMOL-00048" ALT="chemistry mol file" FILE="US06465693-20021015-C00048.MOL"/>
<EMI ID="EMI-C00048" ALT="embedded image" HE="52.81605" WI="96.5034" FILE="US06465693-20021015-C00048.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00218" LVL="0"><PTEXT><PDAT>N-(4-Chlorophenyl)benzophenone hydrazone (1.0 equiv., 0.5 mmol, 153 mg), cyclohexanone (1.5 equiv., 0.75 mmol, 0.078 mL), and TsOH.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 equiv., 1.0 mmol, 190 mg) were dissolved in ethanol (3 mL) and heated to reflux for 41 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (5 mL), neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, and extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;10 mL). The organic extracts were then dried over K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum. Purification by flash column chromatography (10% EtOAc/Hex) gave the title product as a white solid (94 mg, 0.46 mmol, 91% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 15</PDAT></STEXT></H>
<PARA ID="P-00219" LVL="7"><PTEXT><PDAT>Synthesis of N-Benzyl-6-chloro-1,2,3,4-tetrahydrocarbazole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00049">
<CHEMCDX ID="CHEMCDX-00049" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00049.CDX"/>
<CHEMMOL ID="CHEMMOL-00049" ALT="chemistry mol file" FILE="US06465693-20021015-C00049.MOL"/>
<EMI ID="EMI-C00049" ALT="embedded image" HE="85.2201" WI="105.1218" FILE="US06465693-20021015-C00049.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00220" LVL="0"><PTEXT><PDAT>4-Chlorophenyl benzophenone hydrazone (1 equiv., 1 mmol, 306 mg) was dissolved in 5 mL dry Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O in a flame dried flask under argon. n-BuLi (1.1 equiv., 1.1 mmol, 1.58 M in hexane, 0.69 mL) was then added in a drop wise fashion and the solution was then stirred at room temperature for 10 minutes. Distilled tetramethylethylenediamine (TMEDA, 2.2 equiv., 2.2 mmol, 0.33 mL) was then added, followed by benzyl bromide (1.2 equiv., 1.2 mmol, 0.21 mL). After 3 hours the solution was quenched with an aqueous NH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>Cl solution, extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;10 mL), the Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O extracts were dried over K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum to give N-benzyl-N4-chlorophenylbenzophenone hydrazone as a yellow oil which was used without further purification. This crude product was dissolved in EtOH (3 mL), TsOH.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (380 mg) was then added and the reaction mixture was heated to reflux for 23 hours. The reaction mixture was then cooled to room temperature, neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2&times;10 mL) and then with EtOAc (2&times;10 mL). The combined organic extracts were then dried over K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, filtered and concentrated to give the crude product as a brown oil. Purification by flash column chromatography (2 % EtOAc/Hex) afforded the title product as a pale yellow oil which solidified on standing (269 mg, 0.91 mmol, 91% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 16</PDAT></STEXT></H>
<PARA ID="P-00221" LVL="7"><PTEXT><PDAT>Synthesis of 5-Chloro-3-pentylindole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00050">
<CHEMCDX ID="CHEMCDX-00050" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00050.CDX"/>
<CHEMMOL ID="CHEMMOL-00050" ALT="chemistry mol file" FILE="US06465693-20021015-C00050.MOL"/>
<EMI ID="EMI-C00050" ALT="embedded image" HE="56.4165" WI="122.89725" FILE="US06465693-20021015-C00050.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00222" LVL="0"><PTEXT><PDAT>N-(4-Chlorophenyl)benzophenone hydrazone (1.0 equiv., 0.5 mmol, 153 mg), heptanal (5 equiv., 2.5 mmol, 0.29 mL), and TsOH.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (10 equiv., 5 mmol, 951 mg) were dissolved in THF (10 mL) and heated to reflux for 41 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (5 mL), neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, and extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;10 mL). The organic extracts were then dried over K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum. Purification by two flash column chromatographies (10% EtOAc/Hex) gave the title product as a yellow oil (29 mg, 0.13 mmol, 26% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 17</PDAT></STEXT></H>
<PARA ID="P-00223" LVL="7"><PTEXT><PDAT>Synthesis of N-(3,4-Dimethoxyphenyl)benzophenone hydrazone </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00051">
<CHEMCDX ID="CHEMCDX-00051" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00051.CDX"/>
<CHEMMOL ID="CHEMMOL-00051" ALT="chemistry mol file" FILE="US06465693-20021015-C00051.MOL"/>
<EMI ID="EMI-C00051" ALT="embedded image" HE="102.48525" WI="76.80015" FILE="US06465693-20021015-C00051.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00224" LVL="0"><PTEXT><PDAT>Benzophenone hydrazone (1 equiv., 10 mmol, 2.04 g), 4-bromoveratole (1.0 equiv., 10 mmol, 1.44 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.05 equiv., 0.5 mmol, 112 mg), BINAP (0.05 equiv., 0.5 mmol, 311 mg), and toluene (10 mL) were added to an oven dried Schlenk flask and stirred at room temperature for 2 minutes, NaOtBu (1.4 equiv., 14 mmol, 1.345 g) and an additional 10 mL of toluene were then added. The flask was capped with a septum and purged briefly with argon (&tilde;1 min.) and heated to 80&deg; C. under argon for 22 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (10 mL), and concentrated under vacuum to give the crude product as a brown oil. Purification of the crude mixture by flash column chromatography (15% EtAOc/Hex) gave the title product as a yellow solid (2.161 g, 6.5 mmol, 65% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 18</PDAT></STEXT></H>
<PARA ID="P-00225" LVL="7"><PTEXT><PDAT>Synthesis of 5,6-Dimethoxy-2-methyl-3-propylindole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00052">
<CHEMCDX ID="CHEMCDX-00052" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00052.CDX"/>
<CHEMMOL ID="CHEMMOL-00052" ALT="chemistry mol file" FILE="US06465693-20021015-C00052.MOL"/>
<EMI ID="EMI-C00052" ALT="embedded image" HE="51.597" WI="104.41305" FILE="US06465693-20021015-C00052.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00226" LVL="0"><PTEXT><PDAT>N-(3,4-Dimethoxyphenyl)-benzophenone hydrazone (1.0 equiv., 0.32 mmol, 105 mg), 2-hexanone (5 equiv., 1.58 mmol, 0.19 mL), and TsOH.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (10 equiv., 3.2 mmol, 609 mg) were dissolved in THF (10 mL) and heated to reflux for 67 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (5 mL), neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, and extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;10 mL). The organic extracts were then dried over K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum. Purification by flash column chromatography (20% EtOAc/Hex) gave the title product as a yellow oil (60 mg, 0.26 mmol, 80% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 19</PDAT></STEXT></H>
<PARA ID="P-00227" LVL="7"><PTEXT><PDAT>Synthesis of N-(1-Naphthyl)benzophenone hydrazone </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00053">
<CHEMCDX ID="CHEMCDX-00053" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00053.CDX"/>
<CHEMMOL ID="CHEMMOL-00053" ALT="chemistry mol file" FILE="US06465693-20021015-C00053.MOL"/>
<EMI ID="EMI-C00053" ALT="embedded image" HE="85.4469" WI="77.76405" FILE="US06465693-20021015-C00053.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00228" LVL="0"><PTEXT><PDAT>Benzophenone hydrazone (1 equiv., 10 mmol, 2.04 g), 1-bromonaphthalene (1.0 equiv., 10 mmol, 1.39 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.01 equiv., 0.1 mmol, 23 mg), BINAP (0.01 equiv., 0.1 mmol, 63 mg), and toluene (10 mL) were added to an oven dried Schlenk flask and stirred at room temperature for 2 minutes, NaOtBu (1.4 equiv., 14 mmol, 1.345 g) and an additional 10 mL of toluene were then added. The flask was capped with a septum and purged briefly with argon (&tilde;1 min.) and heated to 80&deg; C. under argon for 4.5 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (10 mL), and concentrated under vacuum to give the crude product as a brown solid. Recrystallization of the crude product from hot ethanol (150 mL) gave the desired product as a red solid (1.6939 g, 5.26 mmol, 53% yield). The mother liquor was concentrated until the solution became cloudy, and then heated until the solution became clear, filtered and cooled to &minus;4&deg; C. for 12 hours. The resulting crystals were filtered to give an additional 1.062 g of the title product as an orange/red solid (3.3 mmol, 33% yield), to give a 85% overall yield of the desired product.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 20</PDAT></STEXT></H>
<PARA ID="P-00229" LVL="7"><PTEXT><PDAT>Synthesis of 3-Ethoxyacety1-2-methylbenz&lsqb;g&rsqb;indole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00054">
<CHEMCDX ID="CHEMCDX-00054" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00054.CDX"/>
<CHEMMOL ID="CHEMMOL-00054" ALT="chemistry mol file" FILE="US06465693-20021015-C00054.MOL"/>
<EMI ID="EMI-C00054" ALT="embedded image" HE="85.70205" WI="100.33065" FILE="US06465693-20021015-C00054.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00230" LVL="0"><PTEXT><PDAT>N-(1-Naphthyl)-benzophenone hydrazone (1.0 equiv., 1.0 mmol, 322 mg), levulinic acid (1.5 equiv., 1.5 mmol, 0.18 mL), and TsOH.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 equiv., 2 mmol mmol, 380 mg) were dissolved in ethanol (10 mL) and heated to reflux for 15 hours. The reaction mixture was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (5 mL), neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, and extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;10 mL). The organic extracts were then dried over Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, filtered and concentrated under vacuum. Purification by flash column chromatography (20% EtOAc/Hex) gave the title product as a yellow oil (238 mg, 0.89 mmol, 89% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 21</PDAT></STEXT></H>
<PARA ID="P-00231" LVL="7"><PTEXT><PDAT>Synthesis of N-(3,5-Dimethylphenyl)-N-(4-benzotrifluoro)benzophenone hydrazone </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00055">
<CHEMCDX ID="CHEMCDX-00055" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00055.CDX"/>
<CHEMMOL ID="CHEMMOL-00055" ALT="chemistry mol file" FILE="US06465693-20021015-C00055.MOL"/>
<EMI ID="EMI-C00055" ALT="embedded image" HE="88.08345" WI="102.7404" FILE="US06465693-20021015-C00055.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00232" LVL="0"><PTEXT><PDAT>N-(3,5-Dimethylphenyl)benzophenone hydrazone (1.0 equiv., 0.5 mmol, 150 mg), 4-bromobenzotrifluoride (1.0 equiv., 0.5 mmol, 0.07 mL), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.01 equiv, 0.005 mmol, 2 mg), DPPF (0.01 equiv, 0.005 mmol, 3 mg), and toluene (1 mL) were added to an oven dried test tube and stirred at room temperature for 2 minutes. NaOtBu (1.4 equiv., 0.7 mmol, 67 mg) and an additional 1 mL toluene were then added. The test tube was then capped with a septum, briefly purged with argon (&tilde;1 min.) and then heated to 100&deg; C. under argon for 14 hours. The reaction solution was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, filtered through Celite, and concentrated under vacuum to give the crude product as a brown oil. Purification by flash column chromatography (2% EtOAc/Hex) gave the title product in approximately 72% purity as determined by </PDAT><HIL><SP><PDAT>1</PDAT></SP></HIL><PDAT>H NMR (158 mg, &tilde;0.26 mmol, &tilde;51% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 22</PDAT></STEXT></H>
<PARA ID="P-00233" LVL="7"><PTEXT><PDAT>Synthesis of N-(4-Benzotrifluoro)-6,8-dimethyl-2,3,4,5-tetrahydrocarbazole </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00056">
<CHEMCDX ID="CHEMCDX-00056" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00056.CDX"/>
<CHEMMOL ID="CHEMMOL-00056" ALT="chemistry mol file" FILE="US06465693-20021015-C00056.MOL"/>
<EMI ID="EMI-C00056" ALT="embedded image" HE="114.9876" WI="100.8126" FILE="US06465693-20021015-C00056.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00234" LVL="0"><PTEXT><PDAT>N-(3 ,5-Dimethylphenyl)-N-(4-benzotrifluoro)-benzophenone hydrazone (1 equiv., &tilde;0.26 mmol, &tilde;51% yield), cyclohexanone (1.5 equiv., 0.75 mmol, 0.078 mL), TSOH.H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (2 equiv., 1.0 mmol, 190 mg), and ethanol (3 mL) were heated to reflux for 14 hours. The reaction solution was then cooled to room temperature, neutralized with a saturated NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>solution, extracted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O (3&times;10 mL), and dried over K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>CO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, and concentrated under vacuum. Purification by flash column chromatography (2% EtOAc/Hex) gave the impure title product (73 mg, &tilde;0.21 mmol, a82% yield).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 23</PDAT></STEXT></H>
<PARA ID="P-00235" LVL="7"><PTEXT><PDAT>Synthesis of N-(3,5-Dimethylphenyl)-N-(4-phenylphenyl)benzophenone hydrazone </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00057">
<CHEMCDX ID="CHEMCDX-00057" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00057.CDX"/>
<CHEMMOL ID="CHEMMOL-00057" ALT="chemistry mol file" FILE="US06465693-20021015-C00057.MOL"/>
<EMI ID="EMI-C00057" ALT="embedded image" HE="86.6376" WI="99.8487" FILE="US06465693-20021015-C00057.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00236" LVL="0"><PTEXT><PDAT>N-(3,5-Dimethylphenyl)benzophenone hydrazone (1.0 equiv., 0.5 mmol, 150 mg), 4-bromobiphenyl (1.0 equiv., 0.5 mmol, 117 mg), Pd(OAc)</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(0.01 equiv, 0.005 mmol, 2 mg), DPE-phos (0.01 equiv, 0.005 mmol, 3 mg), and toluene (1 mL) were added to an oven dried test tube and stirred at room temperature for 2 minutes. NaOtBu (1.4 equiv., 0.7 mmol, 67 mg) and an additional 1 mL toluene were then added. The test tube was then capped with a septum, briefly purged with argon (&tilde;1 min.) and then heated to 100&deg; C. under argon for 14 hours. The reaction solution was then cooled to room temperature, diluted with Et</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, filtered through Celite, and concentrated under vacuum to give the crude product as a brown oil. Purification by flash column chromatography (2% EtOAc/Hex) gave the title product as a yellow solid (149 mg, 0.33 mmol, 66% yield).</PDAT></PTEXT></PARA>
<PARA ID="P-00237" LVL="0"><PTEXT><PDAT>All publications cited herein are hereby incorporated by reference.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Equivalents</PDAT></STEXT></H>
<PARA ID="P-00238" LVL="0"><PTEXT><PDAT>Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>We claim: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00239" LVL="0"><PTEXT><PDAT>1. A method for the vinylation of hydrazines, hydrazones, hydroxylamines and oximes, comprising reacting a base, a transition metal catalyst, a substrate vinyl compound comprising an activated carbon bearing a leaving group, and a hydrazine, hydrazone, hydroxylamine or oxime under conditions suitable for the transition metal catalyst to effect the formation of a carbon-heteroatom bond between the activated carbon of said substrate vinyl compound and a heteroatom of said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00240" LVL="0"><PTEXT><PDAT>2. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the transition metal of the transition metal catalyst is selected from the group comprising Fe, Ru, Co, Rh, Ir, Ni, Pd, Pt, and Cu.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00241" LVL="0"><PTEXT><PDAT>3. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in substoichiometric quantities relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00242" LVL="0"><PTEXT><PDAT>4. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in substoichiometric quantities relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00243" LVL="0"><PTEXT><PDAT>5. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 50 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00244" LVL="0"><PTEXT><PDAT>6. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 50 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00245" LVL="0"><PTEXT><PDAT>7. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 10 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00246" LVL="0"><PTEXT><PDAT>8. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 10 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00247" LVL="0"><PTEXT><PDAT>9. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 5 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00248" LVL="0"><PTEXT><PDAT>10. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 5 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00249" LVL="0"><PTEXT><PDAT>11. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 2 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00250" LVL="0"><PTEXT><PDAT>12. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the transition metal catalyst is present in less than or equal to 2 mol % relative to the limiting reagent among said activated aryl or vinyl compound, and said hydrazine, hydrazone, hydroxylamine or oxime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00251" LVL="0"><PTEXT><PDAT>13. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the activated group on the aromatic compound is selected from the group comprising halide s and sulfonates.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00252" LVL="0"><PTEXT><PDAT>14. The method of </PDAT><CLREF ID="CLM-00013"><PDAT>claim 13</PDAT></CLREF><PDAT>, wherein the activated group on the aromatic compound is selected from the group comprising chloride, bromide, iodide, tosylate, mesylate, triflate, and nonaflate.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00253" LVL="0"><PTEXT><PDAT>15. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the activated group on the aromatic compound is selected from the group comprising halides and sulfonates.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00254" LVL="0"><PTEXT><PDAT>16. The method of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, wherein the activated group on the aromatic compound is selected from the group comprising chloride, bromide, iodide, tosylate, mesylate, triflate, and nonaflate.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00255" LVL="0"><PTEXT><PDAT>17. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the hydrazine, hydrazone, hydroxylamine or oxime is selected from the group comprising hydrazine, alkyl and aryl hydrazines, 1,1- and 1,2-dialkyl and diaryl hydrazines, 1,1- and 1,2-alkyl aryl hydrazines, 1,1,2-trialkyl and triaryl hydrazines, 1,1,2-dialkyl aryl and alkyl diaryl hydrazines, aldehyde and ketone hydrazones, N-alkyl and N-aryl aldehyde and ketone hydrazones, hydroxylamine, O-alkyl and O-aryl hydroxylamines, N-alkyl and N-aryl hydroxylamines, N,O-dialkyl and N,O-diaryl hydroxylamines, N,O-alkyl aryl hydroxylamines, N,N-dialkyl and N,N-diaryl hydroxylamines, and N,N-alkyl aryl hydroxylamines, and aldehyde and ketone oximes.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00256" LVL="0"><PTEXT><PDAT>18. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the hydrazine, hydrazone, hydroxylamine or oxime is selected from the group comprising hydrazine, alkyl and aryl hydrazines, 1,1- and 1,2-dialkyl and diaryl hydrazines, 1,1- and 1,2-alkyl aryl hydrazines, 1,1,2-trialkyl and triaryl hydrazines, 1,1,2-dialkyl aryl and alkyl diaryl hydrazines, aldehyde and ketone hydrazones, N-alkyl and N-aryl aldehyde and ketone hydrazones, hydroxylamine, O-alkyl and O-aryl hydroxylamines, N-alkyl and N-aryl hydroxylamines, N,O-dialkyl and N,O-diaryl hydroxylamines, N,O-alkyl aryl hydroxylamines, N,N-dialkyl and N,N-diaryl hydroxylamines, and N,N-alkyl aryl hydroxylamines, and aldehyde and ketone oximes.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00257" LVL="0"><PTEXT><PDAT>19. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, represented by scheme 5: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00058">
<CHEMCDX ID="CHEMCDX-00058" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00058.CDX"/>
<CHEMMOL ID="CHEMMOL-00058" ALT="chemistry mol file" FILE="US06465693-20021015-C00058.MOL"/>
<EMI ID="EMI-C00058" ALT="embedded image" HE="113.54175" WI="214.8363" FILE="US06465693-20021015-C00058.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00258" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>X represents an activated group which can be replaced by a nucleophilic nitrogen in a transition metal-catalyzed vinylation reaction; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>Y represents NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, OR, N&boxH;CR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, N(R)C(O)NR</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R represents independently for each occurrence H, alkyl, alkenyl, formyl, acyl, sulfonyl, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R&rsquo; represents independently for each occurrence H, halogen, lower alkyl, lower alkenyl, lower alkynyl, carbonyl, ester, carboxylate, formate, thiocarbonyl, thiolester, thiolcarboxylate, thiolformate, ketone, aldehyde, amino, acylamino, amido, amidino, cyano, nitro, azido, sulfonyl, sulfonyl, sulfoxido, sulfate, sulfonate, sulfamoyl, sulfonamido, phosphoryl, phosphonate, phosphinate, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;SH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, or a solid or polymeric support; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represnts independently for each occurrence aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>n and m are integers independently for each occurrence selected from the range of 0 to 8 inclusive. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00259" LVL="0"><PTEXT><PDAT>20. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, represented by scheme 6: </PDAT>
<CWU>
<CHEM-US ID="CHEM-US-00059">
<CHEMCDX ID="CHEMCDX-00059" ALT="chemistry chemdraw file" FILE="US06465693-20021015-C00059.CDX"/>
<CHEMMOL ID="CHEMMOL-00059" ALT="chemistry mol file" FILE="US06465693-20021015-C00059.MOL"/>
<EMI ID="EMI-C00059" ALT="embedded image" HE="113.2866" WI="214.58115" FILE="US06465693-20021015-C00059.TIF"/>
</CHEM-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00260" LVL="7"><PTEXT><PDAT>wherein</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>X represents an activated group, which can be replaced by Y in a transition metal- catalyzed vinylation reaction; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>Y represents O,S, or Se; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R independently for each occurrence is absent or represents H, alkyl, alkenyl, alkylidene, formyl, acyl, sulfonyl, or &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R&rsquo; represents independently for each occurrence H, halogen, lower alkyl, lower alkenyl, lower alkynyl, carbonyl, ester, carboxylate, formate, thiocarbonyl, thiolester, thiolcarboxylate, thiolformate, ketone, aldehyde, amino, acylamino, amido, amidino, cyano, nitro, azido, sulfonyl, sulfoxido, sulfate, sulfonate, sulfamoyl, sulfonamido, phosphoryl, phosphonate, phosphinate, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;OH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;O&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;SH, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;lower alkyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;lower alkenyl, &mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>&mdash;S&mdash;(CH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>&mdash;R</PDAT><HIL><SB><PDAT>8</PDAT></SB></HIL><PDAT>, or a solid or polymeric support; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>R</PDAT><HIL><SB><PDAT>8 </PDAT></SB></HIL><PDAT>represents independently for each occurrence aryl, cycloalkyl, cycloalkenyl, heterocycle or polycycle; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>n and m are integers independently for each occurrence selected from the range of 0 to 8 inclusive. </PDAT></PTEXT></CLMSTEP>
</CLM>
</CL>
</SDOCL>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06465716-20021015-D00001.TIF SYSTEM "US06465716-20021015-D00001.TIF" NDATA TIF>
<!ENTITY US06465716-20021015-D00002.TIF SYSTEM "US06465716-20021015-D00002.TIF" NDATA TIF>
<!ENTITY US06465716-20021015-D00003.TIF SYSTEM "US06465716-20021015-D00003.TIF" NDATA TIF>
<!ENTITY US06465716-20021015-D00004.TIF SYSTEM "US06465716-20021015-D00004.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06465716</PDAT></DNUM></B110>
<B130><PDAT>B2</PDAT></B130>
<B140><DATE><PDAT>20021015</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09129112</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19980804</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>A01H  500</PDAT></B511>
<B512><PDAT>C12N 1559</PDAT></B512>
<B512><PDAT>C12N 1552</PDAT></B512>
<B512><PDAT>C12N 1582</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>800278</PDAT></B521>
<B522><PDAT>800287</PDAT></B522>
<B522><PDAT>800298</PDAT></B522>
<B522><PDAT>800290</PDAT></B522>
<B522><PDAT>536 232</PDAT></B522>
<B522><PDAT>536 236</PDAT></B522>
<B522><PDAT>435468</PDAT></B522>
<B522><PDAT>435469</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Nod factor binding protein from legume roots</PDAT></STEXT></B540>
<B560>
<B562><NCIT><STEXT><PDAT>Roberts et al (1999) A Nod factor-binding lectin is a member of a distinct class of apyrases that may be unique to the legumes. Mol. Gen. Genet. 262:261-267.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Etzler et al (1999) A nod factor binding lectin with apyrase activity from legume roots. Proc. Natl. acad. Sci. USA 96:5856-5861.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hsieh et al. Plant Molecular Biology. 1996. Jan. issue. vol. 30: 135-147.</PDAT></STEXT></NCIT><CITED-BY-EXAMINER/></B562>
</B560>
<B570>
<B577><PDAT>21</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>435  4</PDAT></B582>
<B582><PDAT>435 691</PDAT></B582>
<B582><PDAT>435468</PDAT></B582>
<B582><PDAT>435410</PDAT></B582>
<B582><PDAT>435419</PDAT></B582>
<B582><PDAT>536 231</PDAT></B582>
<B582><PDAT>536 236</PDAT></B582>
<B582><PDAT>800278</PDAT></B582>
<B582><PDAT>800290</PDAT></B582>
<B582><PDAT>800295</PDAT></B582>
<B582><PDAT>800298</PDAT></B582>
<B582><PDAT>800287</PDAT></B582>
</B580>
<B590><B595><PDAT>4</PDAT></B595><B596><PDAT>4</PDAT></B596></B590>
</B500>
<B600>
<B630><B631><PARENT-US><CDOC><DOC><DNUM><PDAT>09/129112</PDAT></DNUM></DOC></CDOC><PDOC><DOC><DNUM><PDAT>08/907226</PDAT></DNUM><DATE><PDAT>19970806</PDAT></DATE><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>00</PDAT></KIND></DOC></PDOC><PSTA><PDAT>00</PDAT></PSTA></PARENT-US></B631></B630>
<B690US>
<DOC>
<DNUM><PDAT>20020019995</PDAT></DNUM>
<DATE><PDAT>20020214</PDAT></DATE>
<CTRY><PDAT>US</PDAT></CTRY>
<KIND><PDAT>A1</PDAT></KIND>
</DOC>
</B690US></B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Marilynn E.</PDAT></FNM><SNM><STEXT><PDAT>Etzler</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Davis</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Judith B.</PDAT></FNM><SNM><STEXT><PDAT>Murphy</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Davis</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>The Regents of the University of California</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Oakland</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Townsend &amp; Townsend &amp; Crew LLP</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>Amy J.</PDAT></FNM><SNM><STEXT><PDAT>Nelson</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Anne</PDAT></FNM><SNM><STEXT><PDAT>Kubelik</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>1638</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention provides NBP46 polynucleotides that are useful in modulating Nod factor binding and other plant functions.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>CROSS REFERENCE TO RELATED APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This is a continuation in part of U.S. Ser. No. 08/907,226, filed Aug. 6, 1997, which is incorporated herein by reference.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention was made with Government support under Grant No. GM21882, awarded by the National Institutes of Health and under Grant No. DCB 9004967, awarded by the National Science Foundation. The Government has certain rights in this invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>Usable nitrogen is the major limiting nutrient in crop plant growth. Plants derive most of their nutrients including nitrogen from the soil through uptake in the root system. Although most of the nitrogen in the soil is in the form of ammonium ions which is rapidly converted to usable nitrates by bacteria in the soil, the harvesting of plants results in a steady decrease of nitrogen from the soil. Unless the soil is augmented with nitrogen-containing compounds, the soil becomes depleted of usable nitrogen and only atmospheric nitrogen remains.</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>Legumes, unlike other higher plants, are able through a symbiotic relationship with bacteria to utilize atmospheric nitrogen in the soil. The bacteria, Rhizobia, infect leguminous seedlings and induce nodulation, the end result being the presence within the root system of nodules which contain the rhizobial bacteroids. Once within the root system, the bacteroids are able to &ldquo;fix&rdquo; atmospheric nitrogen into organic compounds the legumes can use. In exchange for the conversion of atmospheric nitrogen, the plants provide the bacteroids with carbon-containing compounds, other nutrients, and a protective environment.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Although the &ldquo;fixed&rdquo; nitrogen is used throughout the plant in the growth and development of its organs and tissues, much of the usable nitrogen remains within the nodules of the roots. This empirical finding has led to the practice of crop rotation wherein a non-leguminous plant, i.e., corn, is grown and harvested and then the field is sown with a legume, such as alfalfa. After harvest of the legume, the remaining roots are plowed under and thus, usable nitrogen is returned to the soil for the sowing of the non-leguminous crop.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>The legumes recognize the rhizobial bacteria through a lectin-carbohydrate interaction. Within the root system, the plants contain lectins that bind to specific carbohydrates found on the Rhizobium cell wall. This interaction is very specific; with each plant recognizing and being infected by one rhizobial strain.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>In addition to their involvement in recognition of rhizobial bacteria, oligosaccharide signaling events play important roles in the regulation of plant development, defense, and other interactions of plants with the environment (Ryan, C. A. and Farmer, E. E. </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Plant Physiol. Plant Mol. Bio. </PDAT></ITALIC></HIL><PDAT>42:651-674 (1991); Cote, F. and Hahn, M. G. </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol </PDAT></ITALIC></HIL><PDAT>26:1379-1411 (1994); Denarie, I. et al. </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Biochem. </PDAT></ITALIC></HIL><PDAT>65:503-535 (1996)). Although the structures of some of these oligosaccharides have been characterized, little is known about the plant receptors for these signals, nor the mechanism(s) by which these signals are transduced.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>Previously, a root lectin, NBP46 (formerly called DB46), was isolated from young </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>root extracts. NBP46 is a 46 kDa protein that was isolated by affinity chromatography on hog gastric mucin blood group A&plus;H substance conjugated to Sepharose (Quinn, J. M. and Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>258:535-544 (1987)).</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Identification and characterization of protein and the genes that encode them is important to modulation of oligosaccharide signaling in plants. For instance, a transgenic non-leguminous plant containing a factor that allows rhizobial bacteria to infect the plant and fix nitrogen would lessen the need for the addition of nitrogen-containing fertilizer to soil and preclude the necessity of crop rotation in nitrogen-depleted fields. This would lead to higher yields of crop plants in areas of the world where the soil has been overplanted and replenishment of the depleted soil with usable nitrogen. The present invention addresses these and other needs.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>This invention provides for the isolation and cloning of the cDNA of NBP46 (SEQ ID NO:1), which encodes NBP46, a Nod factor binding lectin. Nod factors are carbohydrates on the surface of Rhizobium which bind to lectins on the surface of leguminous plant organs and can initiate nodulation of the root system by the plants. The NBP46 gene encodes a polypeptide of between 50 and 560 amino acids, more preferably 462 amino acids (SEQ ID NO:2).</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>In a preferred embodiment, the NBP46 coding sequence is operably linked to a plant specific promoter, more preferably a root specific promoter, such as the NBP46 promoter (SEQ ID NO:3).</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>In another embodiment, an expression cassette comprising the NBP46 gene is introduced into a transgenic plant. In a preferred embodiment, the expression of NBP46 by the transgenic plant confers to the plant the ability to bind to rhizobial bacteria and utilize atmospheric nitrogen. In a particularly preferred embodiment, the expression of NBP46 confers to the plant the ability to catalyze the hydrolysis of the phosphoanhydride bonds of di- and tri-phosphates, leading to greater availability of nutrients to the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>In a further embodiment of the instant invention, methods of modulating the rhizobial interactions and in the phosphatase activity in plants by the introduction of an expression cassette comprising NBP46 are disclosed.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE FIGURES</PDAT></STEXT></H>
<PARA ID="P-00015" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> indicates the inhibition of binding of </PDAT><HIL><SP><PDAT>125</PDAT></SP></HIL><PDAT>I-NBP46 to HBG A&plus;H-Sepharose&reg;.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> A, the legend is as follows: HBG A&plus;H (&squf;); human ovarian cyst blood group A substance (&diams;); human ovarian cyst blood group H substance (</PDAT><HIL><SP><PDAT>&dtrif;</PDAT></SP></HIL><PDAT>); de-N-acetylated HBG A&plus;H (&Circlesolid;).</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>In </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> B, the legend is as follows: </PDAT><HIL><ITALIC><PDAT>Bradyrhizobium japonicum </PDAT></ITALIC></HIL><PDAT>USDA 110 Nod factor (&squf;); &bgr;-O-methyl galactose &bgr;(1-3) N-acetyl-D-glucosamine (O); methyl &agr;-N-acetyl-D-glucosamine (&Circlesolid;); methyl &bgr;-N-acetyl-D-glucosamine (&diams;); dimer (&Dgr;), trimer (&square;), and tetramer (O) of &bgr;(1-4) N-acetyl-D-glucosamine.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> shows the effect of carbohydrate ligands on phosphatase activity of NBP46, NBP46 (201 ng/ml) was preincubated for 1 hour in the presence of various concentrations of </PDAT><HIL><ITALIC><PDAT>B. japonicum </PDAT></ITALIC></HIL><PDAT>USDA110 Nod factor (&squf;), R sp. NGP,234(Ac) Nod factor (</PDAT><HIL><SP><PDAT>&dtrif;</PDAT></SP></HIL><PDAT>), R sp. NGR234(S) Nod factor (</PDAT><HIL><SP><PDAT>&utrif;</PDAT></SP></HIL><PDAT>), </PDAT><HIL><ITALIC><PDAT>R. meliloti </PDAT></ITALIC></HIL><PDAT>Nod factor (&Circlesolid;), or cis-vaccenic acid (&diams;) and then assayed for phosphatase activity using a final concentration of 3 mM Mg-ADP.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> shows inhibition of binding of </PDAT><HIL><SP><PDAT>125</PDAT></SP></HIL><PDAT>I-NBP46 to chitin. Various concentrations of mono- and oligosaccharides were combined with 109 ng </PDAT><HIL><SP><PDAT>125</PDAT></SP></HIL><PDAT>I-NBP46 and 250 &mgr;g of chitin in a total volume of 100 &mgr;l. </PDAT><HIL><ITALIC><PDAT>B. japonicum </PDAT></ITALIC></HIL><PDAT>USDA110 Nod factor (</PDAT><HIL><SP><PDAT>&squf;</PDAT></SP></HIL><PDAT>); R. sp. NGR234(NGR</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>) Nod factor (</PDAT><HIL><SP><PDAT>&utrif;</PDAT></SP></HIL><PDAT>); R. sp. NGR234(NGR</PDAT><HIL><SB><PDAT>B</PDAT></SB></HIL><PDAT>) Nod factor (&nabla;); </PDAT><HIL><ITALIC><PDAT>R. meliloti </PDAT></ITALIC></HIL><PDAT>Nod factor (</PDAT><HIL><SP><PDAT>&Circlesolid;</PDAT></SP></HIL><PDAT>), N-acetylglucosamine (&square;), chitin disaccharide (</PDAT><HIL><SP><PDAT>&dtrif;</PDAT></SP></HIL><PDAT>); chitin tetrasaccharide (&Dgr;); chitin pentasaccharide (&diams;), chitin hexasaccharide (O).</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>I. Definitions</PDAT></STEXT></H>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>The phrase &ldquo;isolated nucleic acid molecule&rdquo; or &ldquo;isolated protein&rdquo; refers to a nucleic acid or protein which is essentially free of other cellular components with which it is associated in the natural state. It is preferably in a homogeneous state although it can be in either a dry or aqueous solution. Purity and homogeneity are typically determined using analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography. A protein which is the predominant species present in a preparation is substantially purified. In particular, an isolated NBP46 gene is separated from open reading frames which flank the gene and encode a protein other than NBP46. The term &ldquo;purified&rdquo; denotes that a nucleic acid or protein gives rise to essentially one band in an electrophoretic gel. Particularly, it means that the nucleic acid or protein is at least 85% pure, more preferably at least 95% pure, and most preferably at least 99% pure.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>A &ldquo;promoter&rdquo; is defined as an array of nucleic acid control sequences that direct transcription of an operably linked nucleic acid. As used herein, a &ldquo;plant promoter&rdquo; is a promoter that functions in plants. Promoters include necessary nucleic acid sequences near the start site of transcription, such as, in the case of a polymerase II type promoter, a TATA element. A promoter also optionally includes distal enhancer or repressor elements, which can be located as much as several thousand base pairs from the start site of transcription. A &ldquo;constitutive&rdquo; promoter is a promoter that is active under most environmental and developmental conditions. An &ldquo;inducible&rdquo; promoter is a promoter that is active under environmental or developmental regulation. The term &ldquo;operably linked&rdquo; refers to a functional linkage between a nucleic acid expression control sequence (such as a promoter, or array of transcription factor binding sites) and a second nucleic acid sequence, wherein the expression control sequence directs transcription of the nucleic acid corresponding to the second sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>The term &ldquo;plant&rdquo; includes whole plants, plant organs (e.g., leaves, stems, flowers, roots, etc.), seeds and plant cells and progeny of same. The class of plants which can be used in the method of the invention is generally as broad as the class of higher plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), as well as gymnosperms. It includes plants of a variety of ploidy levels, including polyploid, diploid, haploid and hemizygous.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>A polynucleotide sequence is &ldquo;heterologous to&rdquo; an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, a promoter operably linked to a heterologous coding sequence refers to a coding sequence from a species different from that from which the promoter was derived, or, if from the same species, a coding sequence which is different from any naturally occurring allelic variants.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>A polynucleotide &ldquo;exogenous to&rdquo; an individual plant is a polynucleotide which is introduced into the plant by any means other than by a sexual cross. Examples of means by which this can be accomplished are described below, and include Agrobacterium-mediated transformation, biolistic methods, electroporation, and the like. Such a plant containing the exogenous nucleic acid is referred to here as an R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>generation transgenic plant. Transgenic plants which arise from sexual cross or by selfing are descendants of such a plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>The phrase &ldquo;rhizobial binding&rdquo; refers to the binding between rhizobial bacteria and plant cells. Typically, enhanced binding leads to infection by rhizobial bacteria of the roots of plants. This in turn leads to nodule formation in the roots. For example, a non-leguminous transgenic plant comprising a polynucleotide of this invention and expressing its corresponding polypeptide in the roots of the plant would bind to Nod factors of rhizobial bacteria allowing the plant to become infected by the rhizobial bacteria and allowing the plant to reduce the atmospheric nitrogen contained in the soil and using it as a nutrient.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>The phrase &ldquo;operably linked&rdquo; refers to a functional linkage between a promoter and a second sequence, wherein the promoter sequence initiates transcription of RNA corresponding to the second sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>The term &ldquo;polynucleotide,&rdquo; &ldquo;polynucleotide sequence&rdquo; or &ldquo;nucleic acid sequence&rdquo; refers to deoxyribonucleotides or ribonucleotides and polymers thereof in either single- or double-stranded form. Unless specifically limited, the term encompasses nucleic acids containing known analogs of natural nucleotides which have similar binding properties as the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides. Unless otherwise indicated, a particular NBP46 nucleic acid sequence of this invention also implicitly encompasses conservatively modified variants thereof (e.g., degenerate codon substitutions) and complementary sequences and as well as the sequence explicitly indicated. Specifically, degenerate codon substitutions may be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and/or deoxyinosine residues (Batzer et al., </PDAT><HIL><ITALIC><PDAT>Nucleic Acid Res. </PDAT></ITALIC></HIL><PDAT>19:5081 (1991); Ohtsuka et al., </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><PDAT>260:2605-2608 (1985); and Cassol et al., 1992; Rossolini et al., </PDAT><HIL><ITALIC><PDAT>Mol. Cell. Probes </PDAT></ITALIC></HIL><PDAT>8:91-98 (1994)). The term nucleic acid is used interchangeably with gene, cDNA, and mRNA encoded by a gene.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>A &ldquo;NBP46 polynucleotide&rdquo; is a nucleic acid sequence comprising (or consisting of) a coding region of about 100 to about 2000 nucleotides, sometimes from about 1400 to about 1500 nucleotides, which hybridizes to SEQ ID NO:1 under stringent conditions (as defined below), or which encodes a NBP46 polypeptide.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>The term &ldquo;sexual reproduction&rdquo; refers to the fusion of gametes to produce seed by pollination. A &ldquo;sexual cross&rdquo; is pollination of one plant by another. &ldquo;Selfing&rdquo; is the production of seed by self-pollinization, i.e., pollen and ovule are from the same plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>In the case of both expression of transgenes and inhibition of endogenous genes (e.g., by antisense, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical, but may be only &ldquo;substantially identical&rdquo; to a sequence of the gene from which it was derived. As explained below, these substantially identical variants are specifically covered by the term NBP46 nucleic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional polypeptide, one of skill will recognize that because of codon degeneracy a number of polynucleotide sequences will encode the same polypeptide. These variants are specifically covered by the terms &ldquo;NBP46 nucleic acid&rdquo;. In addition, the term specifically includes those sequences substantially identical (determined as described below) with an NBP46 polynucleotide sequence disclosed here and that encode polypeptides that are either mutants of wild type NBP46 polypeptides or retain the function of the NBP46 polypeptide (e.g., resulting from conservative substitutions of amino acids in the NBP46 polypeptide). In addition, variants can be those that encode dominant negative mutants as described below.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>Two nucleic acid sequences or polypeptides are said to be &ldquo;identical&rdquo; if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The terms &ldquo;identical&rdquo; or percent &ldquo;identity,&rdquo; in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence over a comparison window, as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. When percentage of sequence identity is used in reference to proteins or peptides, it is recognized that residue positions that are not identical often differ by conservative amino acid substitutions, where amino acids residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. Where sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated according to, e.g., the algorithm of Meyers &amp; Miller, </PDAT><HIL><ITALIC><PDAT>Computer Applic. Biol. Sci. </PDAT></ITALIC></HIL><PDAT>4:11-17 (1988) e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif., USA).</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>The phrase &ldquo;substantially identical,&rdquo; in the context of two nucleic acids or polypeptides, refers to sequences or subsequences that have at least 60%, preferably 80%, most preferably 90-95% nucleotide or amino acid residue identity when aligned for maximum correspondence over a comparison window as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. This definition also refers to the complement of a test sequence, which has substantial sequence or subsequence complementarity when the test sequence has substantial identity to a reference sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>A &ldquo;comparison window&rdquo;, as used herein, includes reference to a segment of any one of the number of contiguous positions selected from the group consisting of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith &amp; Waterman, </PDAT><HIL><ITALIC><PDAT>Adv. Appl. Math. </PDAT></ITALIC></HIL><PDAT>2:482 (1981), by the homology alignment algorithm of Needleman &amp; Wunsch, </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol. </PDAT></ITALIC></HIL><PDAT>48:443 (1970), by the search for similarity method of Pearson &amp; Lipman, </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>One example of a useful algorithm is PILEUP. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments to show relationship and percent sequence identity. It also plots a tree or dendogram showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng &amp; Doolittle, </PDAT><HIL><ITALIC><PDAT>J. Mol. Evol. </PDAT></ITALIC></HIL><PDAT>35:351-360 (1987). The method used is similar to the method described by Higgins &amp; Sharp, </PDAT><HIL><ITALIC><PDAT>CABIOS </PDAT></ITALIC></HIL><PDAT>5:151-153 (1989). The program can align up to 300 sequences, each of a maximum length of 5,000 nucleotides or amino acids. The multiple alignment procedure begins with the pairwise alignment of the two most similar sequences, producing a cluster of two aligned sequences. This cluster is then aligned to the next most related sequence or cluster of aligned sequences. Two clusters of sequences are aligned by a simple extension of the pairwise alignment of two individual sequences. The final alignment is achieved by a series of progressive, pairwise alignments. The program is run by designating specific sequences and their amino acid or nucleotide coordinates for regions of sequence comparison and by designating the program parameters. For example, a reference sequence can be compared to other test sequences to determine the percent sequence identity relationship using the following parameters: default gap weight (3.00), default gap length weight (0.10), and weighted end gaps.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>Another example of algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol. </PDAT></ITALIC></HIL><PDAT>215:403-410 (1990). Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul et al, supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLAST program uses as defaults a wordlength (W) of 11, the BLOSUM62 scoring matrix (see Henikoff &amp; Henikoff, </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>89:10915 (1989)) alignments (B) of 50, expectation (E) of 10, M&equals;5, N&equals;&minus;4, and a comparison of both strands.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>The BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin &amp; Altschul, </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.2, more preferably less than about 0.01, and most preferably less than about 0.001.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>&ldquo;Conservatively modified variants&rdquo; applies to both amino acid and nucleic acid sequences. With respect to particular nucleic acid sequences, conservatively modified variants refers to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical sequences. Because of the degeneracy of the genetic code, a large number of functionally identical nucleic acids encode any given protein. For instance, the codons GCA, GCC, GCG and GCU all encode the amino acid alanine. Thus, at every position where an alanine is specified by a codon, the codon can be altered to any of the corresponding codons described without altering the encoded polypeptide. Such nucleic acid variations are &ldquo;silent variations,&rdquo; which are one species of conservatively modified variations. Every nucleic acid sequence herein which encodes a polypeptide also describes every possible silent variation of the nucleic acid. One of skill will recognize that each codon in a nucleic acid (except AUG, which is ordinarily the only codon for methionine) can be modified to yield a functionally identical molecule. Accordingly, each silent variation of a nucleic acid which encodes a polypeptide is implicit in each described sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>As to amino acid sequences, one of skill will recognize that individual substitutions, deletions or additions to a nucleic acid, peptide, polypeptide, or protein sequence which alters, adds or deletes a single amino acid or a small percentage of amino acids in the encoded sequence is a &ldquo;conservatively modified variant&rdquo; where the alteration results in the substitution of an amino acid with a chemically similar amino acid. Conservative substitution tables providing functionally similar amino acids are well known in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>The following six groups each contain amino acids that are conservative substitutions for one another:</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="1"><PTEXT><PDAT>1) Alanine (A), Serine (S), Threonine (T);</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="1"><PTEXT><PDAT>2) Aspartic acid (D), Glutamic acid (E);</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="1"><PTEXT><PDAT>3) Asparagine (N), Glutamine (Q);</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="1"><PTEXT><PDAT>4) Arginine (R), Lysine (K);</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="1"><PTEXT><PDAT>5) Isoleucine (I), Leucine (L), Methionine (M), Valine (V); and</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="1"><PTEXT><PDAT>6) Phenylalanine (F), Tyrosine (Y), Tryptophan (W).</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="7"><PTEXT><PDAT>(see, e.g., Creighton, </PDAT><HIL><ITALIC><PDAT>Proteins </PDAT></ITALIC></HIL><PDAT>(1984)).</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>An indication that two nucleic acid sequences or polypeptides are substantially identical is that the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the antibodies raised against the polypeptide encoded by the second nucleic acid. Thus, a polypeptide is typically substantially identical to a second polypeptide, for example, where the two peptides differ only by conservative substitutions. Another indication that two nucleic acid sequences are substantially identical is that the two molecules or their complements hybridize to each other under stringent conditions, as described below.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>The phrase &ldquo;selectively (or specifically) hybridizes to&rdquo; refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent hybridization conditions when that sequence is present in a complex mixture (e.g., total cellular or library DNA or RNA).</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>The phrase &ldquo;stringent hybridization conditions&rdquo; refers to conditions under which a probe will hybridize to its target subsequence, typically in a complex mixture of nucleic acid, but to no other sequences. Stringent conditions are sequence-dependent and will be different in different circumstances. Longer sequences hybridize specifically at higher temperatures. An extensive guide to the hybridization of nucleic acids is found in Tijssen, </PDAT><HIL><ITALIC><PDAT>Techniques in Biochemistry and Molecular Biology&mdash;Hybridization with Nucleic Probes, </PDAT></ITALIC></HIL><PDAT>&ldquo;Overview of principles of hybridization and the strategy of nucleic acid assays&rdquo; (1993). Generally, highly stringent conditions are selected to be about 5-10&deg; C. lower than the thermal melting point (T</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>) for the specific sequence at a defined ionic strength pH. Low stringency conditions are generally selected to be about 15-30&deg; C. below the T</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>. The T</PDAT><HIL><SB><PDAT>m </PDAT></SB></HIL><PDAT>is the temperature (under defined ionic strength, pH, and nucleic concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (as the target sequences are present in excess, at T</PDAT><HIL><SB><PDAT>m</PDAT></SB></HIL><PDAT>, 50% of the probes are occupied at equilibrium). Stringent conditions will be those in which the salt concentration is less than about 1.0 M sodium ion, typically about 0.01 to 1.0 M sodium ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30&deg; C. for short probes (e.g., 10 to 50 nucleotides) and at least about 60&deg; C. for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. For selective or specific hybridization, a positive signal is at least two times background, preferably 10 time background hybridization.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides which they encode are substantially identical. This occurs, for example, when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code. In such cased, the nucleic acids typically hybridize under moderately stringent hybridization conditions.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>In the present invention, genomic DNA or cDNA comprising NBP46 nucleic acids of the invention can be identified in standard Southern blots under stringent conditions using the nucleic acid sequences disclosed here. For the purposes of this disclosure, suitable stringent conditions for such hybridizations are those which include a hybridization in a buffer of 40% formamide, 1 M NaCl, 1% SDS at 37&deg; C., and at least one wash in 0.2&times; SSC at a temperature of at least about 50&deg; C., usually about 55&deg; C. to about 60&deg; C., for 20 minutes, or equivalent conditions. A positive hybridization is at least twice background. Those of ordinary skill will readily recognize that alternative hybridization and wash conditions can be utilized to provide conditions of similar stringency.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>A further indication that two polynucleotides are substantially identical is if the reference sequence, amplified by a pair of oligonucleotide primers, can then be used as a probe under stringent hybridization conditions to isolate the test sequence from a cDNA or genomic library, or to identify the test sequence in, e.g., a northern or Southern blot.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>The phrase &ldquo;transgenic plant&rdquo; refers to a plant into which heterologous polynucleotides have been introduced by any means other than sexual cross or selfing. Examples of means by which this can be accomplished are described below, and include Agrobacterium-mediated transformation, biolistic methods, electroporation, in planta techniques, and the like. Such a plant containing the heterologous polynucleotides is referred to here as an R</PDAT><HIL><SB><PDAT>1 </PDAT></SB></HIL><PDAT>generation transgenic plant. Transgenic plants may also arise from sexual cross or by selfing of transgenic plants into which heterologous polynucleotides have been introduced.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>II. Introduction</PDAT></STEXT></H>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>The present invention provides polynucleotides referred to here as NBP46 polynucleotides, as exemplified by SEQ ID NO:1. Polypeptides encoded by the genes of the invention are lectins involved in binding a variety of carbohydrates. In addition, polypeptides function as an enzyme, catalyzing the dephosphorylation of nucleotide di- and triphosphates. As explained below, the nucleic acid sequences of the invention code for a Nod factor binding lectin naturally expressed in the root tissue of leguminous plants.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>The polypeptides of the invention are also involved oligosaccharide signaling events that play important roles in the regulation of plant development, defense, and other interactions of plants with the environment. Although the structures of some of these oligosaccharides have been characterized in the prior art, little is known about the plant receptors for these signals, nor the mechanism(s) by which these signals are transduced. The results presented below show that polyepetides of the invention serve as receptors in oligosaccharide signaling.</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>Generally, the nomenclature and the laboratory procedures in recombinant DNA technology described below are those well known and commonly employed in the art. Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA polymerase, restriction endonucleases and the like are performed according to the manufacturer&apos;s specifications. These techniques and various other techniques are generally performed according to Sambrook, et al.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>III. Isolation Of Nucleic Acid Sequences From Plants</PDAT></STEXT></H>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>The isolation of sequences from the genes of the invention may be accomplished by a number of techniques. For instance, oligonucleotide probes based on the nucleic acid and peptide sequences disclosed herein can be used to identify the desired gene in a cDNA or genomic DNA library from a desired leguminous plant species. To construct genomic libraries, large segments of genomic DNA are generated by random fragmentation, e.g., using restriction endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector. To prepare a library of tissue-specific cDNAs, mRNA is isolated from tissues and a cDNA library which contains the gene transcripts is prepared from the mRNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>The cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned gene such as the polynucleotides disclosed here. Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>Alternatively, the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques. For instance, polymerase chain reaction (PCR) technology can be used to amplify the sequences of the genes directly from mRNA, from cDNA, from genomic libraries or cDNA libraries. PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes known to those of skill.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>Appropriate primers and probes for identifying NBP46 genes from </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>or transgenic plant tissues are generated from comparisons of the sequences provided herein. For a general overview of PCR see PCR PROTOCOLS: A GUIDE TO METHODS AND APPLICATIONS, (Innis, M, Gelfand, D., Sninsky, J. and White, T., eds.), Academic Press, San Diego (1990). Appropriate degenerate primers for this invention include, for instance: a 5&prime; PCR primer &lsqb;5&prime;-TA(T/C)GCNGTNAT(T/C)TT(T/C)GATGC-3&prime;&rsqb; (SEQ ID NO:4) and a 3&prime; PCR primer &lsqb;5&prime;-AT(A/G)TT(A/G)TA(T/A/G)AT(G/A)CCNGG-3&prime;&rsqb; (SEQ ID NO:5) where N denotes all nucleotides. The amplification conditions are typically as follows. Reaction components: 10 mM Tris-HCl, pH 8.3, 50 mM potassium chloride, 1.5 mM magnesium chloride, 0.001% gelatin, 200 &mgr;M dATP, 200 &mgr;M dCTP, 200 &mgr;M dGTP, 200 &mgr;M dTTP, 0.4 &mgr;M primers, and 100 units per mL Taq polymerase. Program: 96&deg; C. for 3 min., 30 cycles of 96&deg; C. for 45 sec., 50&deg; C. for 60 sec., 72&deg; C. for 60 sec, followed by 72&deg; C. for 5 min.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>Using the above primers, a partial coding sequence will be obtained. There are many techniques known to those of skill to determine and isolate the complete coding sequence. These methods include using the PCR amplified subsequence to probe a cDNA library for longer sequences.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>A preferred method is RACE (Frohman, et. al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>85:8998 (1988)). Briefly, this technique involves using PCR to amplify a DNA sequence using a random 5&prime; primer and a defined 3&prime; primer, e.g., (SEQ ID NO:6) (5&prime; RACE) or a random 3&prime; primer and a defined 5&prime; primer, e.g., (SEQ ID NO:7) (3&prime; RACE). The amplified sequence is then subcloned into a vector where it is then sequenced using standard techniques. Kits to perform RACE are commercially available (e.g. 5&prime; RACE System, GIBCO BRL, Grand Island, N.Y., USA). In this manner, the entire NBP46 coding sequence of about 1600 bp can be obtained (SEQ ID NO:1). The invention also provides genomic sequence of the NBP46 (SEQ ID NO:3).</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>Alternatively, primers can be selected and synthesized by those of skill from the cDNA sequence disclosed in SEQ ID NOs:1 and 3.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>Polynucleotides may also be synthesized by well-known techniques as described in the technical literature. See, e.g., Carruthers, et al., </PDAT><HIL><ITALIC><PDAT>Cold Spring Harbor Symp. Quant. Biol. </PDAT></ITALIC></HIL><PDAT>47:411-418 (1982), and Adams, et al., </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc. </PDAT></ITALIC></HIL><PDAT>105:661 (1983). Double stranded DNA fragments may then be obtained either by synthesizing the complementary strand and annealing the strands together under appropriate conditions, or by adding the complementary strand using DNA polymerase with an appropriate primer sequence.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>IV. Use Of Nucleic Acids Of The Invention To Modulate Gene Expression</PDAT></STEXT></H>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>The polynucleotides of the invention can be used to enhance expression (i.e., increase expression of an endogenous gene or provide NBP46 expression in a plant that does not normally express NBP46) of genes of the invention and thereby enhance infection of transgenic plants by rhizobial bacteria, increase the level of nutrients taken up by the plants, and affect the growth and development of transgenic plants. Alternatively, enhanced expression can be used to modulate oligosaccharide signaling in the plant. This can be accomplished by the overexpression of NBP46 polypeptides in the tissues of transgenic plants.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>The heterologous NBP46 polynucleotides do not have to code for exact copies of the NBP46 proteins exemplified herein. Modified NBP46 polypeptide chains can also be readily designed utilizing various recombinant DNA techniques well known to those skilled in the art and described for instance, in Sambrook et al., supra. Hydroxylamine can also be used to introduce single base mutations into the coding region of the gene (Sikorski, et al., </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol. </PDAT></ITALIC></HIL><PDAT>194: 302-318 (1991)). For example, the chains can vary from the naturally occurring sequence at the primary structure level by amino acid substitutions, additions, deletions, and the like. These modifications can be used in a number of combinations to produce the final modified protein chain.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>Alternatively, the nucleic acid sequences of the invention can be used to inhibit expression of an endogenous gene. One of skill will recognize that a number of methods can be used to inactivate or suppress NBP46 activity or gene expression. The control of the expression can be achieved by introducing mutations into the gene or using recombinant DNA techniques. These techniques are generally well known to one of skill and are discussed briefly below.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>Methods for introducing a genetic mutations into a plant genes are well known. For instance, seeds or other plant material can be treated with a mutagenic chemical substance, according to standard techniques. Such chemical substances include, but are not limited to, the following: diethyl sulfate, ethylene imine, ethyl methanesulfonate and N-nitroso-N-ethylurea. Alternatively, ionizing radiation from sources such as, for example, X-rays or gamma rays can be used. Desired mutants are selected by assaying for increased seed mass, oil content and other properties.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>Gene expression can be inactivated using recombinant DNA techniques by transforming plant cells with constructs comprising transposons or T-DNA sequences. NBP46 mutants prepared by these methods are identified according to standard techniques. For instance, mutants can be detected by PCR or by detecting the presence or absence of NBP46 mRNA, e.g., by Northern blots. Mutants can also be selected by assaying for increased seed mass, oil content and other properties.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>The isolated sequences prepared as described herein, can also be used in a number of techniques to suppress endogenous NBP46 gene expression. A number of methods can be used to inhibit gene expression in plants. For instance, antisense technology can be conveniently used. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the antisense strand of RNA will be transcribed. The construct is then transformed into plants and the antisense strand of RNA is produced. In plant cells, it has been suggested that antisense RNA inhibits gene expression by preventing the accumulation of mRNA which encodes the enzyme of interest, see, e.g., Sheehy et al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat. Acad. Sci. USA, </PDAT></ITALIC></HIL><PDAT>85:8805-8809 (1988), and Hiatt et al., U.S. Pat. No. 4,801,340.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>The nucleic acid segment to be introduced generally will be substantially identical to at least a portion of the endogenous NBP46 gene or genes to be repressed. The sequence, however, need not be perfectly identical to inhibit expression. The vectors of the present invention can be designed such that the inhibitory effect applies to other genes within a family of genes exhibiting homology or substantial homology to the target gene.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>For antisense suppression, the introduced sequence also need not be full length relative to either the primary transcription product or fully processed mRNA. Generally, higher homology can be used to compensate for the use of a shorter sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and homology of non-coding segments may be equally effective. Normally, a sequence of between about 30 or 40 nucleotides and about full length nucleotides should be used, though a sequence of at least about 100 nucleotides is preferred, a sequence of at least about 200 nucleotides is more preferred, and a sequence of about 500 to about 1700 nucleotides is especially preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>Catalytic RNA molecules or ribozymes can also be used to inhibit expression of NBP46 genes. It is possible to design ribozymes that specifically pair with virtually any target RNA and cleave the phosphodiester backbone at a specific location, thereby functionally inactivating the target RNA. In carrying out this cleavage, the ribozyme is not itself altered, and is thus capable of recycling and cleaving other molecules, making it a true enzyme. The inclusion of ribozyme sequences within antisense RNAs confers RNA-cleaving activity upon them, thereby increasing the activity of the constructs.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>A number of classes of ribozymes have been identified. One class of ribozymes is derived from a number of small circular RNAs which are capable of self-cleavage and replication in plants. The RNAs replicate either alone (viroid RNAS) or with a helper virus (satellite RNAs). Examples include RNAs from avocado sunblotch viroid and the satellite RNAs from tobacco ringspot virus, lucerne transient streak virus, velvet tobacco mottle virus, solanum nodiflorum mottle virus and subterranean clover mottle virus. The design and use of target RNA-specific ribozymes is described in Haseloff et al. </PDAT><HIL><ITALIC><PDAT>Nature, </PDAT></ITALIC></HIL><PDAT>334:585-591 (1988).</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>Another method of suppression is sense cosuppression. Introduction of nucleic acid configured in the sense orientation has been recently shown to be an effective means by which to block the transcription of target genes. For an example of the use of this method to modulate expression of endogenous genes see, Napoli et al., </PDAT><HIL><ITALIC><PDAT>The Plant Cell </PDAT></ITALIC></HIL><PDAT>2:279-289 (1990), and U.S. Pat. Nos. 5,034,323, 5,231,020, and 5,283,184.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>The suppressive effect may occur where the introduced sequence contains no coding sequence per se, but only intron or untranslated sequences homologous to sequences present in the primary transcript of the endogenous sequence. The introduced sequence generally will be substantially identical to the endogenous sequence intended to be repressed. This minimal identity will typically be greater than about 65%, but a higher identity might exert a more effective repression of expression of the endogenous sequences. Substantially greater identity of more than about 80% is preferred, though about 95% to absolute identity would be most preferred. As with antisense regulation, the effect should apply to any other proteins within a similar family of genes exhibiting homology or substantial homology.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>For sense suppression, the introduced sequence, needing less than absolute identity, also need not be full length, relative to either the primary transcription product or fully processed mRNA. This may be preferred to avoid concurrent production of some plants which are overexpressers. A higher identity in a shorter than full length sequence compensates for a longer, less identical sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and identity of non-coding segments will be equally effective. Normally, a sequence of the size ranges noted above for antisense regulation is used.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>A. Preparation of Recombinant Vectors</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>To use isolated sequences in the above techniques, recombinant DNA vectors suitable for transformation of plant cells are prepared. Techniques for transforming a wide variety of higher plant species are well known and described in the technical and scientific literature. See, for example, Weising, et al., </PDAT><HIL><ITALIC><PDAT>Ann. Rev. Genet. </PDAT></ITALIC></HIL><PDAT>22:421-477 (1988). A DNA sequence coding for the desired polypeptide, for example a cDNA sequence encoding the full length NBP46 protein, will preferably be combined with transcriptional and translational initiation regulatory sequences which will direct the transcription of the sequence from the gene in the intended tissues of the transgenic plant, i.e., a root-specific promoter.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>Promoters can be identified by analyzing the 5&prime; sequences of a genomic clone in which naturally occurring Nod factor binding protein-specific genes, i.e., NBP46, can be found. At the 5&prime; end of the coding sequence, nucleotide sequences characteristic of promoter sequences can be used to identify the promoter. Sequences controlling eukaryotic gene expression have been extensively studied. For instance, promoter sequence elements include the TATA box consensus sequence (TATAAT), which is usually 20 to 30 base pairs upstream of the transcription start site. In most instances the TATA box is required for accurate transcription initiation. In plants, further upstream from the TATA box, at positions &minus;80 to &minus;100, there is typically a promoter element with a series of adenines surrounding the trinucleotide G (or T) N G. J. Messing, et al., in GENETIC ENGINEERING IN PLANTS, pp. 221-227 (Kosage, Meredith and Hollaender, eds. (1983)).</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>A number of methods are known to those of skill in the art for identifying and characterizing promoter regions in plant genomic DNA (see, e.g., Jordano, et al., </PDAT><HIL><ITALIC><PDAT>Plant Cell </PDAT></ITALIC></HIL><PDAT>1:855-866 (1989); Bustos, et al., </PDAT><HIL><ITALIC><PDAT>Plant Cell </PDAT></ITALIC></HIL><PDAT>1:839-854 (1989); Green, et al., </PDAT><HIL><ITALIC><PDAT>EMBO J. </PDAT></ITALIC></HIL><PDAT>7:4035-4044 (1988); Meier, et al., </PDAT><HIL><ITALIC><PDAT>Plant Cell </PDAT></ITALIC></HIL><PDAT>3:309-316 (1991); and Zhang, et al., </PDAT><HIL><ITALIC><PDAT>Plant Physiology </PDAT></ITALIC></HIL><PDAT>110:1069-1079 (1996)).</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>In construction of recombinant expression cassettes of the invention, a plant promoter fragment may be employed which will direct expression of the gene in all tissues of a regenerated plant. Such promoters are referred to herein as &ldquo;constitutive&rdquo; promoters and are active under most environmental conditions and states of development or cell differentiation. Examples of constitutive promoters include the cauliflower mosaic virus (CaMV) 35S transcription initiation region, the 1&prime;- or 2&prime;-promoter derived from T-DNA of </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumafaciens, </PDAT></ITALIC></HIL><PDAT>and other transcription initiation regions from various plant genes known to those of skill.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>Alternatively, the plant promoter may direct expression of the polynucleotide of the instant invention in a specific tissue (tissue-specific promoters) or may be otherwise under more precise environmental control (inducible promoters). Examples of tissue-specific promoters under developmental control include promoters that initiate transcription only in certain tissues, such as roots, fruit, seeds, or flowers. Examples of environmental conditions that may affect transcription by inducible promoters include anaerobic conditions, elevated temperature, or the presence of light.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>If proper polypeptide expression is desired, a polyadenylation region at the 3&prime;-end of the coding region should be included. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>The vector comprising the sequences (e.g., promoters or coding regions) from genes of the invention will typically comprise a marker gene which confers a selectable phenotype on plant cells. For example, the marker may encode biocide resistance, particularly antibiotic resistance, such as resistance to kanamycin, G418, bleomycin, hygromycin, or herbicide resistance, such as resistance to chlorosluforon or Basta.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>B. Production of Transgenic Plants</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>DNA constructs of the invention may be introduced into the genome of a desired plant host by a variety of conventional techniques. For example, the DNA construct may be introduced directly into the genomic DNA of a plant cell using techniques such as electroporation and microinjection of plant cell protoplasts, or the DNA constructs can be introduced directly into plant tissue using ballistic methods, such as DNA particle bombardment. Alternatively, the DNA constructs may be combined with suitable T-DNA flanking regions and introduced into a conventional </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens </PDAT></ITALIC></HIL><PDAT>host vector. The virulence functions of the </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens </PDAT></ITALIC></HIL><PDAT>host will direct the insertion of the construct and adjacent marker into the plant cell DNA when the cell is infected by the bacteria.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>Microinjection techniques are known in the art and well described in the scientific and patent literature. The introduction of DNA constructs using polyethylene glycol precipitation is described in Paszkowski, et al, </PDAT><HIL><ITALIC><PDAT>EMBO J. </PDAT></ITALIC></HIL><PDAT>3:2717-2722 (1984). Electroporation techniques are described in Fromm, et al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>82:5824 (1985). Ballistic transformation techniques are described in Klein, et al., </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>327:70-73 (1987).</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens</PDAT></ITALIC></HIL><PDAT>-mediated transformation techniques, including disarming and use of binary vectors, are well described in the scientific literature. See, for example Horsch, et al., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>233:496-498 (1984), and Fraley, et al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>80:4803 (1983).</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>Transformed plant cells which are derived by any of the above transformation techniques can be cultured to regenerate a whole plant which possesses the transformed genotype and thus the desired phenotype. Such regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide and/or herbicide marker which has been introduced together with the desired nucleotide sequences. Plant regeneration from cultured protoplasts is described in Evans, et al., PROTOPLASTS ISOLATION AND CULTURE, HANDBOOK OF PLANT CELL CULTURE, pp. 124-176, Macmillian Publishing Company, New York (1983); and Binding, REGENERATION OF PLANTS, PLANT PROTOPLASTS, pp. 21-73, CRC Press, Boca Raton (1985). Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee, et al., </PDAT><HIL><ITALIC><PDAT>Ann. Rev. of Plant Phys. </PDAT></ITALIC></HIL><PDAT>38:467-486 (1987).</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>To determine the presence of a reduction or increase of NBP46 activity, a variety of assays can be used including enzymatic, immunochemical, electrophoretic detection assays (either with staining or western blotting), or complex carbohydrate binding assays.</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>In a preferred embodiment, a competitive solid phase assay is used to measure NBP46 activity (Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Glycoconj. J. </PDAT></ITALIC></HIL><PDAT>11:395 (1994)). This assay measures the ability of various ligands to inhibit the binding of labeled NBP46 protein to pronase-digested hog gastric mucin blood group A&plus;H substance (HBG A&plus;H) conjugated to Sepharose&reg; (Quinn, J. M. &amp; Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>258:535 (1987)).</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>The nucleic acids of the invention can be used to confer desired traits on essentially any plant. Thus, the invention has use over a broad range of plants, including species from the genera Asparagus, Avena, Brassica, Citrus, Citrullus, Capsicum, Cucurbita, Daucus, Glycine, Hordeum, Lactuca, Lycopersicon, Malus, Manihot, Nicotiana, Oryza, Persea, Pisum, Pyrus, Prunus, Raphanus, Secale, Solanum, Sorghum, Triticum, Vitis, Vigna, and Zea.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>One of skill will recognize that after the expression cassette is stably incorporated in transgenic plants and confirmed to be operable, it can be introduced into other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>Effects of gene manipulation can be observed by northern blots of the mRNA isolated from the tissues of interest. Typically, if the amount of mRNA has increased, it can be assumed that the gene is being expressed at a greater rate than before. Other methods of measuring NBP46 expression would be by measuring the rhizobial infection of the transgenic plants. Alternatively, the ability of the plant to reduce atmospheric nitrogen could be assessed. In addition, levels of NBP46 could be measured immunochemically, i.e., ELISA, RIA, EIA and other antibody based assays well known to those of skill in the art.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>V. EXAMPLES</PDAT></STEXT></H>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>The following examples are offered to illustrate, but not to limit the claimed invention.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 1</PDAT></STEXT></H>
<PARA ID="P-00099" LVL="7"><PTEXT><PDAT>Characterization and cloning of NBP46</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="7"><PTEXT><PDAT>Carbohydrate binding and characterization of NBP46</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>It has been previously demonstrated that NBP46 is a 46 kDa protein that can be isolated from young </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>root extracts by affinity chromatography on hog gastric mucin blood group A&plus;H substance (HBG A&plus;H) conjugated to Sepharose&reg; (Quinn, J. M. &amp; Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>258:535 (1987)). The monomeric nature of NBP46 in solution precluded the use of conventional precipitin or agglutination assays in determining the carbohydrate binding specificity of this lectin. Therefore a complex carbohydrate binding assay was employed (Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Glycoconj. J. </PDAT></ITALIC></HIL><PDAT>11:395 (1994)).</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>, various concentrations of blood group substances (A) and oligosaccharides (B) were combined with 109 ng </PDAT><HIL><SP><PDAT>125</PDAT></SP></HIL><PDAT>I-NBP46 (isolated as described in Quinn, J. M. &amp; Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>258:535 (1987)) and a pronase digest of HBG A&plus;H-Sepharose&reg; (final concentration 1%) in a volume of 100 &mgr;L of 5 mM MOPS, pH 7.2, containing 0.025% Tween-20&reg; and 0.01% NaN</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. Hog blood group A&plus;H substance was isolated from hog gastric mucin (Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Glyconj. J. </PDAT></ITALIC></HIL><PDAT>11:395 (1994)) and de-N-acetylated as described in Etzler, M. E., et al., </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>141:588 (1970). After incubation at room temperature overnight, binding was measured as previously described (Etzler, M. E., </PDAT><HIL><ITALIC><PDAT>Glyconj. J. </PDAT></ITALIC></HIL><PDAT>11:395 (1994)). Although the binding of the NBP46 to this resin was inhibited by free HBG A&plus;H (FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>A), no significant inhibition was obtained with up to 50 mM concentrations of any of the monosaccharides present in the blood group substance, including N-acetyl-D-galactosamine and L-fucose, the immunodominant sugars of the blood type A and H determinants, respectively (Watkins, W. M., </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>152:172 (1966); and Lloyd, K. O., et al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>61:1470 (1968)). Individual human ovarian cyst blood group A and H substances (provided by Elvin A. Kabat, Columbia University) were equal to one another in inhibitory capacity but much weaker than HBG A&plus;H (FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>A). De-N-acetylation of the blood type A determinant did not alter the ability of the HBG A&plus;H to inhibit the binding of NBP46 (FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>A).</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>These results indicated that the binding of NBP46 to the above blood group substances was due to its recognition of some portion of the oligosaccharide chains other than the blood type A and H determinants and that its carbohydrate binding site accommodated more than a simple sugar. The carbohydrate specificity of NBP46 thus differs from the blood type A specific seed lectin from </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus, </PDAT></ITALIC></HIL><PDAT>which recognizes the &agr; N-acetyl-D-galactosamine residues which are at the nonreducing ends of the oligosaccharide chains of blood group A substance (Etzler, M. E., et al., </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>9:869 (1970)).</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>A variety of oligosaccharides were tested in an attempt to obtain more information on the carbohydrate specificity of NBP46 (FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>B). The strongest inhibition was obtained with the purified Nod factor from </PDAT><HIL><ITALIC><PDAT>Bradyrhizobium japonicum </PDAT></ITALIC></HIL><PDAT>USDA 110, a bacterial rhizobial strain that nodulates soybean and can also nodulate </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus. </PDAT></ITALIC></HIL><PDAT>The Nod factor was isolated as described in Sanjuan, J., et al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>89:8789 (1992). The Nod factor from </PDAT><HIL><ITALIC><PDAT>Bradyrhizobium japonicum </PDAT></ITALIC></HIL><PDAT>USDA 110 is composed of a &bgr;1-4 N-acetyl-D-glucosamine pentasaccharide backbone, modified by a 2-O-methyl &agr;-L-fucose on C-6 of the sugar at the reducing end and the substitution of the acetyl group on the sugar at the nonreducing end with a C</PDAT><HIL><SB><PDAT>18:1 </PDAT></SB></HIL><PDAT>fatty acyl chain (Sanjuan, J., et al., </PDAT><HIL><ITALIC><PDAT>Proc. Nat&apos;l. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>89:8789 (1992)). Thus, NBP46 can be characterized as a Nod factor binding lectin.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="7"><PTEXT><PDAT>Phosphohydrolase Activity of NBP46</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>A search of protein and nucleotide data bases using the NCB1 BLASTP and BLASTN programs (Altschul, S. F., et al., </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol. </PDAT></ITALIC></HIL><PDAT>215:403 (1990)) showed no significant similarities between NBP46 to the amino acid or cDNA sequences of any other plant or animal lectin yet described. It did, however, show 65.6 and 47.6% amino acid identity and 70.7 and 58.7% nucleotide identity with the sequences of a pea nucleotide triphosphatase (Hsieh, H.-L., et al., </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol. </PDAT></ITALIC></HIL><PDAT>30:135 (1996), GenBank Accession No. Z32743) and an apyrase isolated from potato tubers (Handa, M., et al., </PDAT><HIL><ITALIC><PDAT>Biochem. Biophys. Res. Comm. </PDAT></ITALIC></HIL><PDAT>218:916 (1996)). Thus, the pea triphosphatase gene could also be used in the methods of the invention. Considerably less, but significant, similarity was found with the sequences of several other animal and yeast phosphohydrolases. Of particular interest in this comparison was the presence in all of these sequences of four motifs (designated by the boxes in SEQ ID NO: 2) identified as conserved regions among a variety of plant and animal apyrases (Handa, M., et al., </PDAT><HIL><ITALIC><PDAT>Biochem. Biophys. Res. Comm. </PDAT></ITALIC></HIL><PDAT>218:916 (1996)).</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>The sequence similarities found between NBP46 and the above enzymes prompted the testing of NBP46 for phosphohydrolase activity. The reactions were conducted in 300 &mgr;L of 60 mM MOPS, pH 6.8, containing 1 mM MgCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>in a microtiter plate using a multichannel pipette. At various time points up to 4 minutes, 30 or 60 &mgr;L aliquots were removed and assayed for inorganic phosphate by a photometric microtiter assay (Drueckes, P., et al., </PDAT><HIL><ITALIC><PDAT>Anal. Biochem. </PDAT></ITALIC></HIL><PDAT>230:173 (1995)). Conditions were chosen so that less than 10% of the total substrate was converted to product, and the initial velocity (v) was determined from the above rate measurements. The K</PDAT><HIL><SB><PDAT>m </PDAT></SB></HIL><PDAT>of NBP46 for Mg-ADP was found to be 615 &mgr;M.</PDAT></PTEXT></PARA>
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>NBP46 catalyzed the hydrolysis of phosphate from both ATP and ADP (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>) but showed no activity with AMP, pyrophosphate or glucose-6-phosphate. It also had a broad specificity for nucleotide triphosphates, including GTP, CTP and UTP. This substrate specificity has been found to be characteristic of the apyrase category of phosphohydrolases (EC 3.6.1.5). Preincubation of NBP46 with 10 &mgr;g/mL of HBG A&plus;H (which results in 46% inhibition of carbohydrate binding activity) resulted in an increase in the V</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>of NBP46. No increase in phosphatase activity was observed upon preincubation of NBP46 with human blood group H substance at a concentration that shows no inhibition in the carbohydrate binding assay described above (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>). The V</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>of NBP46 was also increased in the presence of low concentrations (1 to 5 micromolar) of Nod factors, with lower concentrations required for the Nod factors produced by rhizobia that nodulate the plant than for the </PDAT><HIL><ITALIC><PDAT>R. meliloti </PDAT></ITALIC></HIL><PDAT>Nod factor. These results suggest that there is interaction between the carbohydrate binding and phosphatase sites of NBP46.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="7"><PTEXT><PDAT>Isolation and Characterization of NBP46 cDNA and Encoded Protein</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>Two consensus N-glycosylation sites are present in the sequence of the mature protein at residues 111 and 276. Work in progress in our laboratory has established that NBP46 is indeed glycosylated at at least one of these sites. It should be noted, however, that we do not yet know whether other posttranslational modifications of this protein may occur, such as the COOH-terminal proteolysis that modifies two other lectins from this plant (Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>33:9778-9783 (1994); Schnell, D. T. et al. </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>310:229-235 (1994)). A search of protein and nucleotide data bases using the NCB1 TBLASTN and BLASTN programs (Altschul, S. F. et al. </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol </PDAT></ITALIC></HIL><PDAT>215:403-410 (1990)) showed no significant similarities of NBP46 to the amino acid or cDNA sequences of any other plant or animal lectin yet described. It did, however, show 65.6 and 47.6% amino acid identity and 70.7 and 58.7% nucleotide identity with the sequences of a pea nucleotide triphosphatase (Hsieh, H-L. et al. </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol. </PDAT></ITALIC></HIL><PDAT>30:135-147 (1996)) and an apyrase isolated from potato tubers (Handa, M. and Guidotti, </PDAT><HIL><ITALIC><PDAT>G. Biochem. Biphys. Res. Comm. </PDAT></ITALIC></HIL><PDAT>218: 916-923 (1996)), respectively. Considerably less, but significant, similarity was also found with the sequences of several other animal and yeast phosphohydrolases. Of particular interest in this comparison is the presence in all of these sequences of four motifs (designated by the boxes in SEQ ID NO: 2) identified as conserved regions among a variety of plant and animal apyrases (Handa, M. and Guidotti, </PDAT><HIL><ITALIC><PDAT>G. Biochem. Biphys. Res. Comm. </PDAT></ITALIC></HIL><PDAT>218: 916-923 (1996)).</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>The sequence similarities found among NBP46 and the above enzymes prompted us to test NBP46 for phosphohydrolase activity. NBP46 catalyzes the hydrolysis of phosphate from both ATP and ADP but showed no activity with AMP, pyrophosphate or glucose-6-phosphate. The K</PDAT><HIL><SB><PDAT>m </PDAT></SB></HIL><PDAT>of NBP46 for Mg</PDAT><HIL><SP><PDAT>&plus;&plus;</PDAT></SP></HIL><PDAT>-ADP is 615 &mgr;M. The lectin has a broad specificity for nucleotide triphosphates, including GTP, CTP and UTP (data not shown). This substrate specificity is characteristic of the apyrase category of phosphohydrolases (EC 3.6.1.5). Preincubation of NBP46 with ligands that are recognized by its carbohydrate binding site results in an increase in the V</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>of this enzyme. Low micromolar concentrations of the above Nod factors stimulate this increase in activity, with lower concentrations required for the Nod factors produced by rhizobia that modulate the plant than for the </PDAT><HIL><ITALIC><PDAT>R. meliloti </PDAT></ITALIC></HIL><PDAT>Nod factor (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>). Such an increase in enzyme activity is also obtained with low millimolar concentrations of the chitin oligosaccharides and N-acetylglucosamine, but not with N-acetylgalactosamine (data not shown). These results suggest that there is interaction between the carbohydrate binding and phosphatase sites of NBP46. Whether this interaction represents a direct stimulation of the enzyme activity or perhaps a stabilization of the enzyme under the assay conditions remains to be determined.</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="7"><PTEXT><PDAT>NBP46 Binds to Chitin and Other Carbohydrates</PDAT></PTEXT></PARA>
<PARA ID="P-00113" LVL="0"><PTEXT><PDAT>NBP46 also binds to chitin, a polymer of &bgr;(1-4) linked N-acetyl-D-glucone residues; this binding is saturable with a B</PDAT><HIL><SB><PDAT>max </PDAT></SB></HIL><PDAT>of 28 nmoles of NBP46/gram of chitin and a K</PDAT><HIL><SB><PDAT>d </PDAT></SB></HIL><PDAT>of 48 nM. Using chitin as a solid phase, a competitive binding assay was utilized to examine the carbohydrate specificity of this protein (FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>). Inhibition of binding was obtained with high concentrations of N-acetyl-D-glocosamine but not with similar concentrations of N-acetyl-D-galactosamine, the C4 epimer of this sugar, nor with other common monosaccharides. The chitin disaccharide gave approximately ten-fold better inhibition than the monosaccharide, whereas the chitin penta- and hexasaccharides were slightly better inhibitors than the disaccharide. No inhibition was obtained with the de-N-acetylated chitin oligosaccharides; however, when tested in the millimolar range of concentrations, several of these oligosaccharides precipitated the lectin even under highly buffered conditions. Whether this precipitation is specific or nonspecific is under investigation.</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>Of all the oligosaccharides tested, the best inhibition was obtained with the Nod factor isolated from </PDAT><HIL><ITALIC><PDAT>Bradyrhizobium japonicum </PDAT></ITALIC></HIL><PDAT>USDA110 (FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>), a rhizobial strain that nodulates </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus. </PDAT></ITALIC></HIL><PDAT>The chitolipo-saccharidic Nod factors have been identified as the signals produced by rhizobia that initiate the nodulation of legumes (Denarie, I. et al </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Biochem. </PDAT></ITALIC></HIL><PDAT>65:503-535 (1996)). The </PDAT><HIL><ITALIC><PDAT>B. japonicum </PDAT></ITALIC></HIL><PDAT>USDA110 Nod factor consists of a chitin pentasaccharide backbone, modified by a 2-O-methyl &agr;-L-fucose on C-6 of the sugar at the reducing end and the substitution of the acetyl group on the sugar at the nonreducing end with cis-vaccenic acid (Sanjuan, J. et al. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA, </PDAT></ITALIC></HIL><PDAT>89:8789-8793 (1992); Carlson, R. W. et al. </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem. </PDAT></ITALIC></HIL><HIL><BOLD><PDAT>268:18372-18-81 </PDAT></BOLD></HIL><PDAT>(1993)). The higher relative affinity of NBP46 for the intact Nod factor than for the chitin pentasaccharide backbone alone indicates that the modifications of this backbone contribute to the recognition of the Nod factor by the lectin. No significant inhibition of NBP46 binding to chitin was obtained with cis-vaccenic acid when tested at concentrations up to 1.2 mM nor with L-fucose at concentrations up to 50 mM.</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="0"><PTEXT><PDAT>Two Nod factors from Rhizobium sp. NGR234, another strain that nodulates </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus, </PDAT></ITALIC></HIL><PDAT>were also able to inhibit the binding of NBP46 to chitin. These Nod factors differ from the USDA110 10 Nod factor in that they have a sulfate on C-3 (NodNGR</PDAT><HIL><SB><PDAT>A</PDAT></SB></HIL><PDAT>) or an acetate on C-4 (NodNGR</PDAT><HIL><SB><PDAT>B</PDAT></SB></HIL><PDAT>) of the 2-O-methylfucose; they are also methylated on the amino group and partially carbamoylated at C-3, C-4 or C-6 of the sugar at the nonreducing end (Price, N. P. J. et al. </PDAT><HIL><ITALIC><PDAT>Carbohyd. Res. </PDAT></ITALIC></HIL><PDAT>289:115-136 (1993)). The Nod factor from </PDAT><HIL><ITALIC><PDAT>Rhizobium meliloti, </PDAT></ITALIC></HIL><PDAT>a strain that does not modulate Dolichos biflorus, gave the weakest inhibition when tested at equivalent concentrations (FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>). This Nod factor differs from the USDA110 Nod factor in that it has a chitin tetrasaccharide backbone, contains a sulfate instead of a fucose at the reducing end and is acetylated at C-6 of the sugar at the nonreducing end (Lerouge, P. </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>344:781-784 (1990)).</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>Although the differences in relative affinity of NBP46 for the above Nod factors indicate a small preference of the lectin for Nod factors produced by rhizobia that modulate the plant, it must be pointed out that both the </PDAT><HIL><ITALIC><PDAT>B. japonicum </PDAT></ITALIC></HIL><PDAT>USDA110 and R. sp. NGR234 strains are only weak nodulators of </PDAT><HIL><ITALIC><PDAT>Dolichos fiblorus, </PDAT></ITALIC></HIL><PDAT>and the nodules formed with the former strain do not fix nitrogen. Nod factors from rhizobial strains that are strong nodulators of this plant have not yet been purified or characterized.</PDAT></PTEXT></PARA>
<PARA ID="P-00117" LVL="7"><PTEXT><PDAT>Antiserum Raised Against NBP46 Inhibits Nodulation</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="0"><PTEXT><PDAT>Confocal immunofluorescence microscopy of whole mounts of 7-day old </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>roots that had been fixed prior to staining showed that NBP46 is present on the surfaces of the newly emerging and young root hairs. Treatment of young roots of this plant with antiserum to the lectin inhibited the ability of these roots to be nodulated by rhizobia (Table 1). Although it is possible that such inhibition could be due to stearic hindrance of adjacent sites, these results, coupled with the above finding that NBP46 is a Nod factor binding protein, suggest that this root lectin may play a role in rhizobium-legume symbiosis either as a host/strain specific receptor or perhaps as a second, less stringent receptor postulated for this process (Ardourel, M. et al. </PDAT><HIL><ITALIC><PDAT>Plant Cell </PDAT></ITALIC></HIL><PDAT>6:1357-1374 (1994)). Previous attempts to implicate lectins in this symbiosis have been focused on the legume seed lectins (Diaz, C. L. et al. </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>338:579-581 (1989); Hirsch, A. M. et al. </PDAT><HIL><ITALIC><PDAT>Symbiosis </PDAT></ITALIC></HIL><PDAT>19:155-173 (1995)), which have not been reported to bind Nod factors. It is also possible that NBP46 may function in the recognition of endogenous Nod-factor like signals that have been proposed to play a role in the regulation of plant growth and organogenesis (Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>33:9778-9783 (1994)).</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE 1</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Effect of anti-NBP46-serum</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>on nodulation of </PDAT><HIL><ITALIC><PDAT>D. biflorus </PDAT></ITALIC></HIL><PDAT>roots</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="offset" colwidth="84pt" align="left"/>
<colspec colname="1" colwidth="133pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>Average number of nodules (&plusmn; S.E.)</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="84pt" align="left"/>
<colspec colname="2" colwidth="49pt" align="center"/>
<colspec colname="3" colwidth="84pt" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>Treated region</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Region of root emerged</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Treatment</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>of root</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>after treatment</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Untreated</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3.6 &plusmn; 0.5</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>2.2 &plusmn; 0.2</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Preimmunization serum</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3.4 &plusmn; 0.5</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.6 &plusmn; 0.2</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Anti-NBP46-serum</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>0.6 &plusmn; 0.2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>1.4 &plusmn; 0.2</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00119" LVL="7"><PTEXT><PDAT>The roots of 2 sets of 10 3-day old </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>plants were immersed for 1 hour in {fraction (1/100)} dilutions of preimmunization serum or anti-NBP46-serum, washed and transferred to growth pouches. A third set of 10 pts was put directly in growth pouches. Half of each set of plants was inoculated with Bradyrhizobium sp. 24A10. After 3 weeks the number of nodules in the treated region as well as in the region of root that emerged after treatment were recorded. No nodules were observed on the roots that had not been inoculated with rhizobia.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>DISCUSSION</PDAT></STEXT></H>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>The low concentrations (10</PDAT><HIL><SP><PDAT>&minus;12 </PDAT></SP></HIL><PDAT>of Nod factor that have been found to induce physiological responses in legumes (Denarie, I. et al </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Biochem. </PDAT></ITALIC></HIL><PDAT>65:503-535 (1996)) predict that Nod factor receptors have high affinity for their ligands. Indeed, high affinity binding sites for Nod factors have been found on particulate fractions from roots of the legume, </PDAT><HIL><ITALIC><PDAT>Medicago truncatula </PDAT></ITALIC></HIL><PDAT>(Niebel, A. </PDAT><HIL><ITALIC><PDAT>Mol. Plant</PDAT></ITALIC></HIL><PDAT>-</PDAT><HIL><ITALIC><PDAT>Microbe Interact. </PDAT></ITALIC></HIL><PDAT>10:132-134 (1997)). Although the inhibition data show the relative affinities of NBP46 for its ligands, they do not enable the determination of the absolute affinities of this lectin for the Nod factors. The concentrations of Nod factors required for the stimulation of increased phosphatase activity suggest that the K</PDAT><HIL><SB><PDAT>d&apos;s </PDAT></SB></HIL><PDAT>may be in the high nanomolar to low micromolar range. It should be noted, however, that NBP46 is primarily a monomer in solution (Quinn, J. M. and Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>258:535-544 (1987)); as established with antibodies (Hornick, C. L. and Karush, F. </PDAT><HIL><ITALIC><PDAT>Immunochem. </PDAT></ITALIC></HIL><PDAT>9:325-340 (1972)), the multivalence that would occur when this lectin is associated with the cell surface would increase its apparent affinity for multivalent ligands such as Nod factor micelles or Nod factor on the surface of rhizobia by several orders of magnitude.</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>The presence of both carbohydrate binding activity and apyrase activity on NBP46 and the apparent interaction of these sites suggest that, upon binding its carbohydrate ligand, NBP46 may play a role in activating downstream events either directly by signal transduction or indirectly, perhaps by serving as a motor for transport of the carbohydrate. In this context, it is of interest that the human CD39 lymphoid cell activation antigen, one of the apyrases found to have some sequence similarity to NBP46, is thought to be involved in the regulation of B cell adhesion (Kansas, G. S. et al. </PDAT><HIL><ITALIC><PDAT>J. Immunol. </PDAT></ITALIC></HIL><PDAT>146:2235-2244 (1991)). Although these other apyrases have not been tested for lectin activity, it is possible that such dual activities of these proteins may have been conserved throughout evolution.</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>The unique amino acid sequence, carbohydrate specificity and apyrase activity of NBP46 distinguish this lectin from the conventional lectins found in abundance in the seeds of legumes (Sharon, N. and Lis, H. </PDAT><HIL><ITALIC><PDAT>FASEB J. </PDAT></ITALIC></HIL><PDAT>4:3198-3208 (1990)). The possibility that other such plant lectin/enzymes exist is suggested by the recent finding of a CDNA from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>that encodes a receptor-like serine/threonine kinase as well as a legume seed lectin-like domain (Herve, C. et al. </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol </PDAT></ITALIC></HIL><PDAT>258:778-788 (1996)). NBP46 may thus be on one of many multifunctional carbohydrate binding proteins that may function in plant oligosaccharide signaling events. A variety of transgenic experiments are underway to elaborate its role in such processes.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>METHODS</PDAT></STEXT></H>
<PARA ID="P-00123" LVL="7"><PTEXT><PDAT>Preparation of NBP46.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="0"><PTEXT><PDAT>NBP46 was extracted from the roots of 7-day old </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>plants and isolated by affinity chromatography on hog blood group A&plus;H&minus;Sepharose as previously described (Quinn, J. M. and Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Arch. Biochem. Biophys. </PDAT></ITALIC></HIL><PDAT>258:535-544 (1987)), followed by ion exchange chromatography. It was iodinated using the iodine monochloride procedure as previously described (Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Glycoconj. J. </PDAT></ITALIC></HIL><PDAT>11:395-399 (1994)), which gave a specific activity of approximately 500&times;10</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>cpm/mg protein.</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="7"><PTEXT><PDAT>Carbohydrate binding assays.</PDAT></PTEXT></PARA>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>Solid phase binding assays were conducted using iodinated NBP46 and purified shrimp chitin powder (Sigma Chemical Company, St. Louis, Mo.), which was N-acetylated prior to use with 15 mM acetic anhydride in 0.5 M NaHCO</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>for one hour at room temperature. The assays were conducted in a final volume of 100 &mgr;l of 10 mM MOPS buffer, pH 7.2, containing 0.02% Tween-20 and 0.01% NaN</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. After incubation at room temperature for two hours, binding was measured as previously described (Etzler, M. E. </PDAT><HIL><ITALIC><PDAT>Glycoconj. J. </PDAT></ITALIC></HIL><PDAT>11:395-399 (1994)).</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="0"><PTEXT><HIL><ITALIC><PDAT>Bradyrhizobium japonicum </PDAT></ITALIC></HIL><PDAT>USDA110 Nod factor was isolated as previously described (Sanjuan, J. et al. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA, </PDAT></ITALIC></HIL><PDAT>89:8789-8793 (1992)). The Nod factors from </PDAT><HIL><ITALIC><PDAT>Rhizobium meliloti </PDAT></ITALIC></HIL><PDAT>and Rhizobium sp. NGR234 were graciously provided by Dr. Jean Denarie, CNRS-INRA, Toulouse, France. Monosaccharides and the chitin disaccharide were purchased from Sigma Chemical Co., St. Louis, Mo., the other chitin oligosaccharides were obtained from Seikagaku Corp., Tokyo, Japan.</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="7"><PTEXT><PDAT>Cloning of NBP46 cDNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>Total RNA was isolated (Taylor, B. and Powell, A. </PDAT><HIL><ITALIC><PDAT>Focus </PDAT></ITALIC></HIL><PDAT>4:4-6 (1982)) from the roots of 1-day-old </PDAT><HIL><ITALIC><PDAT>D. biflorus </PDAT></ITALIC></HIL><PDAT>plants and reverse transcribed using M-NMV reverse transcriptase and random hexanucleotide primers (Tabor S. RNA-dependent DNA polymerases. In </PDAT><HIL><ITALIC><PDAT>Current Protocols in Molecular Biology, </PDAT></ITALIC></HIL><PDAT>F. M. Ausubel, F. M., et al., Eds., John Wiley &amp; Sons, Inc., Vol. 1, pp. 3.7.1-3.7.3 (1987)). This cDNA was used as a template in a PCR reaction employing Taq polymerase and degenerate sense and antisense primers corresponding to amino acids 6-12 and 244-249 in SEQ ID NO:2. The PCR was performed in an automated thermal cycler for 35 cycles of 94&deg; C. for 2 min, 37&deg; C. for 2 min, and 72&deg; C. for 2 min. The predominant 727 bp fragment was isolated on a 1.2% agarose gel, cloned into the pCRII vector (InVitrogen) and sequenced (Sanger, F. et al. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>74:5463-5467 (1977)). Gene specific primers were used in 5&prime; and 3&prime; RACE reactions (Frohman, M. A. </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci USA </PDAT></ITALIC></HIL><PDAT>85:8998-9002 (1988)); the products were cloned into the pCRII vector and sequenced. The full length (1527 bp) cDNA was assembled by ligating the two RACE products together using an int Sac1 site. The sequences of the overlapping regions of the 5&prime; and 3&prime; RACE products and the original PCR fragment were identical.</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="7"><PTEXT><PDAT>Phosphatase assays.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>N-BP46 (201 ng/ml) was incubated at 25&deg; C. in the presence of various concentrations of substrate in a final volume of 100 &mgr;l of 60 mM MOPS, pH 6.8, containing 1 mM MgCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. The reactions were conducted in a microtiter plate using a multichannel pipette. At various time points, 30 &mgr;l aliquots were removed and assayed for inorganic phosphate by a photometric microtiter assay (Drueckes, P. et al. </PDAT><HIL><ITALIC><PDAT>Anal. Biochem. </PDAT></ITALIC></HIL><PDAT>230:173 (1995)), modified by using four parts ammonium molybdate reagent to one part 10% ascorbate for the reagent mixture. Conditions were chosen so that less than 10% of the total substrate was converted to product.</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="7"><PTEXT><PDAT>Immunofluorescence microscopy.</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>Roots from 7-day old </PDAT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>plants were fixed for 45 minutes at 4&deg; C. in 0.01 M phosphate buffer, pH 7.2, containing 0, 15 M NaCl and 0.3% paraformaldehyde. After washing, the roots were treated for 20 minutes with a {fraction (1/250)} dilution of preimmunization serum or antiserum prepared against recombinant NBP46. After washing, the roots were treated for 20 minutes with fluorescein-labeled goat anti-rabbit IgG (Sigma Chemical Co., St. Louis, Mo.), washed and examined with a Leica TCS NT confocal microscope using a 488 nm laser excitation line and a 560 barrier filter. Confocal images were reconstructed with Imagespace software.</PDAT></PTEXT></PARA>
<PARA ID="P-00134" LVL="7"><PTEXT><PDAT>Nodulation.</PDAT></PTEXT></PARA>
<PARA ID="P-00135" LVL="0"><PTEXT><HIL><ITALIC><PDAT>Dolichos biflorus </PDAT></ITALIC></HIL><PDAT>seeds were sterilized by shaking for 15 minutes in 70% ethanol, followed by 15 minutes in 3% hydrogen peroxide. After extensive washing with sterile H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, the seeds were germinated and grown in sterile growth pouches. At 3 days, the roots were inoculated with 100 &mgr;l of B. sp. 24A10 (1&times;10</PDAT><HIL><SP><PDAT>7 </PDAT></SP></HIL><PDAT>cells/ml). The number of nodules per root was determined after 3 weeks. Antiserum and preimmunization serum used to treat the roots were sterilized by filtration through a 0.45 &mgr;m filter.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 2</PDAT></STEXT></H>
<PARA ID="P-00136" LVL="7"><PTEXT><PDAT>Isolation of NBP46 from Other Species</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>NBP46 nucleic acids have also been isolated from </PDAT><HIL><ITALIC><PDAT>Medicago sativa </PDAT></ITALIC></HIL><PDAT>(SEQ ID NO:8 and 9-12) and </PDAT><HIL><ITALIC><PDAT>Lotus japonicus </PDAT></ITALIC></HIL><PDAT>(SEQ ID NO:13 and 14-17). These nucleic acids were obtained by RT-PCR as follows. Messenger RNA was obtained form the roots of both species and reverse transcribed using oligo-dT primers. Degenerate PCR primers were designed to conserved sequences of the </PDAT><HIL><ITALIC><PDAT>D. biflorus </PDAT></ITALIC></HIL><PDAT>NBP46 disclosed here and the </PDAT><HIL><ITALIC><PDAT>Pisum sativa </PDAT></ITALIC></HIL><PDAT>nucleotide triphosphatase gene described by Hsieh, H.-L., et at., </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol. </PDAT></ITALIC></HIL><PDAT>30:135(1996). These were used to generate internal 850 bp fragments from both </PDAT><HIL><ITALIC><PDAT>Medicago sativa </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><ITALIC><PDAT>Lotus japonicus. </PDAT></ITALIC></HIL><PDAT>cDNA species-specific primers then designed for both 5&prime; and 3&prime; RACE. Full length clones were obtained using primers designed to the 5&prime; and 3&prime; ends of the RACE products. Duplicate clones from each species were obtained in separate PCR reactions and sequenced in their entirety in both directions.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 3</PDAT></STEXT></H>
<PARA ID="P-00138" LVL="7"><PTEXT><PDAT>Isolation of DBX from </PDAT><HIL><ITALIC><PDAT>D. biflorus </PDAT></ITALIC></HIL></PTEXT></PARA>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>A second gene also involved in oligosaccharide signaling has been isolated from </PDAT><HIL><ITALIC><PDAT>D. Biflorus </PDAT></ITALIC></HIL><PDAT>(SEQ ID NO:18 and 19).</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference for all purposes.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00002">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0" pgwide="1" tabstyle="monospace">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="441pt" align="left"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;SEQUENCE&emsp;LISTING </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;160&gt;&emsp;NUMBER&emsp;OF&emsp;SEQ&emsp;ID&emsp;NOS:&emsp;19 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;1643 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Dolichos&emsp;biflorus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;CDS </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(51)..(1439) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;NBP46&emsp;(DB46)&emsp;Nod&emsp;factor&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#binding&emsp;lectin </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;mat_peptide </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(195)..(1436) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaaactgaaa&emsp;cgagtactct&emsp;ttcagtggtg&emsp;aggttctgag&emsp;agattcagaa&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;aat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;56 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;Met&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgg&emsp;gtg&emsp;tgg&emsp;cca&emsp;aag&emsp;aca&emsp;aag&emsp;agc&emsp;atg&emsp;agc&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;cta&emsp;ctc&emsp;ctc&emsp;atc&emsp;act&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;104 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Trp&emsp;Val&emsp;Trp&emsp;Pro&emsp;Lys&emsp;Thr&emsp;Lys&emsp;Ser&emsp;Met&emsp;Ser&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Leu&emsp;Leu&emsp;Leu&emsp;Ile&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;-45&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;-40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;-35 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttt&emsp;cta&emsp;ctc&emsp;ttc&emsp;tca&emsp;ttg&emsp;cca&emsp;aaa&emsp;ctt&emsp;tct&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;tcg&emsp;caa&emsp;tat&emsp;gtt&emsp;ggg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;152 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Phe&emsp;Leu&emsp;Leu&emsp;Phe&emsp;Ser&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Leu&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ser&emsp;Gln&emsp;Tyr&emsp;Val&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>-30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;- </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#25&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;- </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;- </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aac&emsp;agt&emsp;atc&emsp;tta&emsp;cta&emsp;aat&emsp;cat&emsp;cgt&emsp;aag&emsp;ata&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ccc&emsp;aac&emsp;cag&emsp;gaa&emsp;ctc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Ser&emsp;Ile&emsp;Leu&emsp;Leu&emsp;Asn&emsp;His&emsp;Arg&emsp;Lys&emsp;Ile&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Pro&emsp;Asn&emsp;Gln&emsp;Glu&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;-10&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;-5&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;-1&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctt&emsp;acc&emsp;tct&emsp;tac&emsp;gct&emsp;gtc&emsp;atc&emsp;ttt&emsp;gat&emsp;gct&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;agc&emsp;tct&emsp;ggg&emsp;agt&emsp;cgt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;248 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Thr&emsp;Ser&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ile&emsp;Phe&emsp;Asp&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Ser&emsp;Ser&emsp;Gly&emsp;Ser&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtc&emsp;cat&emsp;gtc&emsp;ttc&emsp;aat&emsp;ttt&emsp;gac&emsp;cag&emsp;aac&emsp;tta&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ctc&emsp;ctg&emsp;cac&emsp;att&emsp;ggc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;296 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;His&emsp;Val&emsp;Phe&emsp;Asn&emsp;Phe&emsp;Asp&emsp;Gln&emsp;Asn&emsp;Leu&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Leu&emsp;Leu&emsp;His&emsp;Ile&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aat&emsp;gac&emsp;ctc&emsp;gag&emsp;ttt&emsp;aca&emsp;aaa&emsp;aag&emsp;atc&emsp;aaa&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;ggt&emsp;ttg&emsp;agc&emsp;tca&emsp;tac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;344 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Asp&emsp;Leu&emsp;Glu&emsp;Phe&emsp;Thr&emsp;Lys&emsp;Lys&emsp;Ile&emsp;Lys&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Gly&emsp;Leu&emsp;Ser&emsp;Ser&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;45&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;50 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gct&emsp;gat&emsp;aag&emsp;cct&emsp;gaa&emsp;aaa&emsp;gct&emsp;gca&emsp;gaa&emsp;tct&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;att&emsp;cca&emsp;ctt&emsp;ttg&emsp;gag&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;392 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Asp&emsp;Lys&emsp;Pro&emsp;Glu&emsp;Lys&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Ser&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ile&emsp;Pro&emsp;Leu&emsp;Leu&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;60&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;65 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;gct&emsp;gaa&emsp;gat&emsp;gtt&emsp;gtc&emsp;cct&emsp;gag&emsp;gaa&emsp;ctg&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;ccc&emsp;aag&emsp;aca&emsp;ccc&emsp;ctt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Ala&emsp;Glu&emsp;Asp&emsp;Val&emsp;Val&emsp;Pro&emsp;Glu&emsp;Glu&emsp;Leu&emsp;Hi </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Pro&emsp;Lys&emsp;Thr&emsp;Pro&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aag&emsp;ctt&emsp;ggg&emsp;gca&emsp;aca&emsp;gca&emsp;ggt&emsp;ttg&emsp;agg&emsp;ctc&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gat&emsp;ggg&emsp;gat&emsp;gct&emsp;gct&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;488 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Leu&emsp;Gly&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Gly&emsp;Leu&emsp;Arg&emsp;Leu&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Asp&emsp;Gly&emsp;Asp&emsp;Ala&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;aag&emsp;ata&emsp;ttg&emsp;caa&emsp;gcg&emsp;gtt&emsp;agg&emsp;gaa&emsp;atg&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;agg&emsp;aac&emsp;aga&emsp;agt&emsp;tcc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;536 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Lys&emsp;Ile&emsp;Leu&emsp;Gln&emsp;Ala&emsp;Val&emsp;Arg&emsp;Glu&emsp;Met&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Arg&emsp;Asn&emsp;Arg&emsp;Ser&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctg&emsp;agc&emsp;gtt&emsp;caa&emsp;cct&emsp;gat&emsp;gca&emsp;gta&emsp;tct&emsp;gtt&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gat&emsp;gga&emsp;acc&emsp;caa&emsp;gaa&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;584 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Ser&emsp;Val&emsp;Gln&emsp;Pro&emsp;Asp&emsp;Ala&emsp;Val&emsp;Ser&emsp;Val&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Asp&emsp;Gly&emsp;Thr&emsp;Gln&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#25&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggt&emsp;tct&emsp;tac&emsp;tta&emsp;tgg&emsp;gtt&emsp;aca&emsp;gtt&emsp;aac&emsp;tat&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;tta&emsp;gga&emsp;aag&emsp;ttg&emsp;gga&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;632 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Trp&emsp;Val&emsp;Thr&emsp;Val&emsp;Asn&emsp;Tyr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Leu&emsp;Gly&emsp;Lys&emsp;Leu&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;135&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;140&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;145 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aag&emsp;aag&emsp;ttt&emsp;aca&emsp;aaa&emsp;act&emsp;gtg&emsp;gga&emsp;gtg&emsp;ata&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ctt&emsp;gga&emsp;ggt&emsp;gct&emsp;tca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;680 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Lys&emsp;Phe&emsp;Thr&emsp;Lys&emsp;Thr&emsp;Val&emsp;Gly&emsp;Val&emsp;Ile&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Leu&emsp;Gly&emsp;Gly&emsp;Ala&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;150&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;155&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;160 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtt&emsp;caa&emsp;atg&emsp;gct&emsp;tat&emsp;gct&emsp;gtc&emsp;tca&emsp;aga&emsp;aat&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;gct&emsp;aaa&emsp;aat&emsp;gcc&emsp;cca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;728 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Gln&emsp;Met&emsp;Ala&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ser&emsp;Arg&emsp;Asn&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Lys&emsp;Asn&emsp;Ala&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aaa&emsp;cca&emsp;cca&emsp;caa&emsp;gga&emsp;gag&emsp;gat&emsp;cca&emsp;tac&emsp;atg&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;aag&emsp;ctt&emsp;gta&emsp;ctc&emsp;aag&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;776 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Pro&emsp;Pro&emsp;Gln&emsp;Gly&emsp;Glu&emsp;Asp&emsp;Pro&emsp;Tyr&emsp;Met&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Lys&emsp;Leu&emsp;Val&emsp;Leu&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gga&emsp;aag&emsp;aaa&emsp;tat&emsp;gac&emsp;ctt&emsp;tat&emsp;gtt&emsp;cac&emsp;agt&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;ttg&emsp;cgt&emsp;tat&emsp;ggt&emsp;aac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;824 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Lys&emsp;Lys&emsp;Tyr&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Val&emsp;His&emsp;Ser&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Arg&emsp;Tyr&emsp;Gly&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#05&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gac&emsp;gca&emsp;gca&emsp;cgt&emsp;gtt&emsp;aag&emsp;att&emsp;ttt&emsp;aag&emsp;acc&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gat&emsp;ggt&emsp;gct&emsp;gct&emsp;agt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;872 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Ala&emsp;Ala&emsp;Arg&emsp;Val&emsp;Lys&emsp;Ile&emsp;Phe&emsp;Lys&emsp;Thr&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Asp&emsp;Gly&emsp;Ala&emsp;Ala&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;215&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;220&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;225 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cct&emsp;tgt&emsp;cta&emsp;ttg&emsp;gca&emsp;ggc&emsp;tat&emsp;gaa&emsp;gat&emsp;ata&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;aga&emsp;tat&emsp;tcc&emsp;gga&emsp;gaa&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;920 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Cys&emsp;Leu&emsp;Leu&emsp;Ala&emsp;Gly&emsp;Tyr&emsp;Glu&emsp;Asp&emsp;Ile&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Arg&emsp;Tyr&emsp;Ser&emsp;Gly&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;230&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;235&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcg&emsp;tac&emsp;aat&emsp;atc&emsp;tat&emsp;ggt&emsp;ccc&emsp;act&emsp;tct&emsp;ggt&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;aac&emsp;ttt&emsp;aat&emsp;gag&emsp;tgc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;968 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Tyr&emsp;Asn&emsp;Ile&emsp;Tyr&emsp;Gly&emsp;Pro&emsp;Thr&emsp;Ser&emsp;Gly&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Asn&emsp;Phe&emsp;Asn&emsp;Glu&emsp;Cys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cgt&emsp;gac&emsp;cta&emsp;gct&emsp;ctt&emsp;cag&emsp;att&emsp;ctc&emsp;aga&emsp;ttg&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gag&emsp;cca&emsp;tgt&emsp;tcc&emsp;cat&emsp;&emsp;&emsp;&emsp;&emsp;1016 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Asp&emsp;Leu&emsp;Ala&emsp;Leu&emsp;Gln&emsp;Ile&emsp;Leu&emsp;Arg&emsp;Leu&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Glu&emsp;Pro&emsp;Cys&emsp;Ser&emsp;His </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;aac&emsp;tgc&emsp;acc&emsp;ttt&emsp;ggt&emsp;ggg&emsp;ata&emsp;tgg&emsp;gat&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gga&emsp;aaa&emsp;gga&emsp;agt&emsp;gga&emsp;&emsp;&emsp;&emsp;&emsp;1064 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Asn&emsp;Cys&emsp;Thr&emsp;Phe&emsp;Gly&emsp;Gly&emsp;Ile&emsp;Trp&emsp;Asp&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Gly&emsp;Lys&emsp;Gly&emsp;Ser&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#80&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#85&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cag&emsp;aaa&emsp;aac&emsp;ctt&emsp;gtt&emsp;gtt&emsp;act&emsp;tca&emsp;gct&emsp;ttc&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;tat&emsp;agg&emsp;tct&emsp;tct&emsp;gag&emsp;&emsp;&emsp;&emsp;&emsp;1112 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Lys&emsp;Asn&emsp;Leu&emsp;Val&emsp;Val&emsp;Thr&emsp;Ser&emsp;Ala&emsp;Phe&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Tyr&emsp;Arg&emsp;Ser&emsp;Ser&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;295&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;300&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;305 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtt&emsp;ggt&emsp;ttt&emsp;gtc&emsp;act&emsp;cct&emsp;ccc&emsp;aat&emsp;tcc&emsp;aaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cgc&emsp;cct&emsp;ctg&emsp;gat&emsp;ttt&emsp;&emsp;&emsp;&emsp;&emsp;1160 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Gly&emsp;Phe&emsp;Val&emsp;Thr&emsp;Pro&emsp;Pro&emsp;Asn&emsp;Ser&emsp;Lys&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Arg&emsp;Pro&emsp;Leu&emsp;Asp&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;310&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;315&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;320 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;act&emsp;gca&emsp;gct&emsp;aaa&emsp;caa&emsp;gct&emsp;tgt&emsp;agt&emsp;tta&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ttc&emsp;gag&emsp;gaa&emsp;gcg&emsp;aaa&emsp;&emsp;&emsp;&emsp;&emsp;1208 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Thr&emsp;Ala&emsp;Ala&emsp;Lys&emsp;Gln&emsp;Ala&emsp;Cys&emsp;Ser&emsp;Leu&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Phe&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcc&emsp;act&emsp;ttt&emsp;cca&emsp;aat&emsp;gtt&emsp;gag&emsp;aaa&emsp;gat&emsp;aaa&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cca&emsp;ttt&emsp;gta&emsp;tgc&emsp;gtg&emsp;&emsp;&emsp;&emsp;&emsp;1256 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Thr&emsp;Phe&emsp;Pro&emsp;Asn&emsp;Val&emsp;Glu&emsp;Lys&emsp;Asp&emsp;Lys&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Pro&emsp;Phe&emsp;Val&emsp;Cys&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gat&emsp;ttc&emsp;aca&emsp;tac&emsp;cag&emsp;tat&emsp;aca&emsp;ttg&emsp;ctt&emsp;gtt&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gga&emsp;ttt&emsp;ggc&emsp;cta&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;1304 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Phe&emsp;Thr&emsp;Tyr&emsp;Gln&emsp;Tyr&emsp;Thr&emsp;Leu&emsp;Leu&emsp;Val&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Gly&emsp;Phe&emsp;Gly&emsp;Leu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#70 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cca&emsp;gag&emsp;caa&emsp;gag&emsp;att&emsp;aca&emsp;gtg&emsp;gca&emsp;gaa&emsp;gga&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gaa&emsp;tat&emsp;caa&emsp;gat&emsp;gcc&emsp;&emsp;&emsp;&emsp;&emsp;1352 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Glu&emsp;Gln&emsp;Glu&emsp;Ile&emsp;Thr&emsp;Val&emsp;Ala&emsp;Glu&emsp;Gly&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Glu&emsp;Tyr&emsp;Gln&emsp;Asp&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;375&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;380&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;385 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>att&emsp;gtg&emsp;gaa&emsp;aca&emsp;gca&emsp;tgg&emsp;cct&emsp;cta&emsp;gga&emsp;act&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;ata&emsp;gaa&emsp;gcc&emsp;ata&emsp;tca&emsp;&emsp;&emsp;&emsp;&emsp;1400 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Val&emsp;Glu&emsp;Thr&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gly&emsp;Thr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Ile&emsp;Glu&emsp;Ala&emsp;Ile&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;390&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;395&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;400 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tct&emsp;ttg&emsp;cct&emsp;aaa&emsp;ttt&emsp;aat&emsp;cgt&emsp;cta&emsp;atg&emsp;tat&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;atc&emsp;taa&emsp;gccatgtcct&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1449 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Phe&emsp;Asn&emsp;Arg&emsp;Leu&emsp;Met&emsp;Tyr&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ccacttatga&emsp;ccactttaat&emsp;taaaataaaa&emsp;ctcacccttt&emsp;tcactaaaaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaaaaaaa&emsp;&emsp;&emsp;1509 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aaaagtcctt&emsp;ttttattcca&emsp;ttgagtatca&emsp;agtgttaatt&emsp;tgtttctgac&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atggaggt&emsp;&emsp;&emsp;1569 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtaaaagtga&emsp;aacaaagtat&emsp;gtttttgtca&emsp;gatacgaatg&emsp;gaagtagggt&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tgatgaaa&emsp;&emsp;&emsp;1629 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aaaaaaaaaa&emsp;aaaa&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;1643 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;462 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Dolichos&emsp;biflorus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;PEPTIDE </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(52)..(73) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;motif&emsp;identified&emsp;as&emsp;conse </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#rved&emsp;region&emsp;among&emsp;a </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;variety&emsp;of&emsp;plant&emsp;and&emsp;animal&emsp;apyra </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ses </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;PEPTIDE </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(128)..(144) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;motif&emsp;identified&emsp;as&emsp;conse </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#rved&emsp;region&emsp;among&emsp;a </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;variety&emsp;of&emsp;plant&emsp;and&emsp;animal&emsp;apyra </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ses </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;PEPTIDE </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(173)..(195) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;motif&emsp;identified&emsp;as&emsp;conse </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#rved&emsp;region&emsp;among&emsp;a </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;variety&emsp;of&emsp;plant&emsp;and&emsp;animal&emsp;apyra </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ses </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;PEPTIDE </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(200)..(220) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;motif&emsp;identified&emsp;as&emsp;conse </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#rved&emsp;region&emsp;among&emsp;a </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;variety&emsp;of&emsp;plant&emsp;and&emsp;animal&emsp;apyra </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ses </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Met&emsp;Asn&emsp;Trp&emsp;Val&emsp;Trp&emsp;Pro&emsp;Lys&emsp;Thr&emsp;Lys&emsp;Ser&emsp;Me </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;Ser&emsp;Phe&emsp;Leu&emsp;Leu&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Thr&emsp;Phe&emsp;Leu&emsp;Leu&emsp;Phe&emsp;Ser&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ser&emsp;Ser&emsp;Ser&emsp;Gln&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Gly&emsp;Asn&emsp;Ser&emsp;Ile&emsp;Leu&emsp;Leu&emsp;Asn&emsp;His&emsp;Arg&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Ile&emsp;Leu&emsp;Pro&emsp;Asn&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;45 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Leu&emsp;Leu&emsp;Thr&emsp;Ser&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ile&emsp;Phe&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ala&emsp;Gly&emsp;Ser&emsp;Ser&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Arg&emsp;Val&emsp;His&emsp;Val&emsp;Phe&emsp;Asn&emsp;Phe&emsp;Asp&emsp;Gln&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Leu&emsp;His </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Gly&emsp;Asn&emsp;Asp&emsp;Leu&emsp;Glu&emsp;Phe&emsp;Thr&emsp;Lys&emsp;Lys&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Lys&emsp;Pro&emsp;Gly&emsp;Leu&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Tyr&emsp;Ala&emsp;Asp&emsp;Lys&emsp;Pro&emsp;Glu&emsp;Lys&emsp;Ala&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ser&emsp;Leu&emsp;Ile&emsp;Pro&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Glu&emsp;Asp&emsp;Val&emsp;Val&emsp;Pro&emsp;Glu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Leu&emsp;His&emsp;Pro&emsp;Lys&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;120&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;125 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Leu&emsp;Lys&emsp;Leu&emsp;Gly&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Gly&emsp;Leu&emsp;Ar </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;Leu&emsp;Leu&emsp;Asp&emsp;Gly&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;130&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;135&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Ala&emsp;Glu&emsp;Lys&emsp;Ile&emsp;Leu&emsp;Gln&emsp;Ala&emsp;Val&emsp;Arg&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Met&emsp;Phe&emsp;Arg&emsp;Asn&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>145&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Ser&emsp;Leu&emsp;Ser&emsp;Val&emsp;Gln&emsp;Pro&emsp;Asp&emsp;Ala&emsp;Val&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Val&emsp;Ile&emsp;Asp&emsp;Gly&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Glu&emsp;Gly&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Trp&emsp;Val&emsp;Thr&emsp;Val&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Tyr&emsp;Leu&emsp;Leu&emsp;Gly&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gly&emsp;Lys&emsp;Lys&emsp;Phe&emsp;Thr&emsp;Lys&emsp;Thr&emsp;Val&emsp;Gly&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Ile&emsp;Asp&emsp;Leu&emsp;Gly&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;205 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Ser&emsp;Val&emsp;Gln&emsp;Met&emsp;Ala&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ser&emsp;Ar </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;Asn&emsp;Thr&emsp;Ala&emsp;Lys&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;210&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;215&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Pro&emsp;Lys&emsp;Pro&emsp;Pro&emsp;Gln&emsp;Gly&emsp;Glu&emsp;Asp&emsp;Pro&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Met&emsp;Lys&emsp;Lys&emsp;Leu&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>225&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Lys&emsp;Gly&emsp;Lys&emsp;Lys&emsp;Tyr&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Val&emsp;Hi </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Arg&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Asn&emsp;Asp&emsp;Ala&emsp;Ala&emsp;Arg&emsp;Val&emsp;Lys&emsp;Ile&emsp;Phe&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Thr&emsp;Thr&emsp;Asp&emsp;Gly&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Ser&emsp;Pro&emsp;Cys&emsp;Leu&emsp;Leu&emsp;Ala&emsp;Gly&emsp;Tyr&emsp;Glu&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ile&emsp;Tyr&emsp;Arg&emsp;Tyr&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;280&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;285 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Glu&emsp;Ser&emsp;Tyr&emsp;Asn&emsp;Ile&emsp;Tyr&emsp;Gly&emsp;Pro&emsp;Thr&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gly&emsp;Ala&emsp;Asn&emsp;Phe&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;290&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;295&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Cys&emsp;Arg&emsp;Asp&emsp;Leu&emsp;Ala&emsp;Leu&emsp;Gln&emsp;Ile&emsp;Leu&emsp;Ar </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;Leu&emsp;Asn&emsp;Glu&emsp;Pro&emsp;Cys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>305&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;His&emsp;Glu&emsp;Asn&emsp;Cys&emsp;Thr&emsp;Phe&emsp;Gly&emsp;Gly&emsp;Ile&emsp;Tr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Asp&emsp;Gly&emsp;Gly&emsp;Lys&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Gly&emsp;Gln&emsp;Lys&emsp;Asn&emsp;Leu&emsp;Val&emsp;Val&emsp;Thr&emsp;Ser&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Phe&emsp;Tyr&emsp;Tyr&emsp;Arg&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Glu&emsp;Val&emsp;Gly&emsp;Phe&emsp;Val&emsp;Thr&emsp;Pro&emsp;Pro&emsp;Asn&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Lys&emsp;Asn&emsp;Arg&emsp;Pro&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;360&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;365 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Phe&emsp;Glu&emsp;Thr&emsp;Ala&emsp;Ala&emsp;Lys&emsp;Gln&emsp;Ala&emsp;Cys&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Thr&emsp;Phe&emsp;Glu&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;370&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;375&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Lys&emsp;Ser&emsp;Thr&emsp;Phe&emsp;Pro&emsp;Asn&emsp;Val&emsp;Glu&emsp;Lys&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Lys&emsp;Leu&emsp;Pro&emsp;Phe&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>385&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Cys&emsp;Val&emsp;Asp&emsp;Phe&emsp;Thr&emsp;Tyr&emsp;Gln&emsp;Tyr&emsp;Thr&emsp;Leu&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Val&emsp;Asp&emsp;Gly&emsp;Phe&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Asp&emsp;Pro&emsp;Glu&emsp;Gln&emsp;Glu&emsp;Ile&emsp;Thr&emsp;Val&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Gly&emsp;Ile&emsp;Glu&emsp;Tyr&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;430 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Ala&emsp;Ile&emsp;Val&emsp;Glu&emsp;Thr&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Thr&emsp;Ala&emsp;Ile&emsp;Glu&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Ser&emsp;Ser&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Phe&emsp;Asn&emsp;Arg&emsp;Leu&emsp;Me </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;Tyr&emsp;Phe&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;450&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;455&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;6265 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Dolichos&emsp;biflorus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;genomic&emsp;sequence&emsp;of&emsp;NBP46 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;(DB46) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;exon </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(633)..(944) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;intron </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(945)..(1022) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;exon </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1023)..(1151) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;intron </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1152)..(1559) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;exon </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1560)..(1616) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;intron </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1617)..(1697) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;exon </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1698)..(1790) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctagatgtga&emsp;agtgatttta&emsp;atcttgcaac&emsp;tggtgtaaat&emsp;aaatcataat&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aatatctt&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atcttaaaaa&emsp;taaaatcttc&emsp;ataaaaaata&emsp;aatataatga&emsp;ttaaattatc&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaataaat&emsp;&emsp;&emsp;&emsp;120 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aagtaattat&emsp;ttccttacct&emsp;aacatgatgg&emsp;ccagctcata&emsp;taataacatc&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttcttgga&emsp;&emsp;&emsp;&emsp;180 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gcatatcaat&emsp;gacgaaaacg&emsp;tggacgcaaa&emsp;ttattggcct&emsp;cggggatctg&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttctgcaa&emsp;&emsp;&emsp;&emsp;240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atacttgttt&emsp;ctcccgagaa&emsp;ccggattctc&emsp;attaatttct&emsp;agttgttctc&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaattgct&emsp;&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cactttattt&emsp;tcattgtaaa&emsp;gtaaaaataa&emsp;ttttctacta&emsp;aaaacgatat&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#accatgtt&emsp;&emsp;&emsp;&emsp;360 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agtcacatac&emsp;acattcaata&emsp;atatttaaaa&emsp;tgttatttat&emsp;ttaatgggaa&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#agatttaa&emsp;&emsp;&emsp;&emsp;420 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>taattggggt&emsp;tagttcttac&emsp;aataatacat&emsp;actcaacaaa&emsp;atttttcctc&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atatcaca&emsp;&emsp;&emsp;&emsp;480 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cgatagtaat&emsp;atattaatct&emsp;aatataatct&emsp;cacaaaatca&emsp;tctccatatt&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tatatttc&emsp;&emsp;&emsp;&emsp;540 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atatagatga&emsp;tgttatcatg&emsp;gacgtggatc&emsp;tctgcgacca&emsp;tagcatttta&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tctatata&emsp;&emsp;&emsp;&emsp;600 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tagtggcaag&emsp;agtgacgatt&emsp;agtgcaaact&emsp;gaaacgagta&emsp;ctctttcagt&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tgaggttc&emsp;&emsp;&emsp;&emsp;660 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgagagattc&emsp;agaaatgaat&emsp;tgggtgtggc&emsp;caaagacaaa&emsp;gagcatgagc&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#cctactcc&emsp;&emsp;&emsp;&emsp;720 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcatcacttt&emsp;tctactcttc&emsp;tcattgccaa&emsp;aactttcttc&emsp;ttcgcaatat&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tgggaaca&emsp;&emsp;&emsp;&emsp;780 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtatcttact&emsp;aaatcatcgt&emsp;aagatacttc&emsp;ccaaccagga&emsp;actccttacc&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttacgctg&emsp;&emsp;&emsp;&emsp;840 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcatctttga&emsp;tgctggtagc&emsp;tctgggagtc&emsp;gtgtccatgt&emsp;cttcaatttt&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ccagaact&emsp;&emsp;&emsp;&emsp;900 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tagatctcct&emsp;gcacattggc&emsp;aatgacctcg&emsp;agtttacaaa&emsp;aaaggtcaaa&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaaacctt&emsp;&emsp;&emsp;&emsp;960 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aaattattca&emsp;ttattatttt&emsp;cttcatctta&emsp;ctcttacatt&emsp;cttcttcatt&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tctggtgc&emsp;&emsp;&emsp;1020 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agatcaaacc&emsp;cggtttgagc&emsp;tcatacgctg&emsp;ataagcctga&emsp;aaaagctgca&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atctctca&emsp;&emsp;&emsp;1080 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttccactttt&emsp;ggaggaagct&emsp;gaagatgttg&emsp;tccctgagga&emsp;actgcacccc&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gacacccc&emsp;&emsp;&emsp;1140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttaagcttgg&emsp;ggtgagtatt&emsp;tctcatctct&emsp;acttttgcca&emsp;cagattaata&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tcacactt&emsp;&emsp;&emsp;1200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttacatgaaa&emsp;catgattaag&emsp;ttctttaaac&emsp;atgttgatta&emsp;aagggtgaca&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttgtattt&emsp;&emsp;&emsp;1260 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tttaatcaag&emsp;taatctagaa&emsp;cttaaactat&emsp;ggtaataata&emsp;taaaatgaat&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaaactaa&emsp;&emsp;&emsp;1320 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tatattctga&emsp;tggaacagaa&emsp;gaaagcaata&emsp;tcaagagaga&emsp;caaaacacac&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tttgatga&emsp;&emsp;&emsp;1380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gctctatctt&emsp;ttaaacaaaa&emsp;aatggaattg&emsp;aaagaccaaa&emsp;taaaataggc&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tagcccat&emsp;&emsp;&emsp;1440 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atcataaaat&emsp;cttttgtaaa&emsp;atattaatag&emsp;aaagtaaatg&emsp;aacactatat&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gatgcata&emsp;&emsp;&emsp;1500 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cgtagaaaat&emsp;gtaaaaggat&emsp;ttttgagata&emsp;atatcttttg&emsp;atgttgaatg&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aatgcagg&emsp;&emsp;&emsp;1560 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caacagcagg&emsp;tttgaggctc&emsp;ttggatgggg&emsp;atgctgctga&emsp;aaagatattg&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#agcggtaa&emsp;&emsp;&emsp;1620 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ccatgagctt&emsp;agttcatttc&emsp;cttatgttat&emsp;taactacgct&emsp;ttcaatgtct&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#actttcgt&emsp;&emsp;&emsp;1680 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tttctctcat&emsp;gttgaaggtt&emsp;agggaaatgt&emsp;tcaggaacag&emsp;aagttccctg&emsp;ag </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#cgttcaac&emsp;&emsp;&emsp;1740 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctgatgcagt&emsp;atctgttatt&emsp;gatggaaccc&emsp;aagaaggttc&emsp;ttacttatgg&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atgactta&emsp;&emsp;&emsp;1800 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cttaaagttt&emsp;atttttatca&emsp;gaattcattc&emsp;taattttttt&emsp;acttaagaag&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ggaagaaa&emsp;&emsp;&emsp;1860 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtgtgatcac&emsp;attacctagg&emsp;acattcatct&emsp;tatttaaaat&emsp;aatttattgc&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aataatac&emsp;&emsp;&emsp;1920 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tattttttaa&emsp;ttagaattga&emsp;tatttgcgta&emsp;tattgtgaaa&emsp;aagaaaagta&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttgatttt&emsp;&emsp;&emsp;1980 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcattatggt&emsp;aaagtatttt&emsp;aataaatttt&emsp;tattaactct&emsp;tttttaactt&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaaaatat&emsp;&emsp;&emsp;2040 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aggatcactt&emsp;tatgtgtgtg&emsp;gtgacatgcc&emsp;ataccccata&emsp;tggacaatta&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gacatgcc&emsp;&emsp;&emsp;2100 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atacccgata&emsp;tattaatatt&emsp;ttatcaattg&emsp;tcaatttatt&emsp;tattgtaact&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tttaaaaa&emsp;&emsp;&emsp;2160 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atacttttaa&emsp;ttaaatcatt&emsp;gaggtatcgc&emsp;tttagttttt&emsp;ttttaaattc&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaaaataa&emsp;&emsp;&emsp;2220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttaataatta&emsp;ttagatatac&emsp;tggaagaatt&emsp;tccgaaggat&emsp;attcatatcc&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atatatct&emsp;&emsp;&emsp;2280 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgtaagataa&emsp;cattttttat&emsp;tgaacaaatg&emsp;caacactatc&emsp;tctaaatatg&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttttttat&emsp;&emsp;&emsp;2340 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttatgtcgaa&emsp;tgaatcacga&emsp;cgatataatt&emsp;ttgtataagt&emsp;aattaaattc&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tattcatt&emsp;&emsp;&emsp;2400 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tttatttgtt&emsp;gtgtttcttt&emsp;tagggtccgc&emsp;caattagcta&emsp;aatcttacct&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaagattg&emsp;&emsp;&emsp;2460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caaacaaaga&emsp;aaaaagaaag&emsp;aagcaatgat&emsp;gaaattaaaa&emsp;gtggatcaaa&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atgaggat&emsp;&emsp;&emsp;2520 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atgtttcaaa&emsp;aagaagaatt&emsp;aggttctttg&emsp;ttatgttttc&emsp;aaaaactagt&emsp;ag </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttggaatt&emsp;&emsp;&emsp;2580 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcttaaattc&emsp;aattataatt&emsp;atttaataaa&emsp;attgtctgct&emsp;taattgataa&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#taaaatag&emsp;&emsp;&emsp;2640 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cataactgat&emsp;acatttataa&emsp;attatatttt&emsp;atattaaaat&emsp;ttatttttat&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tatagata&emsp;&emsp;&emsp;2700 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aaatgtattt&emsp;ggtaatattt&emsp;ataatatagt&emsp;tttaaattaa&emsp;tttcaaactt&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tgtgatct&emsp;&emsp;&emsp;2760 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tacttataaa&emsp;ttaattattt&emsp;ttttcagttt&emsp;tcaattattg&emsp;catttttctt&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aatattca&emsp;&emsp;&emsp;2820 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctatattaat&emsp;atttgacaat&emsp;atttcaaaac&emsp;attttcaata&emsp;aaaaaaaaaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaagaagt&emsp;&emsp;&emsp;2880 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tcagtaaact&emsp;tcatatctgc&emsp;attatgttta&emsp;tttgaatagt&emsp;aaaacactat&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aatatatc&emsp;&emsp;&emsp;2940 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>taatgtaaag&emsp;gataaacatg&emsp;cagagtagta&emsp;aaaaacttat&emsp;ttagaatata&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#catttaat&emsp;&emsp;&emsp;3000 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttttcttatg&emsp;atatatcttg&emsp;ggaattttgt&emsp;gtaggttaca&emsp;gttaactatc&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttaggaaa&emsp;&emsp;&emsp;3060 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gttgggaaag&emsp;aagtttacaa&emsp;aaactgtggg&emsp;agtgatagat&emsp;cttggaggtg&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tcagttca&emsp;&emsp;&emsp;3120 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aatggcttat&emsp;gctgtctcaa&emsp;gaaatacagc&emsp;taaaaatgcc&emsp;ccaaaaccac&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#caaggaga&emsp;&emsp;&emsp;3180 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggatccatac&emsp;atgaagaagc&emsp;ttgtactcaa&emsp;gggaaagaaa&emsp;tatgaccttt&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gttcacag&emsp;&emsp;&emsp;3240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gttactttct&emsp;gttatcattc&emsp;atatagcaaa&emsp;ggaacaatta&emsp;tcatttcaat&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ctaaaata&emsp;&emsp;&emsp;3300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tatttataat&emsp;ctctaaaatc&emsp;aaataacata&emsp;aaaaaatggt&emsp;aatataatgt&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#cgttttgg&emsp;&emsp;&emsp;3360 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gattgtttgg&emsp;attaaagggt&emsp;aaatttgaag&emsp;aagaaaaaaa&emsp;ataataaata&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaaaaaga&emsp;&emsp;&emsp;3420 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaaaaaaaat&emsp;aagattgttt&emsp;ggattattag&emsp;aaagagaaaa&emsp;agttgaataa&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atttttat&emsp;&emsp;&emsp;3480 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>attttaatat&emsp;tattttaatt&emsp;atttattatt&emsp;atgaaaataa&emsp;aatatttatt&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#taaattta&emsp;&emsp;&emsp;3540 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tattttatta&emsp;ttatttttta&emsp;attttattat&emsp;tataaaaata&emsp;taaatattat&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ataattat&emsp;&emsp;&emsp;3600 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tattttaatt&emsp;ttatttatta&emsp;atataatata&emsp;ataataaata&emsp;aaatattaat&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tttatgtt&emsp;&emsp;&emsp;3660 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atattatata&emsp;atatttaatt&emsp;atacatatgt&emsp;attttttttc&emsp;tgcaaatttt&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ccttttaa&emsp;&emsp;&emsp;3720 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gcggagaaga&emsp;tgaagggcat&emsp;aaattgttct&emsp;cgaaattagt&emsp;tatattttgt&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aattttaa&emsp;&emsp;&emsp;3780 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caaaatcatc&emsp;tcaaatcagt&emsp;cttcataaat&emsp;agtatttatg&emsp;tagatccaaa&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaggctta&emsp;&emsp;&emsp;3840 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>acgtggtcta&emsp;gttgtacaaa&emsp;cctaaaaggt&emsp;gtttcttttt&emsp;ttctttaatt&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aagaacta&emsp;&emsp;&emsp;3900 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaatattgtt&emsp;tttcaatttg&emsp;aaagacgaag&emsp;gcaaacttaa&emsp;ccaaatttag&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaagtaaa&emsp;&emsp;&emsp;3960 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aacttggtta&emsp;actttataac&emsp;gaatgtcaga&emsp;aaaaatggta&emsp;ggtatgttat&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atacttct&emsp;&emsp;&emsp;4020 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gatatcaaaa&emsp;tggcaaaaac&emsp;tccagagtct&emsp;cacttccaag&emsp;aatcatcact&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttctcacc&emsp;&emsp;&emsp;4080 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttaatctgaa&emsp;ataatgaatg&emsp;cttacttttt&emsp;ttaagatatt&emsp;tatagatatc&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#taatccat&emsp;&emsp;&emsp;4140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgaagttcag&emsp;tgtagtgtaa&emsp;ataaattata&emsp;atgtaaaaac&emsp;ctatacactg&emsp;ag </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tacagatc&emsp;&emsp;&emsp;4200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>catgtgtagt&emsp;tactttttta&emsp;tggtttaact&emsp;gataaatatg&emsp;catgagtcat&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#catggcta&emsp;&emsp;&emsp;4260 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>acgtacaggt&emsp;cttaatcaac&emsp;ttctttgttg&emsp;cagttacttg&emsp;cgttatggta&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gacgcagc&emsp;&emsp;&emsp;4320 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>acgtgttaag&emsp;atttttaaga&emsp;ccactgatgg&emsp;tgctgctagt&emsp;ccttgcctat&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gcaggcta&emsp;&emsp;&emsp;4380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgaaggtaaa&emsp;taaagtattc&emsp;ttttgtacaa&emsp;accctaatgt&emsp;tactttctta&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#cctgcatt&emsp;&emsp;&emsp;4440 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cagaatagtg&emsp;caaaggactg&emsp;aaactagaaa&emsp;ggattccaat&emsp;tcactacaag&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaaaaaaa&emsp;&emsp;&emsp;4500 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agtagtgatt&emsp;tagtgaccaa&emsp;agttactttt&emsp;tcctcactga&emsp;gttctattga&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tgcagaaa&emsp;&emsp;&emsp;4560 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cttgttgcag&emsp;atattttaaa&emsp;tacatattaa&emsp;gtgttttgtc&emsp;agtactgcat&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gtttttag&emsp;&emsp;&emsp;4620 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgatttcaag&emsp;tcgagttttt&emsp;tcttgaagca&emsp;ttaaagctgc&emsp;aaataacatg&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ggtctttt&emsp;&emsp;&emsp;4680 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttctatcttt&emsp;aaagatatat&emsp;acagatattc&emsp;cggagaatcg&emsp;tacaatatct&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ggtcccac&emsp;&emsp;&emsp;4740 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttctggtgcc&emsp;aactttaatg&emsp;agtgccgtga&emsp;cctagctctt&emsp;cagattctca&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttgaatga&emsp;&emsp;&emsp;4800 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gccatgttcc&emsp;catgaaaact&emsp;gcacctttgg&emsp;tgggatatgg&emsp;gatggtggaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ggaagtgg&emsp;&emsp;&emsp;4860 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>acagaaaaac&emsp;cttgttgtta&emsp;cttcagcttt&emsp;ctactatagg&emsp;tcttctgagg&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tccattct&emsp;&emsp;&emsp;4920 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctgttaattt&emsp;cttgtttact&emsp;ttgattactt&emsp;atttgttttt&emsp;ataccaataa&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tttacatt&emsp;&emsp;&emsp;4980 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atagtttata&emsp;ctgtgctaat&emsp;tttgttgttt&emsp;ttaggttggt&emsp;tttgtcactc&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#cccaattc&emsp;&emsp;&emsp;5040 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caaaaatcgc&emsp;cctctggatt&emsp;ttgaaactgc&emsp;agctaaacaa&emsp;gcttgtagtt&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#acattcga&emsp;&emsp;&emsp;5100 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggaagcgaaa&emsp;tccacttttc&emsp;caaatgttga&emsp;gaaagataaa&emsp;cttccatttg&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tgcgtgga&emsp;&emsp;&emsp;5160 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tttcacatac&emsp;cagtatacat&emsp;tgcttgttga&emsp;tggatttggt&emsp;atgttttcat&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ttaattac&emsp;&emsp;&emsp;5220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caagttgata&emsp;tttaacttct&emsp;tccaaaaaac&emsp;tatgttttct&emsp;tttgtcttcc&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#cactgact&emsp;&emsp;&emsp;5280 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cctaattcaa&emsp;cttttggcag&emsp;gcctagatcc&emsp;agagcaagag&emsp;attacagtgg&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaaggaat&emsp;&emsp;&emsp;5340 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgaatatcaa&emsp;gatgccattg&emsp;tggaaacagc&emsp;atggcctcta&emsp;ggaactgcca&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#gaagccat&emsp;&emsp;&emsp;5400 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atcatctttg&emsp;cctaaattta&emsp;atcgtctaat&emsp;gtattttatc&emsp;taagccatgt&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tccactta&emsp;&emsp;&emsp;5460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgaccacttt&emsp;aattaaaata&emsp;aaactcaccc&emsp;ttttcactag&emsp;tcctttttta&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ccattgag&emsp;&emsp;&emsp;5520 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tatcaagtgt&emsp;taatttgttt&emsp;ctgacaaatg&emsp;gaggtgtaaa&emsp;agtgaaacaa&emsp;ag </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tatgtttt&emsp;&emsp;&emsp;5580 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgtcagatac&emsp;gaatggaagt&emsp;agggttatga&emsp;tgacctgcca&emsp;attaactaat&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tctgactt&emsp;&emsp;&emsp;5640 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctttcatcct&emsp;cttattttaa&emsp;ttttgaaaaa&emsp;aaaaatcata&emsp;tatgtaatcg&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaaatttg&emsp;&emsp;&emsp;5700 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atttgcaact&emsp;taaaaaaatg&emsp;accaaataaa&emsp;ttttcctaaa&emsp;ttcctctgca&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#atatacaa&emsp;&emsp;&emsp;5760 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggaccacaaa&emsp;attgaatctg&emsp;tttctttaat&emsp;ggaataagta&emsp;ctttttgaaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ctatcata&emsp;&emsp;&emsp;5820 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttagtaaact&emsp;tatctttttc&emsp;atctaacagg&emsp;cagcaaaatt&emsp;aattgcatga&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ggatccaa&emsp;&emsp;&emsp;5880 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttaattctct&emsp;cgtacagctc&emsp;cagataagaa&emsp;gcgtttaatg&emsp;agataaattg&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ggataata&emsp;&emsp;&emsp;5940 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tatgttgggt&emsp;gtgggtggat&emsp;tatgatacta&emsp;tcgataataa&emsp;atttggaatc&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#attaaatt&emsp;&emsp;&emsp;6000 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttataaaatt&emsp;aatttatcaa&emsp;tatataatat&emsp;tttatatata&emsp;ttaatttgat&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tattttta&emsp;&emsp;&emsp;6060 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ataattttat&emsp;atttttaata&emsp;tttaatttta&emsp;atttaaggaa&emsp;atttttaaga&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#attaattt&emsp;&emsp;&emsp;6120 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tttattttta&emsp;tttttttgta&emsp;tagtactcag&emsp;gacataataa&emsp;tgttattaat&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#aaataaga&emsp;&emsp;&emsp;6180 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cttaaatata&emsp;tatttttctt&emsp;ataatgctta&emsp;aatctcagtc&emsp;ttattattgc&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#tcacataa&emsp;&emsp;&emsp;6240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgacacgaac&emsp;taactagctt&emsp;cactc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;6265 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Artificial&emsp;Sequence </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;Description&emsp;of&emsp;Artificial&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Sequence:degenerate </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&prime;&emsp;PCR&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;modified_base </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(6) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;n&emsp;&equals;&emsp;g,&emsp;a,&emsp;c&emsp;or&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;modified_base </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(9) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;n&emsp;&equals;&emsp;g,&emsp;a,&emsp;c&emsp;or&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>taygcngtna&emsp;tyttygatcg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;17 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Artificial&emsp;Sequence </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;Description&emsp;of&emsp;Artificial&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Sequence:degenerate </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3&prime;&emsp;PCR&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;modified_base </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(15) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;n&emsp;&equals;&emsp;g,&emsp;a,&emsp;c&emsp;or&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atrttrtada&emsp;trccngg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;17 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;6 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;17 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Artificial&emsp;Sequence </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;Description&emsp;of&emsp;Artificial&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Sequence:5&prime;&emsp;RACE </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;6 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cgtccgatac&emsp;ttctata&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;17 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;7 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;18 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Artificial&emsp;Sequence </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;Description&emsp;of&emsp;Artificial&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Sequence:3&prime;&emsp;RACE </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;7 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aacttagatc&emsp;tcctgcac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;18 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;8 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;1458 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Medicago&emsp;sativa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;CDS </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1)..(1458) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;full&emsp;length&emsp;clone </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;CDS </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(13)..(1380) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;NBP46 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;modified_base </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1)..(1458) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;n&emsp;&equals;&emsp;g,&emsp;a,&emsp;c&emsp;or&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;8 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caa&emsp;att&emsp;aag&emsp;aac&emsp;atg&emsp;gag&emsp;ttc&emsp;cta&emsp;att&emsp;aca&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;att&emsp;gcc&emsp;act&emsp;ttt&emsp;tta&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;48 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Ile&emsp;Lys&emsp;Asn&emsp;Met&emsp;Glu&emsp;Phe&emsp;Leu&emsp;Ile&emsp;Thr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ile&emsp;Ala&emsp;Thr&emsp;Phe&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctc&emsp;ttg&emsp;tta&emsp;atg&emsp;cct&emsp;gca&emsp;atc&emsp;act&emsp;tcc&emsp;tcc&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tat&emsp;tta&emsp;gga&emsp;aac&emsp;aac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;96 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Leu&emsp;Met&emsp;Pro&emsp;Ala&emsp;Ile&emsp;Thr&emsp;Ser&emsp;Ser&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Tyr&emsp;Leu&emsp;Gly&emsp;Asn&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cta&emsp;ctc&emsp;act&emsp;aat&emsp;cga&emsp;aag&emsp;att&emsp;ttc&emsp;caa&emsp;aaa&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;gaa&emsp;acc&emsp;tta&emsp;acc&emsp;tct&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;144 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Thr&emsp;Asn&emsp;Arg&emsp;Lys&emsp;Ile&emsp;Phe&emsp;Gln&emsp;Lys&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Glu&emsp;Thr&emsp;Leu&emsp;Thr&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;45 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tac&emsp;gct&emsp;gtc&emsp;ata&emsp;ttt&emsp;gat&emsp;gct&emsp;ggt&emsp;agc&emsp;act&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;act&emsp;cgt&emsp;gtc&emsp;cat&emsp;gtt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;192 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Ala&emsp;Val&emsp;Ile&emsp;Phe&emsp;Asp&emsp;Ala&emsp;Gly&emsp;Ser&emsp;Thr&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Thr&emsp;Arg&emsp;Val&emsp;His&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tac&emsp;cat&emsp;ttt&emsp;gat&emsp;cag&emsp;aac&emsp;tta&emsp;gat&emsp;cta&emsp;ctt&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;att&emsp;ggc&emsp;aat&emsp;gat&emsp;att&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;His&emsp;Phe&emsp;Asp&emsp;Gln&emsp;Asn&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Leu&emsp;Hi </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Ile&emsp;Gly&emsp;Asn&emsp;Asp&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gag&emsp;ttt&emsp;gtt&emsp;gac&emsp;aag&emsp;atc&emsp;aaa&emsp;cca&emsp;ggt&emsp;ttg&emsp;ag </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gca&emsp;tat&emsp;ggg&emsp;gat&emsp;aat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;288 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Phe&emsp;Val&emsp;Asp&emsp;Lys&emsp;Ile&emsp;Lys&emsp;Pro&emsp;Gly&emsp;Leu&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Tyr&emsp;Gly&emsp;Asp&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cct&emsp;gaa&emsp;caa&emsp;gca&emsp;gca&emsp;aaa&emsp;tct&emsp;ctc&emsp;att&emsp;cca&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ttg&emsp;gag&emsp;gaa&emsp;gca&emsp;gaa&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;336 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Glu&emsp;Gln&emsp;Ala&emsp;Ala&emsp;Lys&emsp;Ser&emsp;Leu&emsp;Ile&emsp;Pro&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Leu&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gat&emsp;gtg&emsp;gtt&emsp;cct&emsp;gag&emsp;gat&emsp;ctg&emsp;cac&emsp;ccc&emsp;aaa&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ccc&emsp;ctt&emsp;agg&emsp;ctt&emsp;ggg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;384 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Val&emsp;Val&emsp;Pro&emsp;Glu&emsp;Asp&emsp;Leu&emsp;His&emsp;Pro&emsp;Lys&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Pro&emsp;Leu&emsp;Arg&emsp;Leu&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;120&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;125 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gca&emsp;acc&emsp;gca&emsp;ggt&emsp;ttg&emsp;agg&emsp;ctt&emsp;ttg&emsp;aat&emsp;ggg&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gct&emsp;gct&emsp;gaa&emsp;aag&emsp;ata&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;432 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Thr&emsp;Ala&emsp;Gly&emsp;Leu&emsp;Arg&emsp;Leu&emsp;Leu&emsp;Asn&emsp;Gly&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Lys&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;130&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;135&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttg&emsp;caa&emsp;gcg&emsp;aca&emsp;agg&emsp;aat&emsp;atg&emsp;ttc&emsp;agc&emsp;aac&emsp;ag </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;agt&emsp;acc&emsp;ctc&emsp;aac&emsp;gtt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;480 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gln&emsp;Ala&emsp;Thr&emsp;Arg&emsp;Asn&emsp;Met&emsp;Phe&emsp;Ser&emsp;Asn&emsp;Ar </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;Ser&emsp;Thr&emsp;Leu&emsp;Asn&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>145&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caa&emsp;cgt&emsp;gat&emsp;gca&emsp;gtt&emsp;tct&emsp;att&emsp;att&emsp;gat&emsp;gga&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;caa&emsp;gaa&emsp;ggt&emsp;tct&emsp;tat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;528 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Arg&emsp;Asp&emsp;Ala&emsp;Val&emsp;Ser&emsp;Ile&emsp;Ile&emsp;Asp&emsp;Gly&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gln&emsp;Glu&emsp;Gly&emsp;Ser&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atg&emsp;tgg&emsp;gtg&emsp;aca&emsp;gtt&emsp;aac&emsp;tat&emsp;gta&emsp;ttg&emsp;ggg&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ttg&emsp;gga&emsp;aaa&emsp;agc&emsp;ttc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;576 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Met&emsp;Trp&emsp;Val&emsp;Thr&emsp;Val&emsp;Asn&emsp;Tyr&emsp;Val&emsp;Leu&emsp;Gly&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Leu&emsp;Gly&emsp;Lys&emsp;Ser&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aca&emsp;aaa&emsp;tca&emsp;gtg&emsp;gga&emsp;gta&emsp;att&emsp;gac&emsp;ctt&emsp;gga&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ggt&emsp;tca&emsp;gtt&emsp;caa&emsp;atg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;624 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Lys&emsp;Ser&emsp;Val&emsp;Gly&emsp;Val&emsp;Ile&emsp;Asp&emsp;Leu&emsp;Gly&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Gly&emsp;Ser&emsp;Val&emsp;Gln&emsp;Met </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;205 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aca&emsp;tat&emsp;gca&emsp;gtg&emsp;tca&emsp;aag&emsp;aaa&emsp;aca&emsp;gca&emsp;aaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gct&emsp;cct&emsp;aaa&emsp;gtt&emsp;gct&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;672 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ser&emsp;Lys&emsp;Lys&emsp;Thr&emsp;Ala&emsp;Lys&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Ala&emsp;Pro&emsp;Lys&emsp;Val&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;210&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;215&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gat&emsp;gga&emsp;gag&emsp;gat&emsp;cca&emsp;tat&emsp;att&emsp;aag&emsp;aag&emsp;ctt&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;ctc&emsp;aag&emsp;gga&emsp;aag&emsp;caa&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;720 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Gly&emsp;Glu&emsp;Asp&emsp;Pro&emsp;Tyr&emsp;Ile&emsp;Lys&emsp;Lys&emsp;Leu&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Leu&emsp;Lys&emsp;Gly&emsp;Lys&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>225&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tat&emsp;gat&emsp;ctc&emsp;tat&emsp;gtt&emsp;cat&emsp;agt&emsp;tac&emsp;ttg&emsp;cgt&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ggc&emsp;aaa&emsp;gaa&emsp;gca&emsp;act&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;768 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Val&emsp;His&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Arg&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Gly&emsp;Lys&emsp;Glu&emsp;Ala&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cga&emsp;gca&emsp;cag&emsp;gtt&emsp;ttg&emsp;aat&emsp;gca&emsp;act&emsp;aat&emsp;gga&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gct&emsp;aac&emsp;cct&emsp;tgc&emsp;att&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;816 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Ala&emsp;Gln&emsp;Val&emsp;Leu&emsp;Asn&emsp;Ala&emsp;Thr&emsp;Asn&emsp;Gly&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Asn&emsp;Pro&emsp;Cys&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tta&emsp;cct&emsp;gga&emsp;ttt&emsp;aat&emsp;ggg&emsp;acc&emsp;ttt&emsp;aca&emsp;tat&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;gga&emsp;gtg&emsp;gag&emsp;tat&emsp;aag&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;864 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Pro&emsp;Gly&emsp;Phe&emsp;Asn&emsp;Gly&emsp;Thr&emsp;Phe&emsp;Thr&emsp;Tyr&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gly&emsp;Val&emsp;Glu&emsp;Tyr&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;280&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;285 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gct&emsp;ttt&emsp;tcc&emsp;cct&emsp;tct&emsp;tct&emsp;ggc&emsp;tcc&emsp;aac&emsp;ttt&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gat&emsp;tgc&emsp;aaa&emsp;gaa&emsp;ata&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;912 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Phe&emsp;Ser&emsp;Pro&emsp;Ser&emsp;Ser&emsp;Gly&emsp;Ser&emsp;Asn&emsp;Phe&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Asp&emsp;Cys&emsp;Lys&emsp;Glu&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;290&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;295&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>att&emsp;ctt&emsp;aag&emsp;gtt&emsp;ctt&emsp;aaa&emsp;gta&emsp;aat&emsp;gat&emsp;cca&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ccc&emsp;tat&emsp;ccg&emsp;agt&emsp;tgc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;960 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Leu&emsp;Lys&emsp;Val&emsp;Leu&emsp;Lys&emsp;Val&emsp;Asn&emsp;Asp&emsp;Pro&emsp;Cy </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Pro&emsp;Tyr&emsp;Pro&emsp;Ser&emsp;Cys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>305&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>act&emsp;ttt&emsp;ggt&emsp;gga&emsp;ata&emsp;tgg&emsp;aat&emsp;ggt&emsp;gga&emsp;gga&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;agt&emsp;gga&emsp;caa&emsp;aaa&emsp;aaa&emsp;&emsp;&emsp;&emsp;&emsp;1008 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Phe&emsp;Gly&emsp;Gly&emsp;Ile&emsp;Trp&emsp;Asn&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Ser&emsp;Gly&emsp;Gln&emsp;Lys&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctt&emsp;ttt&emsp;gtt&emsp;act&emsp;tca&emsp;gct&emsp;ttc&emsp;gct&emsp;tac&emsp;ctg&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gaa&emsp;gat&emsp;gtt&emsp;ggt&emsp;atg&emsp;&emsp;&emsp;&emsp;&emsp;1056 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Phe&emsp;Val&emsp;Thr&emsp;Ser&emsp;Ala&emsp;Phe&emsp;Ala&emsp;Tyr&emsp;Leu&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Glu&emsp;Asp&emsp;Val&emsp;Gly&emsp;Met </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtt&emsp;gag&emsp;cca&emsp;aat&emsp;aaa&emsp;cct&emsp;aat&emsp;tcc&emsp;ata&emsp;ctt&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cca&emsp;gta&emsp;gat&emsp;ttc&emsp;gaa&emsp;&emsp;&emsp;&emsp;&emsp;1104 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Glu&emsp;Pro&emsp;Asn&emsp;Lys&emsp;Pro&emsp;Asn&emsp;Ser&emsp;Ile&emsp;Leu&emsp;Hi </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Pro&emsp;Val&emsp;Asp&emsp;Phe&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;360&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;365 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>att&emsp;gaa&emsp;gct&emsp;aag&emsp;cga&emsp;gct&emsp;tgt&emsp;gca&emsp;tta&emsp;aac&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gag&emsp;gat&emsp;gtc&emsp;aaa&emsp;tcc&emsp;&emsp;&emsp;&emsp;&emsp;1152 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Glu&emsp;Ala&emsp;Lys&emsp;Arg&emsp;Ala&emsp;Cys&emsp;Ala&emsp;Leu&emsp;Asn&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Glu&emsp;Asp&emsp;Val&emsp;Lys&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;370&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;375&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>act&emsp;tat&emsp;cct&emsp;cga&emsp;ctt&emsp;acg&emsp;gat&emsp;gca&emsp;aaa&emsp;cgt&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tat&emsp;gta&emsp;tgc&emsp;atg&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;1200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Tyr&emsp;Pro&emsp;Arg&emsp;Leu&emsp;Thr&emsp;Asp&emsp;Ala&emsp;Lys&emsp;Arg&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Tyr&emsp;Val&emsp;Cys&emsp;Met&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>385&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctc&emsp;tta&emsp;tac&emsp;caa&emsp;cat&emsp;gtg&emsp;ttg&emsp;ctt&emsp;gtt&emsp;cat&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ttt&emsp;ggc&emsp;tta&emsp;ggt&emsp;cca&emsp;&emsp;&emsp;&emsp;&emsp;1248 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Tyr&emsp;Gln&emsp;His&emsp;Val&emsp;Leu&emsp;Leu&emsp;Val&emsp;His&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Phe&emsp;Gly&emsp;Leu&emsp;Gly&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cga&emsp;aaa&emsp;gag&emsp;att&emsp;aca&emsp;gta&emsp;ggt&emsp;gag&emsp;gga&emsp;att&emsp;ca </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tat&emsp;cag&emsp;aat&emsp;tct&emsp;gtt&emsp;&emsp;&emsp;&emsp;&emsp;1296 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Lys&emsp;Glu&emsp;Ile&emsp;Thr&emsp;Val&emsp;Gly&emsp;Glu&emsp;Gly&emsp;Ile&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Tyr&emsp;Gln&emsp;Asn&emsp;Ser&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;430 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtg&emsp;gaa&emsp;gct&emsp;gca&emsp;tgg&emsp;cct&emsp;cta&emsp;ggt&emsp;act&emsp;gcc&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gaa&emsp;gcc&emsp;ata&emsp;tca&emsp;gcg&emsp;&emsp;&emsp;&emsp;&emsp;1344 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Glu&emsp;Ala&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gly&emsp;Thr&emsp;Ala&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Glu&emsp;Ala&emsp;Ile&emsp;Ser&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tta&emsp;cct&emsp;aag&emsp;ttt&emsp;aag&emsp;cga&emsp;tta&emsp;atg&emsp;tat&emsp;ttt&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;taa&emsp;gct&emsp;ttt&emsp;aga&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;1392 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Pro&emsp;Lys&emsp;Phe&emsp;Lys&emsp;Arg&emsp;Leu&emsp;Met&emsp;Tyr&emsp;Phe&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;&emsp;&emsp;&emsp;&emsp;Ala&emsp;Phe&emsp;Arg&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;450&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;455&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtc&emsp;aag&emsp;ata&emsp;ttt&emsp;cag&emsp;taa&emsp;cag&emsp;cta&emsp;act&emsp;tta&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;aaa&emsp;att&emsp;aaa&emsp;taa&emsp;aac&emsp;&emsp;&emsp;&emsp;&emsp;1440 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Lys&emsp;Ile&emsp;Phe&emsp;Gln&emsp;&emsp;&emsp;&emsp;&emsp;Gln&emsp;Leu&emsp;Thr&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Leu&emsp;Ser&emsp;Lys&emsp;Ile&emsp;Lys&emsp;&emsp;&emsp;&emsp;&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>465&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgg&emsp;cgc&emsp;att&emsp;ttg&emsp;tct&emsp;ttc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#1458 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Trp&emsp;Arg&emsp;Ile&emsp;Leu&emsp;Ser&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;485 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;9 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;459 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Medicago&emsp;sativa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;MOD_RES </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1)..(459) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;Xaa&emsp;&equals;&emsp;any&emsp;amino&emsp;aci </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#d </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;9 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Ile&emsp;Lys&emsp;Asn&emsp;Met&emsp;Glu&emsp;Phe&emsp;Leu&emsp;Ile&emsp;Thr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ile&emsp;Ala&emsp;Thr&emsp;Phe&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Leu&emsp;Met&emsp;Pro&emsp;Ala&emsp;Ile&emsp;Thr&emsp;Ser&emsp;Ser&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Tyr&emsp;Leu&emsp;Gly&emsp;Asn&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Thr&emsp;Asn&emsp;Arg&emsp;Lys&emsp;Ile&emsp;Phe&emsp;Gln&emsp;Lys&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Glu&emsp;Thr&emsp;Leu&emsp;Thr&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;45 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Ala&emsp;Val&emsp;Ile&emsp;Phe&emsp;Asp&emsp;Ala&emsp;Gly&emsp;Ser&emsp;Thr&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Thr&emsp;Arg&emsp;Val&emsp;His&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;His&emsp;Phe&emsp;Asp&emsp;Gln&emsp;Asn&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Leu&emsp;Hi </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Ile&emsp;Gly&emsp;Asn&emsp;Asp&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Phe&emsp;Val&emsp;Asp&emsp;Lys&emsp;Ile&emsp;Lys&emsp;Pro&emsp;Gly&emsp;Leu&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Tyr&emsp;Gly&emsp;Asp&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Glu&emsp;Gln&emsp;Ala&emsp;Ala&emsp;Lys&emsp;Ser&emsp;Leu&emsp;Ile&emsp;Pro&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Leu&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Val&emsp;Val&emsp;Pro&emsp;Glu&emsp;Asp&emsp;Leu&emsp;His&emsp;Pro&emsp;Lys&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Pro&emsp;Leu&emsp;Arg&emsp;Leu&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;120&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;125 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Thr&emsp;Ala&emsp;Gly&emsp;Leu&emsp;Arg&emsp;Leu&emsp;Leu&emsp;Asn&emsp;Gly&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Lys&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;130&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;135&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gln&emsp;Ala&emsp;Thr&emsp;Arg&emsp;Asn&emsp;Met&emsp;Phe&emsp;Ser&emsp;Asn&emsp;Ar </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;Ser&emsp;Thr&emsp;Leu&emsp;Asn&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>145&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Arg&emsp;Asp&emsp;Ala&emsp;Val&emsp;Ser&emsp;Ile&emsp;Ile&emsp;Asp&emsp;Gly&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gln&emsp;Glu&emsp;Gly&emsp;Ser&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Met&emsp;Trp&emsp;Val&emsp;Thr&emsp;Val&emsp;Asn&emsp;Tyr&emsp;Val&emsp;Leu&emsp;Gly&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Leu&emsp;Gly&emsp;Lys&emsp;Ser&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Lys&emsp;Ser&emsp;Val&emsp;Gly&emsp;Val&emsp;Ile&emsp;Asp&emsp;Leu&emsp;Gly&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Gly&emsp;Ser&emsp;Val&emsp;Gln&emsp;Met </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;205 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ser&emsp;Lys&emsp;Lys&emsp;Thr&emsp;Ala&emsp;Lys&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Ala&emsp;Pro&emsp;Lys&emsp;Val&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;210&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;215&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Gly&emsp;Glu&emsp;Asp&emsp;Pro&emsp;Tyr&emsp;Ile&emsp;Lys&emsp;Lys&emsp;Leu&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Leu&emsp;Lys&emsp;Gly&emsp;Lys&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>225&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Val&emsp;His&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Arg&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Gly&emsp;Lys&emsp;Glu&emsp;Ala&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Ala&emsp;Gln&emsp;Val&emsp;Leu&emsp;Asn&emsp;Ala&emsp;Thr&emsp;Asn&emsp;Gly&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Asn&emsp;Pro&emsp;Cys&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Pro&emsp;Gly&emsp;Phe&emsp;Asn&emsp;Gly&emsp;Thr&emsp;Phe&emsp;Thr&emsp;Tyr&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gly&emsp;Val&emsp;Glu&emsp;Tyr&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;280&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;285 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Phe&emsp;Ser&emsp;Pro&emsp;Ser&emsp;Ser&emsp;Gly&emsp;Ser&emsp;Asn&emsp;Phe&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Asp&emsp;Cys&emsp;Lys&emsp;Glu&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;290&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;295&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Leu&emsp;Lys&emsp;Val&emsp;Leu&emsp;Lys&emsp;Val&emsp;Asn&emsp;Asp&emsp;Pro&emsp;Cy </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Pro&emsp;Tyr&emsp;Pro&emsp;Ser&emsp;Cys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>305&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Phe&emsp;Gly&emsp;Gly&emsp;Ile&emsp;Trp&emsp;Asn&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Ser&emsp;Gly&emsp;Gln&emsp;Lys&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Phe&emsp;Val&emsp;Thr&emsp;Ser&emsp;Ala&emsp;Phe&emsp;Ala&emsp;Tyr&emsp;Leu&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Glu&emsp;Asp&emsp;Val&emsp;Gly&emsp;Met </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Glu&emsp;Pro&emsp;Asn&emsp;Lys&emsp;Pro&emsp;Asn&emsp;Ser&emsp;Ile&emsp;Leu&emsp;Hi </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Pro&emsp;Val&emsp;Asp&emsp;Phe&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;360&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;365 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Glu&emsp;Ala&emsp;Lys&emsp;Arg&emsp;Ala&emsp;Cys&emsp;Ala&emsp;Leu&emsp;Asn&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Glu&emsp;Asp&emsp;Val&emsp;Lys&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;370&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;375&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Tyr&emsp;Pro&emsp;Arg&emsp;Leu&emsp;Thr&emsp;Asp&emsp;Ala&emsp;Lys&emsp;Arg&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Tyr&emsp;Val&emsp;Cys&emsp;Met&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>385&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Tyr&emsp;Gln&emsp;His&emsp;Val&emsp;Leu&emsp;Leu&emsp;Val&emsp;His&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Phe&emsp;Gly&emsp;Leu&emsp;Gly&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Lys&emsp;Glu&emsp;Ile&emsp;Thr&emsp;Val&emsp;Gly&emsp;Glu&emsp;Gly&emsp;Ile&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Tyr&emsp;Gln&emsp;Asn&emsp;Ser&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;430 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Glu&emsp;Ala&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gly&emsp;Thr&emsp;Ala&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Glu&emsp;Ala&emsp;Ile&emsp;Ser&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Pro&emsp;Lys&emsp;Phe&emsp;Lys&emsp;Arg&emsp;Leu&emsp;Met&emsp;Tyr&emsp;Phe&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;450&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;455 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;10 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;9 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Medicago&emsp;sativa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;10 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Phe&emsp;Arg&emsp;Asp&emsp;Val&emsp;Lys&emsp;Ile&emsp;Phe&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;11 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;8 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Medicago&emsp;sativa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;11 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Leu&emsp;Thr&emsp;Leu&emsp;Ser&emsp;Lys&emsp;Ile&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;12 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;7 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Medicago&emsp;sativa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;12 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Trp&emsp;Arg&emsp;Ile&emsp;Leu&emsp;Ser&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;13 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;1489 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Lotus&emsp;japonicus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;CDS </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1)..(1488) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;full&emsp;length&emsp;clone </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;CDS </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(43)..(1413) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;NBP46 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;13 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aag&emsp;tgc&emsp;tct&emsp;tct&emsp;ctc&emsp;tgt&emsp;agt&emsp;tag&emsp;ttg&emsp;cat&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;act&emsp;aaa&emsp;gcc&emsp;atg&emsp;gac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;48 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Cys&emsp;Ser&emsp;Ser&emsp;Leu&emsp;Cys&emsp;Ser&emsp;&emsp;&emsp;&emsp;&emsp;Leu&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#His&emsp;Trp&emsp;Thr&emsp;Lys&emsp;Ala&emsp;Met&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttc&emsp;tta&emsp;att&emsp;agt&emsp;ctc&emsp;atg&emsp;acc&emsp;ttt&emsp;gtg&emsp;ttc&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;tta&emsp;atg&emsp;cct&emsp;gct&emsp;atc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;96 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Phe&emsp;Leu&emsp;Ile&emsp;Ser&emsp;Leu&emsp;Met&emsp;Thr&emsp;Phe&emsp;Val&emsp;Phe&emsp;Me </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;Leu&emsp;Met&emsp;Pro&emsp;Ala&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tct&emsp;tcc&emsp;tcc&emsp;caa&emsp;tat&emsp;ctc&emsp;gga&emsp;aac&emsp;aac&emsp;att&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;atg&emsp;aat&emsp;cgt&emsp;aag&emsp;ata&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;144 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Ser&emsp;Ser&emsp;Gln&emsp;Tyr&emsp;Leu&emsp;Gly&emsp;Asn&emsp;Asn&emsp;Ile&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Met&emsp;Asn&emsp;Arg&emsp;Lys&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;45 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tta&emsp;ctc&emsp;ccc&emsp;aaa&emsp;aat&emsp;cag&emsp;gaa&emsp;cca&emsp;gtt&emsp;aca&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tac&emsp;gct&emsp;gtt&emsp;ata&emsp;ttt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;192 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Asn&emsp;Gln&emsp;Glu&emsp;Pro&emsp;Val&emsp;Thr&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ile&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gat&emsp;gct&emsp;ggt&emsp;agc&emsp;act&emsp;gga&emsp;agc&emsp;aga&emsp;gtc&emsp;cat&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;tac&emsp;aat&emsp;ttt&emsp;gat&emsp;cag&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Ala&emsp;Gly&emsp;Ser&emsp;Thr&emsp;Gly&emsp;Ser&emsp;Arg&emsp;Val&emsp;His&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Tyr&emsp;Asn&emsp;Phe&emsp;Asp&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aac&emsp;tta&emsp;gat&emsp;ctc&emsp;ctt&emsp;ccc&emsp;gtt&emsp;gaa&emsp;aac&emsp;gaa&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gag&emsp;ttt&emsp;tat&emsp;gat&emsp;tcg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;288 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Leu&emsp;Pro&emsp;Val&emsp;Glu&emsp;Asn&emsp;Glu&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Glu&emsp;Phe&emsp;Tyr&emsp;Asp&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtt&emsp;aaa&emsp;ccc&emsp;ggt&emsp;ttg&emsp;agt&emsp;tca&emsp;tac&emsp;gct&emsp;gct&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cct&emsp;gaa&emsp;gaa&emsp;gct&emsp;gca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;336 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Lys&emsp;Pro&emsp;Gly&emsp;Leu&emsp;Ser&emsp;Ser&emsp;Tyr&emsp;Ala&emsp;Ala&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Pro&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;tct&emsp;ctg&emsp;att&emsp;cca&emsp;ctt&emsp;cta&emsp;aaa&emsp;gaa&emsp;gca&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;aat&emsp;gtg&emsp;gtt&emsp;cct&emsp;gtg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;384 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Ser&emsp;Leu&emsp;Ile&emsp;Pro&emsp;Leu&emsp;Leu&emsp;Lys&emsp;Glu&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Asn&emsp;Val&emsp;Val&emsp;Pro&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;120&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;125 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agc&emsp;cag&emsp;caa&emsp;ccc&emsp;aac&emsp;aca&emsp;ccc&emsp;gtt&emsp;aag&emsp;ctt&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gca&emsp;act&emsp;gca&emsp;ggt&emsp;tta&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;432 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Gln&emsp;Gln&emsp;Pro&emsp;Asn&emsp;Thr&emsp;Pro&emsp;Val&emsp;Lys&emsp;Leu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Gly&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;130&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;135&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agg&emsp;ctt&emsp;ttg&emsp;gag&emsp;ggg&emsp;aat&emsp;gct&emsp;gct&emsp;gaa&emsp;aat&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ttg&emsp;caa&emsp;gcg&emsp;gtc&emsp;agg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;480 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Leu&emsp;Leu&emsp;Glu&emsp;Gly&emsp;Asn&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Asn&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Leu&emsp;Gln&emsp;Ala&emsp;Val&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>145&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gat&emsp;atg&emsp;ctc&emsp;agc&emsp;aac&emsp;aga&emsp;agt&emsp;gcc&emsp;ctt&emsp;aat&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;caa&emsp;tca&emsp;gat&emsp;gca&emsp;gta&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;528 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Met&emsp;Leu&emsp;Ser&emsp;Asn&emsp;Arg&emsp;Ser&emsp;Ala&emsp;Leu&emsp;Asn&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Gln&emsp;Ser&emsp;Asp&emsp;Ala&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tct&emsp;att&emsp;ctt&emsp;gat&emsp;gga&emsp;acc&emsp;caa&emsp;gaa&emsp;ggt&emsp;tct&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ctt&emsp;tgg&emsp;gtg&emsp;aca&emsp;att&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;576 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Ile&emsp;Leu&emsp;Asp&emsp;Gly&emsp;Thr&emsp;Gln&emsp;Glu&emsp;Gly&emsp;Ser&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Trp&emsp;Val&emsp;Thr&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aac&emsp;tat&emsp;ctc&emsp;ttg&emsp;ggg&emsp;aag&emsp;ttg&emsp;gga&emsp;aaa&emsp;aga&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;aca&emsp;aag&emsp;aca&emsp;gtg&emsp;gga&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;624 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Tyr&emsp;Leu&emsp;Leu&emsp;Gly&emsp;Lys&emsp;Leu&emsp;Gly&emsp;Lys&emsp;Arg&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Thr&emsp;Lys&emsp;Thr&emsp;Val&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;205 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gta&emsp;gtt&emsp;gat&emsp;cta&emsp;gga&emsp;ggt&emsp;ggg&emsp;tca&emsp;gtg&emsp;caa&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;aca&emsp;tat&emsp;gca&emsp;gtc&emsp;tca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;672 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Val&emsp;Asp&emsp;Leu&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Val&emsp;Gln&emsp;Me </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;Thr&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;210&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;215&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agg&emsp;aac&emsp;aca&emsp;gct&emsp;aaa&emsp;aat&emsp;gct&emsp;cca&emsp;aaa&emsp;gta&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gaa&emsp;gga&emsp;gag&emsp;gat&emsp;cca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;720 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Asn&emsp;Thr&emsp;Ala&emsp;Lys&emsp;Asn&emsp;Ala&emsp;Pro&emsp;Lys&emsp;Val&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Glu&emsp;Gly&emsp;Glu&emsp;Asp&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>225&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tac&emsp;ata&emsp;aag&emsp;aag&emsp;ctt&emsp;gta&emsp;ctc&emsp;cag&emsp;gga&emsp;aag&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tat&emsp;gac&emsp;ctt&emsp;tat&emsp;gtt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;768 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Ile&emsp;Lys&emsp;Lys&emsp;Leu&emsp;Val&emsp;Leu&emsp;Gln&emsp;Gly&emsp;Lys&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Tyr&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cac&emsp;agt&emsp;tac&emsp;ttg&emsp;cgc&emsp;tat&emsp;gga&emsp;aga&emsp;gaa&emsp;gca&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cgt&emsp;gca&emsp;gag&emsp;att&emsp;ttc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;816 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>His&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Arg&emsp;Tyr&emsp;Gly&emsp;Arg&emsp;Glu&emsp;Ala&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Arg&emsp;Ala&emsp;Glu&emsp;Ile&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aag&emsp;gtc&emsp;gct&emsp;ggt&emsp;ggt&emsp;tct&emsp;gct&emsp;aat&emsp;cct&emsp;tgc&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;tta&emsp;gct&emsp;ggc&emsp;ttt&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;864 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Val&emsp;Ala&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Ala&emsp;Asn&emsp;Pro&emsp;Cys&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Leu&emsp;Ala&emsp;Gly&emsp;Phe&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;280&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;285 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggg&emsp;gca&emsp;tat&emsp;aca&emsp;tat&emsp;tcc&emsp;gga&emsp;gca&emsp;gag&emsp;tat&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gtc&emsp;tcg&emsp;gcc&emsp;cca&emsp;gct&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;912 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Ala&emsp;Tyr&emsp;Thr&emsp;Tyr&emsp;Ser&emsp;Gly&emsp;Ala&emsp;Glu&emsp;Tyr&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Val&emsp;Ser&emsp;Ala&emsp;Pro&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;290&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;295&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tca&emsp;gga&emsp;tct&emsp;aac&emsp;ttg&emsp;aat&emsp;caa&emsp;tgc&emsp;aga&emsp;aag&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;gct&emsp;ctt&emsp;aag&emsp;gct&emsp;ctt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;960 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Gly&emsp;Ser&emsp;Asn&emsp;Leu&emsp;Asn&emsp;Gln&emsp;Cys&emsp;Arg&emsp;Lys&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Ala&emsp;Leu&emsp;Lys&emsp;Ala&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>305&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aaa&emsp;gtg&emsp;aat&emsp;gca&emsp;cct&emsp;tgt&emsp;ccc&emsp;tat&emsp;cag&emsp;aat&emsp;tg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;act&emsp;ttt&emsp;ggt&emsp;ggg&emsp;ata&emsp;&emsp;&emsp;&emsp;&emsp;1008 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Val&emsp;Asn&emsp;Ala&emsp;Pro&emsp;Cys&emsp;Pro&emsp;Tyr&emsp;Gln&emsp;Asn&emsp;Cy </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Thr&emsp;Phe&emsp;Gly&emsp;Gly&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgg&emsp;aat&emsp;ggt&emsp;gga&emsp;ggt&emsp;gga&emsp;agt&emsp;ggt&emsp;caa&emsp;aaa&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ctt&emsp;ttc&emsp;ctt&emsp;act&emsp;tca&emsp;&emsp;&emsp;&emsp;&emsp;1056 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Trp&emsp;Asn&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Gly&emsp;Gln&emsp;Lys&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Leu&emsp;Phe&emsp;Leu&emsp;Thr&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tct&emsp;ttc&emsp;tat&emsp;tac&emsp;ctc&emsp;tct&emsp;gaa&emsp;gat&emsp;gtt&emsp;ggg&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;ttt&emsp;gtg&emsp;aat&emsp;aaa&emsp;ccc&emsp;&emsp;&emsp;&emsp;&emsp;1104 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Phe&emsp;Tyr&emsp;Tyr&emsp;Leu&emsp;Ser&emsp;Glu&emsp;Asp&emsp;Val&emsp;Gly&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Phe&emsp;Val&emsp;Asn&emsp;Lys&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;360&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;365 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aat&emsp;gcc&emsp;aaa&emsp;att&emsp;cgt&emsp;cca&emsp;gtt&emsp;gat&emsp;ttg&emsp;aag&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gca&emsp;gct&emsp;aaa&emsp;cta&emsp;gct&emsp;&emsp;&emsp;&emsp;&emsp;1152 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Ala&emsp;Lys&emsp;Ile&emsp;Arg&emsp;Pro&emsp;Val&emsp;Asp&emsp;Leu&emsp;Lys&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Ala&emsp;Lys&emsp;Leu&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;370&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;375&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tgt&emsp;aaa&emsp;aca&emsp;aat&emsp;ctt&emsp;gag&emsp;gat&emsp;gca&emsp;aaa&emsp;tcc&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tac&emsp;cca&emsp;gat&emsp;ctt&emsp;tat&emsp;&emsp;&emsp;&emsp;&emsp;1200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Cys&emsp;Lys&emsp;Thr&emsp;Asn&emsp;Leu&emsp;Glu&emsp;Asp&emsp;Ala&emsp;Lys&emsp;Ser&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Tyr&emsp;Pro&emsp;Asp&emsp;Leu&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>385&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gag&emsp;aaa&emsp;gac&emsp;agt&emsp;gtt&emsp;gaa&emsp;tat&emsp;gtg&emsp;tgc&emsp;ttg&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ctt&emsp;gtc&emsp;tac&emsp;gtg&emsp;tac&emsp;&emsp;&emsp;&emsp;&emsp;1248 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Lys&emsp;Asp&emsp;Ser&emsp;Val&emsp;Glu&emsp;Tyr&emsp;Val&emsp;Cys&emsp;Leu&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Leu&emsp;Val&emsp;Tyr&emsp;Val&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aca&emsp;ttg&emsp;ctt&emsp;gtt&emsp;gat&emsp;gga&emsp;ttt&emsp;ggt&emsp;ctt&emsp;gat&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ttt&emsp;caa&emsp;gag&emsp;gtt&emsp;aca&emsp;&emsp;&emsp;&emsp;&emsp;1296 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Leu&emsp;Leu&emsp;Val&emsp;Asp&emsp;Gly&emsp;Phe&emsp;Gly&emsp;Leu&emsp;Asp&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Phe&emsp;Gln&emsp;Glu&emsp;Val&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;430 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtg&emsp;gcg&emsp;aat&emsp;gaa&emsp;att&emsp;gaa&emsp;tat&emsp;cag&emsp;gat&emsp;gct&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gtg&emsp;gaa&emsp;gcc&emsp;gca&emsp;tgg&emsp;&emsp;&emsp;&emsp;&emsp;1344 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Ala&emsp;Asn&emsp;Glu&emsp;Ile&emsp;Glu&emsp;Tyr&emsp;Gln&emsp;Asp&emsp;Ala&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Val&emsp;Glu&emsp;Ala&emsp;Ala&emsp;Trp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cct&emsp;cta&emsp;ggc&emsp;act&emsp;gcc&emsp;ata&emsp;gaa&emsp;gca&emsp;ata&emsp;tca&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ttg&emsp;cct&emsp;aaa&emsp;ttt&emsp;gag&emsp;&emsp;&emsp;&emsp;&emsp;1392 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Leu&emsp;Gly&emsp;Thr&emsp;Ala&emsp;Ile&emsp;Glu&emsp;Ala&emsp;Ile&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Phe&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;450&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;455&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aga&emsp;tta&emsp;atg&emsp;tat&emsp;ttt&emsp;att&emsp;taa&emsp;act&emsp;act&emsp;agt&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;tgc&emsp;tta&emsp;agc&emsp;ctg&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;1440 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Leu&emsp;Met&emsp;Tyr&emsp;Phe&emsp;Ile&emsp;&emsp;&emsp;&emsp;&emsp;Thr&emsp;Thr&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Ser&emsp;Thr&emsp;Cys&emsp;Leu&emsp;Ser&emsp;Leu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>465&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tac&emsp;ctg&emsp;aag&emsp;aaa&emsp;taa&emsp;aat&emsp;gaa&emsp;ata&emsp;aaa&emsp;gcc&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;tct&emsp;ttc&emsp;ttc&emsp;ctt&emsp;gct&emsp;t&emsp;&emsp;&emsp;1489 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Leu&emsp;Lys&emsp;Lys&emsp;&emsp;&emsp;&emsp;&emsp;Asn&emsp;Glu&emsp;Ile&emsp;Lys&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#Ala&emsp;Ala&emsp;Ser&emsp;Phe&emsp;Phe&emsp;Leu&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;485&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;490&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;495 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;14 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;7 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Lotus&emsp;japonicus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;14 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Cys&emsp;Ser&emsp;Ser&emsp;Leu&emsp;Cys&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;462 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Lotus&emsp;japonicus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;His&emsp;Trp&emsp;Thr&emsp;Lys&emsp;Ala&emsp;Met&emsp;Asp&emsp;Phe&emsp;Leu&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Ser&emsp;Leu&emsp;Met&emsp;Thr&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Phe&emsp;Met&emsp;Leu&emsp;Met&emsp;Pro&emsp;Ala&emsp;Ile&emsp;Ser&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gln&emsp;Tyr&emsp;Leu&emsp;Gly&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Ile&emsp;Leu&emsp;Met&emsp;Asn&emsp;Arg&emsp;Lys&emsp;Ile&emsp;Leu&emsp;Leu&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Lys&emsp;Asn&emsp;Gln&emsp;Glu&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;45 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Thr&emsp;Ser&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ile&emsp;Phe&emsp;Asp&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Ser&emsp;Thr&emsp;Gly&emsp;Ser&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;His&emsp;Val&emsp;Tyr&emsp;Asn&emsp;Phe&emsp;Asp&emsp;Gln&emsp;Asn&emsp;Leu&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Leu&emsp;Leu&emsp;Pro&emsp;Val&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Glu&emsp;Leu&emsp;Glu&emsp;Phe&emsp;Tyr&emsp;Asp&emsp;Ser&emsp;Val&emsp;Lys&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Gly&emsp;Leu&emsp;Ser&emsp;Ser&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Ala&emsp;Asn&emsp;Pro&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Ser&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ile&emsp;Pro&emsp;Leu&emsp;Leu&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Ala&emsp;Glu&emsp;Asn&emsp;Val&emsp;Val&emsp;Pro&emsp;Val&emsp;Ser&emsp;Gln&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Pro&emsp;Asn&emsp;Thr&emsp;Pro&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;120&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;125 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Leu&emsp;Gly&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Gly&emsp;Leu&emsp;Arg&emsp;Leu&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Glu&emsp;Gly&emsp;Asn&emsp;Ala&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;130&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;135&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Asn&emsp;Ile&emsp;Leu&emsp;Gln&emsp;Ala&emsp;Val&emsp;Arg&emsp;Asp&emsp;Met&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ser&emsp;Asn&emsp;Arg&emsp;Ser&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>145&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Asn&emsp;Val&emsp;Gln&emsp;Ser&emsp;Asp&emsp;Ala&emsp;Val&emsp;Ser&emsp;Ile&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Asp&emsp;Gly&emsp;Thr&emsp;Gln&emsp;Glu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Ser&emsp;Tyr&emsp;Leu&emsp;Trp&emsp;Val&emsp;Thr&emsp;Ile&emsp;Asn&emsp;Tyr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Leu&emsp;Gly&emsp;Lys&emsp;Leu&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Arg&emsp;Phe&emsp;Thr&emsp;Lys&emsp;Thr&emsp;Val&emsp;Gly&emsp;Val&emsp;Val&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Leu&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;205 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Gln&emsp;Met&emsp;Thr&emsp;Tyr&emsp;Ala&emsp;Val&emsp;Ser&emsp;Arg&emsp;Asn&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Ala&emsp;Lys&emsp;Asn&emsp;Ala&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;210&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;215&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Val&emsp;Pro&emsp;Glu&emsp;Gly&emsp;Glu&emsp;Asp&emsp;Pro&emsp;Tyr&emsp;Ile&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Lys&emsp;Leu&emsp;Val&emsp;Leu&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>225&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Lys&emsp;Lys&emsp;Tyr&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Val&emsp;His&emsp;Ser&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Arg&emsp;Tyr&emsp;Gly&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Ala&emsp;Phe&emsp;Arg&emsp;Ala&emsp;Glu&emsp;Ile&emsp;Phe&emsp;Lys&emsp;Val&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Ala&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Cys&emsp;Ile&emsp;Leu&emsp;Ala&emsp;Gly&emsp;Phe&emsp;Asp&emsp;Gly&emsp;Ala&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Thr&emsp;Tyr&emsp;Ser&emsp;Gly&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;280&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;285 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Tyr&emsp;Lys&emsp;Val&emsp;Ser&emsp;Ala&emsp;Pro&emsp;Ala&emsp;Ser&emsp;Gly&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Asn&emsp;Leu&emsp;Asn&emsp;Gln&emsp;Cys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;290&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;295&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Lys&emsp;Ile&emsp;Ala&emsp;Leu&emsp;Lys&emsp;Ala&emsp;Leu&emsp;Lys&emsp;Val&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Ala&emsp;Pro&emsp;Cys&emsp;Pro&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>305&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Asn&emsp;Cys&emsp;Thr&emsp;Phe&emsp;Gly&emsp;Gly&emsp;Ile&emsp;Trp&emsp;Asn&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Lys&emsp;Asn&emsp;Leu&emsp;Phe&emsp;Leu&emsp;Thr&emsp;Ser&emsp;Ser&emsp;Phe&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Tyr&emsp;Leu&emsp;Ser&emsp;Glu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Gly&emsp;Ile&emsp;Phe&emsp;Val&emsp;Asn&emsp;Lys&emsp;Pro&emsp;Asn&emsp;Ala&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Ile&emsp;Arg&emsp;Pro&emsp;Val&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;360&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;365 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Lys&emsp;Thr&emsp;Ala&emsp;Ala&emsp;Lys&emsp;Leu&emsp;Ala&emsp;Cys&emsp;Lys&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Asn&emsp;Leu&emsp;Glu&emsp;Asp&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;370&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;375&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Ser&emsp;Lys&emsp;Tyr&emsp;Pro&emsp;Asp&emsp;Leu&emsp;Tyr&emsp;Glu&emsp;Lys&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ser&emsp;Val&emsp;Glu&emsp;Tyr&emsp;Val </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>385&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Cys&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Val&emsp;Tyr&emsp;Val&emsp;Tyr&emsp;Thr&emsp;Leu&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Val&emsp;Asp&emsp;Gly&emsp;Phe&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Asp&emsp;Pro&emsp;Phe&emsp;Gln&emsp;Glu&emsp;Val&emsp;Thr&emsp;Val&emsp;Ala&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#n&emsp;Glu&emsp;Ile&emsp;Glu&emsp;Tyr&emsp;Gln </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;430 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Ala&emsp;Leu&emsp;Val&emsp;Glu&emsp;Ala&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Thr&emsp;Ala&emsp;Ile&emsp;Glu&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Ser&emsp;Ser&emsp;Leu&emsp;Pro&emsp;Lys&emsp;Phe&emsp;Glu&emsp;Arg&emsp;Leu&emsp;Me </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;Tyr&emsp;Phe&emsp;Ile </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;450&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;455&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;16 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;13 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Lotus&emsp;japonicus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;16 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Thr&emsp;Ser&emsp;Thr&emsp;Cys&emsp;Leu&emsp;Ser&emsp;Leu&emsp;Asp&emsp;Tyr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Lys&emsp;Lys </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;17 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;11 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Lotus&emsp;japonicus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;17 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asn&emsp;Glu&emsp;Ile&emsp;Lys&emsp;Ala&emsp;Ala&emsp;Ser&emsp;Phe&emsp;Phe&emsp;Leu&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;18 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;1434 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;DNA </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Dolichos&emsp;biflorus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;220&gt;&emsp;FEATURE: </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;CDS </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1)..(1404) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX&emsp;gene&emsp;involved&emsp;in&emsp;o </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#ligosaccharide&emsp;signaling </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;sig_peptide </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1)..(60) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;mat_peptide </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(61)..(1404) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;Complement((1)..(22)) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBXtop&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(274)..(291) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX8&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(297)..(314) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX7-for/rev&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(667)..(685) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX1-for/rev&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(688)..(704) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX2-for/rev&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;Complement((766)..(785)) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX10&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;misc_feature </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(856)..(857) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;splice&emsp;site </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(857)..(872) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX6&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(878)..(896) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX5&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(933)..(952) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX3&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(955)..(972) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX4&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;misc_feature </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1071)..(1072) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;splice&emsp;site </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;Complement((1075)..(1093)) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX11&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1133)..(1151) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX9-for/rev&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1227)..(1247) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBX12&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;221&gt;&emsp;NAME/KEY:&emsp;primer_bind </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;222&gt;&emsp;LOCATION:&emsp;(1414)..(1434) </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;223&gt;&emsp;OTHER&emsp;INFORMATION:&emsp;DBXbottom&emsp;primer </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;18 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>atg&emsp;agc&emsp;atg&emsp;gat&emsp;ttt&emsp;ctc&emsp;ata&emsp;atc&emsp;cta&emsp;ttt&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ctt&emsp;ctt&emsp;ctc&emsp;tgg&emsp;acg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;48 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Met&emsp;Ser&emsp;Met&emsp;Asp&emsp;Phe&emsp;Leu&emsp;Ile&emsp;Ile&emsp;Leu&emsp;Phe&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Leu&emsp;Leu&emsp;Trp&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>-20&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;- </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;- </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#-5 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctg&emsp;gtt&emsp;gca&emsp;act&emsp;gca&emsp;act&emsp;gca&emsp;act&emsp;gca&emsp;agt&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;ttt&emsp;tcc&emsp;ctc&emsp;cat&emsp;ggg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;96 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Val&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Phe&emsp;Ser&emsp;Leu&emsp;His&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;-1&emsp;&emsp;&emsp;1&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aag&emsp;ggc&emsp;ttc&emsp;aag&emsp;cat&emsp;cgc&emsp;aag&emsp;ttt&emsp;tcc&emsp;tcc&emsp;tc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;gat&emsp;aat&emsp;aat&emsp;tat&emsp;tcg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;144 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Gly&emsp;Phe&emsp;Lys&emsp;His&emsp;Arg&emsp;Lys&emsp;Phe&emsp;Ser&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Asp&emsp;Asn&emsp;Asn&emsp;Tyr&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>att&emsp;gaa&emsp;gaa&emsp;acc&emsp;att&emsp;aat&emsp;gaa&emsp;tct&emsp;tat&emsp;gca&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;atc&emsp;ttc&emsp;gat&emsp;gct&emsp;ggt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;192 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Glu&emsp;Glu&emsp;Thr&emsp;Ile&emsp;Asn&emsp;Glu&emsp;Ser&emsp;Tyr&emsp;Ala&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Ile&emsp;Phe&emsp;Asp&emsp;Ala&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agc&emsp;aca&emsp;gga&emsp;agc&emsp;cgt&emsp;gta&emsp;cac&emsp;gtt&emsp;tac&emsp;cgt&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;aac&emsp;cag&emsp;caa&emsp;cta&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;240 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Thr&emsp;Gly&emsp;Ser&emsp;Arg&emsp;Val&emsp;His&emsp;Val&emsp;Tyr&emsp;Arg&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Asn&emsp;Gln&emsp;Gln&emsp;Leu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;45&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctt&emsp;ctt&emsp;cgc&emsp;att&emsp;ggc&emsp;cat&emsp;gac&emsp;ctt&emsp;gag&emsp;ctg&emsp;tt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;gtc&emsp;aag&emsp;acg&emsp;aag&emsp;cca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;288 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Arg&emsp;Ile&emsp;Gly&emsp;His&emsp;Asp&emsp;Leu&emsp;Glu&emsp;Leu&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Val&emsp;Lys&emsp;Thr&emsp;Lys&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;65&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;70&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;75 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggt&emsp;tta&emsp;agt&emsp;gca&emsp;tac&emsp;gct&emsp;gag&emsp;aat&emsp;cca&emsp;gaa&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;gcc&emsp;gca&emsp;gaa&emsp;tct&emsp;ctt&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;336 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Leu&emsp;Ser&emsp;Ala&emsp;Tyr&emsp;Ala&emsp;Glu&emsp;Asn&emsp;Pro&emsp;Glu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Ser&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;80&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtg&emsp;cca&emsp;ctt&emsp;ttg&emsp;gag&emsp;gaa&emsp;gca&emsp;gaa&emsp;gct&emsp;gtt&emsp;at </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cct&emsp;caa&emsp;gag&emsp;ttg&emsp;cat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;384 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Pro&emsp;Leu&emsp;Leu&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Glu&emsp;Ala&emsp;Val&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Pro&emsp;Gln&emsp;Glu&emsp;Leu&emsp;His </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ccc&emsp;aga&emsp;aca&emsp;ccc&emsp;gtt&emsp;aaa&emsp;gtt&emsp;gga&emsp;gca&emsp;acc&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ggt&emsp;tta&emsp;agg&emsp;caa&emsp;ttg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;432 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Arg&emsp;Thr&emsp;Pro&emsp;Val&emsp;Lys&emsp;Val&emsp;Gly&emsp;Ala&emsp;Thr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Gly&emsp;Leu&emsp;Arg&emsp;Gln&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;110&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;120 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;ggg&emsp;gat&emsp;gct&emsp;tcc&emsp;aac&emsp;aga&emsp;atc&emsp;ttg&emsp;caa&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gta&emsp;agt&emsp;gat&emsp;atg&emsp;ctg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;480 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Gly&emsp;Asp&emsp;Ala&emsp;Ser&emsp;Asn&emsp;Arg&emsp;Ile&emsp;Leu&emsp;Gln&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Val&emsp;Ser&emsp;Asp&emsp;Met&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>125&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aag&emsp;aag&emsp;aga&emsp;agc&emsp;aca&emsp;ttg&emsp;aag&emsp;gtt&emsp;gag&emsp;ggc&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gca&emsp;gtt&emsp;tca&emsp;gtg&emsp;ttg&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;528 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Lys&emsp;Arg&emsp;Ser&emsp;Thr&emsp;Leu&emsp;Lys&emsp;Val&emsp;Glu&emsp;Gly&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ala&emsp;Val&emsp;Ser&emsp;Val&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;145&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;150&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;155 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agt&emsp;gga&emsp;aac&emsp;caa&emsp;gaa&emsp;gga&emsp;gct&emsp;tat&emsp;caa&emsp;tgg&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;act&emsp;att&emsp;aac&emsp;tat&emsp;tta&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;576 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Gly&emsp;Asn&emsp;Gln&emsp;Glu&emsp;Gly&emsp;Ala&emsp;Tyr&emsp;Gln&emsp;Trp&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Thr&emsp;Ile&emsp;Asn&emsp;Tyr&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;160&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ctg&emsp;gga&emsp;aac&emsp;ttg&emsp;gga&emsp;aag&emsp;cat&emsp;tat&emsp;tca&emsp;aag&emsp;ac </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gtt&emsp;gct&emsp;gta&emsp;gtt&emsp;gac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;624 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gly&emsp;Asn&emsp;Leu&emsp;Gly&emsp;Lys&emsp;His&emsp;Tyr&emsp;Ser&emsp;Lys&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Val&emsp;Ala&emsp;Val&emsp;Val&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cta&emsp;ggt&emsp;ggt&emsp;gga&emsp;tct&emsp;gtt&emsp;caa&emsp;atg&emsp;gct&emsp;tac&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;atc&emsp;tca&emsp;gag&emsp;gaa&emsp;gat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;672 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Val&emsp;Gln&emsp;Met&emsp;Ala&emsp;Tyr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Ile&emsp;Ser&emsp;Glu&emsp;Glu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;190&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gct&emsp;gct&emsp;aaa&emsp;gct&emsp;cca&emsp;caa&emsp;gtc&emsp;cca&emsp;gac&emsp;gga&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gaa&emsp;tca&emsp;tac&emsp;ata&emsp;acc&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;720 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Ala&emsp;Lys&emsp;Ala&emsp;Pro&emsp;Gln&emsp;Val&emsp;Pro&emsp;Asp&emsp;Gly&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Glu&emsp;Ser&emsp;Tyr&emsp;Ile&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>205&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gag&emsp;atg&emsp;ttc&emsp;ctc&emsp;agg&emsp;gga&emsp;aag&emsp;aaa&emsp;tat&emsp;tac&emsp;ct </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;tat&emsp;gta&emsp;cac&emsp;agt&emsp;tac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;768 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Met&emsp;Phe&emsp;Leu&emsp;Arg&emsp;Gly&emsp;Lys&emsp;Lys&emsp;Tyr&emsp;Tyr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Tyr&emsp;Val&emsp;His&emsp;Ser&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;225&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;230&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;235 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ttg&emsp;cgt&emsp;tat&emsp;ggt&emsp;ttg&emsp;cta&emsp;gca&emsp;gct&emsp;cgt&emsp;gca&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;gtt&emsp;tta&emsp;aag&emsp;gtt&emsp;tct&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;816 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Arg&emsp;Tyr&emsp;Gly&emsp;Leu&emsp;Leu&emsp;Ala&emsp;Ala&emsp;Arg&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Val&emsp;Leu&emsp;Lys&emsp;Val&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;240&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>cgt&emsp;gat&emsp;tca&emsp;gaa&emsp;aac&emsp;cct&emsp;tgt&emsp;att&emsp;ttg&emsp;tct&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ttt&emsp;gat&emsp;ggg&emsp;tat&emsp;tac&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;864 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Asp&emsp;Ser&emsp;Glu&emsp;Asn&emsp;Pro&emsp;Cys&emsp;Ile&emsp;Leu&emsp;Ser&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Phe&emsp;Asp&emsp;Gly&emsp;Tyr&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aca&emsp;tac&emsp;gga&emsp;gga&emsp;gtg&emsp;cag&emsp;tat&emsp;aaa&emsp;gcc&emsp;aca&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;ccc&emsp;cct&emsp;tca&emsp;ggc&emsp;tca&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;912 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Tyr&emsp;Gly&emsp;Gly&emsp;Val&emsp;Gln&emsp;Tyr&emsp;Lys&emsp;Ala&emsp;Thr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Pro&emsp;Pro&emsp;Ser&emsp;Gly&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;270&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;280 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agc&emsp;ttc&emsp;agc&emsp;aaa&emsp;tgc&emsp;caa&emsp;aat&emsp;gtt&emsp;gtt&emsp;ctt&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;gct&emsp;ctc&emsp;cat&emsp;gtc&emsp;aat&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;960 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Phe&emsp;Ser&emsp;Lys&emsp;Cys&emsp;Gln&emsp;Asn&emsp;Val&emsp;Val&emsp;Leu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ala&emsp;Leu&emsp;His&emsp;Val&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>285&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gca&emsp;aca&emsp;tgc&emsp;tct&emsp;tat&emsp;aag&emsp;gat&emsp;tgc&emsp;act&emsp;ttc&emsp;gg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ggc&emsp;ata&emsp;tgg&emsp;aat&emsp;ggc&emsp;&emsp;&emsp;&emsp;&emsp;1008 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Thr&emsp;Cys&emsp;Ser&emsp;Tyr&emsp;Lys&emsp;Asp&emsp;Cys&emsp;Thr&emsp;Phe&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Gly&emsp;Ile&emsp;Trp&emsp;Asn&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;305&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;310&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;315 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ggt&emsp;ggt&emsp;gga&emsp;gct&emsp;ggg&emsp;gaa&emsp;aac&emsp;aac&emsp;ttt&emsp;ttt&emsp;gt </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gca&emsp;tca&emsp;ttt&emsp;ttc&emsp;ttt&emsp;&emsp;&emsp;&emsp;&emsp;1056 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Gly&emsp;Gly&emsp;Ala&emsp;Gly&emsp;Glu&emsp;Asn&emsp;Asn&emsp;Phe&emsp;Phe&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Ala&emsp;Ser&emsp;Phe&emsp;Phe&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;320&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gaa&emsp;gtg&emsp;gcc&emsp;gat&emsp;gag&emsp;gct&emsp;ggt&emsp;ttt&emsp;gtt&emsp;gat&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;aac&emsp;gat&emsp;gcc&emsp;aat&emsp;gcc&emsp;&emsp;&emsp;&emsp;&emsp;1104 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Val&emsp;Ala&emsp;Asp&emsp;Glu&emsp;Ala&emsp;Gly&emsp;Phe&emsp;Val&emsp;Asp&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Asn&emsp;Asp&emsp;Ala&emsp;Asn&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>ata&emsp;gtt&emsp;cgt&emsp;cct&emsp;gtg&emsp;gat&emsp;ttt&emsp;gaa&emsp;gat&emsp;gca&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;aag&emsp;gtt&emsp;gct&emsp;tgt&emsp;agc&emsp;&emsp;&emsp;&emsp;&emsp;1152 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Val&emsp;Arg&emsp;Pro&emsp;Val&emsp;Asp&emsp;Phe&emsp;Glu&emsp;Asp&emsp;Ala&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Lys&emsp;Val&emsp;Ala&emsp;Cys&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;350&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;360 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>aca&emsp;gaa&emsp;tta&emsp;aag&emsp;gat&emsp;ctc&emsp;aag&emsp;tcc&emsp;gtt&emsp;ttc&emsp;cc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;cgt&emsp;gtt&emsp;aag&emsp;gat&emsp;gga&emsp;&emsp;&emsp;&emsp;&emsp;1200 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Glu&emsp;Leu&emsp;Lys&emsp;Asp&emsp;Leu&emsp;Lys&emsp;Ser&emsp;Val&emsp;Phe&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Arg&emsp;Val&emsp;Lys&emsp;Asp&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>365&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gat&emsp;gtt&emsp;cct&emsp;tac&emsp;ata&emsp;tgt&emsp;ttg&emsp;gat&emsp;cta&emsp;gta&emsp;ta </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#c&emsp;caa&emsp;tat&emsp;aca&emsp;ttg&emsp;ctc&emsp;&emsp;&emsp;&emsp;&emsp;1248 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Val&emsp;Pro&emsp;Tyr&emsp;Ile&emsp;Cys&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Val&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gln&emsp;Tyr&emsp;Thr&emsp;Leu&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;385&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;390&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;395 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>gtt&emsp;gat&emsp;gga&emsp;ttt&emsp;ggc&emsp;att&emsp;gat&emsp;ccc&emsp;cag&emsp;caa&emsp;ga </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#g&emsp;att&emsp;aca&emsp;ttg&emsp;gtg&emsp;agg&emsp;&emsp;&emsp;&emsp;&emsp;1296 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Asp&emsp;Gly&emsp;Phe&emsp;Gly&emsp;Ile&emsp;Asp&emsp;Pro&emsp;Gln&emsp;Gln&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ile&emsp;Thr&emsp;Leu&emsp;Val&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;400&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>caa&emsp;att&emsp;cag&emsp;tat&emsp;cag&emsp;gat&emsp;tct&emsp;ctc&emsp;gtg&emsp;gaa&emsp;gc </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#t&emsp;gca&emsp;tgg&emsp;cca&emsp;cta&emsp;gga&emsp;&emsp;&emsp;&emsp;&emsp;1344 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Ile&emsp;Gln&emsp;Tyr&emsp;Gln&emsp;Asp&emsp;Ser&emsp;Leu&emsp;Val&emsp;Glu&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>agt&emsp;gcc&emsp;ata&emsp;gaa&emsp;gcc&emsp;ata&emsp;tct&emsp;tcg&emsp;tta&emsp;cct&emsp;aa </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;ttt&emsp;gag&emsp;aaa&emsp;tta&emsp;atg&emsp;&emsp;&emsp;&emsp;&emsp;1392 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Ala&emsp;Ile&emsp;Glu&emsp;Ala&emsp;Ile&emsp;Ser&emsp;Ser&emsp;Leu&emsp;Pro&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Phe&emsp;Glu&emsp;Lys&emsp;Leu&emsp;Met </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;430&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;440 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>tat&emsp;ttc&emsp;ctt&emsp;taa&emsp;gctttaaccg&emsp;aggatccatg&emsp;tatgtgttgc&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#1434 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Phe&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;210&gt;&emsp;SEQ&emsp;ID&emsp;NO&emsp;19 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;211&gt;&emsp;LENGTH:&emsp;467 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;212&gt;&emsp;TYPE:&emsp;PRT </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;213&gt;&emsp;ORGANISM:&emsp;Dolichos&emsp;biflorus </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&lt;400&gt;&emsp;SEQUENCE:&emsp;19 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Met&emsp;Ser&emsp;Met&emsp;Asp&emsp;Phe&emsp;Leu&emsp;Ile&emsp;Ile&emsp;Leu&emsp;Phe&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Leu&emsp;Leu&emsp;Leu&emsp;Trp&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;1&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;5&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;10&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;15 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Val&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Thr&emsp;Ala&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Phe&emsp;Ser&emsp;Leu&emsp;His&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;20&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;25&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;30 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Gly&emsp;Phe&emsp;Lys&emsp;His&emsp;Arg&emsp;Lys&emsp;Phe&emsp;Ser&emsp;Ser&emsp;Se </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Asp&emsp;Asn&emsp;Asn&emsp;Tyr&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;40&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;45 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Glu&emsp;Glu&emsp;Thr&emsp;Ile&emsp;Asn&emsp;Glu&emsp;Ser&emsp;Tyr&emsp;Ala&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Ile&emsp;Phe&emsp;Asp&emsp;Ala&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Thr&emsp;Gly&emsp;Ser&emsp;Arg&emsp;Val&emsp;His&emsp;Val&emsp;Tyr&emsp;Arg&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Asn&emsp;Gln&emsp;Gln&emsp;Leu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;65&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;70&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;75&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;80 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Leu&emsp;Arg&emsp;Ile&emsp;Gly&emsp;His&emsp;Asp&emsp;Leu&emsp;Glu&emsp;Leu&emsp;Ph </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Val&emsp;Lys&emsp;Thr&emsp;Lys&emsp;Pro </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;85&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;90&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;95 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Leu&emsp;Ser&emsp;Ala&emsp;Tyr&emsp;Ala&emsp;Glu&emsp;Asn&emsp;Pro&emsp;Glu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ala&emsp;Ala&emsp;Glu&emsp;Ser&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;100&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;105&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;110 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Pro&emsp;Leu&emsp;Leu&emsp;Glu&emsp;Glu&emsp;Ala&emsp;Glu&emsp;Ala&emsp;Val&emsp;Il </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#e&emsp;Pro&emsp;Gln&emsp;Glu&emsp;Leu&emsp;His </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;115&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;120&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;125 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Pro&emsp;Arg&emsp;Thr&emsp;Pro&emsp;Val&emsp;Lys&emsp;Val&emsp;Gly&emsp;Ala&emsp;Thr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Gly&emsp;Leu&emsp;Arg&emsp;Gln&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;130&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;135&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;140 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Gly&emsp;Asp&emsp;Ala&emsp;Ser&emsp;Asn&emsp;Arg&emsp;Ile&emsp;Leu&emsp;Gln&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Val&emsp;Ser&emsp;Asp&emsp;Met&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>145&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#50&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#55&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;1 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#60 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Lys&emsp;Lys&emsp;Arg&emsp;Ser&emsp;Thr&emsp;Leu&emsp;Lys&emsp;Val&emsp;Glu&emsp;Gly&emsp;As </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#p&emsp;Ala&emsp;Val&emsp;Ser&emsp;Val&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;165&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;170&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;175 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Gly&emsp;Asn&emsp;Gln&emsp;Glu&emsp;Gly&emsp;Ala&emsp;Tyr&emsp;Gln&emsp;Trp&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Thr&emsp;Ile&emsp;Asn&emsp;Tyr&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;180&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;185&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;190 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gly&emsp;Asn&emsp;Leu&emsp;Gly&emsp;Lys&emsp;His&emsp;Tyr&emsp;Ser&emsp;Lys&emsp;Th </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Val&emsp;Ala&emsp;Val&emsp;Val&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;195&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;200&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;205 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Gly&emsp;Gly&emsp;Gly&emsp;Ser&emsp;Val&emsp;Gln&emsp;Met&emsp;Ala&emsp;Tyr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Ile&emsp;Ser&emsp;Glu&emsp;Glu&emsp;Asp </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;210&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;215&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;220 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Ala&emsp;Lys&emsp;Ala&emsp;Pro&emsp;Gln&emsp;Val&emsp;Pro&emsp;Asp&emsp;Gly&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Glu&emsp;Ser&emsp;Tyr&emsp;Ile&emsp;Thr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>225&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#30&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#35&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;2 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#40 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Met&emsp;Phe&emsp;Leu&emsp;Arg&emsp;Gly&emsp;Lys&emsp;Lys&emsp;Tyr&emsp;Tyr&emsp;Le </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Tyr&emsp;Val&emsp;His&emsp;Ser&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;245&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;250&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;255 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Leu&emsp;Arg&emsp;Tyr&emsp;Gly&emsp;Leu&emsp;Leu&emsp;Ala&emsp;Ala&emsp;Arg&emsp;Ala&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Val&emsp;Leu&emsp;Lys&emsp;Val&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;260&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;265&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;270 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Arg&emsp;Asp&emsp;Ser&emsp;Glu&emsp;Asn&emsp;Pro&emsp;Cys&emsp;Ile&emsp;Leu&emsp;Ser&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Phe&emsp;Asp&emsp;Gly&emsp;Tyr&emsp;Tyr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;275&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;280&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;285 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Tyr&emsp;Gly&emsp;Gly&emsp;Val&emsp;Gln&emsp;Tyr&emsp;Lys&emsp;Ala&emsp;Thr&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Pro&emsp;Pro&emsp;Ser&emsp;Gly&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;290&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;295&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;300 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Phe&emsp;Ser&emsp;Lys&emsp;Cys&emsp;Gln&emsp;Asn&emsp;Val&emsp;Val&emsp;Leu&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ala&emsp;Leu&emsp;His&emsp;Val&emsp;Asn </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>305&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#10&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#15&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#20 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ala&emsp;Thr&emsp;Cys&emsp;Ser&emsp;Tyr&emsp;Lys&emsp;Asp&emsp;Cys&emsp;Thr&emsp;Phe&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#y&emsp;Gly&emsp;Ile&emsp;Trp&emsp;Asn&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;325&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;330&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;335 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gly&emsp;Gly&emsp;Gly&emsp;Ala&emsp;Gly&emsp;Glu&emsp;Asn&emsp;Asn&emsp;Phe&emsp;Phe&emsp;Va </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#l&emsp;Ala&emsp;Ser&emsp;Phe&emsp;Phe&emsp;Phe </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;340&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;345&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;350 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Glu&emsp;Val&emsp;Ala&emsp;Asp&emsp;Glu&emsp;Ala&emsp;Gly&emsp;Phe&emsp;Val&emsp;Asp&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Asn&emsp;Asp&emsp;Ala&emsp;Asn&emsp;Ala </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;355&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;360&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;365 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ile&emsp;Val&emsp;Arg&emsp;Pro&emsp;Val&emsp;Asp&emsp;Phe&emsp;Glu&emsp;Asp&emsp;Ala&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Lys&emsp;Val&emsp;Ala&emsp;Cys&emsp;Ser </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;370&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;375&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;380 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Thr&emsp;Glu&emsp;Leu&emsp;Lys&emsp;Asp&emsp;Leu&emsp;Lys&emsp;Ser&emsp;Val&emsp;Phe&emsp;Pr </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#o&emsp;Arg&emsp;Val&emsp;Lys&emsp;Asp&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>385&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#90&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;3 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#95&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;4 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#00 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Asp&emsp;Val&emsp;Pro&emsp;Tyr&emsp;Ile&emsp;Cys&emsp;Leu&emsp;Asp&emsp;Leu&emsp;Val&emsp;Ty </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#r&emsp;Gln&emsp;Tyr&emsp;Thr&emsp;Leu&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;405&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;410&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;415 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Val&emsp;Asp&emsp;Gly&emsp;Phe&emsp;Gly&emsp;Ile&emsp;Asp&emsp;Pro&emsp;Gln&emsp;Gln&emsp;Gl </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#u&emsp;Ile&emsp;Thr&emsp;Leu&emsp;Val&emsp;Arg </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;420&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;425&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;430 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Gln&emsp;Ile&emsp;Gln&emsp;Tyr&emsp;Gln&emsp;Asp&emsp;Ser&emsp;Leu&emsp;Val&emsp;Glu&emsp;Al </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#a&emsp;Ala&emsp;Trp&emsp;Pro&emsp;Leu&emsp;Gly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;435&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;440&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;445 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Ser&emsp;Ala&emsp;Ile&emsp;Glu&emsp;Ala&emsp;Ile&emsp;Ser&emsp;Ser&emsp;Leu&emsp;Pro&emsp;Ly </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#s&emsp;Phe&emsp;Glu&emsp;Lys&emsp;Leu&emsp;Met </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;450&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;455&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>#&emsp;&emsp;&emsp;460 </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Tyr&emsp;Phe&emsp;Leu </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>465</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>1. A transgenic plant with enhanced rhizobial binding to roots of the plant comprising an expression cassette containing a plant promoter operably linked to a heterologous NBP46 polynucleotide that specifically hybridizes to SEQ ID NO:1 under hybridization conditions that include at least one wash in 0.2&times; SSC at a temperature of at least about 60&deg; C. for 20 minutes and that encodes an NBP46 polypeptide that enhances rhizobial binding to roots of the plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>2. The transgenic plant of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the NBP46 polypeptide is SEQ ID NO:2.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>3. The transgenic plant of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, which is not a legume.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>4. A method of enhancing rhizobial binding to roots of a plant, the method comprising introducing into the plant an expression cassette comprising plant promoter operably linked to a heterologous NBP46 polynucleotide that specifically hybridizes to SEQ ID NO:1 under hybridization conditions that include at least one wash in 2.0&times; SSC at a temperature of at least 60&deg; C. for 20 minutes and that encodes an NBP46 polypeptide that enhances rhizobial binding to roots of the plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>5. The method of </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT>, wherein the heterologous NBP46 polynucleotide is SEQ ID NO:1.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>6. The method of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, wherein the NBP46 polypeptide has the amino acid sequence as shown in SEQ ID NO:2.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>7. The method of </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT>, wherein the plant is not a legume.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00148" LVL="0"><PTEXT><PDAT>8. The method of </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT>, wherein the expression cassette is introduced into the plant through a sexual cross.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>9. An isolated nucleic acid molecule comprising a sequence encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:9 and that enhances rhizobial binding to roots of a transgenic plant comprising the sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>10. The isolated nucleic acid molecule of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, wherein the sequence encoding an NBP 46 polypeptide is SEQ ID NO:8.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>11. A transgenic plant comprising an expression cassette comprising a nucleic acid encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:9 and that enhances rhizobial binding to roots of a transgenic plant comprising the nucleic acid, wherein the nucleic acid is operably linked to a heterologous promoter sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00152" LVL="0"><PTEXT><PDAT>12. A method enhancing rhizobial binding to roots of a plant, the method comprising introducing into the plant an expression cassette comprising a nucleic acid encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:9 and that enhances rhizobial binding to roots of a transgenic plant comprising the sequence, wherein the nucleic acid is operably linked to a heterologous promoter sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00153" LVL="0"><PTEXT><PDAT>13. The method of </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT>, wherein the NBP 46 polypeptide enhances phosphohydrolase activity.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00154" LVL="0"><PTEXT><PDAT>14. An isolated nucleic acid molecule comprising a sequence encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:15 and that enhances rhizobial binding to roots of a transgenic plant comprising the sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00155" LVL="0"><PTEXT><PDAT>15. The isolated nucleic acid molecule of </PDAT><CLREF ID="CLM-00014"><PDAT>claim 14</PDAT></CLREF><PDAT>, wherein the sequence encoding an NB46 polypeptide is SEQ ID NO:13.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00156" LVL="0"><PTEXT><PDAT>16. A transgenic plant comprising an expression cassette comprising a nucleic acid encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:15 and that enhances rhizobial binding to roots of a transgenic plant comprising the nucleic acid, wherein the nucleic acid is operably linked to a heterologous promoter sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00157" LVL="0"><PTEXT><PDAT>17. A method enhancing rhizobial binding to roots of a plant, the method comprising introducing into the plant an expression cassette comprising a nucleic acid encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:15 and that enhances rhizobial binding to roots of a transgenic plant comprising the nucleic acid, wherein the nucleic acid is operably linked to a heterologous promoter sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>18. The method of </PDAT><CLREF ID="CLM-00017"><PDAT>claim 17</PDAT></CLREF><PDAT>, wherein the NBP 46 polypeptide enhances phosphohydrolase activity.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>19. An isolated nucleic acid molecule comprising a sequence encoding an NBP 46 polypeptide that is at least about 80% identical to SEQ ID NO:2 and that enhances rhizobial binding to roots of a transgenic plant comprising the sequence.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00020">
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>20. The isolated nucleic acid molecule of </PDAT><CLREF ID="CLM-00019"><PDAT>claim 19</PDAT></CLREF><PDAT>, wherein the sequence encoding an NBP 46 polypeptide is SEQ ID NO:1.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00021">
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>21. A transgenic plant comprising an expression cassette comprising a nucleic acid encoding an NBP46 polypeptide that is at least 80% identical to SEQ ID NO:2 and that enhances rhizobial binding to roots of a transgenic plant comprising the nucleic acid.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06465716-20021015-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06465716-20021015-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06465716-20021015-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06465716-20021015-D00004.TIF"/>
</SDODR>
</PATDOC>

